Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3002032	vb-be	mmol/l (mmol/l)	30219	106256	0.00%
3002032	vb-be	— (—)	13176	46144	100.00%	Distribution not available
3002032	vb-emäsylimäärä	mmol/l (—)	1038	1758	100.00%	Distribution not available
3002032	vb-bepika	mmol/l (—)	484	574	100.00%	Distribution not available
3002032	vb-be-vt	mmol/l (—)	186	251	100.00%	Distribution not available
3002032	mb-be	mmol/l (—)	144	1235	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Coronary atherosclerosis

4690

16587

1.95

322.70

5.1

3.5

1.77

1.94

mmol/l

2.14

3864

13651

Codeine or tramadol medication

7474

25548

1.69

321.50

4.3

3.8

1.84

mmol/l

0.00

6108

20900

Other and unspecified iron deficiency

2482

11212

2.45

321.01

5.7

3.8

1.53

1.91

mmol/l

4.70

2026

9075

Schizophrenia or delusion, excluding more controls

1995

8053

2.66

319.67

3.5

3.8

2.27

1.82

mmol/l

4.72

1608

6615

Major coronary heart disease event excluding revascularizations

4729

18131

1.94

319.20

5.0

3.7

1.84

1.92

mmol/l

0.70

3875

14923

Genitourinary diseases

4340

11363

2.01

318.34

6.6

2.9

1.60

1.94

mmol/l

6.61

3543

9142

Major coronary heart disease event

5048

19061

1.89

317.17

4.9

3.7

1.81

1.92

mmol/l

1.10

4124

15695

7504

24496

1.69

316.96

4.9

3.6

2.02

1.74

mmol/l

7.91

6156

19863

Atherosclerosis, excluding cerebral and coronary sclerosis

3306

13277

2.19

313.92

6.6

3.4

1.48

1.97

mmol/l

9.17

2658

10814

Depression

6059

24873

1.75

311.20

4.3

3.9

1.90

1.82

mmol/l

0.74

4950

20461

Mood disorders

6622

26491

1.72

311.09

4.3

3.9

1.89

1.83

mmol/l

0.61

5391

21772

Mood [affective] disorders

6604

26455

1.72

310.39

4.3

3.9

1.89

1.83

mmol/l

0.59

5379

21741

Other chronic obstructive pulmonary disease

3329

14016

2.16

309.97

4.7

3.8

2.81

1.65

mmol/l

40.00

2747

11355

Personality disorders

1791

7045

2.78

309.72

4.0

4.1

1.87

1.82

mmol/l

0.21

1482

5686

Hypothyroidism, drug reimbursement

744

1076

5.31

309.22

4.4

2.2

1.81

1.95

mmol/l

0.44

616

873

Insulin, fast-acting (human)

1199

3834

3.57

308.29

8.5

3.5

1.32

1.95

mmol/l

5.97

1009

3125

Examination and observation for other reasons

4672

12862

2.37

307.65

5.0

3.4

1.79

1.77

mmol/l

0.15

3897

10649

Complications of procedures, not elsewhere classified

5659

25850

2.02

307.65

5.4

3.6

1.78

1.88

mmol/l

1.14

4641

21132

Injuries to the head

7589

29002

1.79

307.65

4.0

4.2

1.82

1.80

mmol/l

0.23

6225

23631

Codes for special purposes

4679

14282

3.86

307.65

5.5

4.1

1.93

1.75

mmol/l

2.55

4019

11464

Extracorporeal dialysis

1392

1882

18.53

307.65

22.5

3.8

0.38

1.94

mmol/l

40.17

1260

1486

Covid-19 confirmed case

2556

9045

3.27

307.65

6.7

4.0

1.83

1.77

mmol/l

0.28

2223

7232

Other medical care

3053

13128

2.50

307.65

4.8

3.0

2.29

1.89

mmol/l

5.96

2488

10546

Persons encountering health services for other counselling and medical advice, not elsewhere classified

7997

25976

1.85

307.65

5.5

3.7

1.78

1.82

mmol/l

0.42

6647

21099

Adjustment and management of implanted device

1627

6067

3.12

307.65

5.3

3.0

1.58

1.88

mmol/l

2.41

1434

4842

Presence of cardiac and vascular implants and grafts

3903

13579

2.43

307.65

4.9

3.2

1.75

1.93

mmol/l

2.04

3202

11033

Viral Sepsis

2192

5801

4.74

307.65

8.0

3.1

1.90

1.86

mmol/l

0.16

1822

4711

Medical observation and evaluation for suspected diseases and conditions

4996

13076

2.07

307.65

5.0

3.3

2.01

1.76

mmol/l

4.38

4020

10807

Other dialysis

656

904

17.54

307.65

20.6

4.9

0.14

1.89

mmol/l

21.71

596

716

Explicit Sepsis

4708

13840

3.90

307.65

8.5

3.2

1.56

1.85

mmol/l

4.97

3856

11189

Preparatory care for dialysis

1035

1247

24.91

307.65

21.0

3.7

0.09

2.03

mmol/l

36.53

945

990

Symptoms and signs involving the circulatory and respiratory systems

7103

18805

1.99

307.65

4.7

3.9

1.95

1.63

mmol/l

9.17

5845

15167

Persons encountering health services for specific procedures and health care

10059

23878

2.89

307.65

6.7

3.0

1.74

1.81

mmol/l

0.97

8396

19310

Persons encountering health services for specific procedures, not carried out

763

1745

5.44

307.65

5.6

3.2

1.49

1.97

mmol/l

2.46

642

1388

Chronic kidney disease

5052

9952

7.56

307.65

12.7

2.7

0.73

2.10

mmol/l

103.01

4235

8031

Transplanted organ and tissue status

1843

2927

11.13

307.65

18.0

3.7

0.53

1.91

mmol/l

39.87

1640

2352

Sub-endpoint used in defining T1D endpoints

2781

10644

2.91

307.65

7.3

4.2

1.27

1.85

mmol/l

10.13

2254

8604

Type 2 diabetes, definitions combined, including avohilmo

6878

19188

2.27

307.65

4.2

3.3

1.82

1.98

mmol/l

2.39

5548

15876

Poisoning by medicine

1915

5691

3.89

307.65

3.8

4.2

1.79

1.82

mmol/l

0.08

1543

4613

Provisional assignment of new diseases of uncertain etiology

4671

14264

3.86

307.65

5.5

4.1

1.92

1.75

mmol/l

2.49

4011

11449

Intracranial trauma

3965

14221

2.21

307.65

4.0

4.1

1.96

1.68

mmol/l

4.50

3232

11511

Poisoning by drugs, medicaments and biological substances

2077

6448

3.70

307.65

3.8

4.1

1.80

1.86

mmol/l

0.25

1676

5232

Type 1 diabetes, wide definition, subgroup 1

2184

5948

4.37

307.65

7.1

4.2

1.28

1.85

mmol/l

7.79

1767

4881

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

1413

4059

4.03

307.65

3.9

4.1

1.62

1.81

mmol/l

0.89

1136

3301

Implicit bacterial Sepsis

4850

12224

4.55

307.65

7.5

3.0

1.80

1.88

mmol/l

0.53

4011

9884

Asthma, unspecified (mode), excluding more controls

3687

11353

2.76

307.65

4.4

3.2

2.29

1.58

mmol/l

21.21

3055

9192

Type 1 diabetes, wide definition

2240

6591

3.98

307.65

7.1

4.3

1.27

1.86

mmol/l

8.34

1815

5413

Care involving dialysis

1917

2172

21.88

307.65

21.2

3.5

0.26

1.87

mmol/l

51.62

1729

1726

Diseases of liver

2545

11558

2.44

307.65

5.2

4.0

1.37

1.92

mmol/l

9.07

2031

9425

Complications of surgical and medical care, not elsewhere classified

7208

26994

2.05

307.65

5.7

3.6

1.77

1.87

mmol/l

1.34

5931

22030

Glomerular diseases

2501

6076

5.61

307.65

14.3

3.6

0.71

1.92

mmol/l

46.41

2175

4870

Asthma (only as main-diagnosis), excluding more controls

4605

12490

2.33

307.65

4.3

3.2

2.20

1.56

mmol/l

21.22

3840

10114

Alcohol use disorder, Swedish definition

4394

18833

2.37

307.65

4.3

4.1

1.68

1.79

mmol/l

0.85

3484

15436

Type 2 diabetes, definitions combined

6896

19338

2.28

307.65

4.2

3.3

1.82

1.99

mmol/l

2.64

5555

16000

Bronchitis

7122

28181

1.73

307.65

5.2

3.7

2.02

1.78

mmol/l

5.76

5903

22878

Intestinal infectious diseases

7238

28336

2.13

307.65

6.1

3.7

1.67

1.84

mmol/l

3.24

5930

23082

Mental and behavioural disorders due to alcohol

4030

17972

2.38

307.65

4.0

4.2

1.75

mmol/l

0.01

3208

14675

Other diseases of intestines

7519

24033

1.92

307.65

5.0

4.0

1.81

1.78

mmol/l

0.27

6216

19475

Cardiovascular diseases (excluding rheumatic etc)

4692

8806

3.33

307.65

6.6

3.3

1.63

1.75

mmol/l

1.21

3863

7029

Parasetamol

5511

14006

2.11

307.65

4.7

3.6

1.80

1.74

mmol/l

0.50

4440

11463

Glomerulonephritis

1118

3219

4.41

307.65

13.7

4.1

0.77

1.90

mmol/l

18.94

961

2580

Oral corticosteroids

7638

25412

1.92

307.65

4.6

3.7

2.12

1.76

mmol/l

12.54

6294

20749

All pneumoniae

9053

25145

2.74

307.65

5.6

3.8

2.13

1.66

mmol/l

22.45

7523

20473

Persons encountering health services in other circumstances, wide

8574

26263

1.78

307.65

5.4

3.7

1.83

1.82

mmol/l

0.06

7090

21310

ILD differential diagnosis

5200

14258

1.91

307.65

4.7

3.3

2.10

1.57

mmol/l

17.75

4245

11529

Atrial fibrillation and flutter

3047

4066

5.68

307.65

5.1

2.3

1.88

2.08

mmol/l

1.52

2608

3299

Syncope and collapse

3375

12483

2.62

307.65

4.4

3.3

2.01

1.81

mmol/l

2.31

2791

10004

Paralytic ileus and intestinal obstruction

2089

8514

2.76

307.65

5.2

3.7

2.20

1.91

mmol/l

2.12

1749

6874

Bacterial pneumoniae

3578

12507

2.84

307.65

5.6

3.6

2.27

1.68

mmol/l

14.14

2981

10138

Other antidepressants

7057

21967

1.75

307.65

4.0

1.93

1.78

mmol/l

2.45

5731

17951

Polyarthropathies

5030

17635

2.02

307.65

5.7

3.8

1.64

1.85

mmol/l

3.18

4137

14339

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

2549

5745

2.99

307.65

5.6

2.5

1.91

2.00

mmol/l

0.55

2136

4648

Influenza and pneumonia

9414

24806

2.75

307.65

5.6

3.7

2.12

1.66

mmol/l

23.01

7813

20181

Valvular heart disease excluding rheumatic fever

3604

11070

2.62

307.65

5.2

3.7

1.74

mmol/l

0.01

2977

8932

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

2027

7672

2.90

307.65

3.7

4.0

1.72

1.84

mmol/l

0.61

1632

6203

Neurological diseases, wide definition

2082

3798

2.92

307.65

5.2

3.8

1.84

1.68

mmol/l

1.08

1720

3071

Non-ischemic cardiomyopathy

2777

7811

3.42

307.65

5.6

3.3

2.53

1.80

mmol/l

13.95

2330

6336

Any mental disorder

7843

22566

1.83

307.65

4.4

4.1

1.95

1.78

mmol/l

2.94

6378

18475

Other disorders of kidney and ureter

1301

4113

3.92

307.65

12.8

3.8

0.87

1.93

mmol/l

21.36

1134

3331

Other anaemias

3846

15259

2.78

307.65

6.8

3.5

1.37

1.96

mmol/l

14.41

3134

12357

Bleeding

6661

23737

2.22

307.65

5.8

3.8

1.80

1.88

mmol/l

0.89

5523

19386

Bacterial pneumonia (organism specified)

3776

15342

2.48

307.65

5.8

3.8

2.25

1.74

mmol/l

11.21

3138

12364

Nephropathy related operations

2723

3919

14.57

307.65

18.9

3.3

0.48

1.98

mmol/l

66.43

2411

3134

Non-invasive ventilation

1283

3587

3.66

307.65

6.1

3.7

3.30

1.88

mmol/l

22.18

954

2948

Type 1 diabetes

2648

7695

4.05

307.65

7.5

4.2

1.24

1.87

mmol/l

11.14

2156

6309

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

8792

25214

2.70

307.65

5.6

3.8

2.16

1.66

mmol/l

24.12

7309

20537

Other disorders of fluid, electrolyte and acid-base balance

3501

9077

4.63

307.65

7.0

3.3

2.02

2.00

mmol/l

0.10

2897

7305

4611

19671

2.35

307.65

4.2

4.1

1.66

1.78

mmol/l

0.95

3658

16096

First line medication for Crohn's disease

8455

23804

2.06

307.65

6.5

3.3

1.85

1.76

mmol/l

1.15

6993

19342

Ischemic heart diseases

5523

18419

2.01

307.65

5.0

3.6

1.91

1.95

mmol/l

0.27

4558

15169

Benign neoplasm: Colon

3430

13065

2.18

307.65

4.8

3.7

1.75

1.95

mmol/l

2.51

2836

10693

Obesity

4155

20075

2.20

307.65

4.8

4.0

2.04

1.77

mmol/l

4.27

3459

16424

Hypertensive heart and/or renal disease

2539

5493

4.24

307.65

6.8

2.6

1.63

2.05

mmol/l

4.84

2107

4434

Symptoms and signs involving cognition, perception, emotional state and behaviour

6860

26180

1.95

307.65

4.2

4.0

1.88

1.83

mmol/l

0.52

5624

21365

Disorders resulting from impaired renal tubular function

715

1056

14.56

307.65

17.6

4.3

0.34

1.81

mmol/l

17.78

648

842

Glomerular disorders in diseases classified elsewhere

1786

3590

7.47

307.65

14.9

3.4

0.59

2.02

mmol/l

43.67

1562

2853

Hypertension, essential

6083

12361

3.07

307.65

5.5

2.7

1.74

2.03

mmol/l

5.96

5020

10120

Complications of medical and surgical care

5151

25908

2.02

307.65

5.9

3.7

1.80

1.88

mmol/l

0.90

4244

21156

Acute renal failure

3180

6327

7.37

307.65

9.3

2.6

0.84

2.14

mmol/l

39.27

2541

5112

Hypo-osmolality and hyponatraemia

1675

5094

3.96

307.65

5.9

3.2

1.88

2.04

mmol/l

0.81

1373

4098

Gout, idiopatic and unspecified

2161

9085

2.76

307.65

7.2

3.7

1.38

1.85

mmol/l

5.89

1807

7316

Heart failure and coronary heart disease

3001

9809

2.61

307.65

5.9

3.5

2.00

1.92

mmol/l

0.44

2463

7970

Cerebrovascular diseases

5260

21169

1.90

307.65

4.8

3.8

1.81

1.92

mmol/l

1.31

4352

17327

Other nutritional deficiencies

4443

20837

2.24

307.65

4.8

4.0

2.01

1.78

mmol/l

3.21

3700

17051

Hypertensive diseases

6217

13093

2.93

307.65

6.5

2.9

1.65

1.99

mmol/l

8.62

5129

10693

Secondary hypertension

1093

1419

10.62

307.65

13.9

3.2

0.49

1.83

mmol/l

20.71

972

1137

Alcohol use disorder, ICD-based

3280

14662

2.46

307.65

4.1

1.76

mmol/l

0.02

2603

12001

Gout

2616

9616

2.86

307.65

7.1

3.6

1.40

1.85

mmol/l

6.16

2161

7729

Used for control exclusion in common control thyroid runs

7279

22348

1.72

307.65

5.3

3.7

1.65

1.81

mmol/l

2.88

5934

18176

Bacterial infection, other or unspecified

5946

15780

4.09

307.65

7.4

3.1

1.72

1.92

mmol/l

3.12

4949

12799

Substance abuse

4633

20000

2.42

307.65

4.2

4.1

1.81

1.76

mmol/l

0.37

3704

16373

COPD (mode)

2611

8040

2.90

307.65

4.6

3.1

2.85

1.58

mmol/l

36.11

2162

6470

Tramadol

6091

17667

2.39

307.65

5.1

3.4

1.69

1.87

mmol/l

2.49

5050

14456

Hypertensive Heart Disease

2105

5177

3.87

307.65

5.9

2.6

1.80

2.04

mmol/l

1.61

1752

4176

L04AD Calcineurin inhibitors

1751

3248

8.46

307.65

17.1

4.1

0.60

1.86

mmol/l

32.62

1539

2623

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

7537

24518

2.25

307.65

7.4

3.3

1.51

1.89

mmol/l

14.86

6285

19918

Type 2 diabetes

7848

19913

2.54

307.65

5.0

3.3

1.74

1.98

mmol/l

5.12

6331

16463

Asthma-related pneumonia

3055

13253

2.58

307.65

5.1

4.2

2.49

1.75

mmol/l

18.40

2564

10697

Metabolic disorders

8746

20691

2.92

307.65

5.7

3.5

1.74

1.91

mmol/l

3.23

7244

16834

Disorders of gallbladder, biliary tract and pancreas

6563

25226

1.76

307.65

5.0

3.8

1.76

1.88

mmol/l

1.61

5439

20572

8185

19322

2.94

307.65

5.5

3.4

2.17

1.66

mmol/l

22.23

6816

15647

Diseases of oesophagus, stomach and duodenum

7407

25755

1.84

307.65

4.7

3.9

1.80

1.86

mmol/l

0.73

6130

21015

Other disorders of skin and subcutaneous tissue

4729

23912

1.93

307.65

6.1

3.7

1.73

1.91

mmol/l

2.46

3911

19540

COPD differential diagnosis

5205

14261

1.91

307.65

4.7

3.3

2.10

1.57

mmol/l

17.82

4250

11532

Hypothyroidism and >3 levothyroxin purchases

1413

1820

4.75

307.65

4.6

2.4

1.67

1.89

mmol/l

1.22

1126

1476

Asthma (only as main-diagnosis)

4753

14118

2.15

307.65

4.3

3.3

2.22

1.57

mmol/l

23.27

3959

11420

Pneumonia, organism unspecified

8140

23400

2.79

307.65

5.6

3.7

2.18

1.68

mmol/l

22.73

6775

19073

Diseases of pulp and periapical tissues

2676

11764

2.50

307.65

7.4

3.3

1.57

1.89

mmol/l

3.91

2257

9569

Depression medications

1800

1912

5.05

307.65

4.2

2.2

1.85

1.98

mmol/l

0.66

1431

1560

COPD

3468

14422

2.17

307.65

4.7

3.8

2.76

1.65

mmol/l

38.38

2862

11694

Malaise and fatigue

5080

12737

3.86

307.65

5.3

3.3

1.98

1.78

mmol/l

2.85

4320

10204

GI-bleeding

2695

12255

2.46

307.65

6.0

3.9

1.63

1.86

mmol/l

2.14

2198

9899

Diseases of arteries, arterioles and capillaries

5359

19681

2.22

307.65

6.2

3.5

1.56

1.96

mmol/l

10.06

4385

16106

Infections of the skin and subcutaneous tissue

4000

20994

2.03

307.65

6.6

4.1

1.72

1.77

mmol/l

0.31

3352

17082

Paroxysmal tachycardia

1556

3784

3.85

307.65

4.9

3.0

1.93

1.88

mmol/l

0.17

1313

3057

Heart failure, strict

6015

15524

3.28

307.65

6.0

3.4

2.20

1.74

mmol/l

12.24

5029

12609

All influenza

2068

7872

2.96

307.65

6.5

3.8

2.07

1.64

mmol/l

5.13

1716

6388

Certain infectious and parasitic diseases

7693

17313

2.38

307.65

5.4

3.0

1.80

1.83

mmol/l

0.22

6294

14029

Antihypertensive medication - note that there are other indications

4015

8137

2.87

307.65

6.3

3.1

1.55

1.89

mmol/l

6.24

3281

6588

Pure hypercholesterolaemia

5566

17032

2.39

307.65

4.5

3.3

1.70

1.97

mmol/l

5.54

4584

13892

Type 2 diabetes, wide definition

7606

17685

3.17

307.65

5.2

3.3

1.72

2.01

mmol/l

7.23

6174

14662

Other disorders of urethra and urinary system

4733

18646

2.02

307.65

5.0

3.7

1.84

1.86

mmol/l

0.17

3938

15032

Personality disorders, excluding more controls

1791

5615

3.52

307.65

4.0

3.8

1.87

1.76

mmol/l

0.51

1482

4606

Condition for Implicit Sepsis (Organ dysfunction codes)

8224

21270

3.17

307.65

6.2

3.1

1.80

1.88

mmol/l

0.89

6760

17392

Dental caries

2838

8575

3.93

307.65

11.8

3.4

1.30

1.83

mmol/l

10.11

2417

6884

Suicide or other Intentional self-harm

1860

6832

3.04

307.65

3.8

4.0

1.77

1.88

mmol/l

0.53

1509

5543

Kidney transplant status

1211

1570

19.04

307.65

20.4

4.5

0.01

1.84

mmol/l

40.69

1097

1237

Infections, IBD-co-morbidities

1589

2338

5.77

307.65

8.5

3.1

1.51

1.82

mmol/l

1.99

1310

1914

Bacterial pneumonia, not elsewhere classified

3403

11867

2.85

307.65

5.6

3.5

2.29

1.68

mmol/l

13.73

2835

9596

Peripheral artery disease

3608

14112

2.28

307.65

6.9

3.4

1.50

1.96

mmol/l

8.70

2897

11501

ILD medications

8652

24805

2.03

307.65

6.7

3.3

1.80

1.79

mmol/l

0.04

7186

20112

ILD medications: prednisolone, methylprednisolone, prednisone

8440

24252

2.10

307.65

6.5

3.2

1.80

mmol/l

0.01

7023

19703

Inflammatory bowel disease treatment related agents

8201

26392

1.86

307.65

5.4

3.8

2.00

1.73

mmol/l

7.68

6770

21511

Asthma

5440

14118

2.19

307.65

4.2

3.3

2.20

1.57

mmol/l

24.43

4529

11420

Chronic periodontitis

1381

4619

3.54

307.65

11.1

3.5

1.18

2.02

mmol/l

12.03

1203

3747

Insulin, fast-acting

3830

12542

3.61

307.65

7.1

4.0

1.49

1.84

mmol/l

5.74

3119

10259

Acute tubulo-interstitial nephritis

5364

17536

3.04

307.65

6.3

2.7

1.62

2.09

mmol/l

14.67

4456

14235

Ischaemic heart disease, wide definition

5475

18122

2.03

307.65

5.0

3.5

1.90

1.96

mmol/l

0.54

4525

14926

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

8576

26086

2.59

307.65

6.7

3.4

1.54

1.92

mmol/l

14.39

7057

21297

Insulin medication

6317

18130

3.45

307.65

6.1

3.8

1.55

1.92

mmol/l

9.49

5086

14921

Anxiety disorders, excluding more controls

5197

18952

1.91

307.65

4.7

3.9

1.97

1.81

mmol/l

2.18

4256

15627

Implicit Sepsis

7829

19716

3.59

307.65

6.4

3.1

1.82

1.87

mmol/l

0.43

6465

16062

Iron deficiency anaemia

3172

14843

2.33

307.65

5.8

3.8

1.59

1.93

mmol/l

5.09

2585

12041

Insulin, intermediate and long-acting

5834

20348

3.29

307.65

6.0

3.7

1.57

1.89

mmol/l

7.10

4698

16639

Obesity due to excess calories

3071

14423

2.30

307.65

5.0

4.1

1.96

1.80

mmol/l

1.49

2556

11755

Asthma, excluding more controls

5218

12490

2.37

307.65

4.2

3.2

2.20

1.56

mmol/l

23.74

4344

10114

Insulin, fast-acting or short human

3845

13442

3.35

307.65

7.1

4.1

1.48

1.83

mmol/l

5.63

3131

10949

Heart failure, not strict

8410

16946

4.08

307.65

7.3

2.9

1.83

1.82

mmol/l

0.03

7060

13798

ILD medications: immunosuppressive drugs

4584

20457

2.32

307.65

9.4

3.3

1.43

1.82

mmol/l

10.34

3857

16680

Non-rheumatic valve diseases

3547

10887

2.61

307.65

5.2

3.6

1.74

1.75

mmol/l

0.05

2930

8794

Hypothyroidism, levothyroxine purchases

1413

1820

4.75

307.65

4.6

2.4

1.67

1.89

mmol/l

1.22

1126

1476

Diabetes, insulin treatment (Kela reimbursement)

8718

22831

2.56

307.65

5.0

3.7

1.66

1.94

mmol/l

7.87

6993

18873

Substance use, excluding alcohol

1528

5087

3.40

307.65

4.4

4.0

2.04

1.80

mmol/l

1.42

1244

4174

Diseases of arteries, arterioles and capillaries (FINNGEN)

2281

3183

5.88

307.65

7.3

2.5

1.48

2.01

mmol/l

6.09

1918

2585

Cardiovascular diseases

4069

8031

2.94

307.65

6.7

3.4

1.67

1.65

mmol/l

0.12

3344

6378

Hyperlipidaemia, other/unspecified

3102

12352

2.66

307.65

5.2

3.2

1.70

1.97

mmol/l

3.81

2570

10007

Renal tubulo-interstitial diseases

10285

21797

4.31

307.65

7.9

2.6

1.25

2.07

mmol/l

68.16

8524

17743

Other soft tissue disorders, not elsewhere classified

6419

22632

1.85

307.65

5.1

4.0

1.85

1.78

mmol/l

0.84

5394

18360

Insulin, combination of fast acting with intermediate-acting or long-acting

6331

21921

3.06

307.65

6.1

3.7

1.55

1.89

mmol/l

8.26

5098

17881

Other septicaemia

4174

12145

4.10

307.65

8.9

3.3

1.54

1.91

mmol/l

7.02

3412

9808

Other heart diseases, wide

7296

18787

2.61

307.65

5.6

3.8

1.89

1.74

mmol/l

2.43

6088

15228

Autoimmune diseases excluding thyroid diseases, strict definition

7432

23064

1.89

307.65

5.7

3.7

1.64

1.82

mmol/l

3.44

6102

18781

Hypothyroidism (congenital or acquired)

1443

1837

4.81

307.65

4.8

2.4

1.65

1.88

mmol/l

1.28

1149

1491

COPD/asthma/ILD related infections

7458

19340

2.04

307.65

4.9

3.4

2.11

1.66

mmol/l

16.93

6127

15662

Asthma, unspecified (mode)

3784

12849

2.52

307.65

4.3

3.3

2.31

1.59

mmol/l

22.49

3137

10385

Unspecified kidney failure

1476

2876

7.65

307.65

11.0

2.5

0.90

2.14

mmol/l

19.66

1202

2287

Codeine

6321

18648

1.96

307.65

4.2

3.4

1.81

1.83

mmol/l

0.13

5173

15210

Anaemias

2331

1956

9.26

307.65

9.2

2.7

1.30

1.75

mmol/l

4.67

1934

1553

Angina pectoris

4385

15365

2.08

307.65

4.5

3.5

1.95

1.94

mmol/l

0.03

3593

12640

Dialysis, with operation codes

2836

3685

16.01

307.65

18.6

2.9

0.48

2.11

mmol/l

76.59

2506

2965

General symptoms and signs

9075

18861

2.60

307.65

5.0

3.3

1.91

1.75

mmol/l

3.05

7444

15151

Alcohol abuse, main dg, excluding more controls

1266

3857

3.80

307.65

3.8

3.9

1.71

1.75

mmol/l

0.10

1011

3143

Any gastric operation

5941

13757

2.29

307.65

5.6

2.7

1.80

1.86

mmol/l

0.54

4845

11033

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

2027

6183

3.64

307.65

3.7

1.72

1.76

mmol/l

0.15

1632

5046

Dialysis

857

1093

17.19

307.65

21.8

4.1

0.25

1.96

mmol/l

27.61

784

863

Other heart diseases

4322

7232

4.45

307.65

6.4

3.3

1.85

1.87

mmol/l

0.09

3650

5825

Covid-19 suspected case

2328

5454

5.25

307.65

4.5

4.1

2.05

1.75

mmol/l

4.05

1984

4361

Diabetic nephropathy, excluding more controls

1750

4601

4.14

307.65

12.4

3.3

0.94

1.72

mmol/l

13.12

1482

3718

Hard cardiovascular diseases

5784

18901

2.12

307.65

5.0

3.7

1.90

1.94

mmol/l

0.36

4760

15566

GASTRO-related operations

5941

13757

2.29

307.65

5.6

2.7

1.80

1.86

mmol/l

0.54

4845

11033

Aplastic and other anaemias

4234

16199

2.84

307.65

7.4

3.6

1.35

1.96

mmol/l

17.35

3459

13139

Renal failure

7245

14030

6.74

307.65

10.2

2.7

0.82

2.12

mmol/l

109.87

5939

11398

COPD/asthma related infections

7458

19340

2.04

307.65

4.9

3.4

2.11

1.66

mmol/l

16.93

6127

15662

Heart failure and bmi 25plus

3260

8243

3.18

307.65

6.0

3.4

2.32

1.67

mmol/l

13.51

2729

6648

Substance abuse, excluding more controls

4633

16385

2.73

307.65

4.2

4.0

1.81

1.71

mmol/l

0.81

3704

13404

Diverticular disease of intestine

5148

17742

2.06

307.65

4.5

3.5

1.79

1.91

mmol/l

1.41

4292

14440

Diabetes, varying definitions

8522

21556

2.57

307.65

5.1

3.6

1.69

1.94

mmol/l

6.07

6885

17794

Mental and behavioural disorders due to psychoactive substance use

4752

20329

2.41

307.65

4.2

4.1

1.81

1.75

mmol/l

0.38

3799

16641

Diabetes medication

8505

22550

2.49

307.65

4.9

3.7

1.70

1.93

mmol/l

5.30

6832

18635

Cerebrovascular diseases (FINNGEN)

2461

4350

4.54

307.65

5.2

2.4

1.79

2.04

mmol/l

2.15

2032

3527

Cardiac arrhythmias

4568

9636

3.42

307.65

4.9

3.6

1.87

1.92

mmol/l

0.36

3848

7895

All-cause Heart Failure

5876

15304

3.25

307.65

5.9

3.4

2.21

1.74

mmol/l

12.27

4906

12422

Other CVD (FINNGEN)

1034

1506

6.53

307.65

5.9

2.2

1.99

1.85

mmol/l

0.45

872

1202

Dentinal caries

2462

7507

3.91

307.65

10.8

3.4

1.31

1.85

mmol/l

8.84

2094

6045

Endocrine, nutritional and metabolic diseases

6122

12495

2.66

307.65

5.4

3.3

1.63

1.87

mmol/l

4.30

4931

10200

Heart failure,strict

5627

12379

3.93

307.65

6.1

2.8

2.22

1.79

mmol/l

10.30

4716

10039

Psychiatric diseases

7720

21775

1.87

307.65

4.5

4.1

1.95

1.77

mmol/l

3.45

6277

17836

Gout, FINNGEN

2616

11086

2.71

307.65

7.1

3.5

1.40

1.85

mmol/l

6.38

2161

8932

Nutritional anaemias

3690

17608

2.23

307.65

5.7

3.7

1.58

1.92

mmol/l

5.56

2997

14254

Diabetes mellitus

8574

21558

2.58

307.65

5.1

3.6

1.69

1.94

mmol/l

6.06

6921

17802

Other bacterial diseases

9954

22875

3.45

307.65

6.6

3.2

1.79

1.87

mmol/l

1.19

8253

18679

Heart failure and antihypertensive medication

2999

3352

7.39

307.65

7.2

2.7

2.13

2.22

mmol/l

0.45

2521

2775

Other (not insulin) diabetes medications

7175

20522

2.26

307.65

4.3

3.4

1.80

1.97

mmol/l

2.74

5761

16984

Obesity and other hyperalimentation

4175

20172

2.20

307.65

4.8

4.0

2.04

1.77

mmol/l

4.24

3474

16495

Glucagon-like peptide-1 (GLP-1) analogues

5068

16227

2.94

307.65

5.1

3.6

1.65

1.96

mmol/l

6.35

4041

13429

Opioids

6770

19006

1.97

307.65

4.8

3.4

1.83

1.82

mmol/l

0.11

5509

15481

Asthma-related infections

4418

21636

2.17

307.65

4.7

4.2

2.35

1.74

mmol/l

20.30

3679

17524

Hyperkalaemia

698

1474

6.64

307.65

10.9

3.0

1.18

2.13

mmol/l

5.23

556

1159

Volume depletion

984

2688

4.58

307.65

6.7

3.6

1.79

1.98

mmol/l

0.59

801

2109

Atrial fibrillation and flutter with reimbursement

2571

3218

6.04

307.65

4.3

2.4

1.91

2.04

mmol/l

0.75

2203

2627

Erysipelas

4705

16942

2.83

307.65

5.5

3.1

1.96

1.92

mmol/l

0.23

3912

13790

Hypokalaemia

1209

3042

4.98

307.65

6.4

3.3

2.99

2.09

mmol/l

7.47

1030

2468

Disorders of lipoprotein metabolism and other lipidaemias

6729

18147

2.55

307.65

4.8

3.3

1.66

1.97

mmol/l

8.20

5585

14811

Statin medication

4498

12366

2.15

307.65

5.7

3.1

1.63

2.06

mmol/l

10.34

3653

10193

Autoimmune diseases

7619

23867

1.70

307.65

5.4

3.7

1.64

1.83

mmol/l

3.70

6223

19445

Diarrhoea and gastroenteritis of presumed infectious origin

5689

23743

2.36

307.65

6.4

3.7

1.63

1.82

mmol/l

3.00

4686

19290

Speech therapy

2730

9060

3.60

307.65

4.6

4.1

2.19

1.94

mmol/l

3.25

2274

7363

Symptoms and signs involving the digestive system and abdomen

7477

20462

1.93

307.65

5.0

3.8

1.87

1.77

mmol/l

1.41

6124

16599

Symptoms and signs involving the urinary system

5475

23625

1.91

307.65

5.5

3.8

1.76

1.90

mmol/l

1.79

4500

19297

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

2379

4159

3.03

307.65

4.5

2.9

1.92

1.52

mmol/l

4.40

1932

3320

Pain in throat and chest

6513

17820

2.40

307.65

4.2

3.8

1.90

1.66

mmol/l

5.30

5439

14415

Pain, not elsewhere classified

1939

6972

3.08

307.65

5.4

3.3

2.02

1.81

mmol/l

1.48

1575

5609

Abnormalities of heart beat

2428

10333

2.53

307.65

3.8

3.6

2.07

1.70

mmol/l

6.11

2006

8318

Fever of other and unknown origin

5141

15654

3.45

307.65

6.8

3.3

1.78

1.76

mmol/l

0.11

4299

12545

Abnormalities of breathing

7062

18732

2.41

307.65

4.8

3.9

2.09

1.63

mmol/l

17.88

5818

15108

Bacterial Sepsis

5376

13638

4.31

307.65

7.3

3.1

1.78

1.89

mmol/l

1.00

4456

11072

Other acute lower respiratory infections

3940

19890

2.03

307.65

5.6

4.2

2.15

1.76

mmol/l

8.32

3301

16008

Benign neoplasm of colon, rectum, anus and anal canal

3813

13819

2.12

307.65

4.8

3.6

1.81

1.95

mmol/l

1.45

3156

11330

Oedema, not elsewhere classified

2445

8892

3.07

307.65

5.9

3.2

2.14

1.81

mmol/l

3.91

2090

7125

Dyspnoea

7378

25528

2.42

307.65

4.8

3.8

2.25

1.73

mmol/l

24.11

6119

20757

Nausea and vomiting

2587

8487

3.47

307.65

7.6

4.0

1.75

1.80

mmol/l

0.21

2156

6802

Convulsions, not elsewhere classified

2054

6421

3.59

307.65

5.2

3.6

1.58

1.68

mmol/l

0.53

1690

5072

Mental and behavioural disorders due to alcohol, excluding acute intoxication

3571

15984

2.46

307.65

4.1

1.77

1.76

mmol/l

0.05

2838

13075

Other and unspecified anaemias

3813

15152

2.78

307.65

6.8

3.5

1.37

1.96

mmol/l

14.25

3106

12264

4768

20112

2.31

307.65

4.2

4.1

1.67

1.77

mmol/l

0.85

3783

16466

Dizziness and giddiness

4984

22773

1.88

307.65

4.1

3.9

1.93

1.87

mmol/l

0.68

4116

18575

Headache

4200

16090

2.32

307.65

4.6

3.3

1.80

1.75

mmol/l

0.44

3487

12964

Diseases of the digestive system

3560

17784

2.18

307.65

6.1

4.0

1.62

1.87

mmol/l

3.31

2922

14434

Mood disorders, excluding more controls

6282

21158

1.90

307.65

4.2

3.8

1.92

1.81

mmol/l

1.23

5124

17411

Early onset COPD, excluding more controls

1587

5766

3.09

307.65

5.0

3.3

2.84

1.53

mmol/l

22.58

1326

4645

Abdominal and pelvic pain

7293

20438

1.88

307.65

4.8

3.8

1.88

1.77

mmol/l

1.41

5991

16579

Hypertension

6204

13075

2.93

307.65

6.5

2.9

1.65

1.99

mmol/l

8.64

5119

10679

Septicaemia

4603

13395

3.99

307.65

8.6

3.3

1.55

1.91

mmol/l

6.88

3774

10850

Other arrhythmias

4107

14817

2.26

307.65

4.0

3.4

1.91

1.80

mmol/l

1.26

3414

11990

Ulcer of lower limb, not elsewhere classified

1541

4656

4.21

307.65

8.4

3.5

1.40

2.02

mmol/l

6.06

1317

3744

Implicit viral Sepsis

2188

5791

4.74

307.65

8.0

3.1

1.91

1.87

mmol/l

0.16

1819

4701

Fall on same level

7701

26590

1.69

307.65

4.6

4.1

1.82

1.78

mmol/l

0.45

6432

21526

Continuous positive airway pressure

1444

3617

3.87

307.65

7.2

4.5

2.11

1.75

mmol/l

2.37

1241

2924

Asthma, hospital admission 2, infections

4418

21636

2.17

307.65

4.7

4.2

2.35

1.74

mmol/l

20.30

3679

17524

Care involving use of rehabilitation procedures

5461

20778

2.77

307.65

5.5

3.1

1.99

1.86

mmol/l

1.91

4480

16843

Pain in limb

5631

21813

1.99

307.65

5.3

3.9

1.82

1.80

mmol/l

0.14

4751

17709

Other pulmonary diagnosis

5282

14245

1.94

307.65

4.8

3.3

2.09

1.57

mmol/l

17.10

4309

11525

STROKE

4153

11942

2.63

307.65

4.9

3.2

1.86

2.02

mmol/l

1.83

3437

9873

Anxiety (asthma-related co-morbidities)

3570

13917

2.14

307.65

4.6

4.1

1.83

1.79

mmol/l

0.22

2919

11452

Other diseases of the digestive system

2675

12144

2.47

307.65

6.0

3.9

1.62

1.86

mmol/l

2.36

2194

9826

Pneumonias (Asthma/COPD co-morbidities)

9023

25057

2.76

307.65

5.6

3.7

2.14

1.67

mmol/l

22.56

7502

20386

Excluding asthma or asthma-COPD overlap

5243

14245

1.93

307.65

4.7

3.3

2.09

1.57

mmol/l

17.52

4277

11525

Oxycodone

2926

11829

2.67

307.65

5.4

3.5

2.29

1.87

mmol/l

6.74

2431

9621

Asthma, hospital admissions 3, pneumonia

3062

13290

2.57

307.65

5.1

4.2

2.50

1.75

mmol/l

18.55

2571

10726

Asthma (mode)

5107

14258

2.07

307.65

4.1

3.3

2.10

1.57

mmol/l

17.21

4241

11529

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

8185

19322

2.94

307.65

5.5

3.4

2.17

1.66

mmol/l

22.23

6816

15647

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

8350

20805

2.69

307.65

5.0

3.6

1.65

1.96

mmol/l

8.44

6709

17204

Hypertensive diseases (excluding secondary)

4260

6537

4.20

307.65

7.2

2.9

1.58

1.93

mmol/l

5.79

3524

5278

Biguanides

6977

21553

2.13

307.65

4.0

3.7

1.81

1.94

mmol/l

1.81

5594

17864

Any reimbursement code in KELA

3834

6213

3.30

307.65

5.5

2.1

1.71

1.82

mmol/l

0.92

3102

5034

L04AA Selective immunosuppressants

2045

6535

3.71

307.65

12.9

3.7

0.91

1.95

mmol/l

29.87

1754

5325

Type 2 diabetes, strict (exclude DM1)

6906

19485

2.27

307.65

4.2

3.3

1.82

1.99

mmol/l

2.68

5561

16129

Asthma-related pneumonia or sepsis

3062

13290

2.57

307.65

5.1

4.2

2.50

1.75

mmol/l

18.55

2571

10726

Autoimmune diseases excluding thyroid diseases

7688

23722

1.90

307.65

5.7

3.7

1.65

1.83

mmol/l

3.36

6304

19329

3115

15441

2.15

305.25

4.9

4.5

2.27

1.72

mmol/l

12.69

2588

12512

Asthma (diagnoses ohter than nonallergic)

5743

29380

1.76

304.50

4.2

4.1

2.25

1.73

mmol/l

19.12

4773

23855

Myocardial infarction

3698

13885

2.07

303.23

5.3

3.5

1.73

1.91

mmol/l

2.02

3022

11390

Viral pneumonia

1116

3497

3.76

300.72

6.2

4.0

2.03

1.71

mmol/l

1.70

929

2811

Constipation

5936

25578

1.75

300.42

4.5

4.2

1.98

1.81

mmol/l

2.91

4922

20822

Disorders of adult personality and behaviour

1848

7494

2.68

299.41

3.9

4.1

1.88

1.79

mmol/l

0.41

1523

6050

Cardiomyopathy

1402

5002

3.19

299.08

6.1

3.5

1.76

1.69

mmol/l

0.23

1170

4004

Diabetic nephropathy

1763

7213

3.03

298.24

12.4

3.8

0.95

1.76

mmol/l

15.74

1489

5748

Viral hepatitis, IBD co-morbidity

464

715

7.65

296.45

4.1

2.5

1.58

1.83

mmol/l

0.62

367

594

Chronic lower respiratory diseases

7936

27402

1.63

295.62

4.3

4.2

2.26

1.64

mmol/l

34.90

6541

22292

Other anxiety disorders

2701

11330

2.24

295.60

4.3

3.9

1.70

1.78

mmol/l

0.43

2202

9266

Other functional intestinal disorders

3173

15351

2.12

295.03

5.1

4.0

2.02

1.84

mmol/l

2.05

2633

12356

Gout, strict definition

1621

6384

3.01

293.99

7.7

3.7

1.38

1.89

mmol/l

5.02

1366

5085

Gastrointestinal diseases

3814

9775

2.04

293.76

5.5

2.8

1.72

1.79

mmol/l

0.44

3126

7831

Gout, unspecified

1774

7278

2.84

293.71

7.3

3.6

1.33

1.88

mmol/l

6.69

1491

5828

Concussion

3197

13957

2.10

293.22

4.0

4.1

1.98

1.68

mmol/l

4.65

2588

11298

Haemorrhage from respiratory passages

2485

10755

2.33

290.02

5.4

3.7

1.96

1.67

mmol/l

3.11

2025

8655

Intestinal stricture

2377

11036

2.40

289.46

5.4

3.9

2.09

1.89

mmol/l

1.31

1961

8949

Alcohol dependence

2083

9136

2.53

288.71

4.3

4.1

1.84

1.76

mmol/l

0.32

1661

7449

Hypertensive Renal Disease

473

802

8.36

287.12

11.6

2.5

0.65

1.99

mmol/l

9.53

398

628

Benzodiazepine use

6428

28407

1.68

284.38

3.9

4.0

1.97

1.80

mmol/l

2.71

5232

23257

All anxiety disorders

3617

15428

1.99

283.04

4.6

4.0

1.82

1.80

mmol/l

0.06

2955

12624

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

4025

22397

1.91

281.20

6.1

3.7

1.76

1.90

mmol/l

1.46

3317

18334

Hernia of abdominal wall, postoperative

1307

4645

3.15

278.08

6.4

2.7

1.52

1.92

mmol/l

3.13

1118

3766

Obesity, other/unspecified

2121

9458

2.43

278.02

4.7

4.0

2.08

1.86

mmol/l

1.56

1790

7689

Cardiodefibrillation

2850

14423

2.19

276.93

4.3

3.9

1.72

1.86

mmol/l

1.28

2501

11680

Other retinal disorders

4395

20164

1.87

276.76

6.2

3.6

1.63

1.95

mmol/l

6.25

3584

16486

Other diseases of urinary system

6648

23318

1.67

275.93

4.9

3.9

1.74

1.80

mmol/l

0.70

5494

18863

Other or unspecified ileus, impaction or obstruction

1513

5895

2.92

273.13

5.2

3.7

2.31

1.93

mmol/l

2.50

1257

4766

Specific personality disorders

1532

5938

2.82

273.09

3.9

4.1

1.92

1.83

mmol/l

0.36

1259

4781

Other reaction to severe stress, and adjustment disorders

2163

9761

2.37

272.90

5.6

3.9

1.79

1.83

mmol/l

0.19

1781

7985

Exposure to unspecified factor

6254

30368

1.67

272.70

4.7

4.1

1.78

1.81

mmol/l

0.24

5250

24661

COPD related to multimorbidity

2996

12942

2.14

271.02

4.8

3.8

2.78

1.71

mmol/l

30.62

2473

10451

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

855

1647

4.34

270.42

5.1

2.9

2.20

1.89

mmol/l

1.16

710

1337

Other chronic obstructive pulmonary disease, including avohilmo

3834

17683

1.94

270.34

4.5

3.8

2.72

1.73

mmol/l

34.42

3145

14397

Problems related to lifestyle

863

2464

4.07

266.43

4.5

3.5

1.82

1.84

mmol/l

0.06

704

1960

Neurotic, stress-related and somatoform disorders

5411

23230

1.73

266.23

4.7

4.0

1.92

1.84

mmol/l

0.87

4428

19092

Anxiety disorders

5460

23522

1.72

261.85

4.7

4.0

1.92

1.83

mmol/l

0.91

4464

19329

Chronic periapical parodontitis

1592

6477

2.75

261.31

8.6

3.4

1.39

1.97

mmol/l

7.08

1345

5245

Cystic kidney disease

486

954

7.93

259.49

15.0

4.4

-0.04

1.72

mmol/l

18.12

425

757

Unspecified haematuria

3062

13743

2.07

258.68

5.8

3.8

1.58

1.86

mmol/l

3.72

2522

11126

COPD, early/later onset

3354

15304

2.01

258.40

4.7

3.8

2.82

1.72

mmol/l

36.17

2767

12397

Other diseases of pleura

3342

16033

2.00

258.22

5.6

3.9

2.76

1.71

mmol/l

38.55

2803

12943

Low back pain

4650

21057

1.78

257.11

4.0

3.9

2.04

1.76

mmol/l

5.52

3858

17204

COPD, hospital admissions

3327

15212

2.01

256.77

4.7

3.8

2.82

1.72

mmol/l

35.96

2744

12326

Other disorders of teeth and supporting structures

1619

6690

2.70

256.71

6.9

3.4

1.89

1.99

mmol/l

0.43

1364

5423

Disorders of choroid and retina

5320

23646

1.73

256.12

5.9

3.6

1.64

1.94

mmol/l

6.80

4354

19363

Pain (limb, back, neck, head abdominally)

5020

14714

1.78

256.03

4.9

3.9

1.85

1.73

mmol/l

1.32

4118

11833

Stroke, including SAH

4357

18719

1.84

255.81

4.7

3.8

1.84

1.92

mmol/l

0.66

3590

15303

Alcohol abuse, main dg

1266

4659

3.10

255.76

3.8

4.2

1.71

1.80

mmol/l

0.32

1011

3762

COPD, hospital admission 2, with asthma infections

2490

10438

2.25

254.51

5.0

3.8

2.93

1.71

mmol/l

31.84

2063

8337

Deposits [accretions] on teeth

853

2467

4.30

253.52

19.1

3.5

1.26

1.71

mmol/l

3.24

749

1962

Secondary uncertain malignant neoplasm, excluding all cancers (controls excluding all cancers)

2885

13145

2.09

251.57

3.9

3.8

2.16

1.94

mmol/l

2.23

2331

10757

Dorsalgia

6425

21970

1.65

250.10

3.9

1.91

1.75

mmol/l

2.58

5286

17922

Direct fill therapy

1200

4394

3.19

247.70

13.5

4.4

1.27

1.83

mmol/l

6.20

1037

3561

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

4245

23136

1.81

246.08

4.9

3.9

2.08

1.85

mmol/l

3.65

3554

18838

Myocardial infarction, strict

3340

13259

1.98

243.72

5.1

3.5

1.70

1.90

mmol/l

2.07

2719

10872

Disorders of thyroid, IBD co-morbidities

1042

2411

3.37

242.19

3.9

2.8

1.86

1.80

mmol/l

0.20

863

1975

Acute alcohol intoxication, ICD10

1503

6173

2.72

241.81

3.9

4.3

1.70

1.81

mmol/l

0.46

1198

5013

Venous thromboembolism

3657

20177

1.88

241.42

4.7

3.7

2.09

1.89

mmol/l

2.39

3044

16423

Obesity related asthma

2219

10701

2.25

241.34

4.9

4.1

2.32

1.77

mmol/l

8.79

1877

8745

Benign neoplasm of colon, rectum, anus and anal canal

4112

21756

1.82

241.21

4.8

3.7

1.78

1.93

mmol/l

1.80

3403

17788

Other bacterial intestinal infections

1419

5698

2.81

240.65

7.5

3.6

1.68

1.92

mmol/l

1.54

1167

4585

Stroke, excluding SAH

4135

17896

1.83

240.49

4.8

3.8

1.83

1.90

mmol/l

0.58

3406

14604

Emotionally unstable personality disorder

830

2449

3.79

240.34

3.7

1.67

1.81

mmol/l

0.43

681

1973

Conduction disorders

1984

7509

2.39

240.32

4.8

3.5

1.84

1.74

mmol/l

0.55

1587

6033

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

612

1480

4.92

239.42

3.8

4.0

1.77

1.85

mmol/l

0.18

492

1211

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

1250

4780

3.07

238.78

5.8

4.2

1.10

1.87

mmol/l

7.42

979

3868

Lower back pain or/and sciatica

6360

28462

1.61

238.20

3.9

2.03

1.79

mmol/l

5.24

5247

23236

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

1604

6829

2.59

236.67

4.8

3.9

1.89

1.95

mmol/l

0.21

1303

5679

Unspecified mental disorder

2569

13101

2.09

236.28

3.8

4.1

2.25

1.81

mmol/l

6.23

2079

10716

Acute bronchitis

2900

15141

2.01

236.06

5.4

4.1

2.22

1.80

mmol/l

7.26

2438

12177

Neurological diseases

5654

17577

1.68

235.91

4.6

4.2

1.91

1.67

mmol/l

4.83

4578

14182

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

1414

5553

2.82

235.18

10.0

5.5

0.96

1.73

mmol/l

13.74

1204

4477

Episodal and paroxysmal disorders

7188

24142

1.58

234.95

4.4

4.2

1.89

1.75

mmol/l

2.43

5913

19524

Cutaneous abscess, furuncle and carbuncle

1752

7785

2.46

233.88

7.1

4.0

1.67

1.84

mmol/l

0.95

1471

6298

Myocardial infarction, without ST-elevation

2989

14944

2.01

232.77

5.3

3.6

1.71

1.90

mmol/l

1.80

2422

12128

Osteopathies and chondropathies

3573

19329

1.86

231.10

6.2

3.7

1.87

1.93

mmol/l

0.33

2963

15837

Acute alcohol intoxication

1860

8560

2.38

228.83

4.0

4.2

1.73

1.76

mmol/l

0.12

1491

6952

Congenital malformations of the urinary system

671

1851

4.72

227.15

13.7

5.6

0.24

1.72

mmol/l

20.83

580

1474

Use of hypnotics and sedatives

6703

25376

1.59

227.06

4.5

4.0

1.80

1.83

mmol/l

0.29

5483

20789

Retention of urine

2508

10856

2.13

226.72

5.0

3.7

1.59

1.84

mmol/l

2.37

2039

8758

Disorders of other endocrine glands

2930

15623

1.97

226.04

8.1

4.1

1.60

1.88

mmol/l

3.84

2456

12676

ILD medications: azathioprine

1133

4181

3.04

225.59

12.0

3.4

1.47

1.83

mmol/l

2.42

951

3398

COPD, hospital admissions 3, with asthma pneumonia sepsis

2127

8793

2.28

224.29

5.1

3.7

2.96

1.69

mmol/l

28.94

1764

6990

Amputation

957

3311

3.49

221.95

10.3

3.4

1.24

1.92

mmol/l

4.94

785

2621

Nephrotic syndrome

466

1014

7.02

221.62

18.4

5.2

0.69

1.85

mmol/l

9.05

419

805

Disorders of lens

4388

16559

1.76

221.56

6.1

3.6

1.78

1.87

mmol/l

0.92

3579

13657

General examination and investigation of persons without complaint and reported diagnosis

4200

13022

1.79

220.91

5.4

3.4

2.00

1.76

mmol/l

3.47

3311

10772

Falls/tendency to fall

7003

23135

1.57

220.64

4.4

4.1

1.80

1.78

mmol/l

0.15

5796

18661

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

638

1705

4.55

220.36

4.2

1.59

1.82

mmol/l

0.64

518

1371

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

3644

21233

1.82

219.79

6.0

3.7

1.75

1.91

mmol/l

1.59

2998

17393

Other neurological diseases

4690

23303

1.70

219.17

4.4

3.9

1.90

1.88

mmol/l

0.13

3854

19007

Amiodarone users

971

3449

3.46

217.10

4.9

3.9

1.69

1.99

mmol/l

1.87

856

2752

Intracranial injury

3759

21375

1.79

217.03

3.9

4.3

1.95

1.79

mmol/l

1.91

3080

17316

Benign neoplasm: Colon

3501

19892

1.84

216.91

4.8

3.7

1.74

1.93

mmol/l

2.32

2890

16250

Sulfonylureas

2603

10916

2.06

215.21

5.5

3.5

1.57

1.98

mmol/l

5.51

2056

8989

Hydronephrosis

893

2989

3.46

214.74

7.3

2.6

1.17

2.18

mmol/l

9.92

696

2402

Type 1 diabetes, definitions combined

857

2782

3.52

214.59

5.3

5.7

1.16

1.77

mmol/l

3.55

689

2303

Diseases of the skin and subcutaneous tissue

6583

21636

1.58

213.85

5.1

3.7

1.77

1.82

mmol/l

0.43

5386

17549

AV-block

1289

4690

2.78

213.56

4.8

3.3

1.81

1.73

mmol/l

0.28

1017

3707

Cardiomyopathies, Primary/intrinsic

971

3413

3.26

213.56

6.5

3.5

1.68

1.70

mmol/l

0.03

799

2722

Type 1 diabetes, strict (exclude DM2)

853

2775

3.51

212.93

5.2

5.9

1.14

1.77

mmol/l

3.81

685

2295

Schizophrenia or delusion

1995

9699

2.21

210.21

3.5

4.1

2.27

1.85

mmol/l

4.34

1608

7923

Peripheral artery operations in Hilmo

1125

4335

3.00

210.04

9.2

3.3

1.26

1.95

mmol/l

6.14

918

3464

Cardiomyopathy (excluding other)

994

3578

3.17

209.21

6.5

3.5

1.71

1.70

mmol/l

0.04

814

2841

Later onset COPD, excluding more controls

1599

5512

2.53

209.04

4.5

3.1

2.85

1.54

mmol/l

25.62

1320

4400

Explicit bacterial Sepsis

863

2886

3.49

208.52

7.1

3.2

1.44

1.87

mmol/l

2.37

719

2303

Abnormal findings on examination of blood, without diagnosis

3229

17315

1.87

207.70

5.9

4.1

1.67

1.78

mmol/l

0.92

2689

14052

Streptococcal septicaemia

756

2355

3.85

207.62

7.0

3.4

1.49

1.89

mmol/l

1.84

630

1883

Pulmonary heart disease, diseases of pulmonary circulation

2265

11670

2.12

207.11

4.6

3.8

2.31

1.88

mmol/l

5.35

1866

9448

Schizophrenia, schizotypal and delusional disorders

1998

9779

2.19

206.75

3.5

4.1

2.27

1.86

mmol/l

4.01

1610

7989

Other symptoms and signs involving cognitive functions and awareness

2949

15424

1.92

206.63

3.7

3.9

1.88

1.89

mmol/l

0.03

2417

12508

Disorders of mineral metabolism

702

2094

4.01

205.83

9.1

3.5

2.38

2.00

mmol/l

1.39

603

1677

Bacterial intestinal infections, IBD co-morbidities

1406

6060

2.60

204.68

7.5

3.8

1.68

1.95

mmol/l

1.87

1157

4902

Azathioprine

1133

4398

2.88

204.52

12.0

4.0

1.47

1.77

mmol/l

1.90

951

3587

Factors influencing health status and contact with health services

2145

5086

2.22

203.94

4.4

2.4

1.84

1.85

mmol/l

0.04

1708

4157

Anaemia in chronic diseases classified elsewhere

359

670

8.62

203.36

16.3

3.8

0.75

1.97

mmol/l

7.31

306

529

Pacemaker

2479

12909

2.05

203.08

4.7

3.7

1.94

1.88

mmol/l

0.35

2009

10427

Other special examinations and investigations of persons without complaint or reported diagnosis

4316

13079

1.74

202.66

5.1

3.3

1.89

1.76

mmol/l

1.29

3448

10810

Ascites

664

1939

4.18

202.58

7.6

3.4

1.25

1.97

mmol/l

4.03

529

1568

Ischaemic Stroke, excluding all haemorrhages

3814

17245

1.78

202.20

4.7

3.8

1.83

1.92

mmol/l

0.77

3121

14064

Chronic nephritic syndrome

469

1092

5.80

199.97

12.8

3.3

0.29

2.11

mmol/l

18.97

403

869

Acute upper respiratory infections of multiple and unspecified sites

4510

21013

1.67

199.77

5.5

3.8

1.91

1.77

mmol/l

1.59

3753

17030

Autoimmune diseases related-to ILD

5144

29218

1.61

199.64

5.0

3.9

1.85

1.82

mmol/l

0.25

4239

23900

Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)

5372

20421

1.62

197.78

5.4

4.0

1.96

1.86

mmol/l

1.12

4438

16760

Malignant neoplasm, wide definition for exclusion

5372

20425

1.62

197.64

5.4

4.0

1.96

1.86

mmol/l

1.12

4438

16763

Malignant neoplasm, excluding all cancers (controls excluding all cancers)

5372

20431

1.62

197.43

5.4

4.0

1.96

1.86

mmol/l

1.18

4438

16765

Other disorders of glucose regulation and pancreatic internal secretion

796

2643

3.61

197.24

7.5

4.5

1.47

1.88

mmol/l

1.87

662

2097

DVT of lower extremities and pulmonary embolism

2816

15723

1.92

197.11

4.6

3.7

2.16

1.89

mmol/l

3.11

2331

12785

Cystitis

5098

19841

1.63

196.99

4.4

3.8

1.77

1.82

mmol/l

0.43

4207

15989

Depression or dysthymia

4394

15021

1.70

196.69

4.2

4.0

1.86

1.78

mmol/l

0.67

3632

12340

Asthma, hospital admissions , main diagnosis only

5061

29367

1.61

194.15

4.3

4.2

2.21

1.75

mmol/l

14.47

4211

23877

Kela-code for severe mental illness

2263

11832

2.03

193.82

3.7

4.1

2.26

1.83

mmol/l

5.18

1820

9673

Epilepsy

2169

11213

2.07

192.29

4.5

1.79

1.71

mmol/l

0.47

1800

9037

Vocal cord dysfunction

712

2003

3.56

191.14

4.2

3.4

2.19

1.91

mmol/l

1.02

585

1633

Asthma, including avohilmo

7291

29240

1.50

190.87

4.1

4.2

2.17

1.70

mmol/l

18.93

5996

23797

Asthma/COPD (KELA code 203)

5817

27241

1.56

190.53

4.1

2.31

1.64

mmol/l

31.77

4826

22168

Acute peritonitis

647

1947

4.15

190.52

14.2

3.8

1.19

1.92

mmol/l

4.67

555

1536

Enterocolitis due to Clostridium difficile

932

3446

3.16

189.38

8.1

3.5

1.71

2.02

mmol/l

1.58

772

2741

Diabetic retinopathy, excluding more controls

2073

5837

2.24

188.19

7.8

3.3

1.38

1.75

mmol/l

3.49

1681

4726

Coronary revascularization (ANGIO or CABG)

3135

12595

1.86

187.86

4.7

3.5

1.61

1.90

mmol/l

3.86

2523

10319

Bipolar affective disorders

1117

4454

2.71

187.21

3.4

3.7

1.65

1.84

mmol/l

0.85

896

3596

Disorders of calcium metabolism

563

1556

4.44

186.24

9.1

3.4

2.42

2.08

mmol/l

0.96

482

1244

Other and unspecified nonorganic psychotic disorders

1200

4971

2.62

186.10

3.3

4.1

1.98

1.78

mmol/l

0.79

953

4055

Early onset COPD

1587

7512

2.33

183.43

5.0

4.0

2.84

1.73

mmol/l

16.97

1326

6057

Non-allergic asthma (mode), excluding more controls

1237

5173

2.56

183.38

4.3

3.4

2.17

1.58

mmol/l

6.24

1036

4118

Elevated blood glucose level

748

2511

3.56

182.04

8.1

4.0

1.57

1.97

mmol/l

1.79

635

1992

Mental and behavioural disorders due to sedatives or hypnotics

575

1626

4.19

181.81

4.0

3.7

2.16

1.87

mmol/l

0.89

455

1320

Unspecified privation

879

3225

3.15

180.06

6.1

3.9

1.43

1.97

mmol/l

3.37

734

2594

IgA nephropathy (IgA glomerulonephritis)

324

611

7.89

178.87

14.5

3.7

-0.03

1.79

mmol/l

12.81

277

486

Amputation of toe

691

2275

3.77

176.61

11.1

3.6

1.23

2.00

mmol/l

4.68

574

1786

Disorder of lipoprotein metabolism, unspecified

1020

4066

2.84

176.22

5.8

3.2

1.46

1.97

mmol/l

4.19

900

3261

COPD, hospital admissions 1, only main diagnosis

2472

11671

1.95

176.11

4.8

3.8

2.92

1.73

mmol/l

30.85

2048

9370

Chronic periodontitis, complicated

806

2876

3.33

175.99

11.6

3.7

0.97

1.98

mmol/l

9.24

700

2320

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

375

816

6.58

175.81

18.9

5.3

0.21

1.76

mmol/l

12.39

325

651

Valvular operations

1067

4342

2.76

175.65

5.1

3.8

1.53

1.71

mmol/l

0.77

873

3443

Fungal Sepsis

400

906

5.87

175.57

11.1

2.9

2.12

1.96

mmol/l

0.30

336

719

Superficial injury of head

1568

7488

2.28

175.56

3.8

4.3

1.82

1.81

mmol/l

0.06

1313

6063

Peripheral arterial reconstruction

1374

6306

2.47

175.13

7.0

3.6

1.34

1.89

mmol/l

5.13

1073

5065

Cholelithiasis, broad definition with cholecystitis

5122

23126

1.58

174.52

4.3

3.7

1.89

mmol/l

0.03

4225

18830

Nerve, nerve root and plexus disorders

6317

27233

1.51

173.27

4.4

3.8

1.96

1.83

mmol/l

1.89

5184

22273

Senile cataract

3933

15111

1.70

173.22

5.6

3.6

1.87

1.88

mmol/l

0.01

3192

12468

Diseases of the respiratory system

3920

11940

1.70

173.14

4.4

3.4

2.09

1.55

mmol/l

14.79

3196

9640

Pulmonary embolism

1998

10489

2.07

172.65

4.6

3.7

2.25

1.90

mmol/l

3.57

1654

8506

Malignant neoplasm

5363

21091

1.56

172.55

5.3

4.1

2.00

1.85

mmol/l

2.04

4420

17337

Congenital malformations, deformations and chromosomal abnormalities

3321

19196

1.73

172.48

6.6

4.1

1.47

1.80

mmol/l

6.07

2778

15527

Chronic pancreatitis

975

3859

2.90

172.32

6.6

3.9

1.43

1.88

mmol/l

2.49

813

3096

Hypoglycaemia, other or unspecified

648

2069

3.79

172.01

7.6

4.7

1.51

1.85

mmol/l

1.19

541

1642

Abnormal findings on diagnostic imaging of lung

3086

17963

1.78

170.77

4.8

3.8

2.16

1.84

mmol/l

4.75

2589

14558

Type 1 diabetes, strict definition, subgroup 1

639

1994

3.65

170.77

4.6

6.0

1.08

1.74

mmol/l

3.24

494

1653

Persons encountering health services for examination and investigation

4200

13080

1.67

170.73

4.4

3.3

1.89

1.76

mmol/l

1.34

3362

10810

Other disorders involving the immune mechanism, not elsewhere classified

384

872

6.14

170.22

18.6

5.1

0.21

1.82

mmol/l

13.71

334

698

Pulmonary heart disease

1998

10543

2.06

170.04

4.6

3.7

2.25

1.91

mmol/l

3.41

1654

8550

Other CVD

1468

6994

2.35

169.01

5.4

3.7

1.99

1.91

mmol/l

0.35

1214

5616

Cellulitis

1489

7097

2.30

168.21

7.2

4.0

1.71

1.86

mmol/l

0.79

1250

5757

Other external causes of accidental injury

5180

17027

1.57

166.83

4.5

4.1

1.85

1.79

mmol/l

0.42

4219

13705

Other dorsopathies, not elsewhere classified

6150

22138

1.51

166.72

4.0

1.90

1.75

mmol/l

2.52

5042

18061

Gastroduodenal ulcer

1864

9645

2.09

166.63

5.5

3.6

1.60

1.87

mmol/l

1.99

1514

7761

Combinations of oral blood glucose lowering drugs

1804

9264

2.11

165.85

3.7

3.8

1.67

1.86

mmol/l

1.27

1416

7694

Intestinal adhesions without obstruction

704

2401

3.45

165.60

5.4

3.7

2.22

2.04

mmol/l

0.48

601

1941

Calcific aortic valvular stenosis

2174

11687

1.99

164.89

5.0

3.7

1.71

1.91

mmol/l

1.58

1751

9426

Calcific aortic valvular stenosis, operated

2174

11687

1.99

164.89

5.0

3.7

1.71

1.91

mmol/l

1.58

1751

9426

Hypotension

1288

5897

2.47

164.55

5.4

3.5

1.97

1.90

mmol/l

0.23

1075

4722

Calcific aortic valvular stenosis, diagnosis (helper)

2166

11645

1.99

164.18

5.0

3.6

1.71

1.91

mmol/l

1.59

1746

9397

Operations 2 for CAVS

2166

11645

1.99

164.18

5.0

3.6

1.71

1.91

mmol/l

1.59

1746

9397

Open wound of head

3317

20061

1.71

163.86

4.1

4.4

1.72

1.79

mmol/l

0.45

2726

16316

Mental and behavioural disorders due to opioids

343

709

5.94

163.83

4.3

3.7

2.03

1.82

mmol/l

0.40

271

580

856

3217

2.94

163.41

7.5

3.4

1.66

1.88

mmol/l

0.85

721

2597

Calcific aortic valvular stenosis, including rheumatic fever

2170

11688

1.98

163.01

5.0

3.6

1.70

1.91

mmol/l

1.61

1750

9436

Other cataract

2751

12371

1.83

161.84

6.1

3.7

1.72

1.88

mmol/l

1.31

2286

10183

Type 1 diabetes, strict definition

666

2204

3.43

161.26

4.7

6.2

1.05

1.77

mmol/l

3.84

516

1828

Respiratory insufficiency

681

2304

3.44

161.03

5.3

3.4

4.96

1.53

mmol/l

52.51

587

1808

Unstable angina pectoris

2638

12663

1.85

160.97

4.4

3.6

1.93

1.92

mmol/l

0.02

2137

10362

Implicit fungal Sepsis

363

817

5.91

160.60

11.0

2.7

2.02

1.90

mmol/l

0.21

304

645

Malignant neoplasm of digestive organs, excluding all cancers (controls excluding all cancers)

2805

12845

1.81

159.72

3.7

3.8

1.83

1.94

mmol/l

0.64

2238

10506

Spondylopathies

4840

19412

1.57

159.49

3.8

3.9

2.00

1.81

mmol/l

2.76

3971

15892

Artificial opening status

531

1597

4.20

157.30

6.9

3.9

1.80

1.87

mmol/l

0.13

435

1244

Behavioural syndromes associated with physiological disturbances and physical factors

1815

9441

2.04

157.23

5.3

4.2

1.75

1.77

mmol/l

0.08

1498

7584

COPD-related respiratory insufficiency

964

3982

2.79

156.76

6.2

3.6

3.78

1.70

mmol/l

29.93

806

3161

Other gastritis (incl. Duodenitis)

1548

7684

2.19

156.75

5.3

3.7

1.71

1.92

mmol/l

1.32

1259

6228

Cholelithiasis

4862

22758

1.55

156.43

4.2

3.7

1.88

1.90

mmol/l

0.14

4002

18537

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

354

783

5.55

156.35

11.0

3.3

1.58

2.17

mmol/l

2.11

303

639

Disorders of parathyroid gland

1461

7034

2.26

156.24

9.7

3.4

1.48

2.07

mmol/l

7.85

1251

5719

Sleep disorders (combined)

5768

26057

1.50

155.95

4.6

3.9

2.10

1.79

mmol/l

7.92

4827

21233

Selective serotonin reuptake inhibitors

6135

22322

1.49

155.71

3.9

4.0

1.99

1.78

mmol/l

4.23

5016

18247

Finngen Rheumatological endpoints

5723

22367

1.50

153.97

4.6

3.9

1.87

1.79

mmol/l

0.90

4655

18219

Fibrosis and cirrhosis of liver

641

2176

3.54

153.58

6.2

3.6

1.08

1.96

mmol/l

5.21

507

1752

Sciatica+with lumbago

2907

16595

1.74

153.57

3.9

2.10

1.81

mmol/l

4.12

2380

13628

Enlarged lymph nodes

973

4004

2.64

153.51

5.2

3.6

1.94

1.74

mmol/l

1.03

805

3194

Accidents

5102

17027

1.55

153.14

4.5

4.1

1.83

1.79

mmol/l

0.29

4155

13705

Hernia

5588

26097

1.50

153.04

4.7

4.0

1.80

1.89

mmol/l

0.91

4608

21351

Other respiratory disorders and diseases

1498

7447

2.22

153.01

5.8

4.0

3.68

1.74

mmol/l

45.34

1270

5968

Other diseases of the respiratory system

1498

7447

2.22

153.01

5.8

4.0

3.68

1.74

mmol/l

45.34

1270

5968

Non-allergic asthma (mode)

1237

5602

2.35

152.56

4.3

3.5

2.17

1.59

mmol/l

6.07

1036

4472

Cirrhosis of liver, NAS

504

1504

4.30

152.01

6.1

3.6

0.94

2.05

mmol/l

6.23

392

1195

Recurrent or chronic depression

2091

8136

1.93

151.55

4.2

4.0

1.76

1.77

mmol/l

0.05

1723

6750

Dermatitis

3578

22797

1.64

151.22

5.1

4.0

1.81

1.87

mmol/l

0.40

2927

18646

Polyneuropathies and other disorders of the peripheral nervous system

1535

7733

2.19

151.20

7.1

3.9

1.84

mmol/l

0.02

1310

6226

Delirium, not induced by alcohol and other psychoactive substances

917

3765

2.80

150.33

4.5

3.5

1.76

1.94

mmol/l

0.66

760

2999

Soft tissue disorders

6363

23163

1.47

149.64

4.9

4.0

1.80

1.77

mmol/l

0.19

5201

18779

Injuries to the abdomen, lower back, lumbar spine and pelvis

2452

14163

1.82

149.56

4.5

3.9

1.94

1.85

mmol/l

0.52

2045

11459

Benign neoplasms

4375

16125

1.58

149.42

5.0

3.8

1.80

1.74

mmol/l

0.58

3600

13074

Panic disorder

811

3085

2.83

149.16

3.8

3.7

1.92

1.74

mmol/l

0.62

649

2491

Cough

2333

12779

1.84

149.09

5.4

4.1

1.93

1.69

mmol/l

2.69

1980

10334

Acute pancreatitis

1353

6519

2.27

149.02

6.0

3.8

1.47

1.87

mmol/l

2.80

1116

5246

Other specified and unspecified personality disorders

631

2125

3.34

148.40

4.2

3.8

2.04

1.86

mmol/l

0.52

520

1733

Neoplasms

4506

15861

1.57

146.57

6.1

3.9

1.81

1.71

mmol/l

0.95

3685

12845

Hyperparathyroidism

1303

6169

2.30

146.26

10.1

3.3

1.36

2.07

mmol/l

9.98

1110

5016

Primary_lymphoid and hematopoietic malignant neoplasms

1613

8340

2.11

146.17

7.4

3.9

1.83

1.89

mmol/l

0.22

1330

6779

Other/unspecified dorsalgia

2239

12674

1.85

146.10

4.1

3.9

2.03

1.85

mmol/l

1.46

1854

10307

External causes of morbidity and mortality

4056

13020

1.61

144.84

4.4

4.0

1.86

1.78

mmol/l

0.64

3302

10463

Injuries to the thorax

2785

16915

1.74

144.62

4.6

3.9

2.00

1.84

mmol/l

1.33

2320

13753

Nonorganic sleeping disorders, excluding more controls

994

4230

2.52

144.57

4.8

4.0

1.71

1.78

mmol/l

0.24

807

3419

ILD, hospital admission 2, with pulmonary infections

733

2750

3.07

143.97

5.1

3.3

2.44

1.76

mmol/l

4.34

609

2182

Alcoholic liver disease

789

3082

2.96

143.89

4.8

3.9

1.06

1.94

mmol/l

5.86

607

2479

Other and unspecified dermatitis

2967

18349

1.70

142.32

5.0

4.0

1.81

1.89

mmol/l

0.50

2435

14946

Transient ischemic attack

3254

17026

1.67

140.95

4.1

3.7

1.89

1.94

mmol/l

0.35

2698

13879

All influenza (not pneumonia)

1007

4401

2.50

139.87

7.0

3.8

1.97

1.68

mmol/l

1.50

825

3551

Other and unspecified polyneuropathies, also in other diseases

1344

6665

2.23

138.62

6.8

3.8

1.79

1.90

mmol/l

0.45

1141

5347

Sequelae of external causes of morbidity and mortality

1604

8428

2.06

138.04

6.1

3.9

1.70

1.91

mmol/l

1.29

1342

6831

Noninfective enteritis and colitis

2787

17089

1.71

137.72

5.6

4.3

1.70

1.82

mmol/l

0.90

2243

13936

Any operation in hilmo

247

145

9.15

137.72

3.6

1.4

1.90

1.44

mmol/l

0.61

191

106

Dysphagia

1476

7523

2.11

137.56

4.3

3.7

2.31

1.84

mmol/l

4.98

1250

6103

Diseases of peritoneum

796

3186

2.85

137.37

12.3

3.6

1.43

1.98

mmol/l

3.52

681

2545

Cardiomyopathy, other and unspecified

586

1992

3.38

137.07

5.7

3.3

1.83

1.80

mmol/l

0.07

497

1585

Unspecified fall

3035

18935

1.67

136.57

4.6

4.3

1.73

1.85

mmol/l

1.07

2538

15358

Cardiac arrest

431

1008

4.13

135.92

6.4

2.6

1.84

1.81

mmol/l

0.04

345

786

Assault

813

3277

2.71

134.39

3.8

4.3

1.43

1.85

mmol/l

1.98

651

2658

Any event in cancer register

5246

21629

1.48

132.81

4.9

4.0

1.94

1.85

mmol/l

0.92

4298

17751

Unspecified acute lower respiratory infection

1034

4697

2.42

132.10

5.7

4.0

2.42

1.85

mmol/l

4.37

872

3767

KRA_PSY_EATING, excluding more controls

430

1211

3.84

131.32

6.2

3.9

1.67

1.54

mmol/l

0.26

356

958

Emergency coronary revascularization (for ACS)

3617

17029

1.61

131.02

4.6

3.8

1.61

1.91

mmol/l

4.46

2881

13931

Mental and behavioural disorders due to use of other stimulants, including caffeine

258

506

6.28

130.89

3.7

3.6

2.02

1.74

mmol/l

0.47

204

414

Cytomegalovirus infection, IBD co-morbidity

269

566

6.74

130.86

14.8

4.7

0.88

2.05

mmol/l

4.77

224

452

Acute pancreatitis (for exclusion)

1353

6843

2.16

130.83

6.0

3.8

1.47

1.88

mmol/l

2.88

1116

5516

Non-selective monoamine reuptake inhibitors

2274

13002

1.79

130.64

4.0

3.8

2.17

1.91

mmol/l

2.53

1880

10660

Diseases of the eye and adnexa

4827

16453

1.51

130.50

5.5

3.9

1.77

1.74

mmol/l

0.28

3910

13395

Benign neoplasms

5818

23108

1.44

127.81

4.8

3.9

1.82

1.78

mmol/l

0.33

4793

18741

Certain disorders involving the immune mechanism

1252

6206

2.20

127.65

10.3

4.1

1.30

1.92

mmol/l

7.65

1047

5041

Cytomegaloviral disease

271

587

6.42

126.97

14.7

4.5

0.88

1.92

mmol/l

3.91

225

470

Other viral hepatitis

463

1435

3.71

126.13

4.6

4.0

1.60

1.94

mmol/l

1.00

366

1173

Viral and other specified intestinal infections

1267

6126

2.15

126.12

8.4

4.1

1.57

1.68

mmol/l

0.55

1011

4868

Speech and linguistic disorders, excluding more controls

600

2012

3.14

126.12

8.5

6.3

1.04

1.57

mmol/l

2.43

482

1607

Osteoporosis

1645

8570

1.98

125.31

6.1

3.4

2.19

2.07

mmol/l

0.56

1366

7002

Failure and rejection of transplanted organs and tissues

199

335

9.66

125.08

20.4

4.1

0.33

2.03

mmol/l

7.35

172

275

Symptoms and signs involving the skin and subcutaneous tissue

3852

25853

1.54

124.78

4.9

4.0

1.84

mmol/l

0.00

3175

21117

Viral pneumonia (unknown virus, not influenza)

525

1778

3.43

124.41

6.4

4.2

1.73

1.76

mmol/l

0.06

461

1413

ILD, hospital admissions 3, with pneumonia sepsis

641

2431

3.06

123.99

5.3

3.2

2.53

1.74

mmol/l

5.13

533

1935

Decubitus ulcer and pressure area

522

1786

3.53

123.87

8.6

3.4

1.97

2.07

mmol/l

0.22

455

1392

Idiopathic gout

745

3060

2.85

123.87

7.7

3.5

1.46

1.99

mmol/l

2.73

617

2426

Coronary artery bypass grafting

1904

8216

1.90

123.62

4.8

3.5

1.42

1.91

mmol/l

6.44

1546

6651

Primary_lymphoid and hematopoietic malignant neoplasms

1613

8828

1.98

123.39

7.4

4.0

1.83

1.86

mmol/l

0.10

1330

7135

Symptoms and signs concerning food and fluid intake

705

2780

2.82

123.23

6.6

3.6

2.18

1.71

mmol/l

2.58

570

2185

Other diseases of liver

1100

5259

2.28

123.14

5.1

3.9

1.46

1.96

mmol/l

4.02

883

4306

Injury, poisoning and certain other consequences of external causes

3261

10352

1.63

122.18

4.4

4.0

1.87

1.76

mmol/l

0.86

2628

8354

Other/unspecified cytomegaloviral diseases

233

460

7.34

122.11

16.3

4.8

0.82

1.99

mmol/l

4.17

197

363

Iron deficiency anaemia secondary to blood loss (chronic)

1091

5241

2.29

121.50

6.8

3.6

1.67

1.92

mmol/l

1.28

881

4260

Hernia of abdominal wall

2704

17076

1.67

120.10

5.1

3.9

1.77

1.83

mmol/l

0.33

2269

13905

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

637

2433

2.97

120.01

5.6

3.7

2.08

1.91

mmol/l

0.46

527

1959

Gout due to impairment of renal function

176

279

12.00

119.76

14.3

4.0

1.12

1.73

mmol/l

1.14

153

220

Gastric ulcer

1226

6180

2.16

119.50

5.5

3.5

1.71

1.92

mmol/l

0.93

1012

4986

Injuries to the hip and thigh

2870

16783

1.64

119.48

4.5

3.9

1.92

1.88

mmol/l

0.23

2364

13607

Vascular disorders of the intestines

552

1975

3.28

119.41

6.3

3.3

1.49

2.13

mmol/l

2.70

449

1562

Chronic gastritis

1766

9999

1.89

119.35

4.5

3.6

1.70

1.94

mmol/l

1.63

1479

8129

Need for immunization against other single viral diseases

252

545

6.61

119.14

18.2

3.8

1.07

1.70

mmol/l

1.54

219

430

Invasive ventilation

621

2385

3.06

118.32

6.7

4.3

2.01

1.74

mmol/l

0.78

502

1869

Chronic viral hepatitis

391

1135

3.98

118.04

4.2

3.9

1.59

2.02

mmol/l

1.22

307

927

Secondary and unspecified malignant neoplasm of lymph nodes, excluding all cancers (controls excluding all cancers)

1002

4721

2.35

117.83

4.2

3.9

2.23

1.88

mmol/l

2.40

815

3849

Acidosis

232

469

6.95

117.74

9.5

3.9

0.76

2.07

mmol/l

2.71

191

365

Other and unspecified effects of external causes

1531

8302

1.95

117.53

4.6

1.74

1.80

mmol/l

0.27

1245

6727

Osteomyelitis

555

2019

3.27

117.52

10.6

3.8

1.27

1.84

mmol/l

2.28

470

1590

Acute upper respiratory infections

6015

27485

1.41

116.85

4.9

3.8

1.93

1.81

mmol/l

1.47

4945

22355

Dipeptidyl peptidase 4 (DPP-4) inhibitors

821

3586

2.57

116.63

5.1

3.6

1.74

2.00

mmol/l

1.14

665

2958

Benign neoplasm: Colon, unspecified

1501

8125

1.98

116.34

5.2

3.7

1.65

1.94

mmol/l

2.34

1237

6596

Other viral diseases

1682

9410

1.88

115.55

8.8

4.6

1.67

1.73

mmol/l

0.27

1392

7602

Acute sinusitis

2691

15847

1.64

115.46

5.2

3.8

1.88

1.81

mmol/l

0.51

2199

12905

Schizoaffective disorder

514

1785

3.24

114.77

2.9

3.7

2.46

1.94

mmol/l

1.90

413

1453

Other noninfective gastroenteritis and colitis

1552

8543

1.94

114.66

6.0

4.4

1.69

1.83

mmol/l

0.70

1248

6910

Misadventures to patients during surgical and medical care

909

4155

2.41

114.55

5.9

3.5

2.13

1.97

mmol/l

0.59

742

3350

Diaphragmatic hernia

2148

12977

1.75

114.47

4.3

3.7

1.64

1.97

mmol/l

3.94

1797

10607

Parodontitis or operation codes

5050

26600

1.44

114.24

5.6

3.7

1.60

1.93

mmol/l

7.67

4207

21833

Missing teeth due to accident, extraction or parodontitis

789

3411

2.57

113.91

6.9

3.4

1.98

2.08

mmol/l

0.30

673

2777

Other infectious diseases

622

2431

2.94

113.15

7.3

3.6

1.64

1.91

mmol/l

1.20

519

1933

Parodontitis

5038

26598

1.44

113.00

5.6

3.7

1.60

1.93

mmol/l

7.64

4195

21834

Dorsopathies

6056

22533

1.41

112.96

4.3

4.0

1.94

1.74

mmol/l

3.70

4957

18382

Other diseases of intestine

823

3637

2.51

112.84

6.9

3.7

1.75

1.96

mmol/l

0.78

667

2930

Abnormal findings on examination of urine, without diagnosis

408

1276

3.92

112.76

8.6

4.0

0.73

1.88

mmol/l

6.91

342

1006

Chronic periodontitis, including avohilmo

5007

26604

1.44

110.66

5.6

3.7

1.60

1.93

mmol/l

7.84

4169

21841

Systemic connective tissue disorders

2026

12149

1.76

110.57

5.4

3.7

2.03

1.96

mmol/l

0.37

1717

9887

Cholecystectomy

3894

23756

1.50

110.48

4.2

3.8

1.85

1.92

mmol/l

0.59

3251

19378

Allergic asthma (mode), excluding more controls

1137

5549

2.10

110.24

3.9

3.3

1.97

1.54

mmol/l

3.16

937

4461

Fracture of rib(s), sternum and thoracic spine

1829

10710

1.82

110.04

4.5

3.9

2.01

1.85

mmol/l

0.88

1527

8696

Coronary angioplasty

2352

11175

1.71

109.78

4.4

3.5

1.75

1.91

mmol/l

1.24

1847

9126

Mycoses

1543

8596

1.91

109.76

6.5

4.0

1.94

1.86

mmol/l

0.37

1277

6977

Secondary malignant neoplasm of other and unspecified sites, excluding all cancers (controls excluding all cancers)

1414

7708

1.98

109.21

3.6

3.8

2.11

1.91

mmol/l

1.03

1126

6296

Other and unspecified drugs and medicaments

604

2367

2.90

108.64

5.7

3.8

2.17

1.91

mmol/l

0.79

500

1906

Viral infections characterized by skin and mucous membrane lesions

2406

15123

1.67

108.13

6.4

4.3

1.84

mmol/l

0.01

1988

12309

Mixed and other personality disorders

499

1759

3.15

107.83

3.9

3.8

1.84

1.92

mmol/l

0.15

425

1434

Schizophrenia

961

4576

2.26

107.74

3.6

4.0

2.61

1.81

mmol/l

7.31

774

3727

Other headache syndromes

2153

13161

1.70

107.09

3.8

1.93

1.85

mmol/l

0.51

1770

10726

Alcohol withdrawal state with delirium

559

2136

3.05

106.95

5.0

4.1

2.02

1.94

mmol/l

0.14

450

1715

Isolated proteinuria

295

774

4.90

106.86

9.8

4.1

0.53

1.86

mmol/l

6.58

251

610

Diseases of oral cavity, salivary glands and jaws

5615

20962

1.41

106.63

6.0

3.3

1.72

1.89

mmol/l

2.67

4601

16923

Symptoms and signs involving the nervous and musculoskeletal systems

3291

22222

1.54

106.51

4.7

4.1

2.00

1.84

mmol/l

1.66

2642

18185

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

1064

4767

2.15

106.10

6.7

5.6

1.28

1.49

mmol/l

1.09

863

3795

Viral hepatitis

500

1790

3.15

105.96

4.6

4.0

1.59

1.97

mmol/l

1.37

397

1453

Sleep apnoea

5078

24915

1.42

105.82

4.6

3.9

2.13

1.81

mmol/l

7.86

4293

20368

Undetermined asthma, excluding more controls

706

2971

2.56

105.57

5.2

3.0

2.43

1.57

mmol/l

7.44

575

2377

Injuries to the ankle and foot

3606

22521

1.50

105.35

5.3

4.2

1.78

1.77

mmol/l

0.05

3047

18310

Endocarditis

308

833

4.51

105.13

9.9

3.4

1.57

1.90

mmol/l

0.72

264

640

Pain in joint

3045

13198

1.57

105.05

4.2

3.8

1.69

1.77

mmol/l

0.49

2535

10714

Focal epilepsy

1365

7438

1.97

104.98

4.2

4.6

1.94

1.80

mmol/l

0.82

1147

5995

Ventral hernia

1464

8149

1.92

104.89

4.9

3.7

1.83

1.92

mmol/l

0.39

1218

6636

Functional dyspepsia

1454

8065

1.91

103.93

4.2

3.7

1.98

1.95

mmol/l

0.13

1229

6563

Chronic ulcer of skin, not elsewhere classified

543

2075

3.05

103.93

8.7

3.3

2.15

1.97

mmol/l

0.51

444

1636

Diseases of the myoneural junction and muscle

847

3962

2.38

102.09

5.9

4.1

2.00

1.96

mmol/l

0.13

713

3192

Toxic effects of substances chiefly nonmedicinal as to source

743

3277

2.50

101.88

4.3

4.4

1.71

1.89

mmol/l

0.67

596

2629

Other blood glucose lowering drugs, excl. Insulins

1047

5280

2.15

101.76

4.8

3.7

1.90

1.98

mmol/l

0.27

852

4358

Vitreous haemorrhage

710

3093

2.58

101.69

9.8

3.7

1.18

1.98

mmol/l

6.99

598

2496

Sequelae of cerebrovascular disease

2185

11958

1.70

101.26

4.6

3.7

1.95

1.92

mmol/l

0.17

1781

9658

Organic, including symptomatic, mental disorders

3041

14650

1.57

101.18

3.8

2.06

1.89

mmol/l

1.53

2488

11881

Other and unspecified myopathies

646

2726

2.71

100.18

5.8

3.7

2.04

2.00

mmol/l

0.11

545

2174

Spinal stenosis

3016

15783

1.56

100.14

3.8

1.98

1.86

mmol/l

0.93

2476

12903

Noninfectious colitis NAS

883

4216

2.29

99.58

5.7

4.2

1.66

1.92

mmol/l

1.24

698

3412

Sequelae with surgical and medical care as external cause

1229

6600

2.01

99.48

6.3

3.8

1.66

1.95

mmol/l

1.81

1038

5352

Coagulation defects, purpura and other haemorrhagic conditions

1176

6218

2.04

99.30

7.1

4.2

1.68

1.85

mmol/l

0.79

988

5023

Mental disorders, not otherwise specified

490

1793

3.01

98.52

4.5

3.7

1.85

1.80

mmol/l

0.10

416

1464

Secondary malignant neoplasm of respiratory and digestive organs, excluding all cancers (controls excluding all cancers)

1094

5683

2.09

98.18

3.7

2.31

1.91

mmol/l

2.87

874

4645

Other diseases of anus and rectum

1697

10004

1.79

98.12

4.8

3.7

1.98

1.89

mmol/l

0.42

1392

8073

Charcot foot

184

353

7.02

97.86

12.2

2.8

1.03

1.87

mmol/l

1.64

160

294

Type1 diabetes, definitions combined, early onset

541

2101

2.89

97.75

5.5

7.0

1.07

1.65

mmol/l

2.25

422

1728

Presence of other functional implants

3242

15574

1.53

97.68

5.2

3.2

1.91

1.98

mmol/l

0.51

2653

12705

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

5395

25968

1.39

97.43

4.8

3.8

1.93

1.84

mmol/l

0.86

4481

21210

Other intervertebral disc disorders

4589

20181

1.43

97.26

3.7

3.9

1.98

1.79

mmol/l

2.88

3704

16519

Phobic anxiety disorders

663

2809

2.51

97.04

5.4

4.1

1.89

1.71

mmol/l

0.57

546

2271

Fitting and adjustment of other devices

1962

11192

1.71

96.96

4.0

2.9

2.30

1.90

mmol/l

6.30

1563

8963

Other diseases of blood and blood-forming organs, wide

1314

7258

1.94

96.76

7.0

4.0

1.92

1.89

mmol/l

0.09

1067

5906

Other respiratory diseases principally affecting the interstitium

1186

6373

2.03

96.74

5.4

3.7

2.27

1.89

mmol/l

2.56

985

5124

Visual disturbances and blindness

2842

19014

1.56

96.69

5.2

4.0

1.83

1.88

mmol/l

0.36

2341

15523

Other metabolic disorders

679

2928

2.50

96.41

6.1

3.4

2.06

1.97

mmol/l

0.23

557

2368

Follow-up examination after treatment for conditions other than malignant neoplasms

2369

9789

1.64

96.10

4.0

3.4

1.92

1.80

mmol/l

0.74

1965

8169

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

1422

7907

1.86

96.09

10.2

4.0

1.50

1.69

mmol/l

1.25

1156

6319

Poisoning by narcotics and psychodysleptics [hallucinogens]

168

300

7.29

95.47

3.5

3.7

1.83

1.74

mmol/l

0.10

130

239

Gastro-oesophageal reflux disease

3669

22805

1.47

94.95

4.7

3.9

1.83

1.90

mmol/l

0.48

3030

18660

Dentofacial anomalies [including malocclusion]

1416

7899

1.86

94.68

9.2

3.2

1.83

1.87

mmol/l

0.22

1196

6401

Allergic asthma (mode)

1137

5863

1.98

94.25

3.9

3.4

1.97

1.55

mmol/l

3.03

937

4720

Chronic tubulo-interstitial nephritis

304

872

4.10

94.17

10.8

2.2

1.08

2.18

mmol/l

5.42

259

705

Second line medication for Crohn's disease

3018

20514

1.52

94.15

7.1

4.0

1.82

1.86

mmol/l

0.22

2475

16830

Other complications of surgical and medical care, not elsewhere classified

619

2614

2.62

93.80

5.4

3.4

2.08

1.97

mmol/l

0.28

512

2111

Other and unspecified mood [affective] disorders

401

1350

3.25

93.34

3.5

3.8

1.36

1.83

mmol/l

1.61

342

1092

Visual disturbances

2601

17216

1.58

93.17

5.1

4.0

1.89

mmol/l

0.02

2137

14043

Pleural effusion

1043

5447

2.10

92.84

5.9

3.6

2.32

1.73

mmol/l

5.14

876

4343

Colectomy operation

1089

5766

2.06

92.68

5.0

3.8

1.61

1.94

mmol/l

1.73

872

4678

Persistent mood disorders

1049

5450

2.04

91.84

4.5

3.7

1.87

1.93

mmol/l

0.17

849

4439

Other and unspecified local infections of skin and subcutaneous tissue

646

2820

2.55

91.59

9.0

4.1

1.93

1.90

mmol/l

0.07

565

2257

Alcohol-induced chronic pancreatitis

494

1916

2.98

91.52

6.0

4.1

1.46

1.95

mmol/l

1.49

405

1533

L04AX Other immunosuppressants

2943

20021

1.52

91.50

7.2

3.9

1.83

1.87

mmol/l

0.26

2420

16423

Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)

866

4251

2.25

91.43

4.7

3.7

1.37

1.83

mmol/l

3.08

715

3382

Diabetic neuropathy

985

5134

2.21

91.36

8.1

4.7

1.42

1.73

mmol/l

1.68

817

4102

Injuries to the knee and lower leg

6666

29258

1.33

91.20

4.3

4.0

1.88

1.80

mmol/l

0.90

5517

23825

Dermatitis and eczema

6099

30392

1.35

91.13

4.6

4.1

1.76

1.82

mmol/l

0.64

5007

24791

Disorders of psychological development

799

3499

2.30

90.92

7.4

6.4

1.07

1.57

mmol/l

3.34

643

2797

Other diseases of pericardium

336

1056

3.73

90.60

7.6

3.5

1.55

1.86

mmol/l

0.69

279

832

Mental and behavioural disorders due to cannabinoids

221

514

5.00

90.56

2.8

3.7

1.81

1.71

mmol/l

0.12

168

421

Generalized anxiety disorder

713

3212

2.35

90.37

3.5

3.8

1.58

1.75

mmol/l

0.50

583

2590

Extreme obesity with alveolar hypoventilation

335

1061

3.80

90.25

5.2

3.5

4.87

1.84

mmol/l

20.90

297

855

Myocarditis

273

737

4.10

90.09

5.8

2.5

2.00

mmol/l

0.00

223

595

Benign neoplasm: Colon, unspecified

1501

8823

1.82

89.93

5.2

3.8

1.65

1.89

mmol/l

1.79

1237

7166

Undetermined asthma

706

3187

2.38

89.92

5.2

3.1

2.43

1.59

mmol/l

7.14

575

2550

Other local infections of skin and subcutaneous tissue

673

3012

2.48

89.83

8.8

4.0

1.94

1.91

mmol/l

0.08

588

2415

Amputation of foot

267

750

4.74

89.24

11.6

3.7

0.44

1.96

mmol/l

5.29

228

584

Focal epilepsy, strict definition

1241

6912

1.93

89.13

4.2

4.6

1.98

1.80

mmol/l

1.05

1049

5569

Sleep disorders

1137

6129

1.96

89.11

4.7

4.2

1.86

1.85

mmol/l

0.05

930

4951

Oesophageal varices

367

1245

3.60

89.08

6.5

4.2

0.61

1.81

mmol/l

6.83

295

979

Traumatic subdural haemorrhage

846

4102

2.21

87.40

4.2

3.6

1.82

1.69

mmol/l

0.47

704

3238

Transport accidents

2346

13548

1.58

87.30

3.8

3.9

1.75

1.78

mmol/l

0.15

1929

10936

Sleep apnoea, including avohilmo

5225

25367

1.37

87.20

4.5

3.9

2.14

1.80

mmol/l

8.75

4401

20715

Dependence on enabling machines and devices, not elsewhere classified

191

437

7.22

87.20

28.0

5.9

0.69

1.52

mmol/l

2.72

175

324

Open wound of lower leg

915

4660

2.13

86.56

5.3

4.1

1.91

1.89

mmol/l

0.05

747

3788

Fracture of lumbar spine and pelvis

1335

7682

1.86

85.62

4.5

3.6

2.04

1.94

mmol/l

0.41

1109

6211

Injuries to the shoulder and upper arm

4646

28902

1.39

85.51

4.1

1.84

1.86

mmol/l

0.11

3793

23682

Other viral diseases, not elsewhere classified

1127

6143

1.95

85.47

9.1

4.7

1.89

1.70

mmol/l

1.03

929

4941

Other problems related to primary support group, including family circumstances

736

3376

2.31

85.41

16.3

4.1

1.43

1.56

mmol/l

0.50

607

2689

Postprocedural endocrine and metabolic disorders, not elsewhere classified

604

2614

2.48

85.02

4.8

3.2

2.13

1.98

mmol/l

0.40

498

2125

Diabetic retinopathy

2547

10815

1.60

83.88

7.5

4.2

1.38

1.76

mmol/l

4.85

2058

8744

Parodontitis and operation codes

4579

26394

1.39

83.74

5.7

3.7

1.62

1.93

mmol/l

6.35

3816

21683

Other pleural conditions

724

3471

2.32

82.26

6.3

3.7

2.09

1.71

mmol/l

1.79

596

2722

Diseases of the musculoskeletal system and connective tissue

3223

11140

1.49

82.06

5.2

4.1

1.78

1.67

mmol/l

0.99

2612

8975

Post-traumatic stress disorder

383

1345

3.06

82.03

5.0

3.7

1.74

1.62

mmol/l

0.23

299

1082

Focal epilepsy, mode (most common among epilepsy diagnosis)

1152

6437

1.92

81.79

3.7

4.5

1.97

1.81

mmol/l

0.89

969

5176

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

580

2553

2.57

81.71

6.7

3.5

1.71

1.97

mmol/l

0.82

470

2052

Hepatic failure, not elsewhere classified

310

1000

3.76

81.44

6.9

3.5

1.04

1.96

mmol/l

2.87

231

783

Nonorganic sleeping disorders

994

5286

1.99

81.34

4.8

4.1

1.71

1.81

mmol/l

0.40

807

4283

Assault by bodily force

443

1709

2.84

80.48

3.5

4.2

1.31

1.99

mmol/l

2.52

350

1394

Migraine

2177

12062

1.58

80.13

3.8

4.0

1.66

1.77

mmol/l

0.81

1770

9784

Other disorders of gingiva or/and edentulous alveolar ridge

413

1571

3.06

79.98

14.8

3.3

1.24

1.81

mmol/l

2.61

368

1257

Other necrotizing vasculopathies

518

2192

2.69

79.91

8.4

3.5

1.68

2.03

mmol/l

1.52

455

1754

Irritable bowel syndrome

1312

7629

1.80

79.05

4.0

3.6

1.85

1.95

mmol/l

0.47

1105

6176

Diabetic retinopathy, strict definition

1383

7287

1.84

79.00

9.5

4.1

1.28

1.73

mmol/l

4.15

1119

5883

Emotional disorders starting during childhood or adolecense, excluding more controls

315

997

3.45

78.93

6.5

5.9

1.03

1.56

mmol/l

1.84

253

802

Hyperkinetic disorders, excluding more controls

479

1867

2.65

78.72

6.3

5.2

1.26

1.54

mmol/l

0.96

386

1494

Abnormalities of gait and mobility

816

4163

2.17

78.46

5.5

4.3

1.65

1.86

mmol/l

0.78

680

3354

Total colectomy

323

1083

3.49

78.45

7.2

3.8

1.25

1.94

mmol/l

1.75

254

869

Total colectomy operation

323

1083

3.49

78.45

7.2

3.8

1.25

1.94

mmol/l

1.75

254

869

Purpura and other haemorrhagic conditions

848

4368

2.11

78.15

7.0

4.2

1.70

1.90

mmol/l

0.86

714

3527

Fracture of lower leg, including ankle

2937

20499

1.47

78.13

4.6

4.0

1.93

1.87

mmol/l

0.35

2431

16751

Fracture of skull and facial bones

1160

6569

1.87

77.65

4.5

4.3

1.82

1.78

mmol/l

0.11

950

5350

Spondylosis

2895

17315

1.48

77.64

3.5

3.8

2.16

1.84

mmol/l

4.93

2405

14214

Fracture of femur

1638

9294

1.70

77.57

4.7

3.7

1.93

1.94

mmol/l

0.03

1353

7506

Diagnoses used for exclusion with ILD

1493

9097

1.73

77.20

5.0

3.9

2.22

1.87

mmol/l

3.14

1246

7335

Cholangitis (primary sclerosing, PSC)

457

1855

2.81

77.00

7.0

4.0

1.22

1.90

mmol/l

3.56

382

1461

Benign neoplasm of other and ill-defined parts of digestive system

980

5314

1.98

76.61

4.8

3.6

1.88

1.97

mmol/l

0.33

816

4335

Other obstructive and reflux uropathy

295

941

3.55

76.57

8.6

3.0

1.33

2.12

mmol/l

3.43

246

740

Disturbances of skin sensation

1317

7746

1.78

76.48

3.9

1.83

1.90

mmol/l

0.30

1088

6286

Polyuria

1292

7604

1.81

76.47

4.6

3.7

1.81

1.88

mmol/l

0.29

1068

6170

Other diseases of biliary tract

587

2667

2.46

76.22

6.2

3.7

1.49

1.97

mmol/l

2.49

496

2135

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1653

10343

1.67

76.10

5.2

4.2

2.08

1.83

mmol/l

2.10

1317

8397

Vascular diseases of the intestine

314

1066

3.51

75.28

6.6

3.1

1.35

2.05

mmol/l

1.92

258

841

Haemorrhage, not elsewhere classified

290

938

3.65

74.98

7.3

3.3

1.79

1.78

mmol/l

0.01

245

723

Tobacco use

354

1275

3.17

74.95

4.6

3.8

2.25

1.92

mmol/l

0.69

299

1008

Acute and transient psychotic disorders

651

3075

2.28

74.66

3.6

3.8

2.36

1.90

mmol/l

1.82

528

2500

Candidiasis

761

3825

2.15

74.45

8.1

3.6

1.97

1.92

mmol/l

0.15

638

3083

Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)

823

4269

2.09

74.34

5.2

3.6

1.91

1.93

mmol/l

0.04

677

3478

ILD, hospital admissions

951

5187

2.00

74.32

4.9

3.7

2.24

1.88

mmol/l

2.00

790

4161

Renal tubulo-interstitial disorders in diseases classified elsewhere

126

224

8.34

74.03

13.5

2.1

0.76

2.20

mmol/l

3.77

102

181

Disorders of eyelid, lacrimal system and orbit

4550

26938

1.36

73.93

4.3

4.0

1.97

1.85

mmol/l

1.39

3756

21997

Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)

770

3936

2.14

73.06

6.2

3.7

1.21

1.89

mmol/l

5.08

627

3180

Temporomandibular joint disorders

716

3512

2.14

72.84

4.2

3.5

2.07

1.89

mmol/l

0.76

580

2847

Other interstitial pulmonary diseases

959

5277

1.98

72.80

4.9

3.7

2.25

1.89

mmol/l

2.05

797

4235

Shoulder lesions

4215

19203

1.38

72.33

4.0

3.7

1.93

1.87

mmol/l

0.47

3423

15702

Interstitial lung disease endpoints

959

5289

1.97

72.28

4.9

3.7

2.25

1.89

mmol/l

2.09

797

4245

Interstitial lung disease

959

5289

1.97

72.28

4.9

3.7

2.25

1.89

mmol/l

2.09

797

4245

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1732

11109

1.63

71.75

4.7

4.2

1.97

1.91

mmol/l

0.29

1419

9088

Speech and linguistic disorders

638

2930

2.30

71.70

8.4

6.5

1.03

1.51

mmol/l

2.33

515

2346

Other necrotizing vasculopathies (FG)

438

1803

2.76

71.63

7.4

3.4

1.73

2.00

mmol/l

0.94

387

1454

Tubulo-interstitial nephritis, not specified as acute or chronic

431

1743

2.72

71.58

6.7

2.6

1.12

2.25

mmol/l

6.72

356

1397

Pneumonitis due to solids and liquids

577

2674

2.41

71.49

5.1

3.6

2.58

1.92

mmol/l

4.07

487

2081

Intentional self-harm by unspecified means

126

228

7.24

70.86

4.7

3.4

1.46

1.94

mmol/l

0.63

104

178

Later onset COPD

1793

9122

1.64

70.48

4.4

3.6

2.81

1.71

mmol/l

21.04

1463

7293

Open wound of ankle and foot

624

2981

2.28

70.42

7.3

4.1

1.42

1.85

mmol/l

2.04

536

2388

Insomnia

818

4281

2.03

70.42

5.0

3.9

1.94

1.84

mmol/l

0.32

669

3484

Other diseases of pancreas

508

2249

2.54

70.36

6.0

3.6

1.63

1.94

mmol/l

0.94

431

1807

Inflammatory bowel disease

1639

10422

1.64

70.10

5.1

4.3

1.67

1.86

mmol/l

1.22

1326

8494

Aortic aneurysm

1385

8353

1.73

69.92

4.7

3.5

1.55

1.85

mmol/l

2.01

1146

6711

Colorectal cancer, excluding all cancers (controls excluding all cancers)

1564

9569

1.67

69.26

3.3

3.7

1.78

1.94

mmol/l

0.85

1232

7787

Zoster [herpes zoster]

1028

5842

1.88

69.16

5.3

3.7

1.92

1.94

mmol/l

0.09

856

4731

Disorders of tooth development and eruption

416

1648

2.78

69.07

22.5

3.6

1.43

1.56

mmol/l

0.41

374

1302

ILD, hospital admissions 1, main diag only

855

4620

2.02

69.04

4.8

3.8

2.25

1.92

mmol/l

1.63

714

3704

Superficial injury of lower leg

1285

7746

1.74

68.52

4.3

4.0

1.97

1.86

mmol/l

0.51

1082

6285

Viral pneumonia (known virus, not influenza)

233

709

4.19

68.49

7.9

5.8

2.33

1.54

mmol/l

1.85

179

559

Eating disorder

432

1771

2.61

68.20

6.2

4.5

1.67

1.46

mmol/l

0.52

358

1398

Special screening examination for other diseases and disorders

495

2170

2.46

67.97

6.6

3.3

1.46

1.78

mmol/l

1.14

376

1770

Nonischemic cardiomyopathy

393

1579

2.82

67.41

6.5

3.8

1.61

1.97

mmol/l

0.89

316

1271

Nonalcoholic fatty liver disease

532

2428

2.39

67.33

4.2

4.0

1.53

1.98

mmol/l

1.67

433

1977

Myalgia

1107

6429

1.80

67.33

4.3

3.7

1.97

1.88

mmol/l

0.37

943

5211

Other embolism and thrombosis

790

4174

2.04

67.32

5.8

3.6

1.63

1.97

mmol/l

1.73

660

3371

Exclusions for E4_PCOS_BROAD

1001

5684

1.88

67.17

7.4

5.0

1.90

1.78

mmol/l

0.56

842

4618

Intentional self-harm by sharp object

195

521

4.40

67.02

4.7

3.8

1.24

1.41

mmol/l

0.27

155

412

Benign neoplasm: Sigmoid colon

1014

5798

1.87

66.86

4.5

3.8

1.69

1.92

mmol/l

1.02

844

4734

Other arthritis (FG)

1615

10379

1.62

66.09

4.9

3.8

1.88

1.86

mmol/l

0.06

1351

8408

Emphysema

482

2146

2.51

65.68

4.9

3.7

2.69

1.61

mmol/l

5.73

397

1684

Unspecified nephritic syndrome

206

591

4.32

65.35

11.7

3.2

1.14

2.07

mmol/l

3.17

175

471

Pneumonia due to other infectious organisms, not elsewhere classified

242

762

3.73

65.31

9.7

2.9

1.76

1.64

mmol/l

0.19

195

589

Eating disorders

523

2379

2.34

65.14

5.8

4.2

1.60

1.59

mmol/l

0.02

433

1891

Other systemic involvement of connective tissue (FG)

1350

8291

1.69

65.14

4.0

3.5

2.18

1.95

mmol/l

1.68

1139

6720

Hypothyroidism, strict autoimmune

3704

18228

1.38

64.41

4.2

3.4

1.85

1.87

mmol/l

0.11

3028

14857

Lack of expected normal physiological development

267

784

3.67

64.04

11.2

5.2

0.92

1.11

mmol/l

0.44

212

582

Fracture of shoulder and upper arm

1956

13198

1.54

64.00

4.4

4.1

1.86

1.92

mmol/l

0.28

1615

10780

Abnormal involuntary movements

775

4139

2.02

63.86

4.9

4.1

1.80

1.92

mmol/l

0.40

641

3363

Paralytic ileus

290

1029

3.27

63.76

6.4

3.5

1.65

2.05

mmol/l

0.65

246

800

Adverse effects, not elsewhere classified

992

5688

1.84

63.63

5.1

4.4

1.79

1.81

mmol/l

0.05

819

4612

Dissociative [conversion] disorders

234

723

3.62

63.63

4.3

3.3

1.26

1.84

mmol/l

1.46

190

569

Gingival hyperplasia

290

1041

3.34

63.52

18.7

3.4

0.94

1.76

mmol/l

3.58

262

827

Somatoform disorder

794

4253

1.97

63.49

4.4

3.8

2.14

1.90

mmol/l

1.13

652

3467

Use of disulfiram, acamprosate or naltrexone

522

2425

2.35

63.28

3.8

4.2

1.99

1.90

mmol/l

0.17

426

1968

Congenital malformations of the circulatory system

910

4966

1.91

63.19

6.6

5.9

1.45

1.68

mmol/l

1.14

773

3998

Parodontitis or/and operation codes

3192

13802

1.41

63.18

5.8

3.9

1.64

1.90

mmol/l

3.26

2656

11343

Suppurative and necrotic conditions of lower respiratory tract

397

1666

2.72

62.64

5.6

3.8

1.91

1.98

mmol/l

0.09

325

1305

Agranulocytosis

658

3362

2.13

62.15

7.7

3.9

2.05

1.91

mmol/l

0.48

539

2740

Soft tissue disorders related to use, overuse and pressure

1381

8701

1.66

61.80

4.2

3.7

1.89

1.92

mmol/l

0.09

1143

7072

Phlebitis and thrombophlebitis (not including DVT)

1219

7470

1.72

61.60

5.1

3.7

1.82

1.90

mmol/l

0.28

1012

6077

Other diseases of arteries and capillaries

552

2653

2.27

61.59

7.3

3.4

1.37

2.00

mmol/l

3.17

463

2136

Toxic effect of other and unspecified substances

123

247

6.30

61.50

4.7

1.69

2.01

mmol/l

0.41

198

Other disorders of skin and subcutaneous tissue, not elsewhere classified

821

4523

1.94

61.20

7.3

3.6

2.09

2.01

mmol/l

0.26

671

3662

Unknown and unspecified causes of morbidity

399

1667

2.58

61.17

5.4

3.1

1.73

1.76

mmol/l

0.05

318

1305

Duodenal ulcer

709

3737

2.05

61.13

5.1

3.6

1.39

1.90

mmol/l

2.49

556

2967

Disorders of the thyroid gland

5044

25784

1.30

60.96

4.2

4.0

1.86

1.81

mmol/l

0.37

4129

21004

Other and unspecified injuries of head

410

1760

2.60

60.73

3.6

4.4

2.11

1.90

mmol/l

0.52

341

1401

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

590

2928

2.20

60.70

6.6

3.7

1.95

1.92

mmol/l

0.06

481

2371

Disorders of skin appendages

2283

15987

1.47

60.65

5.5

4.1

1.81

1.82

mmol/l

0.07

1900

13038

Benign neoplasm: Transverse colon

605

3039

2.19

60.48

5.2

3.5

1.76

1.97

mmol/l

0.65

500

2475

Exposure to other specified factors

3763

26768

1.35

60.38

4.5

4.2

1.77

1.80

mmol/l

0.16

3110

21889

Cervicobrachial syndrome

1079

6424

1.76

60.08

3.6

3.9

2.21

1.85

mmol/l

3.15

893

5215

Gingivitis and periodontal diseases

5073

20428

1.31

60.03

5.1

3.3

1.65

1.91

mmol/l

5.10

4171

16551

Migraine with aura

993

5760

1.79

60.01

3.2

4.0

1.72

1.78

mmol/l

0.21

822

4660

Cerebral palsy and other paralytic syndromes

687

3604

2.06

59.80

5.4

4.3

2.06

1.91

mmol/l

0.45

582

2883

Adrenocortical insufficiency

267

940

3.32

59.75

8.3

4.2

2.16

1.85

mmol/l

0.62

231

763

Lung transplant status

104

192

8.56

59.67

10.1

6.6

1.53

1.85

mmol/l

0.26

161

Lung transplantation

104

192

8.54

59.64

10.1

6.6

1.53

1.85

mmol/l

0.26

161

Sequelae of other external causes

348

1399

2.79

59.29

6.1

3.6

1.68

1.93

mmol/l

0.52

288

1102

Maltreatment syndromes

292

1066

3.01

59.20

3.2

4.3

1.68

1.78

mmol/l

0.18

231

866

Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)

651

3380

2.10

59.10

6.3

3.6

1.19

1.91

mmol/l

4.98

533

2724

Pneumocystosis

168

457

4.94

59.06

10.2

3.9

1.92

2.00

mmol/l

0.11

138

362

Other eating disorders

286

1033

3.03

59.00

5.7

4.7

1.69

1.45

mmol/l

0.43

241

821

Arthropathies in other diseases classified elsewhere

273

981

3.22

58.70

10.3

3.5

1.15

1.76

mmol/l

1.45

236

784

Other specified/unspecified arthritis

1398

8941

1.63

58.57

4.9

3.8

1.87

1.92

mmol/l

0.19

1169

7248

Exclusions for E4_PCOS_CONSORTIUM

3444

16083

1.37

58.55

4.8

4.0

1.95

1.91

mmol/l

0.32

2866

13145

Need for other prophylactic measures

392

1684

2.63

58.51

11.3

4.2

1.15

1.87

mmol/l

2.70

338

1339

Ulcerative colitis

1249

7778

1.68

58.51

5.0

4.1

1.70

1.84

mmol/l

0.62

1000

6329

Fentanyl

614

3121

2.12

58.33

5.1

3.2

2.85

1.92

mmol/l

6.88

492

2495

Coxarthrosis [arthrosis of hip](FG)

2963

15702

1.41

58.33

3.7

3.6

1.98

1.88

mmol/l

0.75

2458

12787

Mental and behavioural disorders due to tobacco

487

2280

2.33

58.05

5.5

3.8

2.20

1.87

mmol/l

0.83

413

1849

Lumbar disc prolapse

3178

18746

1.38

57.78

3.9

1.91

1.80

mmol/l

0.89

2573

15421

Malignant neoplasm of bladder

513

2474

2.31

57.72

5.1

3.6

1.41

1.88

mmol/l

1.99

443

1925

Benign neoplasm of other and ill-defined parts of digestive system

980

5787

1.80

57.65

4.8

3.8

1.88

1.96

mmol/l

0.28

816

4707

Toxic effect of ethanol

275

995

3.11

57.53

5.5

4.2

1.43

1.88

mmol/l

1.02

212

781

Somnolence, stupor and coma

307

1180

2.94

57.48

5.7

3.9

2.32

1.85

mmol/l

1.13

248

934

Pain in thoracic spine

748

4079

1.93

56.65

3.9

4.0

2.13

1.88

mmol/l

1.30

615

3299

Secondary right heart disease

320

1277

2.91

56.62

5.4

3.7

3.00

1.91

mmol/l

3.20

254

1002

Erosion of teeth

166

457

4.63

56.45

22.7

3.3

1.34

1.86

mmol/l

1.09

153

364

Smoking dependency

487

2309

2.30

56.25

5.5

3.7

2.20

1.89

mmol/l

0.78

413

1868

Other pulmonary heart/vessel disease

351

1469

2.75

56.09

5.3

4.0

2.92

1.88

mmol/l

3.24

277

1153

Other postsurgical states

413

1843

2.49

55.95

4.9

3.9

2.21

1.88

mmol/l

1.26

338

1439

Migraine without aura

806

4495

1.86

55.79

4.4

4.5

1.63

1.75

mmol/l

0.46

643

3625

Other degenerative diseases of the nervous system

1405

6830

1.62

55.67

3.4

3.6

2.01

1.80

mmol/l

1.19

1164

5471

Urolithiasis

1786

12198

1.53

55.60

4.8

4.0

1.63

1.80

mmol/l

1.10

1457

9896

Non-follicular lymphoma, hilmo, excluding all cancers

573

2908

2.15

55.55

5.6

3.6

1.99

1.97

mmol/l

0.02

474

2356

Arterial embolism and thrombosis

404

1793

2.51

55.52

7.1

3.3

1.48

2.02

mmol/l

1.55

324

1393

Budesonide

679

3619

1.99

55.40

4.7

3.6

1.49

1.89

mmol/l

1.89

544

2949

Additional codes for the location of defect, injury or illness

369

1578

2.62

55.26

4.4

3.8

1.78

1.91

mmol/l

0.33

301

1263

Asthma and allergy, excluding more controls

560

2742

2.10

55.19

4.3

3.6

1.82

1.54

mmol/l

0.89

464

2174

Malignant neoplasm of digestive organs

2151

14998

1.47

55.11

3.8

1.94

1.89

mmol/l

0.24

1663

12184

Umbilical hernia

1427

9316

1.60

55.06

5.3

4.0

1.75

1.81

mmol/l

0.26

1211

7607

Event of undetermined intent

384

1668

2.54

54.96

4.7

4.2

1.83

1.88

mmol/l

0.11

324

1329

DVT of lower extremities

1081

6632

1.72

54.79

4.6

3.6

1.95

1.89

mmol/l

0.21

901

5355

Congenital malformations of heart and great arteries

821

4537

1.88

54.71

6.7

6.2

1.58

1.66

mmol/l

0.26

697

3644

Neuromuscular dysfunction of bladder

530

2622

2.19

54.66

6.0

3.5

1.65

1.99

mmol/l

1.11

429

2125

Left side

121

12.98

54.64

4.1

4.4

2.28

1.90

mmol/l

0.48

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

467

2208

2.32

54.62

6.1

3.6

2.08

1.98

mmol/l

0.24

385

1787

Fracture of foot, except ankle

1146

7111

1.68

54.41

5.9

4.1

1.94

1.85

mmol/l

0.33

970

5777

severe traumatic brain injury, does not include concussion

1267

8095

1.65

54.36

4.1

3.9

1.94

1.84

mmol/l

0.46

1061

6479

Lung diseases due to external agents

845

4886

1.85

53.88

4.7

3.6

2.53

1.86

mmol/l

5.85

715

3878

Coxarthrosis

2762

13725

1.40

53.86

3.7

3.6

1.94

1.92

mmol/l

0.08

2288

11129

Benign neoplasm: Ascending colon

719

3983

1.94

53.16

5.2

3.6

1.68

1.96

mmol/l

1.35

607

3260

Arthropathies

4971

19967

1.29

53.11

4.5

4.0

1.75

1.79

mmol/l

0.28

4047

16181

Degeneration of macula and posterior pole

2558

15423

1.42

52.88

4.2

3.5

1.78

1.97

mmol/l

1.75

2072

12564

Gonarthrosis [arthrosis of knee](FG)

4031

18330

1.32

52.87

3.4

3.6

2.02

1.88

mmol/l

1.60

3307

14976

Lung cancer and mesothelioma

999

5138

1.75

52.85

3.4

3.2

2.44

1.50

mmol/l

11.13

840

4104

Blood alcohol or alcohol intoxication level

185

562

3.85

52.78

5.6

3.9

1.71

mmol/l

0.00

139

445

Other specific joint derangements/joint disorders

3644

18664

1.34

52.73

4.1

3.9

1.74

1.81

mmol/l

0.49

3024

15191

Drug-induced hypoglycaemia without coma

159

446

4.50

52.57

8.3

3.8

1.18

1.91

mmol/l

1.45

131

354

Calculus of kidney and ureter

1641

11150

1.54

52.50

4.8

4.1

1.66

1.83

mmol/l

0.98

1340

9031

Other skin changes

938

5616

1.78

52.49

5.9

3.9

1.88

1.92

mmol/l

0.14

774

4544

Social phobias

369

1587

2.46

52.47

4.5

3.9

1.80

1.85

mmol/l

0.09

302

1288

Familial hypercholesterolemia

856

4999

1.82

52.20

4.4

3.4

1.90

1.92

mmol/l

0.05

679

4001

Crohn disease

675

3667

1.95

52.09

6.0

4.2

1.48

1.84

mmol/l

1.62

567

2977

Injuries to the elbow and forearm

3502

24263

1.33

51.98

4.5

4.1

1.78

1.89

mmol/l

1.05

2903

19813

Left ventricular outflow tract obstruction (LVOTO), broad definition

616

3277

2.04

51.90

6.8

5.2

1.66

1.82

mmol/l

0.52

518

2649

Hypoplasia of dental enamel, including avohilmo

195

714

6.25

51.80

31.9

7.4

1.23

1.26

mmol/l

0.07

183

564

Mixed hyperlipidaemia

277

1068

2.94

51.74

5.0

3.2

1.44

2.22

mmol/l

2.73

227

848

Right side

190

9.00

51.50

4.0

3.7

1.98

1.99

mmol/l

0.01

153

Benign neoplasm: Sigmoid colon

1014

6235

1.73

51.36

4.5

3.8

1.69

1.96

mmol/l

1.32

844

5061

Injuries to the wrist and hand

5083

29499

1.27

51.30

4.1

4.2

1.87

1.79

mmol/l

0.74

4160

24145

Isolated proteinuria with specified morphological lesion

120

280

5.72

51.29

10.4

3.2

1.15

2.06

mmol/l

1.80

223

Other disorders of adrenal gland

312

1284

2.75

51.16

7.8

4.7

2.11

1.75

mmol/l

0.92

267

1038

Molar incisor enamel hypoplasia, with caries

179

626

6.65

50.90

30.1

5.3

1.16

mmol/l

0.01

163

495

Pneumonia due to Streptococcus pneumoniae

273

1052

2.90

50.64

5.1

3.3

2.24

1.72

mmol/l

1.40

226

809

Asthma and allergy

559

2822

2.04

50.61

4.2

3.7

1.82

1.53

mmol/l

0.96

463

2240

Diseases of pulp and periapical tissues, including avohilmo

5993

25305

1.25

49.91

4.5

3.9

1.69

1.87

mmol/l

2.92

4868

20698

Obsessive-compulsive disorder

302

1215

2.66

49.91

6.2

3.9

1.88

1.79

mmol/l

0.18

262

972

Other disorders starting during childhood or adolecense, excluding more controls

320

1286

2.63

49.68

10.9

7.7

1.04

1.34

mmol/l

0.89

266

1020

Alcohol-induced acute pancreatitis

261

1002

3.00

49.66

5.7

3.9

1.16

1.98

mmol/l

1.85

219

788

In situ neoplasms

1666

10905

1.51

49.63

4.4

3.5

1.68

2.01

mmol/l

2.76

1379

8875

Amputation of ankle bones

190

621

3.73

49.27

15.2

3.7

0.71

2.00

mmol/l

3.83

164

489

Type of accident

1427

9533

1.56

49.19

4.9

4.2

2.17

1.83

mmol/l

3.20

1146

7757

Dental pulpitis 4

5994

25352

1.25

49.11

4.6

3.9

1.69

1.87

mmol/l

2.88

4867

20739

Hypothyroidism, other/unspecified

4558

23896

1.28

48.75

4.2

4.0

1.86

1.82

mmol/l

0.28

3701

19501

Dental pulpitis 1

5986

25358

1.25

48.41

4.5

3.9

1.69

1.87

mmol/l

2.87

4861

20744

Other systemic involvement of connective tissue

1380

9193

1.56

48.34

4.3

3.6

2.17

1.95

mmol/l

1.50

1164

7474

Postprocedural disorders of digestive system, not elsewhere classified

241

902

3.11

48.33

9.0

4.2

1.59

1.96

mmol/l

0.71

199

705

Subjective visual disturbances

1183

7621

1.62

48.32

4.5

3.9

1.96

1.93

mmol/l

0.14

986

6214

Superficial injury of hip and thigh

811

4767

1.80

48.28

4.5

3.6

2.27

1.97

mmol/l

1.39

666

3818

Emotional disorders and disorders of social functioning with onset specific to childhood

350

1524

2.49

48.14

6.6

6.3

1.05

1.50

mmol/l

1.65

280

1229

Attention to artificial openings

269

1067

2.87

47.74

6.9

3.4

1.95

1.98

mmol/l

0.04

216

826

Gangrene, not elsewhere classified

149

7.67

47.68

10.0

2.9

0.42

1.73

mmol/l

1.42

Disorders of vitreous body and globe

2493

18045

1.39

47.59

5.5

3.8

1.86

1.97

mmol/l

0.89

2105

14802

Intestinal malabsorption

285

1159

2.75

47.49

12.0

3.7

1.01

1.92

mmol/l

3.15

247

916

Benign neoplasm of other and unspecified endocrine glands

640

3531

1.93

47.38

5.1

3.7

1.99

1.96

mmol/l

0.05

523

2893

Injuries to unspecified part of trunk, limb or body region

576

3088

2.01

47.24

5.7

4.3

1.54

1.90

mmol/l

1.42

489

2479

Cholecystitis

787

4623

1.81

47.14

4.6

3.6

1.92

1.90

mmol/l

0.04

655

3698

Pericarditis

227

827

3.08

46.95

7.6

3.1

2.05

1.75

mmol/l

0.57

191

645

Multiple myeloma, excluding all cancers (controls excluding all cancers)

317

1370

2.62

46.93

7.0

3.2

1.50

2.06

mmol/l

1.63

251

1093

Benign neoplasm: Transverse colon

605

3316

1.99

46.92

5.2

3.7

1.76

1.98

mmol/l

0.71

500

2705

Heartburn

505

2579

2.08

46.90

4.9

3.6

2.11

1.86

mmol/l

0.81

418

2101

Thoracic aortic aneurysm

774

4549

1.82

46.84

4.5

3.7

1.54

1.90

mmol/l

1.88

669

3671

Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers)

324

1416

2.59

46.80

6.3

3.2

1.62

2.03

mmol/l

1.02

267

1134

Multiple myeloma and malignant plasma cell neoplasms

314

1354

2.63

46.72

7.0

3.2

1.51

2.05

mmol/l

1.56

248

1080

Behavioural disorders, excluding more controls

144

398

4.11

46.70

3.9

4.9

1.92

1.50

mmol/l

0.73

119

326

Hypothyreosis and Thyroxine purchase for inclusion criteria

4687

24784

1.27

46.50

4.2

3.9

1.88

1.82

mmol/l

0.45

3798

20266

Haemolytic anaemias

260

1033

2.91

46.42

10.7

4.4

1.02

1.89

mmol/l

3.65

216

804

Disorders of vitreous body

2410

17494

1.39

46.30

5.4

3.8

1.85

1.97

mmol/l

0.93

2038

14352

Superficial injury of abdomen, lower back and pelvis

772

4521

1.80

46.28

4.5

4.2

1.83

mmol/l

0.00

645

3642

Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)

1035

6570

1.66

45.76

3.5

3.6

1.65

1.95

mmol/l

1.54

805

5331

Heart failure and hypertrophic cardiomyopathy

163

512

4.03

45.76

7.0

3.6

2.02

1.97

mmol/l

0.06

143

409

Abnormal serum enzyme levels

1690

11721

1.49

45.72

4.8

4.1

1.63

1.74

mmol/l

0.52

1386

9484

Fall on and from stairs and steps

1275

8459

1.57

45.66

4.0

4.1

1.81

1.90

mmol/l

0.36

1028

6864

Appendectomy

3011

22180

1.33

45.63

4.0

1.72

1.85

mmol/l

1.16

2502

18099

Personal history of risk-factors, not elsewhere classified

114

276

5.07

45.47

6.1

4.4

1.56

1.74

mmol/l

0.22

216

Arthrosis

3820

16403

1.31

45.43

3.7

3.6

2.05

1.89

mmol/l

1.89

3110

13359

Pyothorax

295

1254

2.68

45.41

5.4

3.7

2.08

2.03

mmol/l

0.07

243

981

Other maltreatment syndromes

197

677

3.26

45.20

3.7

3.8

1.49

2.00

mmol/l

0.85

159

543

Aortic valve malfunction, age under 60 years

536

2850

2.03

45.15

6.4

4.8

1.74

1.86

mmol/l

0.30

454

2311

Injuries to the neck

1065

6795

1.63

45.12

3.7

4.1

1.91

1.82

mmol/l

0.35

906

5481

Other diseases of hard tissues of teeth

3184

18250

1.33

45.01

8.4

3.3

1.57

1.88

mmol/l

5.28

2678

14857

Psychotic depression

311

1336

2.50

44.85

3.9

3.8

1.80

1.83

mmol/l

0.05

252

1097

Specific development disorders of speech and language

433

2070

2.23

44.80

6.9

7.1

1.08

1.55

mmol/l

1.59

348

1644

Benign neoplasm: Small intestine

273

1129

2.77

44.68

5.1

3.1

1.78

2.09

mmol/l

0.75

233

906

Other diseases of stomach and duodenum

384

1823

2.31

44.55

6.0

3.4

1.68

2.03

mmol/l

0.97

322

1469

Superficial injury of wrist and hand

930

5766

1.68

44.44

4.5

4.4

1.78

1.80

mmol/l

0.05

757

4685

Psoriasis

1390

9441

1.53

44.21

4.3

4.1

1.95

1.89

mmol/l

0.24

1135

7694

Previous suicide attempt

188

6.12

44.20

5.2

4.0

1.47

1.43

mmol/l

0.03

139

Thrombocytopenia, unspecified

439

2204

2.19

44.18

7.2

4.1

1.50

1.90

mmol/l

1.46

370

1743

Other renal tubulo-interstitial diseases

155

469

3.77

44.14

8.8

2.4

0.85

2.23

mmol/l

4.40

128

365

Rotator cuff syndrome

3133

17914

1.33

44.11

4.0

3.7

1.93

1.88

mmol/l

0.32

2536

14680

Mental retardation, excluding more controls

295

1250

2.63

43.81

6.6

7.0

1.87

1.46

mmol/l

1.27

243

988

Acute suppurative otitis media

1177

7186

1.58

43.78

7.4

4.6

1.35

1.60

mmol/l

1.64

963

5739

Complications of cardiac and vascular prosthetic devices, implants and grafts

168

547

3.71

43.72

13.7

3.7

0.91

2.10

mmol/l

3.35

138

425

Explicit fungal Sepsis

142

7.80

43.49

20.3

3.2

1.96

1.70

mmol/l

0.23

111

Non-follicular lymphoma

573

3171

1.96

43.00

5.6

3.8

1.99

2.00

mmol/l

0.03

474

2555

Infection of intervertebral disc (pyogenic)

122

329

4.77

42.93

8.2

4.0

1.45

2.04

mmol/l

0.63

106

254

Other symptoms and signs involving general sensations and perceptions

265

1098

2.72

42.84

4.0

2.05

1.89

mmol/l

0.30

227

886

SLE (Finngen)

212

782

3.03

42.80

5.0

3.4

1.79

1.98

mmol/l

0.28

173

641

Status epilepticus

257

1052

2.76

42.69

6.0

4.7

1.54

1.84

mmol/l

0.62

209

826

Other ulcerative colitis

323

1452

2.42

42.52

6.0

3.8

1.81

1.96

mmol/l

0.32

261

1159

Acute posthaemorrhagic anaemia

240

952

2.85

42.48

7.0

3.1

1.27

2.08

mmol/l

2.62

188

744

Cervicalgia

990

6311

1.63

42.22

4.1

3.8

1.83

1.86

mmol/l

0.08

828

5115

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

113

288

4.81

42.20

4.7

4.6

1.71

1.82

mmol/l

0.11

226

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

1579

11034

1.47

42.10

4.5

4.3

1.79

1.77

mmol/l

0.09

1333

8949

Symptoms and signs involving speech and voice

1585

11158

1.47

41.78

4.2

3.9

2.01

1.92

mmol/l

0.49

1305

9092

Benign neoplasm: Adrenal gland

397

1962

2.20

41.38

4.5

3.6

1.91

2.03

mmol/l

0.23

328

1625

Microscopic polyangiitis

169

7.64

41.11

13.6

4.7

1.32

1.92

mmol/l

0.70

135

Other inflammatory liver diseases

371

1791

2.25

41.06

4.0

3.7

1.63

1.93

mmol/l

0.88

298

1452

Abnormal findings on diagnostic imaging of other body structures

653

3794

1.83

40.77

5.1

3.7

1.95

1.92

mmol/l

0.07

550

3092

Protozoal diseases

204

768

3.11

40.73

9.4

3.5

1.93

1.95

mmol/l

0.03

167

606

Disorders of oesophagus in diseases classified elsewhere

164

549

3.58

40.71

7.1

3.4

2.33

2.20

mmol/l

0.15

134

426

Mixed disorders of conduct and emotions, excluding more controls

139

410

3.76

40.70

5.8

5.9

1.44

1.52

mmol/l

0.11

114

336

Benign neoplasm: Rectum

895

5648

1.67

40.64

4.7

3.7

1.98

1.94

mmol/l

0.12

742

4619

Reimbursement for rheumatic diseases

2812

21644

1.33

40.60

4.9

4.0

1.92

1.90

mmol/l

0.11

2317

17736

Viral warts

520

2824

1.96

40.58

9.8

4.2

1.60

1.86

mmol/l

0.92

427

2274

Diseases of the ear and mastoid process

6225

26228

1.22

40.55

4.4

4.1

1.79

mmol/l

0.03

5116

21364

Pruritus

546

3011

1.92

40.45

6.3

3.7

1.63

1.99

mmol/l

1.53

462

2430

Unspecified jaundice

309

1399

2.43

40.35

6.1

3.7

1.36

1.83

mmol/l

1.14

245

1101

Gonarthrosis

3441

15471

1.30

40.35

3.4

3.6

2.00

1.91

mmol/l

0.76

2821

12582

Deforming dorsopathies

1320

9026

1.51

40.34

4.3

4.0

2.19

1.86

mmol/l

2.52

1097

7337

Other disorders of eye and adnexa

692

4095

1.78

40.14

5.1

4.3

2.06

1.86

mmol/l

0.80

586

3334

Immunodeficiencies

306

1388

2.45

40.11

11.1

4.6

1.74

1.79

mmol/l

0.08

253

1097

Benign neoplasm: Ascending colon

719

4337

1.77

39.67

5.2

3.7

1.68

1.97

mmol/l

1.43

607

3513

Progressive vascular leukoencephalopathy

257

1104

2.72

39.43

2.8

3.0

1.38

2.05

mmol/l

1.81

219

873

Other Crohn's disease

358

1724

2.23

39.42

6.4

4.0

1.08

1.99

mmol/l

4.06

304

1394

Vitamin deficiency

291

1299

2.47

39.37

5.9

3.6

1.29

1.79

mmol/l

1.07

235

1019

Vitamin deficiency, wide

291

1299

2.47

39.37

5.9

3.6

1.29

1.79

mmol/l

1.07

235

1019

Pure hyperglyceridaemia

161

541

3.46

39.16

4.9

3.5

1.46

2.11

mmol/l

1.23

130

423

Dronedarone medication

189

693

3.12

39.15

3.7

2.8

1.80

1.91

mmol/l

0.19

162

545

5-aminosalicylic acid

960

6177

1.61

39.05

4.9

3.8

1.63

1.76

mmol/l

0.53

777

5022

Benign neoplasm: Small intestine

273

1203

2.58

38.94

5.1

3.6

1.78

1.97

mmol/l

0.37

233

957

Crohn's disease NAS

360

1751

2.22

38.86

6.7

4.6

1.19

1.93

mmol/l

2.78

298

1413

Other and unspecified tonsillitis

1462

8651

1.47

38.79

5.6

4.1

1.65

1.61

mmol/l

0.18

1193

6977

Childhood asthma (age<16), excluding more controls

511

2167

1.93

38.78

5.1

4.1

1.46

1.37

mmol/l

0.22

413

1705

Malignant neoplasm of skin, excluding all cancers (controls excluding all cancers)

2704

14173

1.34

38.76

4.3

3.8

1.73

1.96

mmol/l

2.54

2251

11607

Small fibre neuropathy

197

749

3.07

38.60

6.6

3.9

1.94

1.98

mmol/l

0.05

168

601

Carpal tunnel syndrome

2864

20092

1.31

38.55

4.0

3.7

2.04

1.91

mmol/l

1.14

2374

16562

Papulosquamous disorders

1890

13889

1.40

38.54

4.2

4.0

1.93

1.91

mmol/l

0.09

1546

11366

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

470

2527

2.01

38.53

6.0

3.3

1.71

2.03

mmol/l

1.03

393

2000

malignant neoplasm of female genital organs, excluding all cancers (controls excluding all cancers)

835

5143

1.67

38.49

3.5

3.3

2.14

2.19

mmol/l

0.12

688

4267

Superficial injury of thorax

764

4695

1.71

38.43

5.3

3.9

1.97

1.91

mmol/l

0.18

646

3785

Benign intracranial hypertension

158

6.03

38.42

5.1

4.2

-0.31

1.86

mmol/l

2.67

120

Cholangitis (primary sclerosing, PSC), with reimbursement 202

151

498

3.63

38.41

10.8

5.4

0.89

1.72

mmol/l

1.80

133

400

Benign neoplasm: Rectum, anus and anal canal

995

6516

1.60

38.31

4.7

3.7

1.93

1.94

mmol/l

0.05

821

5315

Malignant neoplasm of urinary organs

586

3380

1.87

38.29

6.3

3.7

1.23

2.01

mmol/l

4.96

472

2695

Drug-induced cataract

180

656

3.23

38.29

13.8

3.6

1.38

2.00

mmol/l

1.31

150

524

Other arthrosis

2668

14655

1.33

38.21

3.7

3.6

1.98

1.92

mmol/l

0.30

2198

11955

Benign neoplasm: Caecum

541

3052

1.90

37.90

4.8

3.5

1.75

2.00

mmol/l

0.82

452

2501

Diplopia

676

4048

1.77

37.83

5.0

3.7

1.84

1.95

mmol/l

0.37

551

3284

Myocardial infarction, with ST-elevation

1019

6748

1.59

37.57

4.8

3.8

1.65

1.87

mmol/l

1.09

831

5398

Multiple myeloma and malignant plasma cell neoplasms

314

1489

2.37

37.43

7.0

3.6

1.51

1.98

mmol/l

1.27

248

1179

Other diseases of lip and oral mucosa

783

4870

1.68

37.37

5.4

3.3

1.82

2.03

mmol/l

0.92

666

3965

Other epidermal thickening

270

1197

2.50

37.36

6.0

3.8

2.16

1.89

mmol/l

0.63

214

946

Unspecified misadventure during surgical and medical care

320

1522

2.32

37.27

5.9

3.6

1.98

2.01

mmol/l

0.05

262

1213

Dissocial personality disorder

124

366

3.99

37.25

4.3

3.5

1.44

1.86

mmol/l

0.47

297

Conductive and sensorineural hearing loss

4180

23524

1.25

37.24

4.1

4.0

1.99

1.89

mmol/l

1.08

3412

19296

Benign neoplasm: Descending colon

377

1906

2.16

37.22

5.4

3.4

1.98

2.00

mmol/l

0.04

308

1552

Childhood asthma (age<16)

512

2205

1.90

37.13

5.1

4.2

1.47

1.37

mmol/l

0.25

414

1741

Complications of internal orthopaedic prosthetic devices, implants and grafts

1147

7790

1.54

37.06

4.8

3.3

1.97

1.99

mmol/l

0.06

931

6323

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)

374

1889

2.16

36.99

4.6

3.4

1.11

1.94

mmol/l

3.85

287

1498

Migraine with aura and triptan purchases

571

3256

1.82

36.99

2.9

4.2

1.78

1.80

mmol/l

0.05

468

2652

Cerebral cysts

310

1455

2.31

36.83

6.3

3.9

1.40

1.87

mmol/l

1.23

235

1152

IBD patients in KELA-register

1045

6953

1.55

36.58

4.9

4.2

1.50

1.83

mmol/l

1.97

846

5674

Colitis, primary sclerosing

112

314

4.30

36.58

6.4

4.7

0.40

1.78

mmol/l

3.23

250

Other disorders of ear

4807

26421

1.23

36.56

4.2

4.1

1.88

1.85

mmol/l

0.26

3935

21657

Thyroiditis, ILD-related definition

533

3004

1.87

36.54

4.6

3.9

1.98

1.88

mmol/l

0.25

445

2449

Melanocytic naevi

1219

8372

1.50

36.34

5.6

3.9

1.56

1.88

mmol/l

2.61

1004

6819

ILD-related respiratory insufficiency

234

998

2.72

36.32

6.1

3.6

2.91

1.99

mmol/l

2.45

193

775

Open wound of forearm

491

2716

1.93

36.29

4.8

3.9

1.47

1.89

mmol/l

1.94

401

2174

Pyogenic arthritis

392

2020

2.09

36.26

6.5

3.7

1.66

1.95

mmol/l

0.85

322

1598

Disorders of sclera, cornea, iris and ciliary body

2572

19918

1.32

36.17

5.4

3.9

1.88

1.87

mmol/l

0.02

2120

16278

Acute gastritis

429

2281

2.02

36.07

4.5

3.4

1.87

1.97

mmol/l

0.22

346

1837

Thyrotoxicosis

1118

7573

1.53

36.03

4.0

3.8

2.00

1.98

mmol/l

0.06

921

6204

Acute bronchiolitis

462

2268

2.00

35.88

8.7

7.9

1.60

1.30

mmol/l

1.13

383

1792

Other arterial embolism and thrombosis

195

761

2.91

35.82

7.8

3.4

1.61

2.17

mmol/l

1.00

161

596

Nontraumatic intracranial haemmorrhage

1058

7119

1.55

35.74

4.4

3.6

1.98

1.92

mmol/l

0.24

884

5752

Any dementia, excluding more controls

1883

9663

1.40

35.70

3.3

3.6

2.05

1.86

mmol/l

1.33

1543

7758

Emotional disorders starting during childhood or adolescence

320

1529

2.26

35.70

6.4

6.3

1.03

1.49

mmol/l

1.62

256

1233

Nail disorders

433

2317

2.00

35.58

6.4

4.0

1.75

1.90

mmol/l

0.36

375

1886

Stomatitis and related lesions

425

2256

2.00

35.56

10.0

3.4

1.65

1.95

mmol/l

0.73

348

1824

Anosmia

193

4.72

35.48

3.5

1.7

2.39

2.42

mmol/l

0.03

160

Oesophagitis

324

1576

2.25

35.42

6.5

3.6

1.48

1.98

mmol/l

1.31

277

1251

Other or ill-defined heart diseases

276

1251

2.37

35.42

6.6

3.6

1.58

1.75

mmol/l

0.30

233

974

Benign neoplasm: Stomach

489

2725

1.92

35.41

4.7

3.5

1.86

2.02

mmol/l

0.43

400

2242

Benign neoplasm of other and unspecified endocrine glands

640

3845

1.76

35.40

5.1

3.9

1.99

1.96

mmol/l

0.05

523

3145

Other disorders of electrolyte and fluid balance, not elsewhere classified

193

5.48

35.29

7.6

3.0

3.06

2.27

mmol/l

0.77

155

Disorders of ocular muscles, binocular movement, accommodation and refraction

2163

16287

1.35

35.06

5.6

4.5

1.82

1.78

mmol/l

0.25

1768

13213

Conjunctivitis (acute, non atopic)

1320

9249

1.47

35.00

5.3

4.8

1.81

1.80

mmol/l

0.05

1093

7468

Evidence of alcohol involvement determined by level of intoxication

222

4.91

34.99

7.5

3.7

1.77

1.95

mmol/l

0.13

173

Systemic lupus erythematosus

212

867

2.71

34.96

5.0

3.4

1.79

1.98

mmol/l

0.28

173

703

Pneumonia derived septicemia

232

995

2.63

34.94

7.1

4.8

1.78

1.77

mmol/l

0.02

199

774

Amenorrhoea

283

1295

2.30

34.87

6.1

3.5

1.78

1.65

mmol/l

0.23

241

1036

Malignant neoplasm of kidney, except renal pelvis

533

3077

1.87

34.80

6.5

3.7

1.23

1.97

mmol/l

4.53

436

2459

SLE, strict definition

201

804

2.78

34.72

5.1

3.2

1.65

2.02

mmol/l

0.72

164

647

SLE, ICD10

201

804

2.78

34.72

5.1

3.2

1.65

2.02

mmol/l

0.72

164

647

Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)

2453

12947

1.33

34.60

4.2

3.8

1.73

1.96

mmol/l

2.53

2035

10617

Use of pramipexole

1088

7417

1.53

34.53

6.0

3.7

2.05

1.95

mmol/l

0.33

908

6044

Discitis, unspecified

132

429

3.70

34.53

7.1

3.7

1.55

1.95

mmol/l

0.52

113

340

Immunodeficiency with predominantly antibody defects

181

698

2.96

34.19

14.6

4.6

1.73

2.05

mmol/l

0.54

158

551

Urticaria and erythema

1629

11906

1.40

34.16

5.5

4.4

2.02

1.84

mmol/l

1.29

1344

9672

Psoriatic and enteropathic arthropathies

559

3259

1.80

34.15

3.9

3.8

2.25

1.87

mmol/l

1.70

459

2653

Suppurative and unspecified otitis media

1598

10282

1.41

34.15

6.3

4.4

1.48

1.67

mmol/l

1.38

1295

8277

Other congenital malformations of the digestive system

353

1804

2.19

34.15

13.6

7.0

1.18

1.44

mmol/l

0.84

292

1436

Acquired haemolytic anaemia

182

712

2.99

33.88

11.0

4.1

0.67

2.10

mmol/l

6.71

152

551

Wegener granulomatosis

131

430

3.67

33.76

9.3

3.8

1.72

1.95

mmol/l

0.33

119

340

Drug-induced neutropenia

378

1975

2.07

33.73

5.0

3.7

2.25

1.96

mmol/l

0.73

305

1620

Abscess of anal and rectal regions

420

2266

1.96

33.39

5.2

4.2

1.50

1.91

mmol/l

1.08

351

1831

Colorectal cancer

1233

8673

1.48

33.34

3.3

3.8

1.85

1.89

mmol/l

0.12

956

7051

Parodontitis, under 40 years, or operation codes

331

1634

2.11

33.28

9.0

4.0

1.13

1.56

mmol/l

1.05

273

1310

Fall on same level involving ice and snow

2682

21107

1.30

33.27

4.0

1.75

1.90

mmol/l

1.15

2259

17246

Retinal vascular occlusion

666

4121

1.72

33.27

5.5

3.5

1.78

2.00

mmol/l

0.83

539

3310

Ulcerative colitis, NAS

670

4128

1.70

33.22

5.3

4.2

1.69

1.88

mmol/l

0.58

520

3358

Parodontitis, operation under 40 years and operation codes

315

1530

2.14

33.11

9.1

4.1

1.07

1.54

mmol/l

1.10

259

1226

Manic episode

165

610

2.97

33.01

2.9

3.5

1.79

1.81

mmol/l

0.03

131

492

Other symptoms and signs involving the digestive system and abdomen

705

4395

1.67

33.00

5.7

3.7

1.92

1.90

mmol/l

0.05

587

3588

Collagenous colitis

454

2528

1.92

33.00

5.7

3.8

1.40

1.97

mmol/l

2.21

368

2063

Disorders of magnesium metabolism

151

6.22

32.97

10.4

3.5

3.19

2.24

mmol/l

0.70

117

Sensorineural hearing loss

3945

22609

1.24

32.87

4.0

2.00

1.89

mmol/l

1.17

3219

18551

Hyperosmolality and hypernatraemia

110

329

4.06

32.87

4.8

3.6

2.69

2.18

mmol/l

0.62

257

Other disorders of optic [2nd] nerve and visual pathways

368

1926

2.07

32.86

6.3

4.5

1.58

1.79

mmol/l

0.48

294

1536

Inflammatory bowel disease, strict (require KELA)

1045

7115

1.52

32.76

4.9

4.3

1.50

1.83

mmol/l

1.93

846

5801

Anorexia (incl.atypical)

286

1353

2.24

32.74

6.1

3.8

1.72

1.67

mmol/l

0.08

235

1087

1587

10332

1.41

32.63

3.8

3.4

2.01

1.97

mmol/l

0.15

1277

8373

Aneurysms, operations, SAH

800

5172

1.62

32.57

4.2

3.6

1.92

1.93

mmol/l

0.01

669

4176

Cyst of kidney

395

2131

2.02

32.36

6.8

3.3

1.64

2.00

mmol/l

1.21

332

1694

Parodontitis, under 40 years

328

1631

2.09

32.34

8.8

4.1

1.14

1.56

mmol/l

0.98

270

1308

Cramp and spasm

268

1257

2.34

32.27

4.4

4.3

1.83

1.92

mmol/l

0.12

222

1006

Parodontitis, under 40 years and operation codes

312

1526

2.13

32.20

9.0

4.1

1.09

1.54

mmol/l

1.04

256

1223

Psoriasis vulgaris

897

5959

1.57

32.14

4.7

4.1

1.88

1.89

mmol/l

0.04

733

4844

Osteoporosis with pathological fracture (FG)

391

2107

2.01

32.08

5.5

3.2

3.00

2.04

mmol/l

4.36

323

1743

Secondary and unspecified malignant neoplasm of lymph nodes

465

2642

1.89

31.92

4.9

3.7

1.97

1.95

mmol/l

0.05

381

2108

Retinal vascular disorders

670

4198

1.69

31.76

5.5

3.4

1.78

1.99

mmol/l

0.74

543

3372

Extrapyramidal and movement disorders

1828

13799

1.36

31.59

4.1

3.9

2.22

1.87

mmol/l

3.98

1529

11205

Hypothyroidism, strict autoimmune, 3 medication purchases required

4047

22723

1.23

31.43

4.1

3.8

1.90

1.84

mmol/l

0.41

3298

18598

Other aneurysm

324

1651

2.14

31.37

6.3

3.5

1.59

1.99

mmol/l

1.14

271

1286

Ingrowing nail

291

1419

2.21

31.37

6.3

4.1

1.65

1.90

mmol/l

0.59

254

1139

Benign neoplasm: Adrenal gland

397

2163

1.98

31.34

4.5

3.6

1.91

2.02

mmol/l

0.20

328

1756

Irregular menses

1677

10055

1.38

31.34

5.0

3.5

1.86

1.84

mmol/l

0.11

1368

8207

Agoraphobia

142

497

3.08

31.08

3.3

3.7

1.64

1.70

mmol/l

0.06

117

400

Dermatophytosis

670

4214

1.68

31.07

4.9

3.9

1.89

1.94

mmol/l

0.13

550

3400

Abnormal results of function studies

441

2479

1.89

31.05

6.9

4.2

1.99

1.88

mmol/l

0.24

364

1987

Hepatocellular carcinoma, excluding all cancers (controls excluding all cancers)

195

820

2.72

31.03

4.2

3.3

0.75

2.02

mmol/l

4.37

151

644

Background retinopathy and retinal vascular changes

150

554

3.14

31.00

8.4

3.4

1.44

2.04

mmol/l

1.20

125

442

Injury of unspecified body region

421

2342

1.93

30.97

5.7

4.2

1.56

1.86

mmol/l

0.88

353

1862

Pulmonary oedema

141

506

3.28

30.90

8.8

3.6

2.24

1.99

mmol/l

0.34

113

390

!Aliquae complicationes praecoces traumatis

245

1128

2.38

30.90

4.6

3.8

2.21

1.94

mmol/l

0.41

200

893

Early complications of trauma

245

1128

2.38

30.90

4.6

3.8

2.21

1.94

mmol/l

0.41

200

893

Diseases of salivary glands

862

5717

1.56

30.84

4.4

3.3

2.04

mmol/l

0.02

719

4624

Other benign neoplasms of skin

1666

12190

1.38

30.79

4.6

3.7

1.89

1.95

mmol/l

0.33

1379

9965

Radiculopathy

822

5413

1.58

30.72

4.3

3.8

2.13

1.84

mmol/l

1.47

682

4375

Leisure time condition

865

5762

1.56

30.67

4.9

4.0

2.08

1.89

mmol/l

0.93

694

4659

Hypertrophic cardiomyopathy

261

1245

2.34

30.63

7.0

4.0

1.81

1.84

mmol/l

0.04

227

979

Osteonecrosis

317

1615

2.13

30.58

6.8

3.5

2.08

1.91

mmol/l

0.29

267

1299

Bulimia nervosa (incl. atypical)

141

495

3.05

30.58

5.0

3.5

1.56

1.67

mmol/l

0.10

121

390

Corns and callosities

367

1961

2.01

30.57

7.6

3.4

1.80

1.99

mmol/l

0.41

291

1587

Disorders of synovium and tendon

2390

16851

1.30

30.33

4.2

3.7

1.94

1.86

mmol/l

0.44

1971

13783

Lichen simplex chronicus and prurigo

340

1776

2.06

30.33

6.7

3.7

1.62

2.02

mmol/l

1.12

282

1421

Acquired absence of organs, not elsewhere classified

103

312

4.03

30.30

10.0

3.8

1.71

1.86

mmol/l

0.16

236

Thyrotoxicosis, other and/or unspecified

853

5668

1.56

30.26

3.7

3.8

1.93

1.97

mmol/l

0.12

693

4636

Other diseases of oesophagus

514

3043

1.79

30.18

4.6

3.5

1.87

1.97

mmol/l

0.23

425

2425

Cluster headache, strict

180

732

2.67

29.68

3.4

3.5

1.57

2.11

mmol/l

1.08

151

577

Crohn's disease of small intestine

332

1728

2.04

29.57

6.4

4.1

1.44

1.92

mmol/l

1.40

284

1399

Melanocytic naevi of trunk

517

3072

1.76

29.55

5.9

3.7

1.31

1.87

mmol/l

2.95

425

2488

Orchitis and epididymitis

518

3095

1.78

29.53

5.6

4.4

1.74

1.79

mmol/l

0.11

414

2458

Acute nephritic syndrome

154

591

2.99

29.52

13.1

3.9

1.09

2.00

mmol/l

2.07

126

475

Memory loss

515

3085

1.79

29.40

3.1

3.5

1.59

2.01

mmol/l

1.55

423

2470

Other and unspecified visual disturbances

470

2736

1.82

29.34

5.9

3.8

2.01

1.94

mmol/l

0.15

398

2213

Disorders of muscles

491

2888

1.79

29.25

5.2

3.8

2.04

1.91

mmol/l

0.32

404

2327

Clear cell adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

264

1285

2.27

29.24

5.8

3.3

1.51

2.07

mmol/l

1.34

219

1045

Other joint disorders

4456

19772

1.22

29.24

4.2

3.9

1.77

1.79

mmol/l

0.12

3608

16024

Other disorders of bone

879

5920

1.54

29.23

4.3

3.8

1.53

1.86

mmol/l

1.90

720

4799

Speech disturbances, not elsewhere classified

473

2770

1.82

29.18

4.5

3.6

2.04

1.98

mmol/l

0.15

401

2220

Lesion of ulnar nerve

665

4227

1.64

29.17

4.0

3.8

2.21

1.82

mmol/l

1.76

527

3438

Sequelae of injuries, of poisoning and of other consequences of external causes

1058

7393

1.48

29.13

3.7

4.2

2.19

1.88

mmol/l

1.71

854

6051

Shock, not elsewhere classified

218

4.62

29.12

7.9

4.0

1.52

1.94

mmol/l

0.38

171

Magnesium deficiency

10.73

29.07

5.7

4.9

2.64

2.24

mmol/l

0.17

Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)

448

2587

1.85

29.02

3.3

1.98

1.99

mmol/l

0.00

373

2078

Familial hypercholesterolemia, with ischemic heart disease

520

3132

1.77

28.95

4.6

3.3

1.74

2.04

mmol/l

1.04

410

2518

Dental operations

3759

15837

1.24

28.88

4.5

3.5

1.86

1.87

mmol/l

0.04

3045

12813

Open wound of wrist and hand

1983

15140

1.32

28.85

4.0

4.3

1.79

1.74

mmol/l

0.25

1627

12357

Hypertension, Pulmonary Arterial

184

4.96

28.73

6.7

3.0

1.74

2.00

mmol/l

0.18

134

Secondary parkinsonism, excluding more controls

149

565

2.93

28.71

4.4

3.4

2.99

1.64

mmol/l

4.02

119

431

Arterial embolism and thrombosis of lower extremity artery

222

1016

2.42

28.64

6.7

3.5

1.50

2.09

mmol/l

1.18

175

786

Pneumococcal septicemia

216

981

2.46

28.58

6.3

5.1

1.73

1.87

mmol/l

0.19

184

772

Abdominal aortic aneurysm (AAA)

581

3574

1.70

28.52

5.3

3.5

1.51

1.79

mmol/l

0.88

452

2826

Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)

668

4293

1.64

28.47

4.8

3.4

1.74

1.94

mmol/l

0.74

534

3439

Colorectal adenocarcinoma, excluding all cancers (controls excluding all cancers)

982

6819

1.50

28.47

3.0

3.7

1.83

1.92

mmol/l

0.29

760

5532

Congenital malformations of cardiac septa

461

2622

1.84

28.46

6.8

7.5

1.44

1.49

mmol/l

0.12

385

2081

Asthma and opportunity respiratory infection

271

1345

2.21

28.42

4.0

3.4

2.83

1.83

mmol/l

3.51

230

1070

Disorders of lacrimal system

1881

14452

1.33

28.36

5.0

3.8

1.98

1.96

mmol/l

0.09

1549

11827

Other acute viral hepatitis

268

4.06

28.35

4.7

3.6

1.25

2.11

mmol/l

1.30

216

Drug-induced adrenocortical insufficiency

129

463

3.28

28.35

10.3

4.2

2.66

1.88

mmol/l

1.76

119

372

Hemiplegia

290

1470

2.13

28.25

4.9

3.8

1.96

1.94

mmol/l

0.03

240

1148

Benign neoplasm: Rectum

895

6127

1.53

28.16

4.7

3.8

1.98

1.92

mmol/l

0.17

742

4987

Right hemicolectomy

349

1894

2.00

28.15

4.7

3.5

1.93

1.95

mmol/l

0.02

279

1504

Disorders of optic nerve and visual pathways

464

2723

1.80

28.05

6.2

4.4

1.70

1.80

mmol/l

0.22

376

2175

Evidence of alcohol involvement determined by blood alcohol level

105

334

3.64

28.03

4.8

3.9

1.61

1.79

mmol/l

0.18

259

Trochanteric bursitis

610

3834

1.66

27.98

3.9

3.4

2.02

2.06

mmol/l

0.09

505

3129

Symptoms and signs involving emotional state

168

684

2.70

27.92

6.5

4.8

1.51

1.66

mmol/l

0.19

146

541

Other symptoms and signs involving the nervous and musculoskeletal systems

1909

14721

1.33

27.91

4.7

4.2

2.27

1.84

mmol/l

6.17

1490

12010

Chronic hepatitis, not elsewhere classified

191

828

2.54

27.81

5.1

3.5

1.47

1.95

mmol/l

0.93

152

662

Other and unspecified epidermal thickening

173

721

2.70

27.79

5.3

4.2

2.21

2.02

mmol/l

0.30

135

571

Rheumatoid arthritis

1518

10297

1.37

27.70

3.7

3.5

2.12

1.97

mmol/l

0.76

1223

8348

Volvulus

166

679

2.74

27.65

6.1

3.4

2.20

1.96

mmol/l

0.33

137

520

Disturbance of activity and attention

452

2599

1.79

27.57

6.4

5.7

1.35

1.61

mmol/l

0.91

365

2102

Seborrhoeic keratosis

1071

7598

1.46

27.55

4.8

3.5

1.57

2.02

mmol/l

3.68

884

6188

Molar incisor enamel hypoplasia

290

1489

2.21

27.49

25.4

6.6

1.26

1.33

mmol/l

0.20

258

1173

Redundant prepuce, phimosis and paraphimosis

1032

7235

1.47

27.38

5.2

4.5

1.72

1.71

mmol/l

0.03

838

5886

Late syphilis

103

332

3.71

27.33

10.6

3.8

0.94

2.08

mmol/l

1.58

270

Herpesviral [herpes simplex] infections

530

3240

1.71

27.30

6.0

3.9

1.99

1.90

mmol/l

0.25

440

2600

Conduct disorder

143

546

2.92

27.26

4.0

6.2

1.91

1.61

mmol/l

0.51

119

439

Inflammatory diseases of the central nervous system

414

2374

1.85

27.23

4.8

4.1

1.50

1.96

mmol/l

1.69

353

1904

Migraine without aura and triptan purchases

558

3438

1.67

27.19

4.3

4.2

1.55

1.81

mmol/l

1.09

445

2803

Benign neoplasm: Rectum, anus and anal canal

995

6991

1.48

27.18

4.7

3.8

1.93

1.92

mmol/l

0.01

821

5666

Other specified disorders of kidney and ureter

202

912

2.46

27.01

10.9

3.8

1.43

1.94

mmol/l

1.33

172

720

Disorders of speech understanding and production

317

1669

2.07

26.99

7.3

7.0

1.21

1.46

mmol/l

0.60

257

1309

Paracetamol of NSAID medication

1093

3832

1.47

26.96

4.8

4.9

1.79

1.65

mmol/l

0.52

880

3107

Acute pharyngitis

648

4127

1.61

26.95

6.8

4.4

1.39

1.64

mmol/l

0.87

540

3307

Other symptoms and signs involving the circulatory and respiratory systems

301

1563

2.04

26.94

5.6

3.9

2.10

1.76

mmol/l

0.83

250

1207

Amyloidosis

131

484

3.08

26.89

6.8

3.2

2.27

2.23

mmol/l

0.04

112

378

Parkinson's disease, excluding more controls

649

4074

1.62

26.79

3.4

3.6

2.53

1.70

mmol/l

7.50

531

3248

Fracture at wrist and hand level

1542

11606

1.36

26.76

4.8

4.3

1.84

1.81

mmol/l

0.14

1290

9498

Benign neoplasm: Caecum

541

3365

1.71

26.71

4.8

3.7

1.75

1.99

mmol/l

0.81

452

2736

Vitamin B12 deficiency anaemia

570

3580

1.68

26.62

5.2

3.3

1.54

2.03

mmol/l

2.16

452

2867

Hypopituitarism

408

2356

1.86

26.62

7.0

5.5

1.87

1.76

mmol/l

0.28

330

1896

Benign neoplasm: Descending colon

377

2135

1.91

26.54

5.4

3.5

1.98

2.01

mmol/l

0.06

308

1706

Cluster headache, wide

189

827

2.46

26.53

3.3

3.6

1.72

2.02

mmol/l

0.49

157

651

Other disorders of lacrimal gland

1485

11147

1.37

26.50

5.4

3.8

1.94

1.98

mmol/l

0.15

1223

9116

In situ neoplasms

1666

12723

1.34

26.46

4.4

3.6

1.68

1.96

mmol/l

2.13

1379

10329

Mental and behavioural disorders due to hallucinogens

6.96

26.37

2.9

3.7

1.33

1.87

mmol/l

0.25

Rare circulating lymphoid malignancy, excluding all cancers (controls excluding all cancers)

215

1015

2.39

26.18

17.6

4.3

1.85

1.79

mmol/l

0.12

181

798

Behavioural disorders

144

564

2.85

26.17

3.9

5.8

1.92

1.60

mmol/l

0.56

119

444

Infective dermatitis

558

3497

1.67

26.14

5.2

3.8

2.07

2.01

mmol/l

0.14

456

2812

Other diseases of jaws

324

1743

1.97

26.12

4.4

3.3

2.04

mmol/l

0.00

265

1408

Panniculitis affecting regions of neck and back

202

918

2.38

26.08

4.3

3.7

2.17

1.90

mmol/l

0.48

163

733

Hodgkin lymphoma

168

709

2.62

26.07

5.3

3.3

1.95

1.87

mmol/l

0.11

142

572

Dental pulpitis 2

4019

17177

1.22

26.05

4.8

3.7

1.74

1.92

mmol/l

2.25

3239

13967

Erosion of teeth, including avohilmo

799

5214

1.52

25.91

7.9

3.2

1.55

1.89

mmol/l

1.82

667

4222

Use of biperiden

276

1420

2.09

25.78

3.2

3.8

2.72

1.99

mmol/l

2.20

236

1141

Chronic sinusitis

1900

14782

1.31

25.77

4.1

3.9

1.86

1.84

mmol/l

0.08

1557

12066

Malignant neoplasm of colon

775

5254

1.55

25.74

3.5

3.7

1.75

1.94

mmol/l

0.63

599

4230

Polycystic ovarian syndrome, consortium definition

2809

13681

1.26

25.72

4.2

3.4

2.11

1.94

mmol/l

1.70

2314

11232

Ovarian cyst

1511

6510

1.37

25.68

3.8

3.4

1.85

1.95

mmol/l

0.51

1251

5334

Benign neoplasm: Duodenum

168

722

2.65

25.59

4.8

3.2

1.61

2.04

mmol/l

0.82

143

575

Left ventricular outflow tract obstruction, narrow definition

315

1711

2.01

25.57

6.6

6.4

1.70

mmol/l

0.01

265

1359

Other mental disorders due to brain damage and dysfunction and to physical disease

595

3820

1.64

25.55

4.7

3.5

2.28

1.93

mmol/l

1.63

477

3069

Poisoning by medicine, drug-induced

297

3.67

25.42

3.4

3.3

1.38

2.22

mmol/l

1.04

235

Other disorders of eyelid

2153

16497

1.29

25.40

4.0

3.8

2.02

1.96

mmol/l

0.33

1805

13465

Amputation of thigh

193

881

2.46

25.37

8.2

3.3

1.18

2.03

mmol/l

1.76

153

676

Hyperkinetic disorders

496

2994

1.70

25.33

6.2

6.1

1.21

1.57

mmol/l

1.41

401

2422

Traumatic subarachnoid haemorrhage

203

941

2.36

25.24

5.4

3.3

1.81

1.82

mmol/l

0.01

178

709

Alzheimer disease, excluding more controls

883

4053

1.51

25.24

2.9

3.5

2.08

1.82

mmol/l

1.05

725

3214

Basal cell carcinoma, excluding all cancers (controls excluding all cancers)

2295

12587

1.29

25.22

4.0

3.7

1.69

1.98

mmol/l

3.30

1912

10315

IBD (strict) with PSC

211

4.30

25.22

5.6

5.5

0.91

1.51

mmol/l

0.76

168

Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere

370

2102

1.88

25.21

4.0

3.4

1.99

1.97

mmol/l

0.04

303

1652

Ocular pain

366

2071

1.87

25.12

5.1

4.3

2.01

1.89

mmol/l

0.29

313

1675

Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers

233

1144

2.23

25.11

4.1

3.1

1.83

2.07

mmol/l

0.32

189

909

Vascular syndromes of brain in cerebrovascular disorders

276

1443

2.09

25.10

4.0

3.6

2.20

2.02

mmol/l

0.37

220

1141

Filling of root of tooth

177

779

2.51

25.02

10.0

3.9

1.22

1.93

mmol/l

1.85

151

613

Amyloidosis, other/unspecified

111

391

3.27

25.01

7.3

3.0

2.04

2.38

mmol/l

0.45

308

Assault by sharp object

107

367

3.30

25.00

3.7

3.4

1.49

2.27

mmol/l

1.29

304

Necrotizing fasciitis

120

6.32

24.95

6.5

3.4

2.51

1.75

mmol/l

0.50

Diseases of spleen

123

461

3.09

24.88

7.0

3.4

1.89

2.00

mmol/l

0.12

369

Hypoplasia of dental enamel , including avohilmo

264

1371

2.20

24.83

25.0

6.8

1.24

1.42

mmol/l

0.61

237

1086

Urticaria

1257

9288

1.39

24.78

5.8

4.5

2.03

1.85

mmol/l

1.01

1039

7538

Abscess of lung

109

384

3.31

24.72

5.9

4.8

1.79

1.77

mmol/l

0.01

301

Secondary uncertain malignant neoplasm

652

4301

1.59

24.67

4.4

3.8

2.13

1.93

mmol/l

0.71

519

3450

Intracerebral haemorrhage

656

4330

1.59

24.66

4.8

3.5

1.99

1.92

mmol/l

0.21

556

3473

Erythema intertrigo

151

628

2.72

24.55

6.0

3.5

2.45

2.04

mmol/l

0.65

119

491

Prurigo nodularis

156

659

2.67

24.48

7.3

3.4

1.82

2.07

mmol/l

0.32

128

525

Cardiomyopathy, Hypertrophic obstructive

115

417

3.11

24.36

6.8

2.9

1.54

1.98

mmol/l

0.64

100

325

Otitis media, unspecified

576

3396

1.63

24.25

7.6

5.3

1.38

1.55

mmol/l

0.67

469

2693

Specific development disorders of scholastic skills

272

1410

2.06

24.22

10.3

6.4

0.58

1.57

mmol/l

2.94

217

1152

Carcinoma in situ of skin of other and unspecified parts of face

433

2616

1.78

24.19

4.9

3.3

1.53

2.03

mmol/l

1.66

359

2110

L01XE Protein kinase inhibitors

314

1732

1.96

24.13

5.5

3.7

1.92

2.01

mmol/l

0.13

240

1401

Hypermobility syndrome

214

1021

2.21

24.08

3.2

4.0

1.88

1.75

mmol/l

0.23

175

821

Ulcer of oesophagus

387

2266

1.82

24.04

4.5

3.6

2.19

1.93

mmol/l

0.61

317

1806

Basal cell carcinoma, including avohilmo, excluding all cancers (controls excluding all cancers)

2313

12737

1.28

24.01

4.0

3.7

1.71

1.97

mmol/l

2.76

1931

10438

Monoamine oxidase A inhibitors

529

3337

1.65

23.94

3.8

2.08

1.86

mmol/l

0.59

460

2737

Disorders of vestibular function (Vertigo)

2160

17142

1.28

23.93

3.5

3.8

2.01

1.96

mmol/l

0.25

1810

14025

Benign neoplasm: Stomach

489

3045

1.70

23.88

4.7

3.6

1.86

2.04

mmol/l

0.51

400

2482

Idiopathic pulmonary fibrosis

429

2595

1.77

23.85

4.3

3.5

2.32

1.88

mmol/l

1.33

351

2052

Other general symptoms and signs

253

1281

2.08

23.77

5.3

4.2

1.40

1.45

mmol/l

0.06

213

969

Contact with and exposure to communicable diseases

607

9146

0.65

23.74

8.0

4.6

1.34

1.62

mmol/l

1.22

461

7335

Other surgical follow-up care

168

736

2.48

23.71

4.4

3.5

1.88

1.90

mmol/l

0.01

140

580

Dental caries 2 and operation codes, only avohilmo

2309

17792

0.79

23.59

4.3

4.8

1.68

1.78

mmol/l

0.69

1938

14612

Other and unspecified abdominal hernia

233

1172

2.17

23.56

4.8

3.4

1.91

2.02

mmol/l

0.19

191

921

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

138

566

2.84

23.53

12.5

6.3

1.08

1.56

mmol/l

0.85

118

451

Weight loss

504

3175

1.68

23.52

5.1

4.3

2.34

1.91

mmol/l

1.75

411

2549

Open wound of abdomen, lower back and pelvis

169

748

2.47

23.46

3.9

4.4

1.88

1.78

mmol/l

0.13

138

600

Lymphoid leukaemia

319

1787

1.93

23.32

13.2

4.0

1.85

1.81

mmol/l

0.07

268

1428

Diseases of male genital organs

2997

12443

1.24

23.30

5.0

4.6

1.73

1.67

mmol/l

0.38

2421

10143

Pneumothorax

371

2163

1.82

23.29

4.7

3.7

2.21

1.70

mmol/l

1.63

303

1682

Benign neoplasm: Other and unspecified parts of small intestine

113

421

3.11

23.16

5.3

3.0

2.00

2.30

mmol/l

0.38

330

Localized swelling, mass and lump of skin and subcutaneous tissue

1417

10781

1.35

23.14

5.3

4.1

2.00

1.88

mmol/l

0.59

1149

8726

Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)

246

1272

2.11

23.08

6.4

3.2

1.80

2.04

mmol/l

0.42

201

1016

Diffuse large B-cell lymphoma, helper endpoint

246

1272

2.11

23.08

6.4

3.2

1.80

2.04

mmol/l

0.42

201

1016

Retinal detachments and breaks

1675

13053

1.32

23.03

5.5

3.6

1.69

1.93

mmol/l

2.04

1380

10668

Gonarthrosis,primary

4518

24301

1.19

23.03

3.4

3.9

2.08

1.87

mmol/l

3.54

3700

19926

Melanocytic naevi

1219

9074

1.38

23.01

5.6

4.0

1.56

1.92

mmol/l

3.30

1004

7346

Hodgkin lymphoma, hilmo

168

751

2.47

22.96

5.3

4.0

1.95

1.84

mmol/l

0.15

142

603

Accidental poisoning by and exposure to other and unspecified chemicals and noxious substances

189

883

2.32

22.94

5.7

4.4

1.81

1.83

mmol/l

0.02

157

710

Keratitis

1545

11901

1.33

22.93

5.1

3.9

1.91

1.89

mmol/l

0.12

1265

9707

Superficial injury of ankle and foot

512

3237

1.64

22.93

5.7

4.4

1.63

1.73

mmol/l

0.26

427

2601

Unspecified event, undetermined intent

147

620

2.62

22.91

4.9

4.4

1.81

1.89

mmol/l

0.09

123

494

Sarcoidosis

615

4063

1.58

22.88

5.3

3.7

1.75

1.98

mmol/l

0.83

507

3327

Other bursopathies

609

4015

1.58

22.82

4.2

3.8

1.90

1.95

mmol/l

0.12

497

3253

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

349

1985

1.85

22.80

10.5

7.6

1.01

1.39

mmol/l

1.37

292

1589

Cerebral aneurysm, nonruptured

401

2397

1.76

22.78

4.5

3.7

1.68

2.05

mmol/l

1.24

340

1958

Campylobacter enteritis

159

697

2.52

22.77

4.8

3.8

1.17

1.96

mmol/l

1.75

127

561

Papilloedema, unspecified

136

556

2.73

22.76

6.4

4.6

0.90

1.81

mmol/l

1.83

448

Rare circulating lymphoid malignancy

215

1074

2.24

22.69

17.6

5.0

1.85

1.70

mmol/l

0.32

181

842

Hyperaldosteronism

170

771

2.46

22.68

5.2

3.7

1.77

2.06

mmol/l

0.35

143

610

Mantle cell lymphoma, excluding all cancers (controls excluding all cancers)

108

399

3.19

22.68

4.5

3.3

2.04

2.20

mmol/l

0.20

323

Spondyloarthritis

808

5634

1.48

22.58

5.1

3.7

1.82

1.91

mmol/l

0.25

663

4548

Persons encountering health services in other circumstances

1608

12454

1.32

22.58

5.6

3.7

1.80

1.81

mmol/l

0.02

1297

10052

Encephalopathy

239

3.94

22.57

6.0

4.4

1.53

1.97

mmol/l

0.39

185

Benign neoplasm: Skin of other and unspecified parts of face

503

3189

1.65

22.54

4.3

3.5

2.08

1.96

mmol/l

0.36

414

2590

L04AC Interleukin inhibitors

226

1134

2.13

22.53

4.1

3.7

2.27

1.97

mmol/l

0.63

188

910

Squamous cell neoplasms and carcinomas of the skin

668

4524

1.55

22.52

4.8

3.5

1.74

1.90

mmol/l

0.54

534

3610

Calcinosis cutis

13.90

22.51

17.6

5.1

2.36

2.20

mmol/l

0.06

Benign neoplasm: Duodenum

168

765

2.49

22.48

4.8

3.5

1.61

2.03

mmol/l

0.81

143

614

Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)

609

4037

1.58

22.48

3.2

3.7

1.89

1.94

mmol/l

0.12

488

3279

Disorders of phosphorus metabolism and phosphatases

126

5.71

22.46

9.6

6.7

1.61

1.78

mmol/l

0.11

101

Bronchiectasis

410

2483

1.75

22.45

3.9

3.6

2.79

1.80

mmol/l

4.95

353

2003

Other congenital malformations

448

2767

1.70

22.43

6.7

6.2

1.58

1.62

mmol/l

0.07

376

2200

Parkinson's disease, strict definition, excluding more controls

593

3825

1.58

22.41

3.4

3.6

2.57

1.73

mmol/l

7.47

482

3046

Other noninfective disorders of lymphatic vessels and lymph nodes

186

873

2.32

22.41

5.6

3.5

2.70

1.83

mmol/l

1.81

155

706

Dementia, including avohilmo

2308

12867

1.27

22.40

3.2

3.7

2.06

1.91

mmol/l

1.08

1889

10399

Olecranon bursitis

328

1869

1.87

22.38

5.4

4.0

2.01

1.87

mmol/l

0.24

266

1491

Vascular dementia

484

2949

1.67

22.35

3.6

3.3

1.79

1.97

mmol/l

0.44

395

2319

Operations for atrial fibrillation

116

450

3.06

22.33

4.2

4.0

1.71

2.04

mmol/l

0.44

100

355

Nonsuppurative otitis media

1007

6292

1.42

22.30

7.0

4.6

1.75

1.64

mmol/l

0.50

802

5021

Vitamin D deficiency

109

403

3.04

22.28

7.5

3.5

1.61

1.71

mmol/l

0.09

317

Injuries involving multiple body regions

196

940

2.25

22.27

5.2

3.8

1.54

1.89

mmol/l

0.61

156

752

Other coagulation defects

335

1917

1.85

22.25

6.7

3.9

1.73

1.85

mmol/l

0.24

280

1521

Colitis, primary sclerosing, strict definition

224

3.91

22.25

6.9

4.3

0.66

1.76

mmol/l

2.03

176

Other and unspecified coagulation defects

237

1218

2.08

22.22

7.3

3.8

1.56

1.95

mmol/l

0.91

196

976

Donors of organs and tissues

237

3.71

22.21

2.4

2.6

2.06

1.48

mmol/l

0.96

186

Personal history of other diseases and conditions

493

3100

1.65

22.18

8.0

3.9

1.50

1.59

mmol/l

0.23

407

2442

Coxarthrosis, primary

2957

21337

1.23

22.15

3.7

3.8

1.99

1.93

mmol/l

0.40

2454

17433

Secondary thrombocytopenia

304

3.50

22.12

8.2

3.7

2.59

2.10

mmol/l

0.59

239

Psoriatic arthropathies

456

2832

1.68

22.11

3.9

3.8

2.30

1.98

mmol/l

1.09

370

2288

Hypersensitivity angiitis

136

5.39

22.10

16.9

4.0

1.34

2.15

mmol/l

0.82

103

Portal vein thrombosis

107

397

3.12

22.10

6.3

4.5

1.86

1.80

mmol/l

0.05

323

Clear cell adenocarcinoma of kidney

264

1423

2.03

22.06

5.8

3.7

1.51

2.02

mmol/l

1.17

219

1122

Unspecified dementia

608

3637

1.58

22.02

3.6

3.4

2.06

1.91

mmol/l

0.44

495

2868

Any dementia

1987

11162

1.29

21.93

3.2

3.6

2.06

1.91

mmol/l

0.90

1627

8971

Fracture of forearm

2485

19027

1.24

21.93

4.4

3.9

1.83

1.96

mmol/l

1.03

2082

15593

Nonhereditary hypogammaglobulinemia

237

3.83

21.92

14.1

3.7

1.73

2.26

mmol/l

0.60

190

Reactive arthropathies, FINNGEN

338

1949

1.83

21.81

4.5

3.8

1.75

1.85

mmol/l

0.21

275

1571

Impacted teeth

659

4119

1.53

21.80

5.8

4.3

1.52

1.58

mmol/l

0.16

544

3280

Systemic lupus erythematosus, unspecified

158

702

2.46

21.78

4.8

3.3

1.74

2.02

mmol/l

0.42

128

562

Other extrapyramidal and movement disorders in other diseases

1032

7575

1.41

21.73

4.3

3.9

1.99

1.91

mmol/l

0.32

867

6159

Mixed disorders of conduct and emotions

139

583

2.60

21.72

5.8

7.3

1.44

1.39

mmol/l

0.06

114

468

Dissection of aorta

189

909

2.28

21.64

4.4

3.4

1.70

2.10

mmol/l

0.67

158

709

Dental caries, including avohilmo

4353

19013

1.19

21.64

4.9

3.7

1.79

1.92

mmol/l

1.25

3503

15468

Fall involving bed

203

1011

2.25

21.63

6.1

4.5

2.30

1.94

mmol/l

0.67

172

794

Otitis externa

972

7062

1.42

21.62

5.0

4.3

1.72

1.86

mmol/l

0.56

796

5709

Mental retardation

295

1663

1.95

21.61

6.6

8.2

1.87

1.44

mmol/l

1.42

243

1306

Disorders of continuity of bone

408

2481

1.72

21.56

6.1

3.8

2.34

1.87

mmol/l

1.65

344

2012

1095

7696

1.40

21.50

3.7

3.4

2.16

1.99

mmol/l

0.85

894

6243

Congenital malformations of aortic and mitral valves

252

1348

2.04

21.49

6.4

6.1

1.88

1.76

mmol/l

0.20

212

1071

Other interventions on the root canals of the tooth

108

405

2.99

21.48

12.5

4.3

1.42

2.00

mmol/l

0.74

328

155

694

2.51

21.47

4.4

3.6

3.61

1.84

mmol/l

5.09

140

548

Wet age-related macular degeneration

915

6496

1.44

21.47

3.8

3.4

1.91

2.03

mmol/l

0.41

706

5286

Toxic effect of alcohol

130

535

2.70

21.43

6.7

3.8

1.27

1.88

mmol/l

0.73

107

427

Ulcerative enterocolitis

163

737

2.39

21.43

7.6

3.5

0.97

1.86

mmol/l

1.56

135

595

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

1487

10012

1.32

21.41

4.6

3.5

1.82

1.93

mmol/l

0.58

1213

8246

Recurring oral aphthae, including avohilmo

631

4253

1.54

21.39

7.1

4.0

2.04

1.86

mmol/l

0.63

514

3453

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

1281

9716

1.35

21.37

4.1

4.2

1.91

1.87

mmol/l

0.12

1045

7922

Malignant neoplasm of skin

3121

19669

1.22

21.30

4.0

3.7

1.75

1.95

mmol/l

2.38

2575

16015

Dental caries 1

4353

19035

1.18

21.29

4.9

3.7

1.79

1.92

mmol/l

1.27

3502

15489

Benign paroxysmal vertigo

1296

9869

1.35

21.25

3.6

3.8

2.04

1.98

mmol/l

0.26

1094

8074

Carcinoma in situ of skin

404

2477

1.74

21.24

4.5

3.3

1.77

2.01

mmol/l

0.58

345

2002

Other shoulder lesions

403

2453

1.71

21.15

3.9

3.8

1.92

1.91

mmol/l

0.02

346

1981

Follicular cysts of skin and subcutaneous tissue

810

5731

1.46

21.12

4.9

3.9

1.82

1.88

mmol/l

0.18

674

4655

Malnutrition

152

685

2.56

21.11

10.3

6.2

1.88

1.72

mmol/l

0.18

122

530

Post-traumatic wound infection, not elsewhere classified

151

670

2.49

21.09

4.2

3.7

1.82

1.95

mmol/l

0.11

121

542

Lesion of lateral popliteal nerve

255

1370

2.00

21.09

4.8

3.7

1.84

1.91

mmol/l

0.11

208

1103

Other/unspecified reactive arthropathies

312

1779

1.86

21.05

4.7

3.9

1.79

1.94

mmol/l

0.30

260

1429

Encephalitis

166

766

2.38

21.04

4.5

4.3

1.59

1.84

mmol/l

0.39

137

609

Dislocation, sprain and strain of joints and ligaments at neck level

583

3866

1.56

20.98

3.3

4.1

1.90

1.83

mmol/l

0.19

493

3114

Superficial injury of forearm

432

2684

1.68

20.96

4.3

4.4

1.68

1.82

mmol/l

0.27

359

2170

Crohn's disease of large intestine

245

1299

2.00

20.85

5.8

4.0

0.99

1.95

mmol/l

2.98

204

1048

Faecal incontinence

379

2282

1.74

20.83

4.3

3.2

1.71

2.04

mmol/l

0.87

321

1895

Colon adenocarcinoma, excluding all cancers (controls excluding all cancers)

580

3873

1.57

20.80

3.1

3.5

1.62

1.99

mmol/l

1.38

445

3141

Melanocytic naevi of trunk

517

3358

1.60

20.79

5.9

3.8

1.31

1.91

mmol/l

3.30

425

2695

Injury of other and unspecified intrathoracic organs

326

1896

1.83

20.72

4.3

3.8

2.09

1.95

mmol/l

0.30

269

1488

Voice disturbances

1131

8470

1.37

20.71

4.1

3.9

1.99

1.95

mmol/l

0.15

916

6883

Fracture of neck

312

1799

1.86

20.62

4.1

3.7

2.24

1.97

mmol/l

0.58

259

1426

Other disorders of the musculoskeletal system and connective tissue

667

4581

1.51

20.61

3.5

3.8

2.10

1.96

mmol/l

0.42

539

3739

Henoch-Schönlein purpura nephritis (HSPN)

6.41

20.47

11.8

3.2

1.03

1.70

mmol/l

0.72

Assault by unspecified means

110

426

2.84

20.37

3.2

4.2

1.58

1.85

mmol/l

0.28

337

Carbimazole or st.post thyroidectomy, condition for graves disease

814

5793

1.44

20.37

3.4

3.7

2.03

2.01

mmol/l

0.07

674

4740

Recurrent and persistent haematuria

189

4.12

20.30

12.4

3.1

1.54

2.01

mmol/l

0.46

139

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

137

596

2.59

20.25

12.5

6.5

1.03

1.58

mmol/l

1.30

116

469

Atopic dermatitis, strict definition with reimbursement

1187

8687

1.35

20.13

4.5

4.8

1.48

1.71

mmol/l

1.31

964

6968

Colorectal adenocarcinoma

982

7256

1.40

20.07

3.0

3.7

1.83

1.93

mmol/l

0.32

760

5861

Iridocyclitis

995

7345

1.39

20.06

5.9

3.8

1.86

1.90

mmol/l

0.12

816

5985

Anuria and oliguria

168

4.44

20.05

15.7

3.4

0.84

1.74

mmol/l

0.92

127

Carcinoma in situ of skin of other and unspecified parts of face

433

2747

1.68

20.02

4.9

3.3

1.53

1.99

mmol/l

1.45

359

2205

Cardiomyopathy in other diseases

110

5.48

20.01

5.1

4.5

1.98

1.67

mmol/l

0.19

Certain conditions originating in the perinatal period

476

2709

1.63

19.98

7.9

6.4

1.41

1.42

mmol/l

0.02

388

2143

Rash and other nonspecific skin eruption

467

2998

1.63

19.95

5.3

4.3

1.54

1.91

mmol/l

1.47

391

2433

Other and unspecified types of non-Hodgkin lymphoma, hilmo

233

1244

2.03

19.93

4.1

3.6

1.83

2.05

mmol/l

0.28

189

986

Motor disorders, excluding more controls

163

747

2.48

19.85

8.6

9.5

0.76

1.15

mmol/l

0.75

132

591

Sleep disorders, other/unspecified

161

747

2.32

19.84

5.6

3.7

1.53

1.84

mmol/l

0.50

132

606

Excessive, frequent and irregular menstruation

1609

6974

1.30

19.82

4.7

3.4

1.95

1.92

mmol/l

0.10

1322

5686

Pregnancy hypertension

1295

8917

1.33

19.81

4.8

3.5

1.83

1.91

mmol/l

0.36

1046

7331

Benign neoplasm: Other and unspecified parts of small intestine

113

457

2.85

19.79

5.3

3.2

2.00

2.14

mmol/l

0.15

357

Other sleep disorders

501

3270

1.59

19.73

4.5

3.9

2.14

1.78

mmol/l

1.43

412

2605

Mental retardation, wide definition

303

1768

1.87

19.70

6.5

7.9

1.92

1.51

mmol/l

1.28

249

1390

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

159

748

2.38

19.61

6.8

3.3

1.11

2.07

mmol/l

2.03

124

583

Multiple myeloma

159

748

2.38

19.61

6.8

3.3

1.11

2.07

mmol/l

2.03

124

583

Toxic effect of carbon monoxide

111

445

2.82

19.54

3.3

3.5

2.18

1.93

mmol/l

0.32

348

Assault by blunt object

306

3.20

19.53

4.5

3.9

2.00

1.95

mmol/l

0.03

248

Artrosis, including avohilmo

4265

20141

1.18

19.52

3.5

4.1

2.05

1.80

mmol/l

4.26

3480

16480

Thrombotic microangiopathy

148

4.66

19.47

15.3

3.4

1.15

1.90

mmol/l

0.91

114

Generalized epilepsy

229

1219

2.01

19.47

4.1

5.8

1.18

1.69

mmol/l

1.26

182

971

Hepatomegaly and splenomegaly, not elsewhere classified

219

3.74

19.43

9.0

4.3

1.07

1.43

mmol/l

0.40

176

Enteropathic arthropathies

123

515

2.61

19.39

3.8

3.9

2.13

1.84

mmol/l

0.37

103

394

Spondylolisthesis/Spondylolysis

774

5514

1.45

19.37

3.9

2.08

1.87

mmol/l

0.84

632

4505

Lifestyle-related condition

283

3.37

19.35

10.2

3.5

1.70

2.01

mmol/l

0.37

218

Other encephalitis

155

721

2.36

19.32

4.7

4.1

1.57

1.83

mmol/l

0.37

129

572

Burns and corrosions

629

4322

1.51

19.31

4.1

4.7

1.87

1.78

mmol/l

0.22

512

3482

Inflammatory diseases of female pelvic organs

2238

13769

1.24

19.29

3.8

3.5

1.98

1.97

mmol/l

0.03

1864

11315

Diseases of inner ear

2496

20280

1.23

19.27

3.5

3.8

2.01

1.93

mmol/l

0.56

2067

16643

Other factor of the environment

305

3.25

19.27

10.3

3.5

1.68

1.89

mmol/l

0.23

236

Fibromyalgia

312

1816

1.78

19.20

3.1

3.3

2.33

1.95

mmol/l

1.05

257

1486

Undefined dementia

616

3879

1.52

19.18

3.6

3.2

2.06

1.98

mmol/l

0.21

502

3037

Haemorrhoids and perianal venous thrombosis

1288

9923

1.33

19.13

3.9

3.5

1.82

1.92

mmol/l

0.44

1063

8028

Other specified and unspecified disorders of eye and adnexa

199

1018

2.10

19.08

4.5

3.4

2.18

1.86

mmol/l

0.54

168

804

Benign neoplasm of mouth and pharynx

472

3067

1.60

19.02

3.8

3.6

2.11

1.93

mmol/l

0.48

399

2513

Reactive arthropathies

405

2539

1.66

19.02

4.7

3.8

1.83

1.91

mmol/l

0.17

331

2037

Abnormal blood-pressure reading, without diagnosis

198

1007

2.08

19.02

5.0

3.8

1.91

1.72

mmol/l

0.26

169

788

Diseases of middle ear and mastoid

2494

16915

1.22

18.99

5.6

4.2

1.62

1.75

mmol/l

1.12

2025

13683

Disorders of conjunctiva

3736

26837

1.18

18.95

4.6

4.2

1.78

1.82

mmol/l

0.28

3104

21888

Fissure and fistula of anal and rectal regions

1012

7550

1.37

18.91

4.0

3.7

2.08

1.89

mmol/l

0.81

831

6116

Seborrhoeic dermatitis

458

2968

1.62

18.83

4.5

4.1

1.97

1.95

mmol/l

0.04

372

2376

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

681

4765

1.47

18.83

5.0

4.2

1.74

1.80

mmol/l

0.18

538

3865

Hypothermia

118

497

2.68

18.79

5.4

4.0

1.52

1.92

mmol/l

0.43

399

Acute laryngitis and tracheitis

499

3225

1.57

18.78

6.9

4.4

1.49

1.64

mmol/l

0.41

408

2561

Neovascular glaucoma

222

1188

2.01

18.75

9.4

3.6

1.22

2.05

mmol/l

3.33

186

945

Superficial injuries involving multiple body regions

138

618

2.43

18.71

6.1

3.6

1.57

1.75

mmol/l

0.22

115

491

Infections with a predominantly sexual mode of transmission

1034

7727

1.36

18.71

5.0

3.9

1.44

1.81

mmol/l

2.38

863

6245

malignant neoplasm of female genital organs

655

4570

1.49

18.69

3.4

3.3

2.17

2.16

mmol/l

0.02

535

3794

Allergic contact dermatitis

523

3481

1.55

18.59

4.3

3.9

1.68

1.93

mmol/l

0.75

429

2829

Viral encephalitis, not elsewhere classified/unspecified

125

543

2.57

18.50

4.9

4.3

1.60

1.65

mmol/l

0.06

108

423

Acute appendicitis

3098

24777

1.19

18.49

4.0

1.79

1.80

mmol/l

0.10

2577

20264

Malignant neoplasm of respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

1162

7438

1.35

18.45

3.5

3.8

2.45

1.90

mmol/l

4.88

973

6035

Diseases of tongue

304

1793

1.79

18.32

4.0

3.2

1.94

2.10

mmol/l

0.29

258

1470

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

757

5425

1.43

18.28

5.1

4.2

1.67

1.81

mmol/l

0.46

600

4409

Dementia

2133

12069

1.25

18.25

3.2

3.7

2.09

1.90

mmol/l

1.33

1749

9738

Cluster headache, strict, including avohilmo

207

1086

2.02

18.18

3.3

3.4

1.59

2.03

mmol/l

0.92

172

865

Dental pulpitis 4, only avohilmo

5734

26425

1.14

18.14

4.0

4.1

1.74

1.85

mmol/l

1.30

4651

21671

Sequelae of injuries of lower limb

409

2601

1.64

18.11

4.0

3.8

1.91

1.94

mmol/l

0.05

336

2109

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2734

18140

1.21

18.10

3.9

3.7

1.75

1.96

mmol/l

2.20

2249

14764

Strabismus

1179

9039

1.33

18.10

5.4

4.8

1.83

1.80

mmol/l

0.09

958

7308

Other disorders of white blood cells

276

1594

1.84

18.09

6.5

4.0

1.70

1.86

mmol/l

0.28

226

1276

Dental pulpitis 2, only avohilmo

4017

17713

1.18

18.07

4.8

3.7

1.75

1.92

mmol/l

1.84

3235

14422

Ulcerative colitis (strict definition, require KELA)

700

4963

1.45

18.00

5.0

4.1

1.73

1.82

mmol/l

0.25

553

4034

Abnormal weight loss

443

2887

1.62

18.00

4.7

4.2

2.34

1.90

mmol/l

1.71

363

2302

Other follicular disorders

292

1706

1.79

17.98

5.9

3.8

2.01

1.88

mmol/l

0.24

238

1366

Dental caries 3

4534

20155

1.16

17.94

4.8

3.9

1.80

1.89

mmol/l

0.88

3654

16440

Cervical disc disorders

1616

12915

1.28

17.94

3.7

3.9

2.22

1.82

mmol/l

4.47

1314

10583

Foreign body in alimentary tract

284

1659

1.82

17.91

3.5

4.5

1.86

1.83

mmol/l

0.04

234

1299

Opening and dilatation of root channel of tooth

266

1516

1.84

17.91

8.8

3.7

1.39

1.99

mmol/l

2.20

221

1214

Dependent personality disorder

114

480

2.62

17.90

4.9

3.3

2.34

1.98

mmol/l

0.45

384

Somnolence

300

3.14

17.87

5.6

5.1

2.26

1.59

mmol/l

0.76

232

Car occupant injured in other and unspecified transport accidents

747

5359

1.43

17.86

3.6

4.0

1.69

1.87

mmol/l

0.70

620

4343

Other condition

599

4140

1.50

17.86

5.1

4.1

2.45

1.88

mmol/l

3.59

486

3346

Inflammatory disease of uterus

460

2999

1.58

17.86

3.4

3.6

2.04

1.90

mmol/l

0.35

387

2445

Pain associated with micturition

511

3425

1.55

17.85

6.5

3.8

2.17

1.93

mmol/l

0.83

411

2775

Dermatitis due to substances taken internally

260

1479

1.86

17.78

5.8

4.2

1.92

1.86

mmol/l

0.10

216

1166

Carcinoma in situ of skin of scalp and neck

149

714

2.36

17.76

4.7

3.2

1.46

2.03

mmol/l

0.96

121

571

Mucosal proctocolitis

521

3503

1.54

17.74

5.1

4.1

1.36

1.85

mmol/l

2.04

418

2849

Acute alcohol intoxication ICD-9

189

976

2.09

17.72

3.8

1.86

2.02

mmol/l

0.19

156

774

Non-Hodgkin lymphoma, all

227

1252

1.97

17.65

4.6

3.6

1.85

2.10

mmol/l

0.44

187

983

Alcoholic gastritis

383

2.86

17.65

6.3

3.8

1.33

1.86

mmol/l

0.57

311

Other abnormal findings in urine

104

427

2.78

17.62

5.9

4.1

1.10

1.93

mmol/l

1.28

331

Persistent delusional disorders

348

2147

1.70

17.60

3.1

3.5

2.55

1.97

mmol/l

1.65

277

1740

Left bundle-branch block

297

1756

1.77

17.57

4.3

2.9

1.65

1.84

mmol/l

0.35

244

1404

Cushing syndrome

249

3.36

17.48

4.0

3.5

2.39

1.99

mmol/l

0.33

193

Other diseases of upper respiratory tract

5897

27259

1.14

17.47

4.2

1.94

1.78

mmol/l

2.51

4831

22207

Syphilis

144

678

2.33

17.46

8.7

3.7

0.91

1.95

mmol/l

1.77

124

550

Diffuse large B-cell lymphoma

246

1396

1.91

17.45

6.4

3.8

1.80

2.01

mmol/l

0.35

201

1114

Complications of genitourinary prosthetic devices, implants and grafts

129

580

2.42

17.39

6.6

3.0

1.58

2.02

mmol/l

0.66

110

446

Cardiac murmurs and other cardiac sounds

432

2773

1.60

17.38

6.5

5.4

1.60

1.52

mmol/l

0.19

338

2194

Lymphoid leukaemia

319

1947

1.76

17.35

13.2

4.2

1.85

1.84

mmol/l

0.02

268

1540

Crohn disease (strict definition, require KELA)

271

1568

1.81

17.33

5.1

4.3

0.93

1.97

mmol/l

4.12

228

1268

Epileptic seizures related to drugs

6.85

17.29

4.3

3.7

2.88

2.44

mmol/l

0.21

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

288

1698

1.78

17.21

5.1

4.2

0.91

1.98

mmol/l

4.60

243

1373

Pain and other conditions associated with female genital organs and menstrual cycle

659

4449

1.45

17.21

3.7

3.5

1.85

1.75

mmol/l

0.31

545

3603

Crohn disease (strict definition, require KELA, min 2 HDR)

267

1542

1.82

17.20

5.1

4.3

0.92

1.97

mmol/l

4.14

226

1245

Other disorders of veins

1650

13276

1.27

17.17

4.0

3.6

2.11

1.97

mmol/l

0.82

1407

10855

Other congenital malformations of urinary system

154

4.49

17.15

22.3

8.6

0.30

1.26

mmol/l

1.21

120

Xerosis cutis

403

2.81

17.11

6.1

3.5

2.25

1.99

mmol/l

0.35

319

Hypoparathyroidism

188

984

2.07

17.06

6.5

3.6

2.61

1.98

mmol/l

1.35

168

796

2015

15620

1.24

17.04

4.1

3.6

1.97

1.94

mmol/l

0.13

1654

12651

Kela reimbursement Agammaglobulinemia (D80-84)

191

3.75

16.99

14.2

4.5

1.83

2.22

mmol/l

0.40

145

Drug-induced systemic lupus erythematosus

152

4.20

16.98

6.3

4.2

1.91

2.11

mmol/l

0.12

122

Trigger finger

582

4036

1.49

16.97

4.7

3.8

1.84

1.97

mmol/l

0.40

491

3281

Other specified/unspecified necrotizing vasculopathies

387

2.84

16.94

7.8

3.5

1.62

1.91

mmol/l

0.30

309

Other fall from one level to another

1042

7948

1.35

16.94

4.6

4.7

1.86

1.74

mmol/l

0.50

850

6412

Seropositive rheumatoid arthritis

1100

8426

1.33

16.92

3.7

3.5

2.02

1.97

mmol/l

0.15

882

6831

Other disorders of nervous system

313

1904

1.74

16.91

5.8

3.7

2.08

1.97

mmol/l

0.18

266

1531

Sulfasalazine

1167

9029

1.32

16.82

3.7

3.6

2.11

1.82

mmol/l

1.81

923

7333

Other disorders starting during childhood or adolescence

324

1981

1.73

16.81

11.0

7.8

1.05

1.38

mmol/l

1.09

269

1579

Appendicitis, broad definition

3295

25863

1.18

16.81

4.0

1.79

1.81

mmol/l

0.13

2733

21153

Single spontaneous delivery

1123

7768

0.76

16.78

2.8

3.8

2.20

1.93

mmol/l

1.65

926

6382

Cervicocranial syndrome

440

2894

1.57

16.70

4.5

3.8

2.25

1.93

mmol/l

1.14

365

2344

Postmenopausal osteoporosis with pathological fracture

306

1866

1.75

16.65

4.4

3.0

3.10

2.17

mmol/l

3.25

255

1548

Glaucoma secondary to other eye disorders

222

1235

1.93

16.65

9.4

3.7

1.22

2.09

mmol/l

3.62

186

977

Congenital malformations and deformations of the musculoskeletal system

445

2931

1.58

16.65

6.3

6.8

1.67

1.55

mmol/l

0.35

372

2341

Embolic stroke with flimmer

144

691

2.27

16.57

4.5

3.1

2.01

1.91

mmol/l

0.10

118

517

Endovascular or surgical operations to intracerebral aneurysms

294

1768

1.75

16.54

4.6

3.6

2.23

2.01

mmol/l

0.51

255

1458

Injury of intra-abdominal organs

135

632

2.32

16.54

5.3

3.7

2.05

1.88

mmol/l

0.17

120

499

Focal brain injury

295

1770

1.74

16.52

4.6

3.8

2.04

1.69

mmol/l

0.86

255

1388

Exclusion endpoint for clefts

157

790

2.24

16.51

8.6

9.3

1.80

1.35

mmol/l

0.87

139

633

Cluster headache, wide,, including avohilmo

216

1187

1.92

16.48

3.3

3.4

1.72

1.99

mmol/l

0.48

178

942

Ulcerative colitis (strict) with PSC

169

3.86

16.44

5.4

4.7

1.02

1.73

mmol/l

0.80

135

Congenital malformations of trachea and bronchus

291

3.22

16.40

8.9

7.5

2.34

1.80

mmol/l

0.91

236

Other forms of systemic lupus erythematosus

180

3.75

16.32

5.7

3.6

1.96

2.07

mmol/l

0.10

146

Malignant neoplasm of eye, brain and central nervous system, excluding all cancers (controls excluding all cancers)

329

2043

1.69

16.26

5.4

3.8

2.14

1.92

mmol/l

0.69

277

1640

Other abnormalities of plasma proteins

401

2.76

16.23

10.1

3.4

1.94

2.06

mmol/l

0.11

317

Biological medication for rheuma

598

4203

1.46

16.17

4.3

4.5

1.99

1.78

mmol/l

0.79

489

3421

Other symptoms and signs involving the urinary system

475

3208

1.54

16.16

5.2

3.8

1.98

1.90

mmol/l

0.19

376

2552

Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)

270

1595

1.78

16.15

3.5

3.3

2.54

2.15

mmol/l

0.83

226

1343

Disorders of refraction and accommodation

1098

8448

1.32

16.15

6.6

4.8

1.75

1.79

mmol/l

0.14

898

6830

Malignant neoplasm of endocrine gland, excluding all cancers (controls excluding all cancers)

344

2160

1.66

16.14

5.7

3.6

2.04

1.96

mmol/l

0.16

271

1785

Carcinoma in situ of skin of upper limb, including shoulder

138

666

2.33

16.11

5.4

2.9

1.42

2.09

mmol/l

1.04

110

532

Diseases of appendix

3315

26032

1.17

16.10

4.0

1.79

1.81

mmol/l

0.16

2750

21291

Mild mental retardation

163

833

2.15

16.09

6.9

6.3

2.08

1.68

mmol/l

0.74

136

667

Septal defects

399

2561

1.62

16.06

6.3

8.0

1.45

1.44

mmol/l

0.04

330

2029

Anterior Iridocyclitis

869

6510

1.37

16.04

6.2

3.9

1.95

1.92

mmol/l

0.10

717

5283

Diffuse brain injury

166

844

2.08

16.00

2.6

3.7

2.38

1.74

mmol/l

1.09

135

645

Diseases of external ear

1516

12203

1.27

16.00

4.7

4.3

1.76

1.84

mmol/l

0.42

1243

9919

Delayed milestone in childhood

242

1319

2.03

15.99

11.0

11.2

1.03

1.06

mmol/l

0.08

195

1026

Other enthesopathies

1203

9408

1.30

15.99

3.8

3.7

1.76

1.92

mmol/l

0.74

1008

7688

Basal cell carcinoma

2751

18642

1.20

15.95

3.8

3.7

1.70

1.96

mmol/l

3.30

2272

15161

Arthropathic psoriasis

478

3238

1.53

15.90

3.9

2.26

1.95

mmol/l

1.12

393

2636

Other/unspecified synovitis and tenosynovitis

487

3308

1.52

15.87

4.1

3.8

1.89

2.00

mmol/l

0.29

409

2665

Other specified/unspecified bacterial intestinal infections

310

1913

1.71

15.86

7.2

3.5

1.90

2.06

mmol/l

0.36

252

1539

Drug-induced osteoporosis with pathological fracture

102

438

2.66

15.82

9.5

3.2

2.85

2.14

mmol/l

1.03

354

Other and unspecified psoriasis

306

1883

1.71

15.80

4.4

3.9

1.95

1.99

mmol/l

0.05

258

1505

Dental pulpitis 1, only avohilmo

5704

26520

1.13

15.75

3.9

4.1

1.75

1.85

mmol/l

1.14

4628

21753

Other and unspecified injuries of lower leg

309

1901

1.70

15.74

4.5

4.2

1.58

1.74

mmol/l

0.31

263

1527

Postprocedural disorders of nervous system

263

1547

1.76

15.73

5.1

3.7

2.06

1.80

mmol/l

0.72

213

1252

Special screening examination for infectious and parasitic diseases

780

4261

1.39

15.68

3.1

3.3

1.12

1.71

mmol/l

3.79

640

3548

Pre-eclampsia or eclampsia

663

4759

1.42

15.68

5.5

3.6

1.73

1.99

mmol/l

1.05

548

3923

Right bundle-branch block

168

868

2.07

15.65

6.8

2.9

1.85

1.77

mmol/l

0.10

136

673

Disorders of purine and pyrimidine metabolism

137

4.32

15.65

9.1

3.5

1.64

2.09

mmol/l

0.24

104

Melanocytic naevi, other sites/unspecified

313

1935

1.69

15.64

6.4

3.6

1.70

1.96

mmol/l

0.69

259

1563

Sequelae of intentional self-harm, assault and events of undetermined intent

121

4.33

15.61

5.4

5.7

1.93

1.77

mmol/l

0.10

Ptosis of eyelid

512

3540

1.51

15.60

4.8

3.8

1.78

2.00

mmol/l

0.77

450

2888

Other neurotic disorders

231

1321

1.85

15.59

4.4

3.4

2.02

1.97

mmol/l

0.06

188

1046

Otitis externa, unspecified

464

3137

1.53

15.59

5.5

4.4

1.73

1.87

mmol/l

0.40

380

2513

Psoriatic arthropathies, ICD10

446

2993

1.55

15.57

3.8

2.27

1.94

mmol/l

1.17

362

2451

Vasculitis limited to skin, not elsewhere classified

144

711

2.22

15.55

5.6

3.8

1.76

2.10

mmol/l

0.54

123

563

Sequelae of poisoning by drugs, medicaments and biological substances

11.41

15.50

2.9

2.0

1.26

1.67

mmol/l

0.19

Hyperuricaemia without signs of inflammatory arthritis and tophaceous disease

110

4.80

15.50

10.0

3.6

2.16

2.17

mmol/l

0.01

Other and unspecified vasculitis limited to skin

136

659

2.27

15.49

5.8

3.8

1.73

2.07

mmol/l

0.53

116

523

Atrial septal defect

264

1578

1.81

15.47

6.5

7.8

1.45

1.44

mmol/l

0.03

222

1259

Acute and subacute iridocyclitis

816

6090

1.38

15.47

6.3

3.8

1.94

1.93

mmol/l

0.03

674

4942

Burns and corrosions of external body surface, specified by site

492

3373

1.51

15.47

4.0

4.7

1.84

1.82

mmol/l

0.03

402

2711

Hyperplasia of prostate

1964

9230

1.24

15.46

4.5

4.1

1.70

1.69

mmol/l

0.03

1607

7469

Other and unspecified immunodeficiencies with predominantly antibody defects

326

2.90

15.42

20.1

4.5

1.85

2.05

mmol/l

0.20

254

Other benign neoplasms of skin

1666

13606

1.25

15.36

4.6

3.8

1.89

1.92

mmol/l

0.17

1379

11080

Open wound of thorax

354

2.75

15.31

3.8

3.7

2.05

1.71

mmol/l

0.37

282

Renal agenesis and other reduction defects of kidney

178

4.06

15.27

11.2

9.0

0.30

1.36

mmol/l

1.38

137

Congenital malformations of cardiac chambers and connections

343

3.24

15.26

9.4

11.3

1.11

1.15

mmol/l

0.03

265

Drug-induced osteoporosis

299

3.00

15.25

14.3

2.9

1.60

2.26

mmol/l

0.81

238

Overexertion and strenuous or repetitive movements

423

2820

1.56

15.23

4.7

3.9

1.56

1.88

mmol/l

1.05

372

2281

Sequelae of injuries of head

237

1376

1.82

15.18

3.6

4.0

2.34

1.94

mmol/l

0.75

186

1104

Conotruncal defects

141

717

2.34

15.17

8.3

10.1

1.80

1.21

mmol/l

1.57

120

568

Surgical ablation of atrial fibrillation

141

4.29

15.15

4.6

4.3

2.05

1.88

mmol/l

0.14

107

Rheumatism, unspecified

539

3767

1.47

15.09

3.7

3.5

2.27

2.03

mmol/l

0.90

462

3075

Basal cell carcinoma, including avohilmo

2802

18882

1.19

15.06

3.8

3.7

1.72

1.96

mmol/l

2.85

2317

15363

Congenital malformations of the respiratory system

138

690

2.29

15.03

8.3

8.4

1.97

1.55

mmol/l

0.74

114

553

Other and unspecified vascular occlusions

461

3152

1.53

14.96

5.6

3.4

1.73

2.02

mmol/l

0.93

374

2537

Congenital malformation of biliary tract

209

5.46

14.95

26.4

9.7

0.78

1.10

mmol/l

0.39

158

Delivery

1156

7799

0.77

14.93

2.9

3.8

2.11

1.92

mmol/l

0.99

955

6405

Childhood allergy (age < 16)

612

3589

1.44

14.92

5.0

6.9

1.20

1.25

mmol/l

0.13

505

2814

Benign neoplasm: Skin of other and unspecified parts of face

503

3493

1.50

14.89

4.3

3.7

2.08

2.01

mmol/l

0.20

414

2818

Superficial injury of shoulder and upper arm

486

3347

1.50

14.89

3.9

1.77

1.92

mmol/l

0.38

399

2693

Necrobiosis lipoidica, not elsewhere classified

107

4.51

14.87

7.9

3.2

1.28

2.14

mmol/l

0.86

Other specified congenital malformation syndromes affecting multiple systems

137

685

2.28

14.86

8.7

9.8

1.77

1.27

mmol/l

0.94

121

551

Accidental poisoning by and exposure to alcohol

413

2.56

14.85

7.9

4.1

2.40

1.73

mmol/l

0.75

317

Other noninflammatory disorders of uterus, except cervix

972

5068

1.34

14.85

3.2

3.4

2.30

2.16

mmol/l

0.59

825

4196

Bell's palsy

509

3541

1.49

14.79

4.4

3.8

1.75

1.87

mmol/l

0.30

416

2875

Other psoriatic arthropathies

431

2904

1.54

14.78

3.8

2.33

1.92

mmol/l

1.53

350

2380

Pedal cyclist injured in other and unspecified transport accidents

476

3270

1.51

14.78

4.2

4.1

2.17

1.89

mmol/l

1.02

383

2620

Unspecified contracted kidney

153

4.02

14.74

8.9

3.4

0.26

1.98

mmol/l

2.72

115

Bicuspidal aortic valve syndrome

189

1041

1.95

14.73

4.1

5.3

2.03

1.86

mmol/l

0.28

157

835

Carcinoma in situ of skin

404

2705

1.58

14.73

4.5

3.4

1.77

2.02

mmol/l

0.61

345

2174

Oligomenorrhoea

137

669

2.15

14.70

6.6

3.3

1.01

1.95

mmol/l

2.29

119

539

Adhesive capsulitis of shoulder

707

5205

1.40

14.67

4.6

3.7

1.94

mmol/l

0.01

583

4215

Fibroblastic disorders

1061

8276

1.31

14.65

3.9

3.8

2.04

1.86

mmol/l

0.83

881

6679

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

2306

19074

1.20

14.64

4.6

4.1

1.97

1.79

mmol/l

1.54

1897

15608

Conjunctivitis

3227

24358

1.17

14.62

4.5

4.2

1.75

1.85

mmol/l

0.91

2676

19881

Bacterial, viral and other infectious agents

370

2419

1.59

14.62

7.5

4.5

1.48

1.84

mmol/l

1.18

327

1948

Alcohol induced polyneuropathy

249

3.16

14.53

6.8

3.9

1.66

1.83

mmol/l

0.12

193

Malignant neoplasm of liver and intrahepatic bile ducts

183

1005

1.97

14.53

5.6

4.0

1.29

2.01

mmol/l

1.77

128

783

Dislocation, sprain and strain of joint and ligaments of hip

186

1024

1.95

14.51

5.0

3.5

1.69

2.00

mmol/l

0.72

158

808

Mixed connective tissue disease

272

1658

1.72

14.51

3.6

2.35

2.01

mmol/l

0.80

231

1365

Fibrosis of liver

159

3.87

14.51

10.5

3.7

1.55

2.06

mmol/l

0.38

124

Hepatocellular carcinoma

127

619

2.29

14.44

4.1

0.87

1.79

mmol/l

1.73

484

Hypotension due to drugs

400

2.65

14.39

5.6

3.7

2.66

1.90

mmol/l

1.14

312

Disease of hard tissues of teeth, NOS

215

3.23

14.36

11.0

2.9

1.09

2.44

mmol/l

2.97

181

Osteopathy in diseases classified elsewhere

165

3.77

14.35

10.2

3.6

1.69

2.17

mmol/l

0.33

132

Polymyalgia rheumatica

632

4606

1.42

14.33

3.7

3.4

2.39

2.00

mmol/l

2.11

540

3745

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

1087

8515

1.30

14.31

3.8

4.3

2.03

1.82

mmol/l

1.23

901

6958

Neuralgia and neuritis, unspecified

225

1309

1.81

14.30

4.4

3.3

1.95

1.94

mmol/l

0.01

185

1052

Prolonged pregnancy

152

2610

0.52

14.28

1.6

4.1

1.68

1.51

mmol/l

0.21

117

2101

Pre-existing hypertension complicating pregnancy, childbirth and the puerperium

218

1248

1.80

14.26

6.7

3.3

1.84

1.85

mmol/l

0.01

180

1016

Scoliosis

347

2247

1.60

14.23

4.5

4.3

2.35

1.71

mmol/l

2.69

301

1827

Colon adenocarcinoma

580

4175

1.45

14.21

3.1

3.5

1.62

1.97

mmol/l

1.29

445

3362

Exposure to unspecified smoke, fire and flames

229

3.20

14.21

2.8

4.7

1.53

2.03

mmol/l

0.58

176

Hyperfunction of pituitary gland

204

1154

1.85

14.21

5.1

4.1

1.72

1.84

mmol/l

0.21

180

924

Special screening examination for neoplasms

212

1216

1.84

14.20

4.3

3.5

1.27

1.70

mmol/l

0.72

180

966

Pre-eclampsia

602

4326

1.42

14.19

5.4

3.6

1.72

1.98

mmol/l

0.98

497

3550

Osteonecrosis due to drugs

342

2.80

14.15

8.5

3.3

1.76

1.99

mmol/l

0.23

271

Other keratitis

443

3026

1.51

14.11

5.5

3.9

1.80

1.87

mmol/l

0.15

372

2449

Open wound of shoulder and upper arm

107

488

2.39

14.08

5.0

4.0

1.94

1.69

mmol/l

0.27

382

Mantle cell lymphoma

262

3.15

14.07

4.4

4.3

2.25

1.75

mmol/l

0.82

198

Malignant neoplasm of mesothelium and soft tissue, excluding all cancers (controls excluding all cancers)

312

1988

1.65

14.04

4.6

3.6

1.82

1.96

mmol/l

0.29

264

1601

Carcinoma in situ of skin of scalp and neck

149

782

2.13

13.99

4.7

3.8

1.46

1.96

mmol/l

0.82

121

613

Paraplegia, diplegia of upper limbs

121

583

2.27

13.94

6.1

3.9

2.15

1.80

mmol/l

0.34

105

464

Inflammatory disorders of male genital organs, not elsewhere classified

354

2.69

13.93

5.2

4.2

1.95

1.57

mmol/l

0.44

277

Recurring oral aphthae

231

1370

1.79

13.92

13.8

3.8

2.06

1.75

mmol/l

0.70

190

1081

Embedded and impacted teeth

891

5779

1.33

13.91

5.9

4.2

1.48

1.60

mmol/l

0.44

722

4636

Degeneration of the brain due to alcohol

130

647

2.21

13.88

5.0

4.0

1.48

2.06

mmol/l

0.74

106

506

Carcinoma in situ of skin of upper limb, including shoulder

138

706

2.18

13.86

5.4

3.6

1.42

2.04

mmol/l

0.93

110

547

Acute myeloid leukaemia and myelodysplastic syndromes, excluding all cancers (controls excluding all cancers)

191

1078

1.90

13.80

4.7

3.4

1.54

2.03

mmol/l

0.81

151

839

Implicit parasitic Sepsis

105

4.57

13.80

6.2

4.3

1.15

2.06

mmol/l

0.80

Eosinophilic disease (BM)

323

2.72

13.80

5.2

3.0

1.29

1.48

mmol/l

0.14

251

Methotrexate

593

4286

1.42

13.78

3.8

3.5

1.94

1.88

mmol/l

0.15

480

3489

Acute appendicitis, no complications

2290

19379

1.19

13.78

4.1

1.81

1.79

mmol/l

0.06

1912

15824

Degeneration of nervous system due to alcohol

130

649

2.20

13.77

5.0

3.9

1.48

1.97

mmol/l

0.58

106

507

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum, excluding all cancers (controls excluding all cancers)

461

3200

1.50

13.76

3.0

3.5

1.96

1.93

mmol/l

0.04

362

2584

Acquired absence of limb

234

3.16

13.74

15.3

3.3

1.25

1.96

mmol/l

0.81

175

Pedal cyclist injured in transport accident

909

7006

1.33

13.73

3.9

4.3

2.02

1.83

mmol/l

0.77

744

5700

Subarachnoid haemorrhage

474

3308

1.49

13.69

4.0

3.6

2.12

2.01

mmol/l

0.26

393

2673

Assault by other specified means

183

3.37

13.68

4.1

3.7

1.64

1.88

mmol/l

0.24

140

Viral haemorrhagic fevers, not elsewhere classified/unspecified

351

2308

1.59

13.66

3.7

3.8

1.69

1.96

mmol/l

0.78

282

1848

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

209

1217

1.85

13.66

8.2

7.9

1.79

1.46

mmol/l

0.79

184

975

Other and unspecified follicular disorders

172

938

1.94

13.65

6.0

3.6

1.87

1.95

mmol/l

0.11

135

740

Crushed, pushed or stepped on by crowd or human stampede

301

1907

1.64

13.65

3.8

5.1

1.59

1.81

mmol/l

0.50

250

1533

Enthesopathies of lower limb, excluding foot

851

6501

1.34

13.64

4.8

4.0

1.97

1.81

mmol/l

0.64

714

5300

Polyarthrosis

871

6408

1.34

13.62

4.1

3.5

2.24

2.09

mmol/l

0.54

737

5203

Oesophageal obstruction

187

1053

1.90

13.60

5.0

3.4

2.22

2.01

mmol/l

0.23

158

830

Toxic liver disease

376

2.60

13.60

7.5

4.0

1.39

2.04

mmol/l

0.94

302

Pre-eclampsia or poor fetal growth

859

6540

1.33

13.59

5.3

3.6

1.70

1.85

mmol/l

0.58

704

5331

Acne

356

2337

1.56

13.53

5.9

4.6

1.61

1.65

mmol/l

0.09

286

1887

293

2.83

13.46

4.5

3.7

1.88

2.05

mmol/l

0.11

231

Folate deficiency anaemia

215

3.26

13.43

6.3

3.4

1.06

1.44

mmol/l

0.25

165

Arthropod-borne viral fevers and viral haemorrhagic fevers

426

2925

1.51

13.42

3.8

1.78

1.96

mmol/l

0.48

334

2350

Diabetes mellitus in pregnancy

827

4040

1.34

13.41

4.2

3.8

1.26

1.72

mmol/l

2.67

652

3241

Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)

286

1805

1.66

13.40

3.3

3.2

2.16

2.01

mmol/l

0.26

222

1424

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

241

1464

1.75

13.39

5.1

3.7

1.28

2.09

mmol/l

2.47

173

1149

Chronic rhinitis, nasopharyngitis and pharyngitis

1300

10489

1.26

13.38

4.1

4.3

1.75

1.84

mmol/l

0.38

1092

8556

Other and unspecified disorders of white blood cells

197

1131

1.85

13.35

7.0

3.7

1.88

1.92

mmol/l

0.05

164

892

Atopic dermatitis, strict definition

1130

8788

1.28

13.34

4.6

5.2

1.39

1.69

mmol/l

1.96

920

7072

Problems related to social environment

137

699

2.09

13.30

4.2

3.2

2.47

1.99

mmol/l

0.71

113

563

Adenocarcinoma and papilloma adenocarcinoma of rectum, excluding all cancers (controls excluding all cancers)

446

3099

1.50

13.27

3.1

3.5

1.98

1.93

mmol/l

0.09

351

2502

Secondary parkinsonism+Parkinsonism in other disease

152

810

2.03

13.26

4.3

3.6

3.02

2.03

mmol/l

2.67

121

644

Other enthesopathy of foot (+metatarsalgia)

390

2630

1.53

13.25

4.1

3.9

1.72

2.00

mmol/l

0.84

333

2127

Other and unspecified intracranial injuries

156

838

2.00

13.15

3.6

3.8

1.95

1.76

mmol/l

0.28

122

651

Visual field defects

388

2629

1.54

13.15

4.6

3.7

1.57

2.02

mmol/l

1.91

307

2098

Maze procedure for atrial fibrillation

130

4.20

13.10

3.4

4.3

1.69

1.79

mmol/l

0.06

Other specified/unspecified systemic involvement of connective tissue

242

1471

1.72

13.09

3.7

3.5

2.40

1.96

mmol/l

1.10

207

1205

Dental caries 1 and operation codes

4661

21288

1.13

13.04

4.9

3.7

1.80

1.89

mmol/l

0.80

3777

17299

Other retinal artery occlusion

134

690

2.13

13.03

5.0

3.5

1.76

2.08

mmol/l

0.47

117

554

Viral infections of the central nervous system

306

1971

1.62

13.01

4.1

3.7

1.73

1.91

mmol/l

0.41

261

1588

242

1461

1.70

13.00

3.4

3.3

0.72

1.65

mmol/l

2.71

200

1144

Acute generalized exanthematous pustulosis

209

1229

1.80

12.95

6.3

4.2

2.04

1.80

mmol/l

0.48

176

973

Skin changes due to chronic exposure to nonionizing radiation

1874

14909

1.21

12.94

4.2

3.6

1.93

1.94

mmol/l

0.04

1533

12087

Barrett oesophagus

234

1422

1.75

12.94

4.8

3.7

1.68

1.99

mmol/l

0.55

190

1140

Impetigo

211

1244

1.79

12.91

6.9

5.8

1.81

1.54

mmol/l

0.48

170

978

Spinal instabilities

129

651

2.11

12.91

3.8

3.3

2.21

1.99

mmol/l

0.32

534

Open wound of hip and thigh

158

856

1.97

12.90

4.1

4.5

1.23

1.88

mmol/l

1.31

133

679

Congenital malformations of great arteries

200

1171

1.90

12.88

9.5

10.4

1.41

1.23

mmol/l

0.39

164

922

Secondary parkinsonism

149

798

2.02

12.83

4.4

3.7

2.99

2.04

mmol/l

2.46

119

631

Visual impairment including blindness (binocular or monocular)

332

2193

1.59

12.81

6.9

4.0

1.08

1.95

mmol/l

4.79

277

1747

Other misadventures during surgical and medical care

110

529

2.27

12.77

5.5

4.1

2.70

1.98

mmol/l

0.73

420

Alzheimer’s disease, wide definition, excluding more controls

726

3702

1.37

12.76

2.6

3.4

2.02

1.83

mmol/l

0.65

591

2922

Arthropathy in Crohn disease

202

3.16

12.74

4.9

3.4

1.76

1.77

mmol/l

0.01

155

Malignant neoplasm of brain, excluding all cancers (controls excluding all cancers)

225

1354

1.75

12.73

5.7

3.7

2.11

1.95

mmol/l

0.33

191

1077

Other inflammation of eyelid

551

3997

1.42

12.73

4.4

4.0

2.03

1.93

mmol/l

0.24

451

3258

Metatarsalgia

365

2450

1.54

12.73

4.2

3.8

1.71

1.98

mmol/l

0.80

313

1978

Respiratory disorders in diseases classified elsewhere

345

2.63

12.69

4.9

3.4

2.49

2.01

mmol/l

0.59

271

Other disorders of amino-acid metabolism

127

4.08

12.66

12.3

4.4

1.25

2.12

mmol/l

0.64

100

Abnormal findings on diagnostic imaging of central nervous system

192

1108

1.83

12.64

3.9

4.7

1.61

1.76

mmol/l

0.29

152

880

Dental pulpitis 3

547

2826

1.43

12.64

5.6

6.0

1.20

1.34

mmol/l

0.42

433

2225

Benign neoplasm of major salivary glands

401

2757

1.51

12.53

3.8

3.6

2.07

1.92

mmol/l

0.40

324

2246

Actinic keratosis

1828

14610

1.21

12.52

4.3

3.6

1.92

1.94

mmol/l

0.05

1500

11840

Primary biliary cholangitis (PBC)

107

513

2.26

12.44

5.9

2.6

1.62

1.95

mmol/l

0.33

413

Malignant neoplasm of retroperitoneum and peritoneum, excluding all cancers (controls excluding all cancers)

425

2.41

12.35

4.0

3.5

1.93

2.24

mmol/l

0.34

345

Central retinal artery occlusion

129

670

2.11

12.30

4.8

3.6

1.58

2.11

mmol/l

0.94

528

Exposure to smoke, fire and flames

127

652

2.10

12.30

2.8

4.3

1.95

1.92

mmol/l

0.02

108

516

Other other unspecified disorders of the circulatory system

189

1101

1.83

12.29

5.5

4.0

2.10

1.94

mmol/l

0.19

146

863

Other and unspecified paralytic syndromes

343

2.58

12.28

8.2

3.9

1.86

1.82

mmol/l

0.04

269

Malignant neoplasm of cervix uteri, excluding all cancers (controls excluding all cancers)

108

521

2.21

12.24

6.0

2.9

1.48

2.25

mmol/l

0.98

417

Autoimmune hepatitis

164

3.42

12.23

3.6

3.7

2.22

1.99

mmol/l

0.22

122

Aspergillosis

198

3.23

12.22

5.7

4.1

2.48

1.97

mmol/l

0.30

152

Generalized skin eruption due to drugs and medicaments

185

1070

1.83

12.21

6.8

4.4

1.95

1.87

mmol/l

0.13

154

843

Unspecified visual impairment (binocular)

442

2.40

12.21

5.9

5.4

1.22

1.95

mmol/l

1.25

346

Tongue abnormality

272

1738

1.64

12.18

3.6

3.7

1.99

2.02

mmol/l

0.03

229

1412

Other disorders of conjunctiva

618

4604

1.38

12.15

5.3

3.9

2.07

1.97

mmol/l

0.27

511

3743

Benign neoplasm of mouth and pharynx

472

3365

1.45

12.15

3.8

3.7

2.11

1.96

mmol/l

0.38

399

2729

Other obstetric conditions, not elsewhere classified

776

3819

1.33

12.15

3.8

3.5

1.29

1.54

mmol/l

1.05

583

3075

Malignant neoplasm of thyroid gland, excluding all cancers (controls excluding all cancers)

290

1875

1.61

12.13

3.4

2.11

1.94

mmol/l

0.33

226

1542

Mitochondrial myopathy

4.50

12.13

7.6

4.7

0.73

2.02

mmol/l

1.79

Malignant neoplasm of other and unspecified urinary organs, excluding all cancers (controls excluding all cancers)

200

3.24

12.10

6.2

3.9

1.38

1.89

mmol/l

0.47

160

Social disorders starting during childhood or adolecense, excluding more controls

198

3.16

12.09

5.8

7.4

1.23

1.27

mmol/l

0.03

156

Other strabismus

908

7099

1.30

12.08

5.5

4.8

1.73

1.76

mmol/l

0.08

740

5740

Anomalies of dental arch relationship, including avohilmo

775

5336

1.33

12.06

8.8

4.5

1.59

1.68

mmol/l

0.37

655

4258

Benign lipomatous neoplasm

1158

9343

1.26

12.04

4.3

3.8

2.04

1.92

mmol/l

0.56

940

7639

Infarction of spleen

158

3.62

11.99

5.3

3.7

2.54

2.04

mmol/l

0.46

126

Asthma mixed form (mode), excluding more controls

206

1225

1.74

11.97

4.2

3.2

2.21

1.47

mmol/l

1.73

169

963

Papillary adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

247

1544

1.67

11.95

3.3

3.4

2.06

1.99

mmol/l

0.11

199

1265

Other disorders of bladder

532

3884

1.42

11.93

4.9

3.7

1.78

1.89

mmol/l

0.27

427

3114

Other autoimmune haemolytic anaemias

345

2.60

11.89

6.7

3.6

0.64

1.92

mmol/l

2.12

269

Crowding of teeth, including avohilmo

427

2465

1.48

11.85

10.8

5.8

1.40

1.46

mmol/l

0.19

361

1971

TMD related operations

594

4404

1.38

11.81

5.1

4.2

2.14

1.90

mmol/l

1.15

490

3607

Complex cardiac defects

273

3.03

11.81

9.2

10.5

0.99

1.18

mmol/l

0.19

213

Other and unspecified urticaria

759

5833

1.33

11.78

6.0

4.6

1.95

1.84

mmol/l

0.34

613

4731

Thyrotoxicosis with diffuse goitre

489

3514

1.42

11.78

3.7

3.8

2.13

2.00

mmol/l

0.33

382

2894

Malignant neoplasm of bronchus and lung, excluding all cancers (controls excluding all cancers)

979

6475

1.29

11.77

3.4

3.7

2.43

1.92

mmol/l

3.72

817

5250

Dental caries 3 and operation codes

4817

22181

1.12

11.77

4.8

3.9

1.80

1.87

mmol/l

0.69

3906

18071

Abnormal findings in nipple discharge synovial fluid wound secretions

382

2.45

11.73

7.4

3.9

0.51

2.03

mmol/l

2.48

309

Mixed specific developmental disorders

203

1154

1.83

11.72

7.7

9.6

1.26

1.25

mmol/l

0.02

158

922

102

491

2.24

11.72

8.3

4.7

1.09

1.39

mmol/l

0.37

378

Other and unspecified haemorrhagic conditions

408

2.40

11.72

5.7

4.0

1.82

1.98

mmol/l

0.14

325

Acute nasopharyngitis (common cold)

489

3501

1.43

11.69

5.1

4.2

1.71

1.78

mmol/l

0.15

416

2827

Postprocedural musculoskeletal disorders, not elsewhere classified

313

2084

1.57

11.69

3.7

2.34

1.94

mmol/l

1.17

249

1693

conjunctival haemorrhage

342

2322

1.54

11.62

5.3

3.7

2.25

2.01

mmol/l

0.55

284

1866

Allergic urticaria

334

2248

1.54

11.60

5.5

4.6

2.00

1.82

mmol/l

0.42

285

1811

Chondrocostal junction syndrome [Tietze]

168

960

1.85

11.57

3.3

3.2

1.70

1.95

mmol/l

0.41

143

778

Degenerative macular diseases

568

4219

1.39

11.51

4.2

3.3

1.72

2.01

mmol/l

1.06

470

3434

Atypical facial pain

211

1283

1.72

11.49

2.9

3.3

2.08

1.93

mmol/l

0.29

172

1049

Vascular dementia (subcortical)

165

946

1.88

11.49

3.6

3.2

1.69

2.04

mmol/l

0.50

138

734

Complications following infusion, transfusion and therapeutic injection

386

2.43

11.48

10.9

3.6

1.87

2.13

mmol/l

0.36

300

Suggestive for eosinophilic asthma

389

2708

1.49

11.46

4.2

3.7

2.17

1.84

mmol/l

1.00

322

2177

Other orthopaedic follow-up care

221

1359

1.69

11.44

3.6

3.0

2.21

2.00

mmol/l

0.38

190

1091

Adenocarcinoma and Papillary adenocarcinoma of kidney, excluding all cancers (controls excluding all cancers)

302

2.70

11.41

8.0

3.3

1.14

2.25

mmol/l

2.49

247

Gastrojejunal ulcer

318

2.59

11.38

4.6

3.9

1.75

1.96

mmol/l

0.22

250

Common variable immunodeficiency

129

3.67

11.37

3.8

4.7

1.69

2.02

mmol/l

0.25

101

Exposure to other and unspecified inanimate mechanical forces

295

1952

1.57

11.22

4.8

4.6

1.98

1.88

mmol/l

0.18

250

1552

Burns and corrosions of multiple and unspecified body regions

116

597

2.09

11.20

5.3

4.8

1.58

1.82

mmol/l

0.29

474

Other and unspecified nerve root and plexus disorders, also in other diseases

718

5518

1.33

11.20

3.5

3.9

2.28

1.88

mmol/l

2.63

579

4523

Single delivery by forceps and vacuum extractor

209

2066

0.60

11.18

2.6

4.5

1.38

1.48

mmol/l

0.18

159

1653

Unspecified threat to breathing

248

2.82

11.16

4.9

5.0

1.35

1.71

mmol/l

0.44

191

Specific developmental disorder of motor function

164

950

1.95

11.16

8.6

9.8

0.77

1.23

mmol/l

1.02

133

752

Inguinal hernia

2942

17389

1.15

11.15

4.4

4.1

1.71

1.79

mmol/l

0.53

2381

14139

Anorexia

325

2.51

11.15

7.3

5.3

2.26

1.85

mmol/l

0.33

247

Other and unspecified primary disorders of muscles

215

3.04

11.13

6.8

5.9

2.26

1.92

mmol/l

0.35

176

Other secondary gout

4.80

11.13

8.2

4.6

2.34

2.00

mmol/l

0.11

Car occupant injured in noncollision transport accident

156

881

1.86

11.10

5.2

3.5

1.91

1.85

mmol/l

0.07

124

710

Other disorders of the genitourinary system

516

3793

1.40

11.08

5.3

3.5

1.66

2.09

mmol/l

1.81

438

3133

Malignant neoplasm of small intestine, excluding all cancers (controls excluding all cancers)

151

851

1.90

11.07

6.9

3.2

1.95

2.07

mmol/l

0.12

123

686

Other and unspecified injuries of shoulder and upper arm

140

768

1.94

11.07

4.3

3.8

2.70

1.92

mmol/l

1.63

113

609

Adalimumab

331

2244

1.52

11.06

4.8

4.4

1.92

1.87

mmol/l

0.09

264

1834

Embolic stroke

237

1504

1.66

10.98

4.2

3.4

1.68

1.95

mmol/l

0.47

197

1174

Acne vulgaris

268

1736

1.59

10.97

5.4

4.7

1.53

1.69

mmol/l

0.35

212

1404

Schizoid personality disorder

411

2.31

10.97

4.4

3.4

2.08

2.05

mmol/l

0.02

325

Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)

180

1070

1.79

10.92

3.3

3.4

2.99

2.03

mmol/l

2.06

143

854

Lichen simplex chronicus

160

918

1.85

10.92

6.0

3.5

1.27

2.01

mmol/l

1.63

132

726

Malignant neoplasm of other and unspecified female genital organs, excluding all cancers (controls excluding all cancers)

125

666

2.02

10.91

4.0

3.0

1.88

2.21

mmol/l

0.45

107

553

Other congenital malformations of upper alimentary tract

243

2.94

10.90

7.8

5.6

1.68

1.76

mmol/l

0.08

184

Personal history of certain other diseases

320

2.46

10.89

5.0

4.2

1.65

1.70

mmol/l

0.03

247

Wide developmental disorders, excluding more controls

150

835

1.88

10.88

4.0

7.5

1.15

1.21

mmol/l

0.08

120

658

Other immunodeficiencies

320

2.57

10.87

11.9

5.7

1.89

1.75

mmol/l

0.12

245

Myositis

130

703

1.98

10.83

4.7

3.6

1.75

1.92

mmol/l

0.20

117

547

Other and unspecified mental retardation

150

869

1.97

10.82

5.8

9.9

1.72

1.30

mmol/l

0.89

121

672

Algoneurodystrophy

130

699

1.96

10.81

3.9

3.5

1.49

1.98

mmol/l

0.61

108

561

UC patients in KELA-register (code 208), prior to 1994

204

1254

1.71

10.79

5.9

3.8

1.54

1.97

mmol/l

0.71

156

1011

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

257

2.71

10.78

3.8

3.0

2.12

2.15

mmol/l

0.03

205

Other specified and unspecified retinal disorders

165

961

1.83

10.75

8.5

3.5

1.52

2.08

mmol/l

1.24

137

763

Pyoderma gangrenosum

155

3.32

10.75

5.2

3.5

1.37

2.06

mmol/l

0.55

125

Other noninflammatory disorders of vulva and perineum

320

2165

1.52

10.75

3.5

3.4

2.04

1.97

mmol/l

0.13

268

1763

Disorders of optic nerve, not elsewhere classified

111

574

2.11

10.71

5.4

3.6

1.66

2.00

mmol/l

0.39

459

6-mercaptopurine

130

702

1.95

10.70

11.5

4.1

1.80

1.61

mmol/l

0.25

103

558

Giant cell arteritis

203

1255

1.72

10.66

4.1

3.4

1.88

1.97

mmol/l

0.15

169

1002

Carcinoma in situ of skin of ear and external auricular canal

395

2.38

10.62

7.2

3.1

1.05

1.80

mmol/l

1.07

310

Habit and impulse disorders

351

2.39

10.60

2.1

3.9

1.09

1.44

mmol/l

0.35

278

Atopic dermatitis

2137

15698

1.17

10.60

4.1

4.4

1.58

1.76

mmol/l

1.31

1755

12769

Injury of eye and orbit

546

4068

1.37

10.60

5.3

4.3

1.74

1.79

mmol/l

0.13

449

3303

Other diseases of gallbladder

200

1228

1.71

10.60

4.3

3.4

1.92

1.86

mmol/l

0.09

174

975

Generalized epilepsy, mode (most common among epilepsy diagnosis)

152

867

1.85

10.56

4.0

5.8

1.01

1.65

mmol/l

1.18

123

693

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

244

2.80

10.55

4.4

3.2

1.98

2.10

mmol/l

0.08

197

Other specified/unspecified soft tissue disorders

221

1391

1.66

10.54

3.8

3.1

2.37

2.10

mmol/l

0.57

193

1111

Myelodysplastic syndrome, excluding all cancers (controls excluding all cancers)

149

850

1.88

10.54

4.6

3.2

1.57

2.03

mmol/l

0.61

119

664

Idiopathic thrombocytopenic purpura

154

886

1.86

10.53

6.0

4.3

1.45

1.74

mmol/l

0.35

128

702

Melanocytic naevi, other sites/unspecified

313

2126

1.52

10.49

6.4

3.9

1.70

1.96

mmol/l

0.68

259

1709

Gestational [pregnancy-induced] oedema and proteinuria without hypertension

286

1901

1.55

10.48

5.7

3.4

1.60

2.00

mmol/l

1.07

244

1571

Cytomegaloviral pneumonitis

6.53

10.47

9.3

3.5

-0.04

2.34

mmol/l

2.05

Adult respiratory distress syndrome

324

2.50

10.47

6.6

3.8

2.05

1.92

mmol/l

0.09

260

Viral agents as the cause of diseases classified to other chapters

113

592

2.06

10.43

6.4

5.4

1.21

1.93

mmol/l

1.32

472

Nontoxic multinodular goitre

818

6463

1.29

10.39

3.6

3.5

2.28

2.10

mmol/l

0.83

690

5304

Gestational [pregnancy-induced] hypertension

691

5310

1.32

10.39

4.1

3.5

1.81

1.86

mmol/l

0.14

552

4349

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

742

3711

1.31

10.37

3.9

3.5

1.23

1.53

mmol/l

1.33

557

2986

Rheumatoid arthritis, including avohilmo

1624

13749

1.20

10.37

3.7

2.06

1.98

mmol/l

0.39

1308

11217

Hyperhidrosis

105

531

2.07

10.37

3.7

3.2

2.06

1.65

mmol/l

0.62

416

Disorder of external ear, unspecified

146

829

1.87

10.37

4.5

3.5

1.78

2.09

mmol/l

0.45

122

656

Non-small cell lung cancer, adenocarcinoma, excluding all cancers (controls excluding all cancers)

279

1862

1.57

10.35

3.5

3.4

2.07

1.98

mmol/l

0.15

232

1493

Other and unspecified bullous disorders

258

2.71

10.35

5.3

4.0

2.70

1.92

mmol/l

0.77

205

Alzheimer’s disease (Late onset), excluding more controls

679

3474

1.34

10.29

2.6

3.4

1.98

1.81

mmol/l

0.49

550

2740

Arthropathy in ulcerative colitis

281

2.57

10.29

2.6

3.7

2.65

1.94

mmol/l

0.86

229

Complications of other internal prosthetic devices, implants and grafts

178

1071

1.76

10.27

6.1

3.3

1.96

1.97

mmol/l

0.01

151

852

Deficiency of other B group vitamins

109

567

2.07

10.26

3.8

3.4

1.49

1.79

mmol/l

0.30

447

Oxicams

1318

6189

1.23

10.26

3.5

4.9

2.10

1.70

mmol/l

3.28

1071

5036

Other diseases of blood and blood-forming organs

293

1977

1.54

10.26

4.8

3.6

1.65

1.94

mmol/l

0.56

233

1571

Other specified/unspecified inflammatory spondylopathies

168

988

1.76

10.26

3.7

3.5

2.10

1.87

mmol/l

0.35

140

790

Traction detachment of retina

199

2.95

10.23

15.2

3.9

0.51

2.03

mmol/l

2.69

156

Crossbite

380

2500

1.47

10.22

11.2

6.4

1.59

1.56

mmol/l

0.08

335

1993

Other bacterial agents as the cause of diseases classified to other chapters

272

2.65

10.22

9.0

4.3

1.40

1.76

mmol/l

0.36

210

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

248

2.75

10.22

4.4

4.0

1.98

2.01

mmol/l

0.01

194

Short stature, not elsewhere classified

221

1343

1.72

10.21

14.8

9.7

0.91

1.19

mmol/l

0.57

165

1061

Traumatic ischaemia of muscle

301

2.51

10.20

6.2

3.5

2.69

1.97

mmol/l

1.29

242

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

193

1189

1.71

10.19

8.2

6.4

1.41

1.42

mmol/l

0.02

155

918

Malignant neoplasm of breast, HER2-negative, excluding all cancers (controls excluding all cancers)

1534

8403

1.21

10.17

2.8

3.5

2.10

2.14

mmol/l

0.17

1272

6982

Adenocarcinoma and Papillary adenocarcinoma of kidney

319

2.54

10.14

8.0

4.0

1.14

2.08

mmol/l

2.00

248

Enteropathogenic Escherichia coli infection

4.65

10.14

4.9

8.0

2.55

1.69

mmol/l

0.66

Granulomatous disorders of skin and subcutaneous tissue

114

602

2.01

10.13

5.7

3.4

1.88

1.98

mmol/l

0.13

474

Paranoid personality disorder

424

2.23

10.13

3.2

3.4

2.70

1.88

mmol/l

1.09

339

Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)

1534

8406

1.21

10.13

2.8

3.5

2.10

2.14

mmol/l

0.18

1272

6984

Ulcerative ileocolitis

161

942

1.79

10.13

6.2

3.6

1.17

1.89

mmol/l

1.62

127

759

Spondylopathies in diseases classified elsewhere

304

2.53

10.11

7.5

3.6

2.34

1.93

mmol/l

0.31

241

Premature rupture of membranes

301

3245

0.67

10.10

2.7

3.9

1.73

1.63

mmol/l

0.17

234

2640

Other and unspecified diseases of blood and blood-forming organs

124

677

1.97

10.10

5.9

3.7

0.99

2.02

mmol/l

1.56

101

545

Tumor necrosis factor alpha inhibitors

506

3757

1.38

10.06

4.3

4.4

1.93

1.79

mmol/l

0.40

409

3055

Shoulder region

356

2.39

10.05

4.3

3.8

1.32

1.72

mmol/l

0.43

289

Tibial collateral bursitis [Pellegrini-Stieda]

242

2.68

9.99

3.6

2.6

3.25

1.85

mmol/l

1.42

202

Excessive attrition of teeth

1565

7131

1.21

9.99

6.2

3.2

1.54

1.87

mmol/l

2.78

1287

5774

Pilonidal cyst

305

2076

1.51

9.97

4.7

4.0

1.45

1.87

mmol/l

0.96

244

1667

Malignant neoplasm of renal pelvis, excluding all cancers (controls excluding all cancers)

333

2.45

9.94

7.1

3.2

1.76

2.16

mmol/l

0.32

275

Benign neoplasm of meninges

387

2764

1.44

9.94

3.9

3.4

1.71

2.08

mmol/l

1.21

325

2272

Intentional self-harm by jumping from a high place

3.88

9.93

3.8

3.1

2.33

1.85

mmol/l

0.28

Nontoxic goitre/thyroid nodule

1213

10049

1.23

9.92

3.5

2.17

2.06

mmol/l

0.51

1023

8254

Follicular lymphoma

187

1152

1.71

9.88

4.3

3.2

2.21

2.05

mmol/l

0.24

155

930

Polyarteritis nodosa and related conditions

385

2.31

9.85

7.0

3.8

1.61

1.81

mmol/l

0.21

305

Varicella [chickenpox]

209

1321

1.66

9.85

9.9

5.3

1.22

1.78

mmol/l

1.71

179

1070

Other intracranial haemorrhages

163

973

1.79

9.85

5.7

3.6

1.35

2.10

mmol/l

1.45

131

764

Bronchitis, not specified as acute or chronic

360

2540

1.46

9.85

5.6

3.7

2.23

1.77

mmol/l

1.58

301

2031

Injury of urinary and pelvic organs

102

526

2.08

9.84

4.9

3.8

1.62

1.78

mmol/l

0.15

410

Polyarthritis, unspecified

169

1014

1.76

9.84

4.5

4.0

2.09

1.84

mmol/l

0.37

139

794

Hypothyroidism due to medicaments and other exogenous substances

270

2.60

9.83

5.1

3.4

1.60

2.04

mmol/l

0.59

216

Striking against or struck by other objects

1353

11324

1.21

9.79

4.3

4.7

1.65

1.78

mmol/l

0.65

1111

9192

Cauda equina syndrome

301

2.48

9.78

3.4

3.2

3.04

2.08

mmol/l

1.18

234

Myopia

442

3228

1.40

9.76

6.1

4.5

1.73

1.80

mmol/l

0.14

356

2596

Mature T/NK-cell lymphomas, hilmo, excluding all cancers

368

2.35

9.74

6.1

3.2

1.23

2.07

mmol/l

0.95

300

Vascular dementia (mixed)

456

2.20

9.70

2.1

3.5

2.01

2.00

mmol/l

0.01

349

Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)

685

5037

1.31

9.67

3.2

3.6

2.41

1.88

mmol/l

3.09

572

4069

Colonic or urogenital fistula

1106

9104

1.24

9.65

4.1

2.01

1.90

mmol/l

0.43

907

7398

Benign neoplasm: Parotid gland

312

2156

1.50

9.65

3.7

3.6

2.03

1.94

mmol/l

0.19

249

1752

Blepharochalasis

1243

10358

1.22

9.64

3.7

2.11

1.97

mmol/l

0.76

1033

8490

Right ventricular outflow tract obstruction

442

2.36

9.61

9.1

10.3

1.58

1.02

mmol/l

1.26

348

Maternal care related to the fetus and amniotic cavity and possible delivery problems

911

6671

0.80

9.60

2.9

3.9

1.80

1.81

mmol/l

0.02

715

5443

Motor disorders

164

1008

1.85

9.59

8.6

10.0

0.77

1.20

mmol/l

0.92

133

793

Vulvovaginal ulceration/inflammation in other diseases

178

1082

1.70

9.58

4.4

3.5

1.35

1.75

mmol/l

0.69

149

871

Cerebral palsy

103

541

2.07

9.56

7.5

7.6

1.32

1.36

mmol/l

0.04

415

Congenital malformations of great veins

209

3.58

9.54

8.3

12.5

1.30

1.20

mmol/l

0.09

159

Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)

427

3124

1.41

9.52

3.5

3.7

2.62

1.95

mmol/l

2.51

356

2525

Cardiomyopathies, Secondary/extrinsic

133

3.34

9.49

8.4

2.9

2.41

1.71

mmol/l

0.54

101

L02BB Anti-androgens

451

3343

1.40

9.49

3.3

3.9

1.49

1.76

mmol/l

0.58

339

2626

Other mycoses, not elsewhere classified/unspecified

4.58

9.46

10.6

3.8

2.25

2.13

mmol/l

0.05

Coeliac disease

503

3778

1.37

9.41

5.9

4.3

1.66

1.86

mmol/l

0.68

422

3061

Other and unspecified iridocyclitis

183

1135

1.69

9.36

4.8

3.7

1.78

1.93

mmol/l

0.22

149

913

Bullous disorders

262

1766

1.55

9.34

4.2

3.6

1.75

2.01

mmol/l

0.45

217

1402

Congenital malformations of the musculoskeletal system, not elsewhere classified

332

2.35

9.34

10.4

5.5

1.58

1.70

mmol/l

0.09

246

Contusion of toe(s) without damage to nail

101

527

2.03

9.30

5.8

4.8

1.51

1.60

mmol/l

0.11

422

Anankastic personality disorder

131

740

1.84

9.29

3.4

3.5

1.80

1.92

mmol/l

0.14

107

589

Infective bursitis

143

836

1.82

9.28

4.7

3.9

2.19

2.07

mmol/l

0.18

119

660

Mental and behabioural disorders of puerperum, not classified elsewhere, excluding more controls

111

3.35

9.27

2.3

2.8

0.88

1.95

mmol/l

0.61

Dislocation, sprain and strain of joints and ligaments of head

165

997

1.73

9.26

6.0

5.4

2.02

1.71

mmol/l

0.62

134

804

Carcinoma in situ of other and unspecified digestive organs

122

683

1.92

9.26

5.3

3.1

0.85

2.11

mmol/l

2.54

103

548

Biomechanical lesions, not elsewhere classified

207

1328

1.63

9.23

3.7

3.5

1.61

1.94

mmol/l

0.54

168

1047

Hyphaema and other vascular disorders of iris and ciliary body

101

533

2.05

9.21

8.6

3.6

1.04

1.88

mmol/l

1.44

416

Other abnormal findings of blood chemistry

182

1133

1.68

9.19

7.3

3.8

1.60

1.91

mmol/l

0.43

147

900

Paralytic strabismus

314

2198

1.49

9.19

4.8

3.8

2.14

1.94

mmol/l

0.46

255

1744

Personal history of medical treatment

229

2.69

9.17

8.7

4.4

2.42

1.91

mmol/l

0.34

165

Chronic lymphocytic leukaemia, helper endpoint

140

820

1.83

9.10

3.7

3.1

2.06

2.08

mmol/l

0.01

110

659

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)

140

820

1.83

9.10

3.7

3.1

2.06

2.08

mmol/l

0.01

110

659

Salpingitis and oophoritis

589

4536

1.32

9.09

4.8

3.6

1.96

2.04

mmol/l

0.22

497

3756

Diabetes insipidus

199

2.79

9.09

7.8

4.1

1.69

2.27

mmol/l

0.74

155

Other disorders of binocular movement

104

554

1.99

9.07

7.1

4.6

1.99

1.75

mmol/l

0.33

441

Corneal ulcer

702

5536

1.29

9.07

5.5

3.8

1.81

1.90

mmol/l

0.31

590

4505

Lesion of radial nerve

165

1006

1.72

9.07

3.9

3.4

2.26

1.89

mmol/l

0.57

140

798

Other meningitis

369

2.25

9.06

3.9

3.6

1.55

1.93

mmol/l

0.39

291

D07AA Corticosteroids, weak (group I)

627

4873

1.31

9.03

4.9

5.3

1.80

1.70

mmol/l

0.28

511

3901

Nonalcoholic steatohepatitis

159

3.03

9.03

3.5

4.2

1.69

2.04

mmol/l

0.24

131

Pedestrian injured in transport accident

280

1922

1.51

8.98

3.6

3.7

1.55

1.96

mmol/l

0.96

222

1557

Ulcerative colitis (strict definition, all Crohn cases excluded)

549

4200

1.34

8.97

4.4

4.2

1.70

1.85

mmol/l

0.39

425

3400

Postmenopausal bleeding

1150

5217

1.23

8.97

3.3

3.5

2.22

2.16

mmol/l

0.18

961

4330

Calculus of lower urinary tract

259

1760

1.54

8.96

4.5

3.8

1.53

1.93

mmol/l

1.03

206

1380

Hordeolum and other deep inflammation of eyelid

228

1503

1.58

8.94

5.1

4.1

1.40

1.87

mmol/l

1.30

192

1193

Hypertrophic disorders of skin

209

1348

1.60

8.94

3.6

3.8

1.97

1.88

mmol/l

0.15

167

1078

Dental caries 2, only avohilmo

2510

22405

0.88

8.94

4.3

1.65

1.81

mmol/l

1.37

2111

18291

Scleritis and episcleritis

223

1461

1.58

8.93

5.9

3.7

1.95

1.99

mmol/l

0.05

188

1188

Carcinoma in situ of skin of ear and external auricular canal

424

2.21

8.92

7.2

4.0

1.05

1.77

mmol/l

1.04

331

Ulcerative proctitis

230

1517

1.57

8.92

4.1

3.8

2.04

1.97

mmol/l

0.08

180

1219

Alzheimer’s disease (Atypical or mixed), excluding more controls

349

2154

1.45

8.91

2.8

3.3

1.97

1.85

mmol/l

0.22

278

1683

Myeloid leukaemia

121

682

1.89

8.91

4.9

3.5

2.12

2.13

mmol/l

0.01

560

Effects of foreign body entering through natural orifice

1027

8465

1.23

8.91

4.0

4.6

1.86

1.77

mmol/l

0.33

842

6875

Mature T/NK-cell lymphomas, hilmo

382

2.26

8.90

6.1

3.8

1.23

1.91

mmol/l

0.71

299

Personal history of malignant neoplasm

152

912

1.75

8.86

9.2

3.4

1.83

2.04

mmol/l

0.45

123

719

Other/unspecified enthesopathies of lower limb, excluding foot

257

1736

1.52

8.84

5.1

3.9

1.64

1.79

mmol/l

0.29

217

1402

Bruxism

358

2.23

8.82

4.5

3.7

2.09

1.88

mmol/l

0.31

276

Other specified disorders of muscle

130

749

1.83

8.80

5.7

3.6

2.39

1.97

mmol/l

0.75

101

582

Anogenital herpesviral [herpes simplex] infection

192

1216

1.62

8.80

3.6

3.5

1.54

1.81

mmol/l

0.56

171

964

Chondropathies

599

4651

1.32

8.79

3.8

4.0

1.63

1.86

mmol/l

1.11

486

3772

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

487

3668

1.35

8.76

3.5

3.7

2.00

1.87

mmol/l

0.38

410

2964

Acute appendicitis, with complications

808

6507

1.27

8.75

3.7

4.1

1.73

1.91

mmol/l

0.65

665

5263

Asthma mixed form (mode)

206

1330

1.60

8.75

4.2

3.3

2.21

1.49

mmol/l

1.64

169

1044

Restless leg syndrome

482

3646

1.36

8.68

4.3

3.7

1.90

1.98

mmol/l

0.17

413

2973

Synovial cyst of popliteal space [Baker]

307

2162

1.47

8.64

4.0

3.6

1.81

2.10

mmol/l

0.65

249

1745

malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)

1503

7810

1.19

8.64

4.1

1.58

1.72

mmol/l

0.70

1208

6329

Acute lymphadenitis

231

1537

1.55

8.62

5.6

4.5

1.73

1.76

mmol/l

0.06

195

1226

Other injuries of lower limb, level unspecified

206

2.73

8.58

5.3

4.5

2.25

1.87

mmol/l

0.31

151

Recurrent dislocation of patella

164

1006

1.68

8.56

3.6

3.9

1.81

1.64

mmol/l

0.23

129

805

Retinal haemorrhage

124

715

1.86

8.56

7.3

3.3

2.00

2.19

mmol/l

0.19

105

562

Delivery, wide proxy

1042

6709

0.82

8.55

2.8

3.7

2.07

1.94

mmol/l

0.51

843

5489

Burn and corrosion of trunk

139

825

1.78

8.54

3.0

4.7

2.07

1.82

mmol/l

0.29

119

656

Other and unspecified disorders of vitreous body

1670

14339

1.17

8.51

3.8

2.12

1.99

mmol/l

0.94

1423

11771

Left hemicolectomy

122

702

1.87

8.50

5.4

3.8

2.08

2.11

mmol/l

0.03

103

550

Intracranial and intraspinal abscess and granuloma

302

2.38

8.48

8.5

3.7

0.62

2.09

mmol/l

2.06

246

Renal cell carcinoma of kidney, excluding all cancers (controls excluding all cancers)

160

988

1.71

8.47

6.5

3.0

0.84

2.09

mmol/l

4.12

122

773

Coxarthrosis, primary, with hip surgery

2156

17972

1.15

8.44

3.6

3.8

1.97

1.94

mmol/l

0.13

1783

14681

Excessive vomiting in pregnancy

229

1523

1.54

8.41

3.3

3.4

1.82

1.86

mmol/l

0.06

178

1245

Erectile dysfunction, exclusion

3.76

8.32

9.0

6.0

2.10

0.63

mmol/l

0.90

Psoriasis (vulgaris), strict definition

133

784

1.78

8.32

3.6

3.7

2.61

2.00

mmol/l

0.96

103

630

Anxious personality disorder

346

2.20

8.31

4.8

3.3

2.26

1.79

mmol/l

0.47

281

Mouth breathing

1787

15519

1.17

8.29

4.6

1.79

1.77

mmol/l

0.09

1444

12703

Serous carcinoma of ovary, excluding all cancers (controls excluding all cancers)

139

831

1.76

8.28

3.4

3.3

2.76

2.18

mmol/l

1.04

116

695

Other congenital malformations of heart

319

2.46

8.28

10.4

9.5

0.75

1.43

mmol/l

0.82

240

Burns classified according to extent of body surface involved

253

2.50

8.27

7.6

5.4

1.50

1.82

mmol/l

0.34

190

Other and unspecified glaucoma

319

2286

1.45

8.27

4.1

3.3

1.58

2.07

mmol/l

1.28

268

1844

Preparation and fitting of bite rail to mouth

467

3534

1.35

8.27

5.3

4.1

2.11

1.90

mmol/l

0.87

386

2872

Motor neuron disease (with DMD)

481

2.02

8.23

4.1

4.0

4.22

1.72

mmol/l

5.88

358

Allergic purpura

133

787

1.78

8.21

7.2

3.7

1.73

1.80

mmol/l

0.10

110

632

Noninflammatory disorders of female genital tract

1676

7234

1.18

8.20

4.0

3.4

1.81

1.90

mmol/l

0.43

1364

5876

Infection due to other mycobacteria

378

2.17

8.19

8.1

2.6

2.66

1.89

mmol/l

0.91

305

Autoimmune hyperthyroidism

210

1383

1.56

8.19

3.1

3.0

2.01

1.93

mmol/l

0.11

152

1145

Vascular dementia (undefined)

192

1234

1.61

8.18

3.9

3.1

1.78

2.03

mmol/l

0.42

152

937

Dental caries 1 and operation codes, only avohilmo

1139

6837

0.82

8.16

4.2

6.0

1.92

1.82

mmol/l

0.43

918

5656

Sicca syndrome [Sjögren]

323

2317

1.44

8.16

5.0

3.4

1.83

1.98

mmol/l

0.36

269

1915

Foreign body entering into or through eye or natural orifice

342

2480

1.42

8.16

4.7

1.74

1.89

mmol/l

0.34

282

1978

All dysplastic lesions of the vulva

152

931

1.70

8.14

5.7

3.0

2.06

2.11

mmol/l

0.05

125

762

Trigeminal neuralgia

234

1583

1.53

8.14

3.3

2.09

1.98

mmol/l

0.19

197

1291

Haemangioma and lymphangioma, any site

338

2445

1.42

8.12

3.9

3.8

2.05

1.86

mmol/l

0.48

281

1983

Disorder of pancreatic internal secretion, other and/or unspecified

175

2.83

8.12

9.7

4.2

1.68

2.18

mmol/l

0.48

134

Autism spe, excluding more controls

431

2.04

8.10

3.5

6.1

1.36

1.41

mmol/l

0.05

333

Scleritis

273

2.38

8.09

6.0

3.2

1.21

2.05

mmol/l

1.04

220

Leiomyoma of uterus

1561

7523

1.18

8.07

3.8

3.5

2.03

2.08

mmol/l

0.23

1317

6215

Hypoplasia of dental enamel, prenatal , including avohilmo

342

2.65

8.06

41.9

10.3

1.01

0.77

mmol/l

0.35

254

L02BX Other hormone antagonists and related agents

266

1863

1.50

8.06

3.3

4.1

1.68

1.84

mmol/l

0.31

204

1464

Congenital malformations of the nervous system

125

736

1.82

8.04

7.9

7.5

1.86

1.42

mmol/l

0.86

575

Disseminated intravascular coagulation [defibrination syndrome]

3.99

8.02

17.6

4.2

-0.05

2.13

mmol/l

1.70

Temporal arteritis

176

1131

1.65

8.00

4.0

3.4

1.82

1.91

mmol/l

0.15

151

902

Monoplegia

382

2.15

8.00

5.3

3.2

1.73

2.09

mmol/l

0.30

290

Benign neoplasm of urinary organs

190

1238

1.60

7.97

5.5

3.0

1.17

1.99

mmol/l

2.21

154

994

Benign neoplasm: Parathyroid gland

277

2.40

7.96

13.6

3.2

2.06

2.57

mmol/l

0.51

224

Superficial injury of neck

436

2.04

7.93

2.8

4.5

1.84

1.61

mmol/l

0.22

344

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

1074

9003

1.21

7.87

3.6

3.7

2.03

2.00

mmol/l

0.08

858

7348

Other and unspecified noninflammatory disorders of ovary, fallopian tube and broad ligament

535

1.91

7.85

4.7

3.5

1.94

2.08

mmol/l

0.21

425

Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)

374

2770

1.39

7.84

2.9

3.3

2.24

2.23

mmol/l

0.02

302

2300

Carcinoma in situ of other and unspecified sites

166

1059

1.66

7.81

4.3

3.5

1.13

2.01

mmol/l

2.21

126

838

Hypersplenism

111

3.41

7.77

6.2

3.5

1.91

1.94

mmol/l

0.01

Fistulae involving female genital tract

358

2.15

7.73

5.3

3.1

1.75

2.28

mmol/l

0.72

294

Vasomotor and allergic rhinitis

1488

12628

1.17

7.71

4.1

4.6

1.85

1.72

mmol/l

0.73

1214

10248

Other disorders of central nervous system

287

2.31

7.65

5.5

4.5

1.60

1.81

mmol/l

0.14

226

Other disorders of penis

452

3460

1.35

7.64

5.6

5.1

1.34

1.71

mmol/l

1.15

352

2757

Supervision of normal pregnancy

366

2836

0.73

7.64

2.3

3.8

1.89

1.65

mmol/l

0.63

296

2268

Benign neoplasm: Cerebral meninges

338

2473

1.41

7.64

3.9

3.3

1.64

2.12

mmol/l

1.62

282

2046

Benign neoplasm: Parathyroid gland

282

2.35

7.64

13.6

3.1

2.06

2.50

mmol/l

0.42

226

Contact with sharp object, undetermined intent

507

1.94

7.62

5.1

3.9

2.07

1.93

mmol/l

0.17

395

ILD and respiratory illness in diseases classified elsewhere

129

3.16

7.60

3.7

3.6

3.16

2.08

mmol/l

0.86

102

Ehlers-Danlos syndrome

149

2.81

7.58

12.9

3.1

1.51

2.11

mmol/l

0.47

108

Cysts of oral region, not elsewhere classified

180

1171

1.60

7.57

4.7

3.1

1.18

1.98

mmol/l

1.81

137

935

Temporomandibular joint disorders, including avohilmo

1393

11933

1.18

7.57

3.9

1.85

1.84

mmol/l

0.03

1135

9714

Injury of muscle and tendon at wrist and hand level

528

4120

1.31

7.57

3.3

4.1

1.95

1.85

mmol/l

0.24

431

3368

Contusion of ankle

153

958

1.66

7.57

6.0

4.0

1.33

1.70

mmol/l

0.48

129

760

Giant cell arteritis with polymyalgia rheumatica

176

1147

1.62

7.56

4.0

3.4

1.82

1.98

mmol/l

0.26

151

918

Benign neoplasm of middle ear and respiratory system

314

2275

1.42

7.55

4.1

3.5

1.83

1.92

mmol/l

0.15

264

1838

Other specified/unspecified dorsopathies

139

850

1.70

7.55

3.2

3.6

1.74

1.89

mmol/l

0.14

110

677

Essential (haemorrhagic) thrombocythaemia

158

1001

1.66

7.55

2.9

3.0

1.33

2.08

mmol/l

1.22

130

806

Other salmonella infections

147

913

1.68

7.53

6.9

3.2

1.72

2.06

mmol/l

0.44

123

725

Correction of physiology of bite - very demanding therapy visit

105

595

1.85

7.52

3.4

3.9

2.20

1.88

mmol/l

0.47

478

Carcinoma in situ of skin of trunk

145

905

1.71

7.52

5.6

3.2

0.98

1.96

mmol/l

2.38

123

716

Carcinoma in situ, bladder

155

983

1.67

7.51

4.2

3.5

1.21

2.04

mmol/l

1.98

118

786

Benign neoplasm: Kidney

140

862

1.71

7.51

5.6

3.0

1.25

2.13

mmol/l

1.80

113

695

Contact with hot air and gases

158

2.85

7.50

4.5

0.56

1.81

mmol/l

0.99

123

Impotence

247

1725

1.49

7.47

6.4

4.3

1.76

1.83

mmol/l

0.09

189

1360

Haemangioma, any site

311

2253

1.42

7.46

3.9

3.7

2.12

1.89

mmol/l

0.62

260

1839

Maternal care for other conditions predominantly related to pregnancy

497

3787

1.31

7.45

4.0

3.8

1.33

1.83

mmol/l

2.33

400

3073

Hypertrophic scar

187

1230

1.57

7.41

3.5

3.8

1.97

1.86

mmol/l

0.17

149

980

Nonpyogenic thrombosis of intracranial venous system

220

2.50

7.39

6.9

4.8

1.56

1.88

mmol/l

0.27

173

Coxibs

1470

6716

1.18

7.38

3.1

4.9

1.87

1.67

mmol/l

1.17

1167

5441

Malignant neoplasm of other and unspecified parts of biliary tract, excluding all cancers (controls excluding all cancers)

515

1.93

7.37

3.1

3.2

1.45

2.12

mmol/l

0.82

414

Menorrhagia

1331

6268

1.19

7.37

4.3

3.5

2.15

2.02

mmol/l

0.64

1103

5154

Toxic effect of organic solvents

3.53

7.37

4.4

4.2

2.41

1.84

mmol/l

0.30

Glaucoma

2568

20195

1.13

7.35

4.3

3.8

1.87

1.95

mmol/l

0.52

2061

16494

Other congenital malformations, not elsewhere classified

317

2.29

7.33

9.3

8.2

1.89

1.56

mmol/l

0.37

245

Ovarian dysfunction

184

1204

1.56

7.32

3.2

3.3

1.72

1.69

mmol/l

0.05

146

960

Nystagmus and other irregular eye movements

403

2.08

7.32

7.5

7.1

2.03

1.55

mmol/l

0.79

310

Spondylopathies (FG)

495

3843

1.31

7.31

4.2

3.7

1.89

1.81

mmol/l

0.19

406

3131

Thyroiditis

253

1774

1.47

7.30

4.1

3.7

2.05

1.92

mmol/l

0.28

221

1439

Other and unspecified mononeuropathies, also in other diseases

136

838

1.71

7.30

4.8

3.4

1.87

mmol/l

0.00

121

669

Oter anti-inflammatory and antirheumatic agents, non-steroids

1241

5844

1.20

7.30

3.5

4.8

1.88

1.72

mmol/l

0.71

995

4755

Malignant neoplasm of cervix uteri

325

2.17

7.29

4.9

2.8

1.53

2.26

mmol/l

0.60

257

Postviral fatigue syndrome

118

3.02

7.28

3.9

5.7

2.18

1.84

mmol/l

0.27

Disorders of sphingolipid metabolism and other lipid storage disorders

3.97

7.24

7.4

2.9

1.66

2.61

mmol/l

0.54

Gonarthrosis, primary, with knee surgery

2586

18941

1.13

7.24

3.4

3.9

2.13

1.90

mmol/l

2.51

2109

15514

Defects in the complement system

225

2.53

7.22

14.5

6.4

1.55

1.59

mmol/l

0.03

170

Transepidermal elimination disorders

6.18

7.22

9.8

4.6

2.60

3.07

mmol/l

0.15

Complications peculiar to reattachment and amputation

180

2.70

7.21

11.5

3.3

1.34

2.07

mmol/l

0.61

136

Testicular dysfunction

149

941

1.66

7.20

5.1

4.3

1.73

1.93

mmol/l

0.22

126

754

Other congenital malformations of peripheral vascular system

335

2.16

7.18

4.6

7.0

1.40

1.52

mmol/l

0.08

263

Thyrotoxicosis with toxic multinodular goitre

245

1719

1.48

7.18

3.9

3.3

2.49

2.04

mmol/l

0.94

213

1416

Other hereditary haemolytic anaemias

156

2.83

7.18

3.4

4.8

1.86

1.80

mmol/l

0.03

117

116

3.22

7.17

3.5

3.8

3.14

2.16

mmol/l

0.71

Carcinoma in situ of other and unspecified digestive organs

122

738

1.77

7.17

5.3

3.5

0.85

2.03

mmol/l

2.28

103

590

Seropositive rheumatoid arthritis, wide

1100

9321

1.20

7.17

3.7

2.02

2.00

mmol/l

0.05

882

7611

Primary gonarthrosis, bilateral

2287

17837

1.13

7.15

3.3

3.9

2.14

1.91

mmol/l

2.26

1900

14622

Polyp of the female genital tract

1193

5879

1.19

7.15

3.2

3.4

2.03

2.06

mmol/l

0.12

1026

4852

Other and unspecified acne

260

2.29

7.15

9.4

3.8

1.52

2.01

mmol/l

0.74

205

Contusion of other and unspecified parts of foot

187

1242

1.56

7.14

4.6

4.9

1.62

1.72

mmol/l

0.14

155

985

Benign neoplasm: Tongue

118

706

1.76

7.10

3.8

3.1

2.55

2.04

mmol/l

0.81

106

572

Acetic acid derivatives and related substances

1484

6659

1.17

7.10

3.3

4.9

1.89

1.67

mmol/l

1.25

1190

5395

Follicular lymphoma, hilmo

187

1250

1.57

7.10

4.3

3.6

2.21

2.03

mmol/l

0.28

155

1001

Primary ovarian failure

313

2.15

7.09

3.4

3.6

2.18

1.90

mmol/l

0.29

244

Tooth eruption problems

492

3793

1.31

7.08

9.5

4.8

1.69

1.59

mmol/l

0.25

384

3044

Other/unspecified seropositive rheumatoid arthritis

1086

9203

1.20

7.08

3.6

3.7

2.04

2.01

mmol/l

0.09

869

7510

Benign neoplasm of other and unspecified intrathoracic organs

277

2.29

7.08

5.1

3.4

2.47

2.25

mmol/l

0.16

223

Disorders of breast

1659

13426

1.16

7.07

3.7

3.5

1.99

2.04

mmol/l

0.19

1353

11131

Accidental poisoning by and exposure to other gases and vapours

128

3.03

7.05

3.9

4.6

2.50

1.76

mmol/l

0.48

104

Adenocarcinoma and ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

148

941

1.66

7.05

3.1

1.93

2.13

mmol/l

0.25

121

757

Other injuries of upper limb, level unspecified

244

2.36

7.03

6.7

4.8

0.53

2.02

mmol/l

1.32

189

Pemphigoid

130

804

1.72

7.00

3.6

3.5

1.80

2.06

mmol/l

0.30

111

638

Eosinophilia

438

1.99

6.97

5.7

4.6

1.27

2.00

mmol/l

0.74

346

Metabolic disorder, other/unspecified

3.54

6.95

27.5

9.6

0.56

1.82

mmol/l

0.90

Dislocation, sprain and strain of joints and ligaments of knee

2346

19471

1.13

6.93

3.7

4.0

1.83

1.78

mmol/l

0.29

1957

15958

Other and unspecified injuries of thorax

430

1.98

6.92

4.8

3.4

1.90

1.91

mmol/l

0.01

341

Other and specified injuries of hip and thigh

104

607

1.82

6.91

5.3

3.4

2.41

1.91

mmol/l

0.68

477

Conductive hearing loss, unspecified

343

2559

1.38

6.91

5.5

4.2

2.01

1.91

mmol/l

0.20

279

2064

Perforation of tympanic membrane

406

3103

1.34

6.91

5.1

3.9

1.76

1.90

mmol/l

0.30

334

2513

Drug-induced tremor

172

2.72

6.91

4.4

4.6

1.56

2.00

mmol/l

0.35

136

Dental operations, only avohilmo

3768

17617

1.10

6.89

3.9

4.2

1.82

1.86

mmol/l

0.29

3045

14319

Bullous pemphigoid

108

640

1.81

6.89

3.5

3.7

1.79

2.04

mmol/l

0.23

505

Non-small cell lung cancer, adenocarcinoma

279

2021

1.43

6.89

3.5

2.07

2.00

mmol/l

0.11

232

1594

Non-small cell lung cancer, adenocarcinoma, helper endpoint

279

2021

1.43

6.89

3.5

2.07

2.00

mmol/l

0.11

232

1594

Hypertension, portal

3.76

6.88

9.4

4.1

0.51

1.96

mmol/l

1.44

Other bursitis of elbow

209

2.50

6.87

6.0

3.8

0.82

2.08

mmol/l

1.15

162

Non-allergic asthma

405

3100

1.34

6.86

4.5

5.1

2.09

1.87

mmol/l

0.58

328

2483

Social disorders starting during childhood or adolescence

262

2.34

6.86

5.8

8.9

1.23

1.22

mmol/l

0.00

203

Crohn disease (strict definition, all UC cases excluded)

187

1253

1.54

6.86

4.4

4.2

1.00

1.96

mmol/l

2.49

161

998

Other (seronegative) rheumatoid arthritis, wide

762

6274

1.24

6.85

3.7

2.12

1.99

mmol/l

0.40

609

5110

Myeloproliferative diseases

356

2679

1.37

6.84

3.7

3.5

1.66

2.04

mmol/l

0.92

291

2150

244

1718

1.46

6.81

4.9

3.0

2.67

1.94

mmol/l

1.87

204

1325

Toxic effect of other gases, fumes and vapours

130

2.94

6.80

4.1

3.3

2.55

2.16

mmol/l

0.22

Other congenital malformations of intestine

305

2.24

6.78

16.7

6.0

1.87

1.42

mmol/l

0.54

232

Malignant neoplasm of endocrine gland

269

1936

1.43

6.78

5.8

3.9

2.14

1.97

mmol/l

0.34

216

1573

Hydrocephalus

346

2598

1.38

6.78

4.0

3.8

2.17

1.93

mmol/l

0.59

269

2067

Sequelae of injuries of neck and trunk

123

753

1.71

6.77

3.0

3.5

2.91

1.88

mmol/l

1.38

596

Drug-induced gout

126

3.05

6.76

6.4

3.9

2.35

1.67

mmol/l

0.50

Malignant neoplasm of other connective and soft tissue, excluding all cancers (controls excluding all cancers)

182

1222

1.56

6.76

4.8

3.5

1.66

1.92

mmol/l

0.51

149

966

Other juvenile arthritis

173

1146

1.56

6.74

4.6

6.3

1.54

mmol/l

0.00

137

899

Autonomic disorders

100

581

1.82

6.74

4.1

3.8

2.25

1.86

mmol/l

0.52

462

Blindness, monocular

230

2.40

6.74

8.3

3.3

1.27

2.16

mmol/l

1.29

175

Crystal arthropathies, rheuma endpoint

554

1.86

6.73

5.9

3.8

1.54

1.90

mmol/l

0.40

442

Other specified/unspecified hearing loss

354

2668

1.37

6.72

4.6

3.9

1.90

1.98

mmol/l

0.15

297

2126

Other peripheral vascular diseases

293

2142

1.40

6.69

5.9

3.3

1.68

2.04

mmol/l

0.95

252

1720

Benign neoplasm of major salivary glands

401

3077

1.34

6.68

3.8

3.6

2.07

1.96

mmol/l

0.27

324

2486

Other crystal arthropathies

556

1.85

6.66

5.9

3.8

1.54

1.98

mmol/l

0.51

432

Other and unspecified vaccines and biological substances

131

2.86

6.65

3.6

4.6

1.26

1.96

mmol/l

0.78

Other superficial mycoses

465

1.90

6.60

5.9

3.7

2.28

1.85

mmol/l

0.56

372

Respiratory conditions due to other external agents

549

1.85

6.58

3.9

3.4

2.72

1.89

mmol/l

1.29

438

Myeloid leukaemia

121

746

1.72

6.58

4.9

3.9

2.12

2.18

mmol/l

0.06

591

Other menopausal disorders

678

4798

0.80

6.58

3.2

3.6

2.27

2.09

mmol/l

0.68

580

3983

Carcinoma in situ of colon

384

2.05

6.57

5.0

3.2

0.76

2.09

mmol/l

1.93

313

Other and unspecified injuries of ankle and foot

154

1000

1.59

6.56

5.1

4.6

1.41

1.76

mmol/l

0.62

135

806

Foreign body or object entering through skin

239

1696

1.45

6.54

3.7

4.2

1.28

1.90

mmol/l

1.61

192

1364

Organ-limited amyloidosis

3.42

6.54

4.7

3.2

2.24

1.96

mmol/l

0.15

Malignant neoplasm of larynx, excluding all cancers (controls excluding all cancers)

572

1.82

6.53

3.3

3.2

2.81

2.02

mmol/l

0.74

453

Malignant neoplasm of vulva, excluding all cancers (controls excluding all cancers)

348

2.08

6.53

3.8

2.7

1.93

2.44

mmol/l

0.42

286

Other disorders of iris and ciliary body

121

747

1.71

6.52

8.4

3.6

1.10

1.94

mmol/l

1.76

104

584

Other disorders of prostate

170

1136

1.57

6.51

4.1

4.0

2.19

1.83

mmol/l

0.53

143

867

Chronic lymphocytic leukaemia

140

899

1.65

6.51

3.7

2.06

2.09

mmol/l

0.03

110

720

Disorders of adrenal gland, other and/or unspecified

116

3.03

6.51

4.7

4.6

2.73

2.21

mmol/l

0.43

Dental pulpitis 3, only avohilmo

466

2650

1.31

6.50

4.8

6.1

1.08

1.35

mmol/l

1.07

371

2094

Benign neoplasm: salivary glands, exclude unknown (D119)

354

2681

1.36

6.50

3.8

3.7

2.06

1.97

mmol/l

0.21

289

2161

Urethral stricture

253

1821

1.44

6.48

5.3

3.8

1.82

1.96

mmol/l

0.21

207

1425

Factitial dermatitis

116

3.01

6.48

6.5

3.2

2.16

2.22

mmol/l

0.03

Unspecified protein-energy malnutrition

153

2.78

6.47

5.8

3.8

1.77

2.08

mmol/l

0.14

114

Alcohol abuse counselling and surveillance

419

1.96

6.45

4.1

3.7

2.28

1.99

mmol/l

0.32

336

Phakomatoses, not elsewhere classified

308

2.15

6.44

4.5

6.3

1.17

1.71

mmol/l

0.54

243

Injury of nerves at wrist and hand level

142

910

1.62

6.44

4.9

4.1

1.67

1.90

mmol/l

0.32

114

723

ILD medications: pirfenidone

290

2.23

6.43

2.6

3.5

2.80

1.85

mmol/l

0.88

229

Other and unspecified aplastic anaemias

295

2.18

6.42

13.5

4.0

1.86

1.87

mmol/l

0.00

220

Malignant neoplasm of ureter, excluding all cancers (controls excluding all cancers)

244

2.35

6.37

7.3

3.6

0.78

2.01

mmol/l

1.75

194

Peritonsillar abscess

741

6120

1.23

6.36

3.8

4.2

2.03

1.73

mmol/l

1.45

600

4964

Dislocation, sprain and strain of joints and ligaments of thorax

132

836

1.65

6.35

4.4

3.7

2.03

1.88

mmol/l

0.16

108

666

Benign neoplasm: Pituitary gland, craniopharyngeal duct

184

1251

1.52

6.34

4.3

3.4

2.05

1.98

mmol/l

0.11

146

1016

Contact with other sharp object(s)

230

1629

1.45

6.34

4.0

4.5

1.72

1.84

mmol/l

0.18

195

1299

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

431

3370

1.32

6.31

2.9

3.7

2.04

1.94

mmol/l

0.21

337

2696

Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)

1439

7513

1.16

6.31

4.1

1.60

1.72

mmol/l

0.53

1151

6084

Wilms' tumor, excluding all cancers (controls excluding all cancers)

213

2.47

6.30

10.0

4.4

0.21

1.67

mmol/l

2.11

162

Any prescribed medicine buy

2.76

6.27

6.0

6.2

1.79

0.71

mmol/l

1.03

Juvenile arthritis (FINNGEN)

190

1304

1.50

6.24

5.0

6.0

1.59

1.58

mmol/l

0.01

151

1037

Deep bite

495

3438

1.29

6.22

9.3

5.4

1.50

1.67

mmol/l

0.70

428

2767

Congenital malformations of pulmonary and tricuspid valves

369

2.11

6.22

10.0

10.6

1.69

1.07

mmol/l

1.34

287

Other overlap syndromes

446

1.90

6.21

4.1

3.3

2.44

1.93

mmol/l

0.61

351

Malignant neoplasm of stomach

228

1626

1.46

6.20

3.6

3.5

2.25

1.98

mmol/l

0.44

175

1278

Allergic rhinitis

1127

9585

1.18

6.18

4.4

4.9

1.86

1.71

mmol/l

0.73

924

7758

All dysplastic lesions of the cervix uteri, vagina or vulva

738

6064

1.22

6.18

4.2

3.6

2.04

1.84

mmol/l

0.79

604

4939

Drug-induced polyneuropathy

296

2.20

6.17

20.4

6.5

1.93

1.84

mmol/l

0.07

226

Frostbite

251

2.23

6.16

3.0

3.8

2.89

1.82

mmol/l

1.37

194

Congenital iodine-deficiency syndrome/hypothyroidism

135

868

1.63

6.15

3.9

3.7

1.81

1.89

mmol/l

0.08

106

688

Other specified/unspecified spondylopathies

114

704

1.70

6.15

4.3

3.4

2.32

2.10

mmol/l

0.28

547

Postzoster neuralgia

451

1.92

6.14

3.7

3.3

3.13

1.84

mmol/l

2.49

358

Hyperkinetic disorders (excl. ADHD)

115

710

1.72

6.14

5.6

7.3

0.76

1.38

mmol/l

0.84

571

Contact with heat and hot substances

221

1568

1.46

6.14

4.3

5.1

1.76

1.79

mmol/l

0.04

187

1250

Exposure to other and unspecified man-made environmental factors

361

2.00

6.14

4.5

3.5

2.32

1.88

mmol/l

0.64

282

Testicular hypofunction

128

813

1.64

6.11

5.5

4.3

1.83

1.91

mmol/l

0.07

108

656

Amblyopia ex anopsia

202

1415

1.49

6.11

7.6

6.2

1.54

1.66

mmol/l

0.24

163

1119

Outcome of delivery

247

2120

0.71

6.10

2.4

3.6

1.29

1.67

mmol/l

0.72

206

1703

L01XX Other antineoplastic agents

240

1734

1.44

6.08

3.9

3.5

1.48

2.05

mmol/l

1.47

189

1379

Personality and behavioural disorders due to brain disease, damage and dysfunction

384

1.97

6.08

3.6

3.8

2.76

1.81

mmol/l

1.21

312

Acquired pure red cell aplasia [erythroblastopenia]

103

3.09

6.08

5.9

4.8

1.84

1.83

mmol/l

0.00

Epidural haemorrhage

199

2.38

6.08

2.8

4.8

1.64

1.59

mmol/l

0.03

153

Viral conjunctivitis

470

1.85

6.07

5.8

3.8

1.39

1.91

mmol/l

0.62

380

Infections of genitourinary tract in pregnancy

269

1967

1.39

6.06

4.5

3.7

1.82

1.95

mmol/l

0.23

222

1618

Correction of physiology of bite - demanding therapy visit

221

1566

1.45

6.06

6.6

3.7

2.40

1.90

mmol/l

1.50

184

1272

Herpesviral keratitis and keratoconjunctivitis

175

1192

1.52

6.06

4.9

3.5

2.40

1.93

mmol/l

0.79

135

950

Secondary polycythaemia

102

615

1.75

6.05

4.6

3.6

2.10

2.07

mmol/l

0.03

489

Mental and behavioural disorders associated with the puerperium

142

2.60

6.03

2.3

3.3

0.88

2.17

mmol/l

0.79

113

Benign neoplasm of meninges

387

3000

1.32

6.01

3.9

3.5

1.71

2.08

mmol/l

1.22

325

2470

Other bursitis of hip

541

1.80

6.00

3.3

3.0

2.15

1.98

mmol/l

0.15

431

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

152

1009

1.57

5.99

5.4

3.3

1.51

1.94

mmol/l

0.75

119

808

Multiple delivery

129

1985

0.64

5.98

6.2

4.6

1.80

1.83

mmol/l

0.03

100

1615

Human immunodeficiency virus [HIV] disease resulting in other conditions

415

1.91

5.97

2.7

3.5

0.31

1.92

mmol/l

2.45

339

Persons with potential health hazards related to communicable diseases

1354

11718

1.16

5.97

10.5

4.5

1.23

1.67

mmol/l

4.30

1111

9439

Corneal scars and opacities

117

734

1.68

5.95

6.9

4.0

1.86

2.02

mmol/l

0.18

587

Dental caries 3 and operation codes, only avohilmo

1332

7686

0.86

5.95

4.4

5.8

1.89

1.80

mmol/l

0.41

1081

6374

Melanocytic naevi of upper limb, including shoulder

564

1.77

5.94

4.8

3.3

1.35

1.99

mmol/l

0.82

457

Entropion and trichiasis of eyelid

381

2958

1.33

5.93

3.7

3.6

1.91

1.98

mmol/l

0.12

311

2359

Chronic hepatitis NAS

324

2.05

5.93

7.5

3.1

0.67

2.22

mmol/l

1.81

255

Toxic effect of other noxious substances eaten as food

3.34

5.93

2.7

3.4

1.07

2.12

mmol/l

0.90

Symptoms and signs involving appearance and behaviour

189

2.41

5.92

3.9

2.7

2.88

1.74

mmol/l

1.07

143

Lyme disease

694

8347

0.82

5.90

2.9

4.1

1.54

1.95

mmol/l

2.40

579

6833

Spinal osteochondrosis

248

2.20

5.90

2.7

3.3

2.22

1.64

mmol/l

0.50

196

Otalgia

319

2418

1.36

5.86

5.9

5.0

1.64

1.79

mmol/l

0.29

268

1966

Carrier of infectious disease

566

1.76

5.85

4.2

3.7

1.63

1.86

mmol/l

0.27

456

Benign neoplasm of other and unspecified intrathoracic organs

299

2.11

5.84

5.1

3.8

2.47

1.96

mmol/l

0.46

238

Other infective otitis externa

234

1692

1.43

5.83

4.7

4.0

1.40

1.92

mmol/l

1.53

197

1338

Cachexia

105

2.97

5.83

5.5

4.0

4.56

1.37

mmol/l

1.82

Malignant neoplasm of rectum

412

3239

1.31

5.81

3.1

3.7

1.96

mmol/l

0.01

320

2591

Other sideroblastic anaemias

3.29

5.81

6.0

3.2

0.51

1.54

mmol/l

0.31

Carcinoma in situ of colon

401

1.95

5.80

5.0

3.6

0.76

1.98

mmol/l

1.69

318

Unspecified urinary incontinence

335

2560

1.34

5.79

4.0

3.6

1.86

2.06

mmol/l

0.46

281

2108

Nummular dermatitis

329

2510

1.35

5.79

5.3

3.7

1.38

1.98

mmol/l

1.91

267

2003

Peptic ulcer

258

2.18

5.79

6.1

3.5

1.14

2.13

mmol/l

0.88

202

Internal derangement of knee

1527

13435

1.14

5.79

3.9

3.7

1.86

1.89

mmol/l

0.14

1223

10948

Benign neoplasm: Parotid gland

312

2363

1.36

5.78

3.7

2.03

2.00

mmol/l

0.06

249

1892

Other and unspecified nail disorders

501

1.81

5.78

7.8

3.5

1.91

1.98

mmol/l

0.06

401

Meningitis

191

1334

1.48

5.78

3.8

3.7

1.68

1.99

mmol/l

0.59

166

1069

Motor neuron disease

427

1.88

5.76

3.4

4.82

1.75

mmol/l

6.67

319

Renal cell carcinoma of kidney

160

1085

1.54

5.76

6.5

3.5

0.84

2.11

mmol/l

4.34

122

851

Other peripheral vertigo

362

2800

1.33

5.75

3.3

3.6

2.12

2.02

mmol/l

0.20

303

2272

Burn and corrosion of hip and lower limb, except ankle and foot

592

1.74

5.75

4.3

4.2

1.77

1.97

mmol/l

0.20

473

Hallux valgus (acquired)

1342

8477

1.16

5.75

3.2

3.5

1.91

2.07

mmol/l

0.91

1121

6918

Adenocarcinoma and papilloma adenocarcinoma of rectum

411

3236

1.31

5.74

2.9

3.7

2.07

1.95

mmol/l

0.24

323

2594

Other nutritional anaemias

266

2.15

5.71

7.6

4.0

2.25

2.12

mmol/l

0.09

202

Pediculosis, acariasis and other infestations

215

1538

1.44

5.69

6.0

4.3

1.91

1.86

mmol/l

0.09

187

1226

Human immunodeficiency virus [HIV] disease

466

1.83

5.68

2.6

3.5

0.37

1.94

mmol/l

2.54

376

Serous carcinoma of ovary

139

917

1.58

5.68

3.4

3.0

2.76

2.12

mmol/l

1.18

116

758

Suppurative otitis media, unspecified

112

702

1.67

5.68

5.7

3.9

1.77

1.95

mmol/l

0.26

550

Hereditary retinal dystrophy

372

1.95

5.67

4.5

4.9

1.72

2.03

mmol/l

0.31

299

Dental caries 1, only avohilmo

4255

20146

1.09

5.66

4.0

4.3

1.84

1.88

mmol/l

0.26

3417

16448

Adenocarcinoma and ductal carcinoma of pancreas

148

992

1.56

5.66

3.1

3.6

1.93

2.09

mmol/l

0.20

121

789

Hyperprolactinaemia

109

676

1.66

5.66

4.6

3.4

1.98

1.82

mmol/l

0.20

542

Macular pucker

614

5062

1.24

5.65

4.8

3.6

1.50

1.98

mmol/l

2.62

509

4135

Melanocytic naevi of lower limb, including hip

153

1028

1.54

5.64

5.7

3.3

1.53

2.01

mmol/l

1.29

135

838

Optic atrophy

568

1.76

5.64

9.3

5.1

2.15

1.70

mmol/l

0.54

452

Malignant neoplasm of pancreas

266

1979

1.39

5.63

3.0

3.4

2.08

1.99

mmol/l

0.12

211

1554

Parkinson's disease, including avohilmo

690

5754

1.22

5.62

3.4

3.7

2.47

1.89

mmol/l

4.46

567

4634

Hypermetropia

312

2375

1.35

5.61

7.5

5.6

1.79

1.69

mmol/l

0.24

255

1889

Wilms' tumor

224

2.34

5.61

10.0

5.4

0.21

1.55

mmol/l

1.95

168

Benign neoplasm: Skin of ear and external auricular canal

158

1073

1.53

5.59

3.7

3.1

1.88

1.99

mmol/l

0.14

128

838

Pustulosis palmaris et plantaris

154

1039

1.53

5.59

3.5

2.11

1.99

mmol/l

0.12

126

840

Torticollis

387

1.90

5.58

6.2

4.3

1.51

1.69

mmol/l

0.13

299

Dental caries 3, only avohilmo

4455

21144

1.08

5.57

4.0

4.3

1.82

1.86

mmol/l

0.28

3577

17289

Moderate mental retardation

224

2.32

5.57

5.4

8.3

0.69

1.78

mmol/l

1.66

166

Erythema multiforme

598

1.72

5.56

4.1

4.3

2.65

1.92

mmol/l

1.23

481

Other and unspecified injuries of neck

168

2.43

5.56

4.9

3.8

1.73

1.88

mmol/l

0.10

126

Other erythematous conditions

141

937

1.57

5.56

5.4

3.6

1.67

1.92

mmol/l

0.32

122

751

Nonspecific lymphadenitis

206

1467

1.44

5.55

6.9

3.8

2.25

1.85

mmol/l

0.98

171

1194

Palmar fascial fibromatosis [Dupuytren]

689

5747

1.22

5.55

4.0

3.8

1.84

mmol/l

0.00

572

4620

Hidradenitis suppurativa

116

736

1.63

5.51

5.7

3.5

2.27

1.85

mmol/l

0.54

597

Other predominantly sexually transmitted diseases, not elsewhere classified

482

3866

1.26

5.51

4.4

3.7

1.43

1.88

mmol/l

1.80

385

3135

Autoimmune thyroiditis

381

1.90

5.50

3.3

4.1

2.33

1.97

mmol/l

0.41

301

Other/unspecified soft tissue disorders related to use, overuse and pressure

109

683

1.66

5.50

3.7

3.3

1.41

2.07

mmol/l

0.92

540

Melanocytic naevi of upper limb, including shoulder

577

1.73

5.49

4.8

3.9

1.35

1.86

mmol/l

0.60

452

Other and unspecified mononeuropathies of upper limb

119

763

1.62

5.48

3.8

3.7

2.17

1.97

mmol/l

0.28

104

618

Amoebiasis

139

2.63

5.48

3.9

5.5

2.09

2.23

mmol/l

0.06

109

Other spirochaetal diseases

710

8459

0.83

5.48

3.0

4.1

1.54

1.95

mmol/l

2.39

590

6928

Other drug-induced secondary parkinsonism

244

2.20

5.47

4.4

3.7

3.64

1.99

mmol/l

1.81

196

Carcinoma in situ of skin of lower limb, including hip

574

1.75

5.46

5.1

3.0

0.90

2.12

mmol/l

1.69

468

Benign neoplasm of urinary organs

190

1344

1.47

5.45

5.5

3.6

1.17

1.98

mmol/l

2.18

154

1068

Postpartum haemorrhage due to anatomy

1513

0.61

5.44

4.2

2.9

1.42

1.56

mmol/l

0.16

1190

Laparoscopic right hemicolectomy

239

1762

1.41

5.44

3.0

3.5

1.65

1.95

mmol/l

0.61

189

1419

Dementia in other diseases classified elsewhere

195

1388

1.46

5.44

4.9

3.6

2.52

2.02

mmol/l

1.09

167

1094

Meniscus derangement

2488

15457

1.11

5.42

3.8

3.6

1.95

1.91

mmol/l

0.21

2050

12614

Pustular psoriasis

172

1194

1.49

5.42

3.4

3.6

2.10

1.99

mmol/l

0.12

140

971

Other congenital malformations of circulatory system

102

634

1.69

5.39

6.4

4.5

1.20

2.00

mmol/l

0.93

502

Carcinoma in situ, bladder

155

1063

1.54

5.39

4.2

3.9

1.21

2.03

mmol/l

1.96

118

852

Other localized connective tissue disorders

474

1.80

5.38

8.4

3.1

1.94

2.19

mmol/l

0.24

373

Exposure to other and unspecified forces of nature

128

2.69

5.38

4.4

5.5

0.93

1.52

mmol/l

0.60

Hydrocele

537

4387

1.25

5.38

5.4

4.4

1.54

1.66

mmol/l

0.28

443

3489

TMD related pain

113

718

1.63

5.36

6.7

3.5

2.12

2.07

mmol/l

0.07

578

Acute inflammation of orbit

140

2.57

5.35

5.2

5.3

1.24

2.00

mmol/l

0.74

106

Guillain-Barre syndrome

409

1.87

5.34

4.9

3.6

1.66

1.88

mmol/l

0.21

325

Malignant immunoproliferative diseases

282

2.10

5.33

11.7

3.7

2.58

2.04

mmol/l

0.50

234

Failure of sterile precautions during surgical operation

3.56

5.32

4.3

4.5

3.09

2.06

mmol/l

0.40

HSIL lesion of the vulva

387

1.89

5.31

4.5

2.8

2.02

2.30

mmol/l

0.27

319

Benign neoplasm: Skin of eyelid, including canthus

559

4588

1.24

5.31

4.0

3.5

1.70

1.98

mmol/l

1.16

469

3735

Malignant neoplasm of other and ill-defined digestive organs, excluding all cancers (controls excluding all cancers)

440

1.84

5.30

3.1

3.0

2.19

2.06

mmol/l

0.09

360

Carcinoma in situ of other and unspecified sites

166

1157

1.51

5.30

4.3

3.8

1.13

2.03

mmol/l

2.37

126

921

Convergent concomitant strabismus

221

1609

1.41

5.29

4.6

5.2

1.76

1.79

mmol/l

0.05

183

1276

Other and unspecified acquired haemolytic anaemias

241

2.17

5.24

14.0

4.3

0.80

1.98

mmol/l

1.57

189

Benign neoplasm: Rectosigmoid junction

164

1140

1.50

5.22

4.7

3.1

1.71

2.09

mmol/l

0.68

148

914

Exposure to other and unspecified animate mechanical forces

108

685

1.64

5.22

4.3

5.0

1.28

1.65

mmol/l

0.54

547

Carcinoma in situ of skin of trunk

145

989

1.55

5.21

5.6

3.4

0.98

2.09

mmol/l

2.93

123

786

Malignant neoplasm of ovary

174

1222

1.47

5.20

3.2

2.50

2.12

mmol/l

0.62

143

1012

Generalized epilepsy, strict definition

105

664

1.66

5.20

4.1

6.2

0.79

1.58

mmol/l

1.15

519

Malignant neoplasm of thyroid gland

239

1769

1.39

5.18

3.3

3.6

2.17

2.02

mmol/l

0.25

190

1437

Laparoscopic left hemicolectomy

482

1.79

5.18

3.3

3.5

0.64

2.05

mmol/l

2.19

386

Defect, injury or illness of neck

118

2.72

5.17

3.9

4.4

1.80

2.13

mmol/l

0.21

Non-small cell lung cancer

685

5755

1.21

5.16

3.2

3.7

2.41

1.85

mmol/l

3.49

572

4598

Erythema nodosum

115

743

1.61

5.15

4.5

3.2

2.06

2.08

mmol/l

0.02

598

Listeriosis

101

2.89

5.12

8.8

2.8

0.71

2.05

mmol/l

1.13

Meralgia paraesthetica

131

873

1.56

5.12

3.2

3.4

1.55

2.03

mmol/l

0.85

108

700

Early lumbar disc prolapse, operated

273

2057

1.35

5.12

4.2

3.9

1.78

1.68

mmol/l

0.16

214

1680

Mental and behavioural disorders of puerperium, not classified elsewhere

154

2.39

5.11

2.3

3.6

0.88

1.83

mmol/l

0.52

120

Inflammatory disorders of breast

172

1205

1.46

5.07

4.6

3.3

1.90

1.94

mmol/l

0.05

141

982

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

151

1038

1.51

5.05

4.2

3.3

2.04

2.06

mmol/l

0.02

131

820

Spontaneous rupture of synovium and tendon

309

2384

1.33

5.03

4.1

3.7

2.11

2.02

mmol/l

0.15

250

1932

Myasthenia gravis

455

1.80

5.03

3.9

3.8

2.52

2.13

mmol/l

0.40

363

Thyrotoxicosis factitia

3.38

5.03

6.1

3.5

2.53

2.46

mmol/l

0.04

Malignant neoplasm of testis, excluding all cancers (controls excluding all cancers)

476

1.77

5.03

5.2

3.4

1.59

1.89

mmol/l

0.39

385

Systemic sclerosis (FG)

591

1.68

5.02

4.2

3.5

1.80

1.87

mmol/l

0.07

474

Contraceptive management

1123

9043

0.87

4.98

4.8

4.2

1.72

1.81

mmol/l

0.34

916

7400

Malignant neoplasm of eye, brain and central nervous system

174

1233

1.46

4.98

4.9

4.1

2.36

1.97

mmol/l

1.05

146

973

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

444

3581

1.26

4.97

4.3

3.7

1.89

1.97

mmol/l

0.20

378

2929

Marginal zone B-cell lymphoma, excluding all cancers (controls excluding all cancers)

404

1.84

4.97

4.6

3.3

1.80

2.12

mmol/l

0.23

326

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

104

2.92

4.97

18.1

6.1

1.35

1.63

mmol/l

0.19

Varicose veins

2766

19171

1.10

4.96

3.9

3.7

2.19

1.91

mmol/l

3.80

2293

15633

Hypertrophy of breast in women and men

586

4859

1.22

4.95

3.7

3.8

1.87

1.97

mmol/l

0.27

471

3969

Open wound of neck

191

2.26

4.94

6.2

3.5

0.68

1.73

mmol/l

1.13

153

Use of rasagiline

113

739

1.61

4.93

3.0

3.8

3.03

2.01

mmol/l

2.38

600

Sequelae of other and unspecified effects of external causes

115

2.69

4.92

5.0

3.7

2.09

2.19

mmol/l

0.05

Malignant neoplasm of brain

134

906

1.54

4.91

4.2

4.1

2.28

1.93

mmol/l

0.77

115

731

Pedestrian injured in collision with pedal cycle

128

857

1.55

4.91

3.1

3.5

1.51

2.06

mmol/l

0.99

103

689

Myeloproliferative diseases (CML excluded)

313

2433

1.32

4.90

3.5

3.4

1.55

2.02

mmol/l

1.20

256

1946

Benign lipomatous neoplasm

1158

10164

1.15

4.89

4.3

4.0

2.04

1.93

mmol/l

0.47

940

8285

Unspecified/other endometriosis

240

1787

1.36

4.89

4.2

3.3

1.86

1.76

mmol/l

0.15

191

1456

Traumatic secondary and recurrent haemorrhage

4.57

4.88

3.1

3.2

2.31

1.95

mmol/l

—

Other/unspecified rheumatoid arthritis

495

4053

1.24

4.88

4.0

3.5

2.12

2.03

mmol/l

0.17

401

3275

Iron deficiency

388

1.82

4.88

5.9

2.19

1.36

mmol/l

1.25

303

Other and unspecified papulosquamous disorders

167

2.39

4.87

3.4

3.8

2.15

2.31

mmol/l

0.07

121

Ankylosing hyperostosis [Forestier]

340

1.91

4.86

4.0

3.8

3.36

1.88

mmol/l

1.86

266

Other osteochondrodysplasias

241

2.12

4.86

5.1

7.0

1.42

2.00

mmol/l

0.59

181

Acute epiglottitis

339

1.89

4.84

5.9

3.3

1.96

1.95

mmol/l

0.01

263

Other/unspecified enthesopathies, not elsewhere classified

332

2599

1.30

4.84

3.9

3.7

1.44

2.03

mmol/l

1.95

273

2105

Malignant neoplasm of small intestine

632

1.66

4.82

9.0

3.9

1.52

2.01

mmol/l

0.46

505

Postpartum care and examination

206

1797

0.72

4.81

5.3

3.5

1.28

1.57

mmol/l

0.54

152

1432

Other retinal disorders in diseases classified elsewhere

3.91

4.80

17.8

5.1

1.20

2.21

mmol/l

0.54

Malignant immunoproliferative diseases

293

2.01

4.80

11.7

4.2

2.58

1.82

mmol/l

0.81

236

Other abnormal immunological findings in serum

498

1.73

4.80

3.8

4.3

1.62

1.74

mmol/l

0.11

380

Burn and corrosion of shoulder and upper limb, except wrist and hand

568

1.68

4.79

3.6

4.7

2.32

1.76

mmol/l

0.81

453

Dystonia

198

1442

1.41

4.79

3.9

2.14

1.93

mmol/l

0.38

174

1177

Ectropion of eyelid

183

1322

1.44

4.77

3.7

3.4

1.77

2.01

mmol/l

0.38

151

1025

Follow-up examination after treatment for malignant neoplasms

392

3136

1.27

4.77

3.9

3.4

2.35

1.84

mmol/l

1.62

315

2541

Benign neoplasm: Tongue

118

784

1.57

4.76

3.8

3.3

2.55

1.97

mmol/l

0.99

106

620

Adenocarcinoma of pancreas, excluding all cancers (controls excluding all cancers)

112

737

1.59

4.72

3.1

3.0

1.74

2.14

mmol/l

0.49

592

Muscle strain

116

766

1.57

4.72

7.0

3.6

1.85

1.92

mmol/l

0.07

602

Other rupture of muscle

149

2.42

4.72

4.7

3.2

2.27

1.87

mmol/l

0.22

112

Effects of heat and light

189

2.25

4.70

3.1

3.9

1.70

2.01

mmol/l

0.20

154

Urethritis and urethral syndrome

484

1.72

4.69

4.6

3.0

2.31

2.10

mmol/l

0.29

379

Benign neoplasm: Appendix

265

2.03

4.69

3.9

3.0

1.33

2.10

mmol/l

0.76

215

Disorders of orbit

160

1128

1.46

4.69

3.5

3.6

2.54

1.84

mmol/l

1.68

111

905

Systemic sclerosis

602

1.65

4.69

4.2

3.2

1.80

1.94

mmol/l

0.15

480

Lactose intolerance

111

727

1.58

4.68

4.0

4.1

1.41

1.80

mmol/l

0.72

571

Other and unspecified erythematous conditions

127

859

1.54

4.68

5.4

3.6

1.66

1.93

mmol/l

0.35

112

687

Radial styloid tenosynovitis [de Quervain]

171

1217

1.44

4.68

2.9

3.2

2.01

1.93

mmol/l

0.11

138

989

Burn and corrosion of ankle and foot

344

1.88

4.68

6.4

4.5

1.64

1.95

mmol/l

0.26

274

Other lack of coordination

473

1.75

4.66

4.0

4.6

1.48

1.80

mmol/l

0.36

377

Other endocrine disorders

297

2228

1.33

4.65

12.6

7.4

1.02

1.49

mmol/l

1.38

221

1771

Etanercept

216

1603

1.38

4.64

3.7

4.3

1.95

1.84

mmol/l

0.18

177

1291

Other and unspecified injuries of wrist and hand

139

957

1.50

4.63

4.8

1.27

1.89

mmol/l

0.89

110

772

Other inflammation of vagina/vulva

102

656

1.60

4.61

2.9

3.4

1.34

1.97

mmol/l

0.69

527

Purulent endophthalmitis

158

2.39

4.61

7.1

3.9

1.87

2.36

mmol/l

0.22

119

Malignant neoplasm of oral cavity, excluding all cancers (controls excluding all cancers)

175

1259

1.44

4.61

3.5

3.2

2.81

2.13

mmol/l

1.29

151

1009

Episcleritis

174

1248

1.43

4.60

5.9

3.7

2.13

1.92

mmol/l

0.37

142

1010

Benign neoplasm: Kidney

140

970

1.50

4.59

5.6

3.7

1.25

1.94

mmol/l

1.25

113

776

Drug-induced obesity

183

2.22

4.58

4.7

2.65

1.71

mmol/l

0.68

147

Bacterial agents resistant to antibiotics

5.61

4.58

6.6

2.9

3.66

3.16

mmol/l

0.17

Pseudomembranous colitis

211

2.14

4.58

5.2

3.5

2.17

1.78

mmol/l

0.30

168

Personal history of allergy to drugs, medicaments and biological substances

224

2.08

4.56

3.8

3.2

1.47

2.15

mmol/l

0.61

166

Haemangioma and lymphangioma, any site

338

2675

1.29

4.56

3.9

4.3

2.05

1.86

mmol/l

0.48

281

2147

Protein-energy malnutrition of moderate and mild degree

315

1.97

4.56

10.8

5.9

2.12

1.67

mmol/l

0.45

243

Respiratory and cardiovascular disorders specific to the perinatal period

229

1563

1.41

4.56

12.4

10.1

1.26

1.12

mmol/l

0.37

182

1243

Acute drug-induced interstitial lung disorder

206

2.19

4.55

5.0

4.1

2.29

1.99

mmol/l

0.20

157

Benign lipomatous neoplasm of other sites/unspecified

329

2596

1.29

4.55

3.9

3.4

2.20

1.99

mmol/l

0.45

264

2118

Systemic sclerosis, icd10

607

1.63

4.55

4.2

3.2

1.80

1.97

mmol/l

0.18

486

Impacted maxillary molar

143

989

1.47

4.54

7.1

4.4

1.25

1.48

mmol/l

0.31

122

784

Benign neoplasm: Other and unspecified parts of mouth

127

864

1.52

4.53

4.0

3.1

1.69

2.07

mmol/l

0.53

104

699

Exposure to excessive natural cold

261

2.01

4.53

4.5

3.8

2.53

1.63

mmol/l

0.63

202

Malignant neoplasm of rectosigmoid junction, excluding all cancers (controls excluding all cancers)

120

809

1.55

4.53

3.3

3.2

1.88

2.06

mmol/l

0.22

643

Disorders of puberty, all

100

652

1.62

4.50

6.1

7.7

1.69

1.41

mmol/l

0.50

526

Contusion of toe(s) with damage to nail

254

2.01

4.49

6.9

5.3

1.52

1.43

mmol/l

0.08

200

Ulcerative rectosigmoiditis

286

2219

1.31

4.48

4.5

3.8

2.12

1.98

mmol/l

0.24

228

1795

Pyoderma

500

1.70

4.48

8.4

4.2

2.80

1.67

mmol/l

2.13

393

Malignant neoplasm of breast, ER-positive, excluding all cancers (controls excluding all cancers)

1053

7483

1.15

4.46

2.6

3.4

2.23

2.19

mmol/l

0.11

876

6226

Combined immunodeficiencies

270

1.97

4.43

13.8

4.1

1.86

2.06

mmol/l

0.11

215

Other disorders of optic disc

306

1.91

4.43

5.9

4.2

1.16

1.67

mmol/l

0.54

240

Sixth [abducent] nerve palsy

140

978

1.49

4.42

4.3

3.9

2.11

2.00

mmol/l

0.13

102

781

Residual foreign body in soft tissue

182

1326

1.41

4.42

5.1

3.8

1.78

1.97

mmol/l

0.25

150

1062

Carcinoma in situ of skin, other sites/unspecified

345

1.87

4.42

5.0

3.1

1.99

2.24

mmol/l

0.25

277

Benign neoplasm of middle ear and respiratory system

314

2476

1.30

4.41

4.1

3.7

1.83

2.01

mmol/l

0.33

264

1983

Sacroiliitis, not elsewhere classified

136

939

1.48

4.39

3.8

3.5

1.60

1.71

mmol/l

0.14

111

750

Bitten or struck by other mammals

352

2808

1.27

4.39

4.9

4.2

1.52

1.79

mmol/l

0.66

291

2277

Malignant neoplasm of mesothelium and soft tissue

187

1376

1.41

4.38

4.3

3.6

1.67

1.95

mmol/l

0.49

158

1080

Complications of labour and delivery

1646

10201

0.89

4.36

3.2

3.7

1.89

1.95

mmol/l

0.32

1337

8454

Other/unspecified disorders of vestibular function

156

1114

1.45

4.35

3.8

3.5

2.29

2.01

mmol/l

0.48

132

901

Disorders of synovium and tendon in diseases classified elsewhere

551

1.65

4.35

4.3

3.5

1.85

2.23

mmol/l

0.43

428

Parkinson's disease

650

5529

1.20

4.34

3.4

3.7

2.52

1.91

mmol/l

4.61

532

4461

Sacrococcygeal disorders, not elsewhere classified

635

1.59

4.34

2.7

2.9

2.52

1.79

mmol/l

1.26

510

Injury of nerves and spinal cord at neck level

591

1.63

4.34

3.6

2.61

1.85

mmol/l

1.30

470

Epileptic seizures related to alcohol

155

2.34

4.34

7.6

3.8

1.27

1.97

mmol/l

0.50

122

Other otitis externa (chronic)

243

1857

1.34

4.34

5.4

3.9

1.59

1.87

mmol/l

0.73

207

1478

Third [oculomotor] nerve palsy

514

1.69

4.33

6.4

3.9

2.20

1.85

mmol/l

0.37

410

Muscular dystrophy

260

2.02

4.33

5.5

7.4

2.35

1.84

mmol/l

0.51

212

Endometroid carcinoma of ovary, excluding all cancers (controls excluding all cancers)

230

2.06

4.33

3.4

3.0

2.81

2.55

mmol/l

0.15

189

Inflammatory diseases of prostate (prostatitis)

553

4639

1.21

4.32

3.7

4.1

1.68

1.71

mmol/l

0.07

446

3712

Nontoxic single thyroid nodule

249

1908

1.33

4.32

3.9

3.6

1.90

2.04

mmol/l

0.28

212

1574

Other and unspecified injuries of abdomen, lower back and pelvis

345

1.83

4.31

6.6

3.4

2.22

1.57

mmol/l

0.87

265

Adenocarcinoma and papillary adenocarcinoma of stomach, excluding all cancers (controls excluding all cancers)

113

760

1.54

4.30

3.7

3.0

2.51

2.14

mmol/l

0.39

596

Dementia due to Parkinsons disease, excluding more controls

593

1.63

4.29

2.7

3.3

2.84

1.80

mmol/l

2.03

444

Other specified and unspecified disorders of eyelid

385

1.80

4.28

2.8

3.4

2.15

1.92

mmol/l

0.21

304

277

1.90

4.28

5.6

2.6

2.63

1.91

mmol/l

0.71

208

Other disorders originating in the perinatal period

106

726

1.65

4.28

8.0

11.2

1.26

0.95

mmol/l

0.59

557

Benign neoplasm: Pancreas

104

690

1.58

4.27

6.2

3.0

1.41

2.16

mmol/l

1.12

553

Congenital malformations of eye, ear, face and neck

257

1983

1.33

4.26

6.2

5.9

1.36

1.61

mmol/l

0.52

209

1567

Carcinoma in situ of skin of lower limb, including hip

613

1.63

4.26

5.1

3.2

0.90

2.00

mmol/l

1.45

490

Intermittent heterotropia

254

1959

1.33

4.26

7.5

6.2

1.57

1.56

mmol/l

0.01

205

1540

Persons encountering health services in circumstances related to reproduction

1959

14582

0.90

4.25

5.5

4.7

1.71

1.77

mmol/l

0.36

1628

11950

Injury of nerves at forearm level

295

1.90

4.25

3.3

3.5

1.36

1.89

mmol/l

0.53

238

Other hammer toe(s) (acquired)

696

5583

1.19

4.24

3.7

3.4

1.89

2.10

mmol/l

0.79

595

4560

Scar conditions and fibrosis of skin

135

941

1.48

4.23

7.2

3.7

1.76

1.87

mmol/l

0.15

114

757

Benign neoplasm: Appendix

275

1.95

4.23

3.9

3.6

1.33

2.09

mmol/l

0.77

222

Respiratory tuberculosis, confirmed

524

1.66

4.22

4.7

3.7

2.44

2.04

mmol/l

0.53

410

Benign neoplasm: Cerebral meninges

338

2704

1.28

4.21

3.9

3.5

1.64

2.04

mmol/l

1.21

282

2226

Other diseases of spinal cord

117

797

1.52

4.19

3.6

3.7

2.73

1.94

mmol/l

1.39

623

Other congenital malformations of nervous system

261

1.96

4.19

8.8

5.2

1.93

1.59

mmol/l

0.35

195

Benign mammary dysplasia

495

4118

1.22

4.19

3.6

3.4

2.30

2.08

mmol/l

0.71

410

3414

Seropositive rheumatoid arthritis, strict definition

548

4603

1.21

4.18

3.4

3.7

2.21

1.98

mmol/l

0.73

443

3764

Benign neoplasm of brain and other parts of central nervous system

230

1754

1.34

4.17

3.9

3.5

2.06

2.02

mmol/l

0.05

199

1429

Routine general health check-up of defined subpopulation

324

1.81

4.15

7.1

2.9

2.50

1.60

mmol/l

1.00

265

Malignant neoplasm of oropharynx, excluding all cancers (controls excluding all cancers)

583

1.62

4.14

3.7

3.4

3.24

2.10

mmol/l

2.07

473

Primary coxarthrosis, bilateral

1235

11020

1.13

4.14

3.6

3.8

2.02

1.94

mmol/l

0.31

1017

8977

Seronegative rheumatoid arthritis

431

3542

1.24

4.14

3.5

2.08

1.92

mmol/l

0.41

347

2871

Chronic crepitant synovitis/bursitis of hand and wrist/periarthritis of wrist

365

1.79

4.14

3.0

3.6

2.04

2.22

mmol/l

0.10

281

Haemangioma, any site

311

2469

1.29

4.13

3.9

4.3

2.12

1.86

mmol/l

0.70

260

1979

Bursitis of shoulder

637

1.58

4.13

2.9

3.2

2.19

2.10

mmol/l

0.07

509

Exposure to uncontrolled fire, not in building or structure

3.47

4.13

3.4

5.9

1.38

1.60

mmol/l

0.09

Malignant melanoma, excluding all cancers (controls excluding all cancers)

654

5585

1.19

4.13

4.1

3.7

1.80

1.91

mmol/l

0.33

546

4547

Impingement syndrome of shoulder

921

8060

1.15

4.13

4.1

3.8

2.02

1.85

mmol/l

0.68

740

6583

Tic and related disorders

358

1.80

4.12

4.4

6.0

2.00

1.46

mmol/l

0.92

285

Atrophic disorders of skin

478

3969

1.22

4.12

4.7

3.5

1.93

2.03

mmol/l

0.28

395

3252

Embedded teeth, including avohilmo

266

2067

1.31

4.10

6.3

4.5

1.65

1.76

mmol/l

0.16

202

1654

Divergent concomitant strabismus

269

2098

1.31

4.10

4.1

4.2

1.94

1.86

mmol/l

0.14

220

1690

Malignant neoplasm of corpus uteri

314

2502

1.29

4.10

2.8

3.1

2.29

2.20

mmol/l

0.14

251

2103

Alcoholic cardiomyopathy

133

2.42

4.09

6.9

4.1

3.38

1.44

mmol/l

1.83

101

Examination and encounter for administrative purposes

160

1159

1.42

4.08

4.3

3.5

1.80

1.72

mmol/l

0.10

130

935

Retinal detachment with retinal break

508

4253

1.22

4.08

6.1

3.7

1.36

1.98

mmol/l

3.25

423

3447

Systemic atrophies primarily affecting the central nervous system

171

1256

1.41

4.07

4.4

4.3

3.26

1.86

mmol/l

4.57

144

986

Convalescence

168

1225

1.40

4.06

5.4

2.8

1.59

2.08

mmol/l

0.80

130

983

Plantar fascial fibromatosis

317

2524

1.28

4.06

3.2

3.6

2.36

2.00

mmol/l

1.15

261

2042

Disorders of globe

106

714

1.55

4.06

7.8

3.5

1.83

1.87

mmol/l

0.04

557

Complications predominantly related to the puerperium

669

5718

1.18

4.05

3.2

3.7

1.93

1.87

mmol/l

0.16

568

4692

Use of levodopa decarboxylase inhibitor

567

4802

1.20

4.04

3.2

3.6

2.57

1.92

mmol/l

4.63

476

3856

Malignant neoplasm of bone and articular cartilage, excluding all cancers (controls excluding all cancers)

531

1.64

4.04

17.6

4.0

2.25

1.88

mmol/l

0.43

428

Collapsed vertebra, not elsewhere classified

208

2.08

4.04

7.3

3.1

3.54

2.09

mmol/l

1.83

165

FESS (DNB20)

285

3600

0.78

4.04

3.0

3.9

2.06

1.91

mmol/l

0.30

227

2924

Unspecified human immunodeficiency virus [HIV] disease

250

1.96

4.03

3.0

3.7

0.23

1.97

mmol/l

1.43

203

Benign neoplasm: Oesophagus

309

1.86

4.02

4.4

3.1

1.76

2.21

mmol/l

0.32

245

Striae atrophicae

221

2.01

4.00

3.6

3.5

2.25

1.89

mmol/l

0.28

172

Benign neoplasm: other/unspecified salivary gland

107

725

1.53

3.97

4.4

3.0

2.18

2.07

mmol/l

0.13

585

Other specified/unspecified disorders of bone/cartilage

108

733

1.53

3.96

4.9

3.6

1.05

2.08

mmol/l

1.51

586

Achalasia of cardia

470

1.67

3.96

3.8

3.6

3.17

1.94

mmol/l

2.22

372

Burns and corrosions of multiple body regions

223

2.01

3.95

4.9

4.6

1.75

1.98

mmol/l

0.11

172

Superficial frostbite

147

2.27

3.95

2.5

4.4

2.98

1.96

mmol/l

0.77

108

Benign neoplasm: Oesophagus

311

1.85

3.94

4.4

4.2

1.76

1.95

mmol/l

0.11

242

Other acute skin changes due to ultraviolet radiation

140

1000

1.45

3.92

3.1

3.2

2.10

2.13

mmol/l

0.03

116

785

Bicipital tendinitis

175

1295

1.39

3.92

3.5

3.6

1.74

2.01

mmol/l

0.41

150

1043

Tuberculosis, IBD comorbidity

310

2479

1.28

3.92

4.7

3.2

1.95

1.98

mmol/l

0.04

246

1942

Oral leukoplakia and related diseases, including avohilmo

330

2659

1.27

3.90

4.2

3.6

1.52

2.01

mmol/l

1.37

282

2149

Chromosomal abnormalities, not elsewhere classified

125

881

1.49

3.88

5.9

10.0

1.31

1.20

mmol/l

0.18

100

691

Other noninflammatory disorders of cervix uteri

178

1324

1.38

3.86

4.3

3.4

1.97

2.13

mmol/l

0.21

154

1089

Malignant neoplasm of vulva

270

1.92

3.86

3.3

2.6

1.82

2.75

mmol/l

0.69

222

Kyphosis

343

1.79

3.85

5.2

4.0

3.37

1.97

mmol/l

1.63

279

Polycythaemia vera

142

1022

1.44

3.85

4.1

3.1

1.67

2.09

mmol/l

0.77

115

817

Benign neoplasm: Pituitary gland, craniopharyngeal duct

184

1377

1.37

3.84

4.3

3.6

2.05

1.93

mmol/l

0.18

146

1110

Rheumatic fever incl heart disease

134

955

1.45

3.82

6.4

3.4

1.50

2.04

mmol/l

1.10

113

738

Melanocytic naevi of lower limb, including hip

153

1114

1.41

3.81

5.7

3.7

1.53

1.87

mmol/l

0.79

135

896

Injury of nerves at lower leg level

233

1.96

3.80

4.3

3.7

2.15

1.71

mmol/l

0.29

176

Infectious mononucleosis

234

1808

1.31

3.79

4.7

4.4

1.44

1.77

mmol/l

1.07

193

1443

Monoarthritis, not elsewhere classified

158

1157

1.40

3.79

4.4

3.7

1.89

1.82

mmol/l

0.08

134

914

Other disorders of bone density and structure

593

1.57

3.79

3.7

3.5

1.61

2.00

mmol/l

0.61

471

Astigmatism

267

2108

1.30

3.78

8.4

5.8

1.79

1.65

mmol/l

0.28

219

1680

Other papulosquamous disorders

293

1.85

3.76

3.5

3.6

2.12

1.97

mmol/l

0.10

220

Respiratory tuberculosis, bacteriologically and histologically confirmed

540

1.60

3.75

4.7

3.7

2.44

2.10

mmol/l

0.42

423

Other bullous disorders

110

760

1.50

3.73

4.8

3.7

2.24

2.02

mmol/l

0.22

610

Abscess of Bartholin gland

498

1.61

3.73

3.6

3.0

1.80

2.12

mmol/l

0.28

399

Ganglion

682

5885

1.17

3.73

3.9

3.7

1.73

1.87

mmol/l

0.46

558

4789

Sequelae of infectious and parasitic diseases

276

2189

1.28

3.72

5.2

3.5

1.99

2.00

mmol/l

0.01

233

1745

Marginal zone B-cell lymphoma

229

1.98

3.71

4.6

3.5

2.12

1.94

mmol/l

0.11

187

Dermatopolymyositis (FG)

354

1.75

3.71

6.2

3.4

2.10

1.77

mmol/l

0.30

283

Other/unspecified crystal arthropathies

166

2.18

3.71

7.0

3.3

1.69

2.15

mmol/l

0.38

130

Ductal carcinoma of pancreas

187

2.11

3.71

3.0

3.9

2.56

2.22

mmol/l

0.22

147

Malignant neoplasm of testis

432

1.67

3.68

5.2

4.1

1.41

1.60

mmol/l

0.20

349

Macular hole

217

1678

1.33

3.68

3.9

3.4

1.16

2.09

mmol/l

2.51

176

1375

Interstitial cystitis (chronic), drug-induced

2.64

3.67

2.7

3.7

1.80

2.30

mmol/l

0.24

Disorders in reading

472

1.64

3.67

14.6

6.9

0.88

1.50

mmol/l

0.63

381

Leukaemia of unspecified cell type

237

1.95

3.67

22.3

3.7

2.03

1.98

mmol/l

0.04

176

Pregnancy, childbirth and the puerperium

1039

6127

0.88

3.65

2.8

3.6

2.04

1.95

mmol/l

0.31

835

4984

Endometroid carcinoma of ovary

245

1.93

3.64

3.4

2.6

2.81

2.60

mmol/l

0.12

200

Leiomyosarcoma, excluding all cancers (controls excluding all cancers)

245

1.93

3.64

3.5

3.1

2.26

2.48

mmol/l

0.14

196

Use of antiglaucoma preparations and miotics

349

2856

1.25

3.64

6.0

3.3

1.30

2.08

mmol/l

3.17

275

2290

Malignant neoplasm of larynx

450

1.66

3.63

3.2

4.2

1.92

1.85

mmol/l

0.04

351

Melanocytic naevi of scalp and neck

559

1.57

3.63

4.6

3.4

1.76

1.92

mmol/l

0.20

448

Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)

542

4614

1.19

3.62

4.2

3.6

1.80

1.91

mmol/l

0.31

449

3763

Malignant neoplasm of bone and articular cartilage

253

1.91

3.62

13.1

5.1

2.09

1.65

mmol/l

0.47

193

Open wounds involving multiple body regions

2.65

3.62

3.3

3.5

1.77

2.13

mmol/l

0.12

Disorders of puberty

547

1.60

3.61

6.0

7.2

1.72

1.44

mmol/l

0.42

438

Chronic myeloid leukaemia, excluding all cancers (controls excluding all cancers)

238

1.93

3.61

5.5

3.2

2.48

2.26

mmol/l

0.10

194

Malignant neoplasm of anus and anal canal, excluding all cancers (controls excluding all cancers)

312

1.80

3.61

5.4

3.1

1.56

2.12

mmol/l

0.53

254

Acute lymphocytic leukaemia, excluding all cancers (controls excluding all cancers)

248

1.95

3.60

38.3

5.2

1.87

1.53

mmol/l

0.44

187

Acute lymphocytic leukaemia, helper endpoint

248

1.95

3.60

38.2

5.2

1.87

1.53

mmol/l

0.44

187

Acute lymphocytic leukaemia

248

1.95

3.60

38.3

6.7

1.87

1.46

mmol/l

0.59

185

Open bite

195

1487

1.34

3.60

9.3

6.5

1.74

1.52

mmol/l

0.53

160

1205

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

1955

17655

1.09

3.59

3.8

4.0

1.71

1.90

mmol/l

1.54

1628

14448

Papillary adenocarcinoma of thyroid gland

176

1324

1.36

3.57

3.5

3.3

2.06

1.99

mmol/l

0.08

143

1074

Undescended testicle

596

1.61

3.56

8.0

9.4

2.05

1.23

mmol/l

1.89

467

Allergic contact dermatitis due to drugs in contact with skin

571

1.57

3.56

6.9

3.2

1.89

2.00

mmol/l

0.08

449

Other and unspecified acute skin changes due to ultraviolet radiation

111

777

1.49

3.55

3.1

3.3

1.96

2.23

mmol/l

0.25

619

Dermatopolymyositis

374

1.71

3.55

6.0

4.4

2.10

1.97

mmol/l

0.10

302

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

246

1933

1.29

3.55

5.9

3.7

1.66

1.83

mmol/l

0.33

204

1567

Scabies

151

1111

1.39

3.54

5.5

4.2

1.96

1.85

mmol/l

0.15

131

884

Carcinoma in situ of cervix uteri

200

1528

1.33

3.54

4.9

3.4

1.80

1.73

mmol/l

0.10

154

1213

Acute myeloid leukaemia and myelodysplastic syndromes

517

1.60

3.53

4.3

4.2

1.32

1.93

mmol/l

0.54

397

Osteitis due to dental implant

155

2.18

3.53

7.1

3.7

2.70

2.32

mmol/l

0.32

124

Chronic myeloid leukaemia [CML], BCR/ABL-positive

240

1.92

3.53

5.5

3.8

2.48

1.99

mmol/l

0.25

192

Effects of other external causes

660

1.51

3.51

3.8

4.6

1.61

1.67

mmol/l

0.07

536

Lactose intolerance, other/unspecified

644

1.52

3.51

4.1

4.0

1.42

1.83

mmol/l

0.69

502

Tuberculosis, wide

319

2595

1.25

3.51

4.9

3.4

1.99

1.94

mmol/l

0.09

254

2029

LSIL lesion of the vulva

628

1.53

3.50

6.2

3.0

2.09

2.20

mmol/l

0.11

504

Inguinal or femoral hernia, bilateral

462

3898

1.21

3.50

4.1

1.58

1.82

mmol/l

0.63

375

3121

Other disorders of breast

365

3004

1.23

3.49

3.9

3.6

2.26

1.96

mmol/l

0.76

304

2478

Procreative management

1159

8763

1.12

3.49

7.1

4.9

1.64

1.74

mmol/l

0.51

970

7125

Benign neoplasm: Liver/bile ducts

508

1.59

3.48

5.1

3.2

1.97

2.15

mmol/l

0.24

399

Injury of muscle and tendon at hip and thigh level

336

2748

1.24

3.48

3.8

4.2

1.65

1.86

mmol/l

0.51

271

2224

Other and unspecified disorders of psychological development

548

1.61

3.47

3.1

8.5

1.11

1.28

mmol/l

0.26

425

Benign neoplasm: Rectosigmoid junction

164

1231

1.38

3.47

4.8

3.6

1.71

2.07

mmol/l

0.63

148

978

Malignant neoplasm of other connective and soft tissue

100

691

1.51

3.45

4.7

3.8

1.51

2.02

mmol/l

0.87

551

Malignant neoplasm of retroperitoneum and peritoneum

199

2.02

3.45

3.0

1.01

2.64

mmol/l

1.96

161

Guttate psoriasis

315

1.76

3.45

4.6

3.4

2.09

1.85

mmol/l

0.22

247

Recurrent dislocation and subluxation of joint

209

1615

1.31

3.45

6.2

3.6

1.72

1.86

mmol/l

0.24

175

1303

Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies

150

1107

1.38

3.43

2.7

3.6

2.64

1.97

mmol/l

1.21

113

885

Polyhydramnios

111

777

1.46

3.42

3.5

3.7

2.12

1.66

mmol/l

0.78

612

Other chondrocalcinosis

358

1.73

3.38

5.5

3.8

1.36

1.92

mmol/l

0.43

279

Leukaemia of unspecified cell type

244

1.89

3.37

22.3

4.3

2.03

1.81

mmol/l

0.24

180

Unspecified transport accident

2.46

3.37

2.7

3.8

2.01

2.07

mmol/l

0.03

Certolizumab pegol

301

1.76

3.37

1.9

3.5

1.82

1.93

mmol/l

0.09

246

Autism

610

1.52

3.36

3.5

6.6

1.37

1.47

mmol/l

0.11

482

Congenital malformations of spine and bony thorax

209

1.99

3.36

14.6

7.8

1.77

1.54

mmol/l

0.25

161

Allergic conjunctivitis

2058

18710

1.09

3.35

4.0

4.1

1.72

1.90

mmol/l

1.41

1713

15304

Ethmoidectomy

308

3770

0.81

3.35

3.4

3.9

2.06

1.93

mmol/l

0.26

245

3066

Other maternal disorders predominantly related to pregnancy

1663

9542

1.10

3.35

3.7

3.6

1.76

1.92

mmol/l

1.14

1340

7871

Exclusion endpoint for supernumerary teeth

389

1.68

3.35

8.3

8.0

1.67

1.45

mmol/l

0.22

296

Pityriasis rosea

157

2.09

3.35

3.5

3.6

0.64

1.90

mmol/l

0.69

117

Acute myeloid leukaemia, excluding all cancers (controls excluding all cancers)

259

1.85

3.34

5.0

4.0

1.42

2.10

mmol/l

0.45

204

Acute myeloid leukaemia, helper endpoint

259

1.85

3.34

5.0

4.0

1.42

2.10

mmol/l

0.45

204

Other acquired deformities of musculoskeletal system and connective tissue

172

1305

1.35

3.34

2.8

3.6

2.22

1.92

mmol/l

0.58

141

1043

Demyelinating diseases of the central nervous system

252

2004

1.28

3.33

5.0

3.7

2.14

1.90

mmol/l

0.57

218

1621

Congenital malformation of optic disc

3.33

3.32

17.8

15.2

0.51

1.77

mmol/l

0.62

Pervasive developmental disorders excl. Autism + Asperger

610

1.56

3.32

4.0

9.7

1.15

1.13

mmol/l

0.02

463

Obstructive hydrocephalus

461

1.62

3.32

6.2

5.1

1.66

1.70

mmol/l

0.02

362

Vertigo of central origin

437

1.64

3.32

2.9

3.2

2.98

2.05

mmol/l

1.29

348

Unspecified chronic bronchitis

138

1013

1.40

3.31

6.4

3.3

2.39

1.64

mmol/l

1.64

110

785

Dermatographic urticaria

198

1531

1.32

3.29

5.1

3.7

2.09

1.87

mmol/l

0.35

164

1243

Pulmonary eosinophilia, not elsewhere classified

321

1.74

3.28

6.1

3.0

3.09

2.19

mmol/l

0.50

257

Other and/or unspecified nontoxic goitre

280

2262

1.26

3.28

3.1

3.7

2.07

2.05

mmol/l

0.02

237

1863

Parkinson's disease, strict definition

593

5136

1.17

3.27

3.4

3.6

2.57

1.90

mmol/l

5.11

482

4129

Artificial joint operation, meniscal resection

4210

26498

1.06

3.27

3.6

4.0

2.06

1.87

mmol/l

2.74

3456

21752

Benign neoplasm: Skin, unspecified

133

973

1.40

3.27

6.4

3.3

1.72

2.09

mmol/l

0.67

782

Injury of muscle and tendon at forearm level

469

1.60

3.27

3.9

3.8

2.09

1.90

mmol/l

0.17

370

Localized skin eruption due to drugs and medicaments

253

1.83

3.25

3.0

4.3

2.00

1.87

mmol/l

0.06

197

Achilles tendinitis

355

2940

1.23

3.25

4.9

4.1

2.30

1.77

mmol/l

1.71

300

2388

Disorders of porphyrin and bilirubin metabolism

268

1.80

3.25

6.3

3.9

2.96

2.22

mmol/l

0.43

211

Puerperal sepsis

361

2992

1.22

3.24

3.8

2.13

2.06

mmol/l

0.14

316

2490

Other noninflammatory disorders of vagina

246

1959

1.28

3.24

4.6

3.4

1.74

2.04

mmol/l

0.71

214

1604

Ductal carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

197

1.99

3.22

3.0

3.3

2.56

2.04

mmol/l

0.37

161

Injury of blood vessels at hip and thigh level

2.66

3.22

3.1

3.8

1.12

1.66

mmol/l

0.30

Abscess of external ear

345

1.70

3.22

6.4

3.8

0.84

1.90

mmol/l

1.21

271

Inguinal hernia, bilateral

452

3838

1.20

3.21

4.1

1.56

1.82

mmol/l

0.68

366

3073

Benign neoplasm: Liver

446

1.60

3.21

4.6

3.2

2.15

2.12

mmol/l

0.03

350

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

682

1.48

3.21

5.0

3.9

1.64

1.79

mmol/l

0.12

548

Juvenile Open Angle Glaucoma

112

2.29

3.21

11.1

3.3

1.55

2.18

mmol/l

0.37

Convergence insufficiency and excess

268

1.78

3.21

11.2

4.0

1.86

1.60

mmol/l

0.21

206

Migraine with aura, drug-induced

239

1.85

3.21

2.1

2.9

1.12

2.03

mmol/l

0.58

187

Benign neoplasm: Skin of trunk

139

1028

1.39

3.20

5.8

3.1

1.60

2.06

mmol/l

0.76

119

833

Lateral epicondylitis

419

3527

1.20

3.19

3.6

3.9

2.02

1.89

mmol/l

0.30

352

2871

Oral leukoplakia and related diseases

217

1712

1.30

3.18

4.4

3.5

1.64

1.98

mmol/l

0.67

194

1376

Artificial joint re-operation

273

2213

1.26

3.18

4.6

3.5

2.24

2.09

mmol/l

0.29

219

1790

LSIL lesion of the cervix uteri, vagina or vulva

341

2815

1.22

3.17

4.1

3.6

2.06

1.86

mmol/l

0.43

286

2280

Benign neoplasm: Other and unspecified parts of mouth

127

929

1.41

3.17

4.0

3.4

1.69

2.07

mmol/l

0.53

104

740

Atopic conjunctivitis

152

1141

1.36

3.17

6.1

4.4

1.95

1.80

mmol/l

0.22

122

908

Aphakia

393

1.64

3.15

8.0

3.3

1.96

2.04

mmol/l

0.06

306

Benign neoplasm: Skin of ear and external auricular canal

158

1197

1.36

3.15

3.7

3.4

1.88

1.98

mmol/l

0.13

128

944

Selective deficiency of immunoglobulin A [IgA]y

114

2.31

3.15

6.1

7.1

0.81

2.17

mmol/l

0.75

Other disorders of amniotic fluid and membranes

196

2488

0.77

3.14

3.4

4.0

2.03

1.60

mmol/l

0.97

146

2004

Separation of retinal layers (serosa)

146

1093

1.37

3.13

6.9

3.7

1.43

2.22

mmol/l

2.03

119

878

Carcinoma in situ of skin, other sites/unspecified

382

1.67

3.13

5.0

3.8

1.99

1.88

mmol/l

0.10

291

Erectile dysfunction

361

3018

1.22

3.12

7.1

4.3

1.42

1.73

mmol/l

0.81

290

2384

Prepatellar bursitis

173

1328

1.34

3.12

3.9

4.0

1.89

1.96

mmol/l

0.08

143

1068

Other and unspecified hydrocephalus

549

1.54

3.12

5.9

4.4

2.32

1.81

mmol/l

0.61

431

Haemorrhage in early pregnancy

712

6095

1.15

3.11

2.9

3.7

2.03

1.95

mmol/l

0.27

573

5022

Myocardial infarction, unclassifiable

1054

8459

1.12

3.11

5.1

3.6

1.86

1.89

mmol/l

0.07

840

6737

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, excluding all cancers (controls excluding all cancers)

342

1.70

3.11

8.0

3.8

2.51

2.03

mmol/l

0.48

268

Benign neoplasm of ovary

537

4627

1.17

3.10

3.4

2.08

2.16

mmol/l

0.18

451

3817

Viral meningitis

112

803

1.43

3.10

4.1

3.6

1.42

1.87

mmol/l

0.77

645

Disturbances of smell and taste

136

1008

1.38

3.10

3.1

3.3

2.50

1.95

mmol/l

1.30

111

820

Burns and corrosions confined to eye and internal organs

629

1.49

3.10

3.6

4.0

2.54

2.00

mmol/l

0.63

508

Caught, crushed, jammed or pinched in or between objects

172

1320

1.33

3.09

4.4

4.6

2.00

1.78

mmol/l

0.33

143

1047

Maternal infectious and parasitic diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

301

1.70

3.07

1.8

3.1

2.07

1.90

mmol/l

0.16

241

Other, unspecified and serous retinal detachments

118

859

1.42

3.06

5.1

3.5

1.97

2.11

mmol/l

0.15

679

Injury of nerves and lumbar spinal cord at abdomen, lower back and pelvis level

108

2.30

3.06

2.5

3.7

2.02

2.08

mmol/l

0.03

Impacted maxillary canine

362

1.69

3.06

8.9

8.2

1.41

1.19

mmol/l

0.16

292

Motorcycle rider injured in noncollision transport accidents

104

739

1.45

3.05

3.8

4.3

1.55

1.79

mmol/l

0.29

588

Adenocarcinoma of pancreas

112

810

1.43

3.05

3.1

3.7

1.74

2.06

mmol/l

0.37

640

Malignant neoplasm of tonsil

383

1.65

3.05

3.3

3.6

3.16

2.05

mmol/l

1.31

307

Benign neoplasm: Larynx

117

851

1.42

3.03

3.2

1.95

2.13

mmol/l

0.19

676

Fasciculation

251

1.80

3.03

10.7

4.2

2.49

1.75

mmol/l

0.58

195

Atypical mycobacterium lung infection

337

1.69

3.02

8.3

3.3

3.16

2.06

mmol/l

1.11

256

Disorders of parathyroid gland, other and/or unspecified

201

1.93

3.02

4.7

3.2

1.42

2.62

mmol/l

0.83

159

Foreign body in ear

503

1.55

3.02

4.4

5.9

1.54

1.77

mmol/l

0.25

396

Malignant neoplasm of head and neck

321

2659

1.23

3.02

3.3

3.7

2.76

2.01

mmol/l

2.15

262

2110

Toxic effect of contact with venomous animals

142

1066

1.37

3.01

3.1

4.5

1.59

1.98

mmol/l

0.86

114

854

Use of levodopa decarbox-comt-inhibitor

136

1018

1.38

3.01

3.3

3.8

2.33

2.04

mmol/l

0.53

113

809

Parapsoriasis

504

1.55

2.99

3.7

4.0

1.32

2.05

mmol/l

0.78

398

Macular cyst

104

746

1.45

2.99

7.2

3.5

0.44

2.05

mmol/l

2.88

602

Malignant neoplasm of other and unspecified parts of tongue, excluding all cancers (controls excluding all cancers)

587

1.51

2.98

3.6

3.0

3.15

2.28

mmol/l

1.04

471

Thromboangiitis obliterans

2.43

2.97

3.1

3.8

3.28

2.15

mmol/l

0.40

Neuroendocrine tumor and carcinoma of small intestine, excluding all cancers (controls excluding all cancers)

362

1.66

2.97

5.6

3.2

1.18

2.17

mmol/l

0.78

295

Abnormal findings on diagnostic imaging of breast

322

1.69

2.97

3.7

2.7

3.01

2.16

mmol/l

1.11

267

Pedal cyclist injured in noncollision transport accidents

390

3291

1.20

2.96

3.9

4.4

1.78

1.85

mmol/l

0.12

329

2650

Single delivery by caesarean section

372

2569

0.83

2.95

2.8

4.6

1.38

1.53

mmol/l

0.35

285

2056

Melanocytic naevi of scalp and neck

587

1.49

2.94

4.6

3.5

1.76

1.90

mmol/l

0.17

464

Other congenital malformations of skin

153

1166

1.35

2.93

5.7

5.6

1.23

1.68

mmol/l

0.80

132

929

Disorders of branched-chain amino-acid metabolism and fatty-acid metabolism

3.32

2.93

26.1

7.8

1.37

1.87

mmol/l

0.27

Exfoliative dermatitis

293

1.73

2.92

5.5

4.6

1.83

1.68

mmol/l

0.09

227

Other disorders of binocular vision

253

1.76

2.92

2.1

3.7

2.08

1.72

mmol/l

0.33

197

Wide developmental disorders

150

1144

1.35

2.91

4.0

7.9

1.15

1.27

mmol/l

0.19

120

894

HSIL lesion of the cervix uteri, vagina or vulva

462

3951

1.18

2.91

4.3

3.6

1.95

1.85

mmol/l

0.24

372

3213

Exophthalmic conditions

270

1.75

2.91

3.5

3.0

3.28

2.24

mmol/l

0.95

213

Congenital malformations of posterior segment of eye

183

1.98

2.90

12.7

10.4

1.03

1.57

mmol/l

0.34

149

Pyogenic granuloma

419

1.59

2.88

5.4

4.4

2.25

1.85

mmol/l

0.40

328

Calcific tendinitis of shoulder

188

1474

1.30

2.88

4.1

3.6

2.20

1.98

mmol/l

0.47

153

1195

Benign neoplasm: Liver/bile ducts

532

1.51

2.87

5.1

3.5

1.97

1.95

mmol/l

0.03

420

Malignant neoplasm of tongue, excluding all cancers (controls excluding all cancers)

102

734

1.44

2.86

3.4

3.1

3.10

2.18

mmol/l

1.35

586

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

224

1797

1.27

2.86

3.9

3.5

2.00

2.02

mmol/l

0.02

180

1471

Malignant neoplasm of tonsil, excluding all cancers (controls excluding all cancers)

478

1.55

2.86

3.4

3.3

3.19

2.12

mmol/l

1.47

393

Colitis due to radiation

288

1.73

2.85

5.9

3.9

1.16

1.73

mmol/l

0.17

221

Hypertrichosis

347

1.63

2.84

3.9

3.1

2.38

1.94

mmol/l

0.40

268

Other fibroblastic disorders

2.37

2.83

5.0

2.7

3.31

2.17

mmol/l

0.39

Acute otitis externa, noninfective

405

1.59

2.83

4.5

3.5

2.37

2.02

mmol/l

0.17

319

Use of rotigotine

296

1.71

2.83

5.8

3.3

3.16

2.10

mmol/l

1.44

237

Early lumbar disc prolapse operation

284

2334

1.23

2.82

4.1

3.9

1.89

1.81

mmol/l

0.12

223

1902

Benign neoplasm: Liver

461

1.54

2.81

4.6

3.5

2.15

1.98

mmol/l

0.22

362

Other benign neoplasms of connective and other soft tissue

315

2620

1.22

2.81

3.6

1.90

1.94

mmol/l

0.07

257

2150

Benign neoplasm: Middle ear, nasal cavity and accessory sinuses

151

1158

1.34

2.80

4.2

3.5

2.04

1.98

mmol/l

0.07

131

922

Seminoma of testis, excluding all cancers (controls excluding all cancers)

235

1.79

2.79

6.8

3.0

1.06

1.66

mmol/l

0.52

190

Simple and mucopurulent chronic bronchitis

170

1324

1.31

2.79

6.5

4.5

2.06

1.61

mmol/l

0.70

143

1038

Sequelae of other and unspecified infectious and parasitic diseases

175

1366

1.30

2.78

5.7

3.7

1.46

2.10

mmol/l

1.59

149

1099

Abnormality of white blood cells, not elsewhere classified

206

1.86

2.78

8.8

3.4

2.88

2.04

mmol/l

0.78

162

Carcinoma in situ of other and unspecified genital organs

367

1.61

2.76

3.7

2.7

2.08

2.22

mmol/l

0.12

297

Congenital malformations of genital organs

305

2518

1.22

2.76

5.4

5.7

1.61

1.59

mmol/l

0.04

241

2029

Maternal care for known or suspected malpresentation of fetus

283

2561

0.82

2.76

2.9

4.0

1.81

1.55

mmol/l

0.64

233

2064

Other secondary coxarthrosis

122

909

1.38

2.76

4.8

3.4

2.18

2.04

mmol/l

0.17

101

725

Causalgia

351

1.62

2.76

3.7

3.4

1.84

2.14

mmol/l

0.24

286

Malignant neoplasm of oesophagus

101

732

1.43

2.76

3.2

3.8

3.36

1.94

mmol/l

2.09

575

Adenocarcinoma and papillary adenocarcinoma of stomach

113

833

1.40

2.75

3.7

2.51

2.08

mmol/l

0.48

644

Benign neoplasm: other/unspecified salivary gland

107

782

1.41

2.75

4.4

3.4

2.18

2.02

mmol/l

0.21

618

Cerebral atherosclerosis

344

1.64

2.75

3.9

3.8

2.63

1.93

mmol/l

0.73

268

Injury of nerves at shoulder and upper arm level

267

1.73

2.74

4.1

3.5

0.70

1.71

mmol/l

0.96

213

Lichen planus

452

3892

1.18

2.73

3.8

3.7

1.93

2.04

mmol/l

0.33

372

3176

Juvenile rheumatoid arthirtis

456

1.53

2.71

5.0

4.5

1.89

1.84

mmol/l

0.05

354

Universal erythroderma, KELA reimbursement

378

1.60

2.71

4.5

3.5

2.36

2.05

mmol/l

0.23

302

Chorioretinal inflammation

690

1.43

2.70

4.3

3.4

1.32

2.04

mmol/l

1.15

542

Sexual dysfunction

354

1.61

2.69

4.9

3.3

1.91

1.77

mmol/l

0.12

279

Contact with other hot metals

419

1.57

2.69

4.8

4.7

2.49

1.89

mmol/l

0.75

326

Malignant neoplasm of rectosigmoid junction

444

1.55

2.69

3.4

3.6

2.03

1.91

mmol/l

0.10

353

Other and unspecified rosacea

273

2252

1.23

2.69

6.0

3.6

1.54

1.95

mmol/l

1.11

225

1837

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

252

2063

1.24

2.68

5.7

3.5

1.93

1.99

mmol/l

0.08

197

1704

Unspecified organic or symptomatic mental disorder

2.41

2.67

3.2

4.3

2.21

1.99

mmol/l

0.09

Benign neoplasm: Pancreas

104

762

1.42

2.67

6.2

3.6

1.41

2.03

mmol/l

0.86

599

Disorder of the sleep-wake schedule

493

1.52

2.67

4.6

6.1

2.07

1.57

mmol/l

0.64

382

All dysplastic lesions of the cervix uteri

584

5107

1.15

2.66

4.0

3.6

2.00

1.79

mmol/l

0.70

477

4142

Leiomyosarcoma

187

1.89

2.66

3.7

3.5

1.74

2.38

mmol/l

0.44

151

Nosocomial condition (hospital)

136

2.05

2.65

1.9

3.4

1.52

2.17

mmol/l

0.41

103

Neuroendocrine tumor and carcinoma of small intestine

373

1.60

2.65

5.6

3.5

1.18

2.00

mmol/l

0.59

301

Desensitization to allergens

1238

0.71

2.65

7.6

5.2

1.36

1.65

mmol/l

0.48

990

Degenerative diseases of the nervous system

1532

10648

1.09

2.64

2.9

3.6

2.00

1.93

mmol/l

0.27

1243

8545

Postpartum haemorrhage

430

4356

0.85

2.63

2.9

3.9

1.66

1.76

mmol/l

0.25

345

3532

Acute myeloid leukaemia

279

1.70

2.62

5.0

4.6

1.42

1.69

mmol/l

0.15

221

Narcolepsy and cataplexy

136

2.01

2.61

3.4

3.1

1.96

1.93

mmol/l

0.01

Other diseases of peritoneum

154

1196

1.32

2.60

4.8

3.4

2.48

2.01

mmol/l

0.74

132

968

Malignant neoplasm of oropharynx

431

1.55

2.60

3.3

3.6

3.29

2.10

mmol/l

1.59

341

Endocrine disorders, other/unspecified

485

0.54

2.60

16.7

3.6

1.97

2.18

mmol/l

0.15

386

Haemophagocytic lymphohistiocytosis

3.18

2.60

35.8

5.2

1.03

1.95

mmol/l

0.47

Other prurigo

279

1.69

2.60

9.0

3.1

1.86

1.98

mmol/l

0.07

219

Use of glatiramer acetate

285

1.66

2.59

8.6

3.4

1.95

1.75

mmol/l

0.15

231

Endometriosis

1174

6361

1.10

2.58

3.5

3.4

1.85

1.98

mmol/l

0.62

967

5220

Degenerative conditions of globe

116

2.11

2.58

10.7

4.1

0.56

1.81

mmol/l

1.12

Hypertrophy of breast

448

3866

1.17

2.58

3.1

3.7

1.83

2.00

mmol/l

0.43

364

3186

Intercostal neuropathy

196

1.84

2.57

3.8

3.7

1.69

2.35

mmol/l

0.35

155

Malignant neoplasm of anus and anal canal

124

2.10

2.57

7.6

3.5

2.24

2.08

mmol/l

0.08

Other appendicitis

279

2317

1.22

2.57

4.7

3.8

1.77

1.93

mmol/l

0.36

226

1859

Dislocation of lens

432

1.54

2.57

5.8

3.4

1.34

1.99

mmol/l

0.68

340

Antibody deficiency with near-normal immunoglobulins or with hyperimmunoglobulinaemia

3.93

2.57

36.4

6.6

2.14

3.29

mmol/l

—

Isolated patent ductus arteriosus

3.04

2.57

2.0

2.9

2.65

1.43

mmol/l

0.62

Malignant neoplasm of bone and articular cartilage of limbs, excluding all cancers (controls excluding all cancers)

265

1.71

2.56

26.8

3.8

1.58

1.99

mmol/l

0.35

203

Lagophthalmos

336

1.63

2.56

4.2

3.6

2.33

2.24

mmol/l

0.07

262

Antenatal screening

456

2979

0.86

2.56

3.1

3.8

1.81

1.65

mmol/l

0.45

348

2378

Contact with venomous snakes and lizards

257

1.72

2.56

2.1

4.4

1.99

2.02

mmol/l

0.04

197

Phlebitis and thrombophlebitis of lower extremities, unspecified, drug-induced

250

1.74

2.56

5.1

3.4

2.37

2.05

mmol/l

0.21

192

CR(E)ST syndrome

359

1.59

2.56

4.3

3.0

1.37

2.24

mmol/l

1.01

288

Alzheimer’s disease (Early onset)

111

1477

0.74

2.55

2.4

3.2

1.71

2.13

mmol/l

0.60

1152

Congenital deformities of hip

624

1.45

2.55

6.8

7.9

1.01

1.29

mmol/l

0.44

478

Peripheral retinal degeneration

109

809

1.38

2.55

4.5

3.2

1.94

2.04

mmol/l

0.12

642

Benign neoplasm: Lip

556

1.47

2.54

3.5

3.1

2.34

1.90

mmol/l

0.51

448

Seminoma of testis

242

1.73

2.54

6.8

4.4

1.06

1.58

mmol/l

0.46

200

Other specified/unspecified deforming dorsopathies

415

1.54

2.54

3.6

2.9

2.99

1.76

mmol/l

1.92

326

Injury of muscle and tendon at shoulder and upper arm level

1451

13406

1.09

2.54

3.5

4.1

1.79

1.82

mmol/l

0.14

1186

11002

Inflammation of lacrimal passages (acute and unspecified)

449

1.52

2.53

8.0

3.2

1.97

2.03

mmol/l

0.06

348

Fall on and from ladder

303

2546

1.21

2.53

4.0

1.84

1.91

mmol/l

0.15

265

2039

Long labour

418

4241

0.86

2.53

3.4

4.0

1.53

1.83

mmol/l

0.91

333

3457

Disorders of eyelid in diseases classified elsewhere

115

862

1.37

2.52

5.9

3.5

1.84

1.87

mmol/l

0.04

679

Other female pelvic inflammatory diseases

481

4187

1.16

2.49

3.9

3.4

2.30

2.03

mmol/l

0.95

395

3462

Deviated nasal septum

1342

12358

1.09

2.49

4.0

4.2

1.90

1.77

mmol/l

0.73

1107

10109

Malignant neoplasm, without specification of site, excluding all cancers (controls excluding all cancers)

169

1336

1.29

2.49

3.7

3.0

1.97

2.04

mmol/l

0.08

125

1044

Injury of nerves at ankle and foot level

146

1.95

2.48

2.7

3.5

3.38

2.06

mmol/l

0.68

108

Idiopathic urticaria

450

1.51

2.48

4.8

3.7

2.27

1.90

mmol/l

0.49

356

Gastroenterology and urology devices associated with adverse incidents

4.62

2.48

24.9

5.2

2.35

2.74

mmol/l

—

Benign neoplasm: Brain, supratentorial

386

1.56

2.47

4.6

3.3

2.06

1.90

mmol/l

0.16

307

Granuloma annulare

330

1.60

2.46

2.7

3.7

2.44

2.09

mmol/l

0.38

256

Systemic sclerosis,strict definition

206

1.78

2.46

3.8

3.4

1.34

2.15

mmol/l

0.69

162

Asymptomatic human immunodeficiency virus [HIV] infection status

140

1.98

2.45

2.2

3.4

0.64

2.03

mmol/l

0.82

118

Nasal polyp

747

6702

1.13

2.44

3.6

4.1

1.92

1.79

mmol/l

0.47

613

5405

Benign neoplasm: Mediastinum

2.27

2.43

2.4

4.7

1.43

2.34

mmol/l

0.75

Congenital malformation syndromes predominantly affecting facial appearance

144

2.07

2.43

3.4

10.3

1.78

1.31

mmol/l

0.76

107

Unspecified lump in breast

480

4188

1.16

2.43

4.1

3.4

2.06

mmol/l

0.01

385

3455

Other disorders of choroid

389

1.55

2.42

4.9

3.7

1.70

2.01

mmol/l

0.28

307

Mixed conductive and sensorineural hearing loss

475

4150

1.16

2.41

4.5

3.8

1.95

1.96

mmol/l

0.02

376

3378

Other congenital malformations of brain

195

1.85

2.41

7.3

11.6

0.94

1.14

mmol/l

0.15

144

Sunburn

2.99

2.40

6.9

2.6

2.16

2.48

mmol/l

0.11

Other sexually transmitted chlamydial diseases

146

1135

1.30

2.40

4.0

3.8

0.92

1.72

mmol/l

1.83

121

917

Other disorders of cornea

327

2779

1.19

2.38

4.5

3.7

2.11

2.03

mmol/l

0.16

261

2274

200

1.77

2.38

6.3

4.5

1.63

1.75

mmol/l

0.07

151

Other and unspecified hypertrophic disorders of skin

134

1.97

2.38

3.5

3.2

1.91

1.86

mmol/l

0.03

102

Malignant neoplasm of other and unspecified parts of biliary tract

367

1.57

2.37

3.7

3.9

1.27

1.85

mmol/l

0.44

293

Malignant neoplasm of hypopharynx, excluding all cancers (controls excluding all cancers)

179

1.84

2.37

2.5

3.6

3.05

1.73

mmol/l

0.49

144

Fracture of upper limb, level unspecified

5.72

2.36

1.3

5.5

0.77

1.76

mmol/l

—

Femoral hernia, unilateral

101

752

1.38

2.36

4.4

3.2

1.97

2.11

mmol/l

0.14

593

Inguinal hernia, unilateral

101

752

1.38

2.36

4.4

3.2

1.98

2.11

mmol/l

0.14

593

Inguinal of femoral hernia, unilateral

101

752

1.38

2.36

4.4

3.2

1.98

2.11

mmol/l

0.14

593

Nutritional and metabolic disorders in diseases classified elsewhere

5.26

2.35

24.0

8.9

0.46

1.27

mmol/l

—

Disorders of male genital organs in diseases classified elsewhere

157

1.89

2.35

3.9

3.8

1.29

1.54

mmol/l

0.13

127

Complications of the puerperium, not elsewhere classified

629

1.40

2.35

2.4

3.5

1.47

1.83

mmol/l

0.51

503

Tuberculosis of other organs

651

1.41

2.34

4.1

3.3

1.69

2.17

mmol/l

0.67

509

Foreign body in respiratory tract

192

1555

1.26

2.34

4.1

4.7

1.83

1.77

mmol/l

0.07

162

1231

Struck by thrown, projected or falling objec

161

1277

1.29

2.33

3.7

4.5

1.82

1.84

mmol/l

0.04

133

1014

Chloasma

2.23

2.33

2.8

3.4

0.47

2.19

mmol/l

0.80

Benign neoplasm: Spinal cord

335

1.58

2.33

3.1

3.5

2.40

1.88

mmol/l

0.42

264

Morphin

416

1.52

2.33

4.0

3.2

2.70

2.08

mmol/l

0.70

325

Anomalies of pupillary function

490

1.47

2.33

4.0

4.1

2.22

1.89

mmol/l

0.32

385

Polycystic ovarian syndrome

105

783

1.36

2.32

3.5

3.3

1.25

1.56

mmol/l

0.48

609

Pathological resorption of teeth

692

1.39

2.32

7.7

3.1

1.60

2.14

mmol/l

0.87

541

Malignant neoplasm of eye and adnexa, excluding all cancers (controls excluding all cancers)

459

1.50

2.32

5.8

3.3

1.80

2.04

mmol/l

0.24

363

Autism spe

608

1.42

2.32

3.5

7.1

1.36

1.44

mmol/l

0.09

475

Horner syndrome

320

1.60

2.32

4.1

3.6

1.53

1.93

mmol/l

0.38

256

Other osteochondropathies

234

1934

1.23

2.31

4.0

4.1

1.47

1.89

mmol/l

1.08

178

1560

Tuberculosis

261

2183

1.22

2.31

4.6

3.4

2.11

1.93

mmol/l

0.34

205

1698

Abnormal spermatozoa

389

4484

0.85

2.31

4.0

4.3

2.08

1.78

mmol/l

1.27

305

3587

Benign neoplasm: Spinal cord

336

1.58

2.30

3.1

2.40

2.06

mmol/l

0.25

266

Malignant neoplasm of breast, ER-negative, excluding all cancers (controls excluding all cancers)

736

6356

1.12

2.30

3.3

3.4

2.07

2.21

mmol/l

0.46

610

5273

Communicating hydrocephalus

645

1.41

2.30

3.7

4.5

1.42

1.87

mmol/l

0.57

513

Golimumab

719

1.38

2.29

2.1

4.2

1.80

1.81

mmol/l

0.01

585

Malignant neoplasm of adrenal gland, excluding all cancers (controls excluding all cancers)

228

1.73

2.27

21.4

5.6

2.20

1.88

mmol/l

0.30

179

Severe visual impairment, monocular

235

1.70

2.27

5.8

3.9

1.69

2.11

mmol/l

0.25

182

Other vitreous opacities

136

1062

1.31

2.27

3.7

3.5

2.16

1.94

mmol/l

0.26

109

841

Hypersomnia

321

1.58

2.26

3.1

3.7

3.10

1.87

mmol/l

1.62

260

Intussusception

485

1.46

2.25

3.4

4.1

2.23

2.00

mmol/l

0.22

382

Stenosis and insufficiency of lacrimal passages

342

2934

1.18

2.25

3.7

3.8

2.14

2.02

mmol/l

0.28

282

2391

Crystalline deposits in vitreous body

268

1.66

2.24

4.0

3.8

2.08

2.02

mmol/l

0.05

206

Disorders of fatty-acid metabolism

3.97

2.24

29.4

2.6

0.80

2.16

mmol/l

—

Preterm labour and delivery

669

5989

1.12

2.24

3.7

3.8

1.96

2.02

mmol/l

0.18

546

4968

Glaucoma suspect

1451

13485

1.08

2.23

4.0

3.8

1.97

mmol/l

0.02

1151

11005

Benign neoplasm: Skin of lower limb, including hip

681

1.39

2.23

4.4

2.9

2.25

2.11

mmol/l

0.14

551

Malignant neoplasm of renal pelvis

153

1.89

2.23

5.4

4.2

2.13

1.91

mmol/l

0.05

119

Brachial plexus disorders

254

2122

1.21

2.23

3.1

3.6

2.21

1.85

mmol/l

0.81

186

1728

Pedestrian injured in other and unspecified transport accidents

299

1.60

2.22

3.9

3.4

0.83

2.04

mmol/l

0.80

238

Benign neoplasm: Skin of eyelid, including canthus

559

4967

1.14

2.21

4.0

3.7

1.70

2.02

mmol/l

1.37

469

4065

Medical treatment for female infertility

319

3727

0.85

2.21

3.1

3.8

1.79

1.68

mmol/l

0.24

255

3002

Follow-up care involving plastic surgery

802

0.67

2.21

5.2

2.8

1.33

2.04

mmol/l

0.58

654

Respiratory tuberculosis, confirmed and not-confirmed

222

1840

1.23

2.19

4.7

3.4

2.02

2.00

mmol/l

0.03

172

1434

Maternal care for known or suspected fetal abnormality and damage

242

2580

0.83

2.19

2.6

4.1

1.73

1.57

mmol/l

0.30

195

2069

Rosacea

354

3050

1.17

2.18

6.9

3.7

1.64

1.95

mmol/l

0.85

296

2489

178

1414

1.28

2.18

14.0

10.3

1.04

1.10

mmol/l

0.11

145

1116

Use of amantadine

398

1.51

2.18

8.2

2.9

2.54

2.20

mmol/l

0.39

314

Flatulence and related conditions

237

1.67

2.17

4.8

3.6

1.29

1.92

mmol/l

0.28

189

Beningn neoplasm: Meninges, unspecified

415

1.50

2.17

5.3

2.9

2.26

2.02

mmol/l

0.26

326

Occlusion and stenosis of arteries, not leading to stroke

382

1.52

2.17

3.2

3.5

1.65

2.13

mmol/l

0.38

299

Vascular dementia (other)

185

1.80

2.17

2.5

3.9

1.40

1.91

mmol/l

0.33

146

Respiratory tuberculosis

222

1842

1.23

2.17

4.7

3.4

2.02

2.00

mmol/l

0.03

172

1435

Noise effects on inner ear

1268

0.74

2.16

3.6

4.1

1.80

1.84

mmol/l

0.03

1015

Deformity of finger(s)

154

1.86

2.16

4.5

3.6

2.07

2.35

mmol/l

0.28

120

Frostbite with tissue necrosis

2.29

2.15

3.8

4.2

3.21

1.58

mmol/l

—

198

1565

1.26

2.14

15.5

10.0

1.06

1.12

mmol/l

0.13

165

1242

Periodontosis

2.80

2.14

7.5

3.4

-1.29

2.39

mmol/l

1.24

Certain zoonotic bacterial diseases

483

1.45

2.14

3.9

3.3

1.89

1.85

mmol/l

0.03

382

Rheumatic valve diseases

687

1.38

2.14

6.6

3.5

1.55

2.00

mmol/l

0.64

518

Accidental poisoning by and exposure to pesticides

2.63

2.14

7.2

4.9

1.47

2.59

mmol/l

0.55

Unequal limb length (acquired)

184

1.75

2.12

2.1

5.3

1.39

1.88

mmol/l

0.57

140

Retarded development following protein-energy malnutrition

3.89

2.12

6.9

11.5

2.69

2.32

mmol/l

—

Benign neoplasm of other and unspecified sites

107

817

1.34

2.12

3.6

3.1

2.08

2.02

mmol/l

0.06

653

Other congenital malformations of limb(s)

240

1.67

2.11

7.1

8.6

1.55

1.27

mmol/l

0.28

184

Alopecia areata

627

1.39

2.11

3.8

5.0

2.15

1.93

mmol/l

0.25

505

Other secondary gonarthrosis

192

1576

1.24

2.10

4.2

3.7

2.40

1.95

mmol/l

1.12

161

1278

Colorectal neuroendocrine tumor and carcinoma, excluding all cancers (controls excluding all cancers)

328

1.55

2.09

4.9

3.2

2.56

2.12

mmol/l

0.30

260

Obstructed labour due to malposition and malpresentation of fetus

379

4106

0.86

2.07

3.4

4.0

1.58

1.80

mmol/l

0.57

304

3338

Other conjunctival vascular disorders and cysts

622

1.39

2.07

4.9

3.2

2.47

2.08

mmol/l

0.47

498

Other disorders of skin and subcutaneous tissue related to radiation

2.78

2.07

5.7

2.5

4.10

2.64

mmol/l

0.71

Malignant neoplasm of hypopharynx

113

2.02

2.06

2.0

4.8

3.97

1.77

mmol/l

0.55

Congenital malformations of anterior segment of eye

218

1.69

2.05

5.0

5.9

1.40

1.76

mmol/l

0.20

164

Juvenile osteochondrosis

110

847

1.33

2.05

5.8

4.5

1.19

1.62

mmol/l

1.01

681

Congenital malformation syndromes due to known exogenous causes, not elsewhere classified

3.37

2.05

9.6

2.4

3.71

1.46

mmol/l

—

Dementia in Alzheimer disease

622

5911

0.89

2.05

2.7

3.5

2.21

1.92

mmol/l

1.23

492

4705

Glaucoma secondary to eye trauma

180

1.77

2.04

10.5

4.3

3.28

1.61

mmol/l

0.70

144

Dislocation, sprain and strain of joints and ligaments of elbow

205

1697

1.23

2.04

5.4

5.2

1.50

1.74

mmol/l

0.50

160

1379

Secondary malignant neoplasm of respiratory and digestive organs

364

1.52

2.03

3.0

3.5

2.65

1.92

mmol/l

1.26

281

Congenital ichthyosis

2.18

2.03

7.4

7.2

1.46

1.65

mmol/l

0.12

Eustachian salpingitis and obstruction

218

1814

1.22

2.03

4.4

4.2

1.67

1.81

mmol/l

0.29

181

1478

Benign neoplasm: Anus and anal canal

754

1.35

2.03

3.6

2.9

1.55

2.21

mmol/l

1.03

600

Other abnormal uterine and vaginal bleeding

818

5305

1.11

2.03

3.6

3.3

2.41

2.09

mmol/l

1.80

659

4370

Other and unspecified corneal deformities and disorders

105

806

1.33

2.02

5.1

3.5

2.15

1.99

mmol/l

0.20

654

Disorders of plasma-protein metabolism, not elsewhere classified

142

1.85

2.02

6.7

3.4

1.75

2.50

mmol/l

0.62

106

Medial epicondylitis

113

875

1.31

2.01

3.2

3.7

1.68

1.97

mmol/l

0.31

703

Onycholysis

150

1.83

2.01

6.3

4.9

2.48

1.93

mmol/l

0.31

128

Tuberculosis of other organs, strict

100

765

1.34

2.00

4.6

3.3

1.82

2.05

mmol/l

0.29

598

Benign neoplasm: Skin, unspecified

133

1054

1.29

2.00

6.4

3.6

1.72

1.86

mmol/l

0.19

831

Tic disorders

432

1.47

2.00

4.4

7.1

2.00

1.62

mmol/l

0.59

340

Benign neoplasm: Brain, supratentorial

406

1.48

1.99

4.6

2.06

1.73

mmol/l

0.40

326

Posteruptive colour changes of dental hard tissues

3.95

1.99

35.9

3.2

1.11

0.77

mmol/l

—

Unspecific neurodegenerative disorder

1842

11943

1.07

1.98

2.7

3.6

2.09

1.93

mmol/l

1.01

1485

9620

Benign neoplasm of brain and other parts of central nervous system

230

1933

1.21

1.98

3.9

4.0

2.06

1.91

mmol/l

0.24

199

1555

Burn and corrosion of wrist and hand

133

1056

1.29

1.98

4.4

4.7

1.43

1.72

mmol/l

0.42

113

833

Brain meningioma, excluding all cancers (controls excluding all cancers)

164

1333

1.25

1.98

3.3

3.2

1.65

2.09

mmol/l

1.02

132

1101

Malignant neoplasm of floor of mouth, excluding all cancers (controls excluding all cancers)

237

1.64

1.96

4.0

3.4

3.33

2.15

mmol/l

1.19

190

Chronic Coagulation defects

567

1.39

1.96

5.6

4.5

2.28

1.77

mmol/l

0.73

445

Other and unspecified spinal muscular atrophies

213

1.67

1.96

3.1

4.6

3.08

1.83

mmol/l

1.22

167

Gonococcal infection

748

1.34

1.96

2.5

3.3

2.24

2.13

mmol/l

0.10

617

HSIL lesion of the vagina

292

1.56

1.96

6.0

2.8

1.25

2.35

mmol/l

1.56

236

Contact with sharp glass

114

888

1.31

1.95

4.6

4.2

1.48

1.85

mmol/l

0.42

714

Unspecified maternal hypertension

150

1.78

1.95

2.7

1.74

1.57

mmol/l

0.07

117

Malignant cancer of tonsil and base of tongue, excluding all cancers (controls excluding all cancers)

690

1.36

1.95

3.1

3.3

3.13

2.10

mmol/l

1.56

557

Other bursitis of knee

350

1.51

1.95

3.3

4.0

2.16

2.07

mmol/l

0.07

272

Femoral hernia

164

1337

1.25

1.94

4.4

3.3

2.05

1.99

mmol/l

0.07

132

1062

Benign neoplasm: Mediastinum

101

2.05

1.94

2.4

5.3

1.43

2.07

mmol/l

0.44

Drug phototoxic response

3.67

1.94

1.6

4.9

3.07

3.06

mmol/l

—

Congenital malformations of larynx

205

1.80

1.93

8.8

11.4

1.47

0.94

mmol/l

0.33

152

Postpartum hemorraghe, all women as controls

430

4852

0.88

1.93

2.9

3.7

1.66

1.72

mmol/l

0.12

345

3911

Bitten or stung by nonvenomous insect and other nonvenomous arthropods

121

955

1.30

1.92

3.1

4.9

2.09

1.81

mmol/l

0.43

766

Sequelae of poliomyelitis

223

1.65

1.91

3.9

3.4

2.50

1.96

mmol/l

0.47

175

Other contact dermatitis

253

2150

1.19

1.90

5.8

3.6

1.96

2.00

mmol/l

0.05

209

1721

Allergic colitis

126

1003

1.29

1.90

11.0

8.5

1.51

1.15

mmol/l

0.68

107

787

Pedestrian injured in collision with car, pick-up truck or van

649

1.36

1.89

4.1

3.5

1.81

2.03

mmol/l

0.19

521

Injury of muscle and tendon at lower leg level

534

4786

1.13

1.87

4.5

4.1

1.79

1.81

mmol/l

0.04

436

3884

Impacted cerumen

297

3430

0.85

1.87

4.7

4.2

1.26

1.92

mmol/l

2.95

249

2737

Cholera

133

1064

1.27

1.86

4.3

3.0

2.13

mmol/l

0.00

113

884

Sequelae of burns, corrosions and frostbite

109

1.94

1.86

2.1

3.4

1.85

1.91

mmol/l

0.03

Enterohaemorrhagic Escherichia coli infection

2.72

1.86

6.7

2.1

1.71

2.30

mmol/l

—

Diastasis of muscle

161

1.75

1.86

3.0

3.7

2.49

1.68

mmol/l

0.55

119

Hereditary motor and sensory neuropathy

224

1.63

1.86

5.6

3.9

2.40

2.04

mmol/l

0.18

169

Qualitative platelet defects

125

1.91

1.86

2.5

4.7

2.29

1.83

mmol/l

0.27

Nontoxic diffuse goitre

107

835

1.31

1.85

3.6

3.1

2.03

2.10

mmol/l

0.05

675

Haemorrhagic disorder due to circulating anticoagulants

347

1.50

1.85

4.5

3.8

2.06

1.85

mmol/l

0.09

270

Neurofibromatosis, type 1

154

1.77

1.85

5.6

4.3

1.18

2.08

mmol/l

0.64

119

Lymphangioma, anys site

201

1.67

1.84

3.4

4.1

1.66

1.57

mmol/l

0.06

152

Procedures for purposes other than remedying health state

479

1.41

1.83

4.2

2.4

2.07

2.22

mmol/l

0.09

387

Disorders of vagus nerve

3.04

1.83

20.1

6.1

2.71

2.14

mmol/l

—

MS-disease / Multiple Sclerosis

197

1643

1.21

1.83

4.5

3.6

2.40

1.95

mmol/l

1.34

169

1324

Ulcer of vagina/vulva

557

1.38

1.83

3.8

3.1

2.27

2.09

mmol/l

0.16

444

Hyperprolactinaemia, drug-induced

117

1.89

1.82

2.5

3.5

2.59

2.07

mmol/l

0.29

Beningn neoplasm: Meninges, unspecified

431

1.44

1.82

5.3

3.1

2.26

2.17

mmol/l

0.09

335

Benign neoplasm: Skin of upper limb, including shoulder

481

1.41

1.82

5.6

3.1

1.86

1.96

mmol/l

0.08

390

Benign lipomatous neoplasm of other sites/unspecified

329

2868

1.16

1.82

3.9

3.6

2.20

2.04

mmol/l

0.32

264

2326

Other and unspecified disorders of orbit

125

1.87

1.82

4.1

3.7

2.55

2.18

mmol/l

0.24

Dysplastic lesion of unknown severity in the cervix uteri, vagina or vulva

216

1.62

1.82

4.2

3.0

2.05

2.33

mmol/l

0.23

171

Tonsillectomy and adenotomy

1993

13111

1.06

1.82

4.6

4.8

1.66

1.70

mmol/l

0.18

1617

10635

Other lesions of median nerve

108

848

1.31

1.81

4.5

3.2

1.84

1.85

mmol/l

0.01

687

Lipoprotein deficiency

2.52

1.80

7.8

2.9

-0.67

1.29

mmol/l

1.13

Other disorders of patella

528

4736

1.12

1.80

3.8

3.7

1.83

1.90

mmol/l

0.18

419

3858

Motor- or nonmotor-vehicle accident, type of vehicle unspecified

306

1.51

1.80

4.4

4.0

1.53

1.67

mmol/l

0.06

238

Hirsutism in women

289

1.52

1.79

3.5

2.8

2.33

1.83

mmol/l

0.43

222

Melanocytic naevi of other and unspecified parts of face

167

1376

1.23

1.78

4.8

3.3

1.55

2.00

mmol/l

1.08

133

1110

Rickettsioses

2.64

1.78

6.6

4.3

1.94

2.11

mmol/l

—

Torsion of testis

501

1.39

1.76

4.2

5.7

1.99

1.60

mmol/l

0.62

419

Exposure to uncontrolled fire in building or structure

172

1.70

1.76

2.5

3.7

2.13

1.92

mmol/l

0.17

136

Androgenic alopecia

164

1.71

1.75

2.7

2.8

2.54

2.42

mmol/l

0.05

137

Medical abortion

2196

11308

1.06

1.75

3.6

3.5

1.92

1.99

mmol/l

0.36

1802

9279

Disorders of iron metabolism

300

1.51

1.75

8.0

2.9

2.01

2.41

mmol/l

0.22

241

Benign neoplasm: Skin of trunk

139

1128

1.25

1.75

5.8

3.5

1.60

1.92

mmol/l

0.47

119

893

Benign neoplasm: Lip

598

1.36

1.74

3.5

3.6

2.34

1.94

mmol/l

0.44

483

Hereditary angioödema type 1

3.57

1.74

70.5

2.4

-0.50

2.07

mmol/l

—

Brain glioblastoma, excluding all cancers (controls excluding all cancers)

326

1.50

1.74

2.2

3.3

2.09

2.16

mmol/l

0.06

268

Patellar tendinitis

341

1.47

1.74

3.8

4.1

1.61

1.67

mmol/l

0.05

271

Behçet disease

2.25

1.73

5.0

2.9

2.41

2.78

mmol/l

0.15

Carcinoma in situ of cervix uteri

200

1679

1.20

1.73

4.9

3.3

1.80

1.78

mmol/l

0.03

154

1352

Felty syndrome

158

1.74

1.73

4.8

3.7

2.57

2.37

mmol/l

0.12

129

Other congenital malformations of tongue, mouth and pharynx

616

1.36

1.73

8.6

1.43

1.06

mmol/l

0.40

464

Dissection of cerebral arteries, nonruptured

165

1.71

1.72

6.6

3.0

2.39

2.27

mmol/l

0.05

130

Nezelof syndrome

105

1.93

1.72

21.6

3.3

0.57

2.43

mmol/l

1.58

Other degenerative diseases of the basal ganglia

472

1.41

1.71

3.6

3.8

2.58

1.93

mmol/l

0.48

374

Peroneal tendinitis

318

1.48

1.70

3.6

2.9

2.06

1.87

mmol/l

0.13

253

Carcinoma in situ of lip, oral cavity and pharynx

2.25

1.70

5.4

4.2

1.73

2.90

mmol/l

0.44

Scissor bite

146

1197

1.25

1.69

8.3

6.9

1.33

1.55

mmol/l

0.38

121

985

Measles

229

1.57

1.68

4.5

3.4

3.06

2.06

mmol/l

0.76

192

Flat foot [pes planus] (acquired)

299

2604

1.16

1.68

3.2

3.8

2.30

1.97

mmol/l

0.99

236

2138

Fenamates

658

4038

1.11

1.67

4.3

5.2

1.93

1.73

mmol/l

0.68

559

3313

Contact with other hot fluids

107

849

1.29

1.66

3.5

5.5

1.82

1.68

mmol/l

0.15

684

Urethral discharge

3.00

1.66

9.4

3.0

1.17

3.13

mmol/l

—

Birth trauma

241

1.59

1.66

11.2

9.6

1.09

1.31

mmol/l

0.15

181

Injury of blood vessels at lower leg level

114

1.86

1.65

4.5

1.26

1.91

mmol/l

0.40

175

1.66

1.65

3.7

3.4

1.19

2.36

mmol/l

1.12

146

Benign neoplasm of breast

341

3001

1.15

1.64

3.1

3.5

2.05

2.11

mmol/l

0.12

298

2480

Benign neoplasm: Larynx

117

941

1.27

1.63

3.2

3.9

1.95

1.96

mmol/l

0.01

743

malignant neoplasm of male genital organs

1938

11669

1.06

1.62

4.1

4.2

1.60

1.73

mmol/l

0.77

1539

9396

Traumatic cerebral oedema

2.10

1.61

3.4

3.2

0.62

1.24

mmol/l

—

Carcinoma in situ of rectum

217

1.60

1.61

6.5

3.4

0.59

1.89

mmol/l

0.72

176

Operations 1 for CAVS

125

1.88

1.61

5.4

10.3

1.91

1.63

mmol/l

0.20

TMD muscular pain linked with fibromyalgia

168

1.66

1.61

2.3

2.7

1.48

2.22

mmol/l

0.73

135

Myasthenia gravis, drug-induced

2.66

1.61

3.9

2.7

4.08

3.36

mmol/l

—

Status post-ami

242

2301

0.85

1.61

4.2

3.1

2.10

1.87

mmol/l

0.46

188

1787

Other disorders of pigmentation

146

1204

1.23

1.60

4.4

3.6

1.76

1.96

mmol/l

0.31

123

958

Brain glioblastoma and astrocytoma, excluding all cancers (controls excluding all cancers)

399

1.42

1.60

2.1

3.2

2.17

2.11

mmol/l

0.05

325

Lichen planus, including avohilmo

626

5713

1.10

1.60

3.5

3.7

1.85

2.00

mmol/l

0.54

516

4671

Liposarcoma, excluding all cancers (controls excluding all cancers)

266

1.53

1.60

4.0

3.3

1.22

1.87

mmol/l

0.77

217

Traumatic amputation of wrist and hand

155

1287

1.23

1.60

4.0

4.4

1.87

mmol/l

0.00

129

1025

Benign lipomatous neoplasm of of intra-abdominal organs

2.05

1.59

3.5

4.1

0.46

2.56

mmol/l

—

Exposure to ignition or melting of other clothing and apparel

2.18

1.58

3.2

4.2

1.43

1.84

mmol/l

0.17

Brain glioblastoma

333

1.46

1.58

2.2

3.6

2.09

1.88

mmol/l

0.18

269

Tic and related disorders

453

1.39

1.57

4.4

7.7

2.00

1.62

mmol/l

0.58

351

Galactorrhea

169

1.64

1.57

2.6

3.2

3.03

2.02

mmol/l

0.92

129

Dacryoadenitis

194

1.61

1.56

8.0

3.0

1.56

2.21

mmol/l

0.58

152

Chronic conjunctivitis

105

839

1.28

1.56

6.7

4.5

1.55

1.90

mmol/l

0.38

658

Malignant neoplasm of other and ill-defined sites, excluding all cancers (controls excluding all cancers)

436

1.39

1.55

5.9

3.1

1.48

2.10

mmol/l

0.47

350

Malignant neoplasm of other and ill-defined digestive organs

203

1.60

1.55

3.2

4.1

2.97

1.65

mmol/l

0.65

163

Chalazion

381

3394

1.13

1.55

3.3

4.0

2.15

1.90

mmol/l

0.62

302

2755

Carcinoma in situ of other and unspecified genital organs

419

1.40

1.54

3.7

2.8

2.08

2.31

mmol/l

0.20

341

Other operation for atrial fibrillation

164

1.69

1.54

4.8

3.8

1.15

1.67

mmol/l

0.26

126

Carcinoma in situ of vulva

163

1.66

1.53

4.9

2.9

1.67

2.44

mmol/l

0.56

141

Colorectal neuroendocrine tumor and carcinoma

352

1.44

1.53

4.9

3.5

2.56

2.18

mmol/l

0.25

282

Liveborn infants according to place of birth

506

1.38

1.53

7.1

9.7

0.72

0.92

mmol/l

0.34

391

Contracture of joint

311

1.46

1.50

5.3

3.3

1.61

1.91

mmol/l

0.25

238

Small cell lung cancer

705

0.72

1.49

2.4

3.8

1.41

2.16

mmol/l

0.54

557

Small cell lung cancer, helper endpoint

705

0.72

1.49

2.4

3.8

1.41

2.16

mmol/l

0.54

557

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

444

4002

1.12

1.48

4.3

3.8

1.89

1.95

mmol/l

0.12

378

3273

Chronic myeloproliferative disease

398

1.41

1.48

3.5

3.6

1.91

2.06

mmol/l

0.10

318

Mandibular retrognathia

221

1899

1.17

1.48

6.9

5.3

1.58

1.83

mmol/l

0.65

182

1534

Carcinoma in situ of lip, oral cavity and pharynx

2.11

1.47

5.4

3.6

1.73

2.59

mmol/l

0.30

Sequelae of other accidents

372

1.41

1.46

3.0

3.5

1.18

1.74

mmol/l

0.32

285

Traumatic amputation of hip and thigh

2.65

1.45

11.0

4.1

1.37

0.78

mmol/l

—

Tracheo-bronchomalasia

2.38

1.45

3.6

5.4

1.33

1.38

mmol/l

—

Benign neoplasm: Skin of lower limb, including hip

731

1.28

1.45

4.4

3.5

2.25

1.95

mmol/l

0.34

588

Female infertility, associated with anovulation

139

1150

1.22

1.44

3.2

3.4

1.42

1.44

mmol/l

0.02

120

909

Dysplastic lesion of unknown severity of the cervix uteri

165

1.62

1.44

4.0

3.1

2.09

2.33

mmol/l

0.16

132

LSIL lesion of the cervix uteri

240

2082

1.16

1.44

3.3

3.2

2.03

1.79

mmol/l

0.46

199

1685

Acne conglobata

1.84

1.44

4.9

3.8

2.39

1.86

mmol/l

0.47

Carcinoma in situ of vulva

166

1.63

1.44

4.9

2.7

1.67

2.72

mmol/l

0.87

142

Poor fetal growth

234

2027

1.16

1.43

4.8

3.6

1.56

1.63

mmol/l

0.11

189

1607

Neuroendocrine tumor and carcinoma of pancreas, excluding all cancers (controls excluding all cancers)

159

1.65

1.43

3.8

3.4

1.85

2.05

mmol/l

0.06

121

Supervision of high-risk pregnancy

406

2739

0.89

1.43

2.6

3.8

2.03

1.72

mmol/l

0.92

307

2197

Graves disease, strict definition

270

2367

1.15

1.42

2.6

3.6

2.01

1.90

mmol/l

0.18

204

1937

Carcinoma in situ of rectum

224

1.54

1.42

6.5

3.8

0.59

1.70

mmol/l

0.59

177

Other benign neoplasm of uterus: Other parts/unspecified

117

1420

0.81

1.42

2.6

2.8

1.96

2.35

mmol/l

0.61

1167

Lupus erythematosus

600

1.31

1.42

3.7

3.0

1.31

2.09

mmol/l

1.10

475

Benign neoplasm: Penis

2.24

1.42

2.1

3.7

2.31

1.62

mmol/l

0.26

Severe combined immunodeficiency [SCID] with reticular dysgenesis

1.99

1.42

9.9

4.6

3.07

2.43

mmol/l

—

Epiphora

592

1.31

1.42

2.9

3.4

2.18

2.00

mmol/l

0.18

463

ILD medications: nintedanib

168

1.63

1.40

3.8

3.3

1.61

1.53

mmol/l

0.02

131

Fall involving playground equipment

451

1.40

7.1

11.1

1.82

1.18

mmol/l

1.18

350

Neuroendocrine tumor and carcinoma of pancreas

160

1.64

1.40

3.8

4.0

1.85

1.68

mmol/l

0.05

123

Liposarcoma

184

1.59

1.39

4.7

3.7

0.77

1.90

mmol/l

1.21

135

Congenital deformities of feet

655

1.29

1.39

4.7

5.4

1.81

1.71

mmol/l

0.09

518

Tinnitus

837

7793

1.08

1.37

3.9

4.0

1.79

1.96

mmol/l

0.69

692

6381

Chronic iridocyclitis

165

1401

1.19

1.36

5.4

3.9

2.09

1.89

mmol/l

0.34

136

1126

Congenital musculoskeletal deformities of head, face, spine and chest

404

1.38

1.36

5.6

8.5

2.20

1.36

mmol/l

1.30

311

Triptan medication for migraine, min. 3 purchases

1678

12577

1.06

1.36

3.5

4.0

1.74

1.84

mmol/l

0.64

1372

10268

Burn and corrosion of head and neck

569

1.31

1.36

3.4

4.2

1.43

1.83

mmol/l

0.46

445

Heterophoria

254

2228

1.15

1.36

6.6

4.9

1.79

1.75

mmol/l

0.08

207

1790

Cardiovascular disorders originating in the perinatal period

337

1.50

1.34

12.0

10.1

1.67

0.91

mmol/l

1.27

255

Benign neoplasm of other and unspecified sites

107

874

1.25

1.34

3.6

3.2

2.08

1.90

mmol/l

0.21

695

Actinomycosis

1.98

1.34

6.5

2.5

4.44

1.95

mmol/l

1.22

Helminthiases

492

1.33

6.5

4.3

1.65

2.07

mmol/l

0.50

392

Lymphangioma, anys site

219

1.52

1.33

3.4

6.2

1.66

1.61

mmol/l

0.03

161

Congenital malformations of uterus and cervix

326

1.40

1.33

4.6

3.5

1.94

1.74

mmol/l

0.13

254

Dysplasia of cervi uteri

629

4475

1.09

1.33

4.1

3.5

1.92

1.87

mmol/l

0.14

520

3649

Alzheimer disease, including avohilmo

1541

10563

1.06

1.32

2.6

3.6

2.06

1.94

mmol/l

0.62

1241

8485

Benign neoplasm: Bladder

244

1.49

1.32

5.2

3.8

1.39

1.65

mmol/l

0.17

186

Inhalation of gastric contents

1.99

1.31

4.2

5.8

2.92

1.85

mmol/l

0.76

Convulsions of newborn

2.63

1.31

5.4

10.6

0.48

0.85

mmol/l

—

Benign neoplasm: Skin of upper limb, including shoulder

511

1.32

1.30

5.6

3.2

1.86

1.85

mmol/l

0.01

406

Malignant neoplasm of breast

1723

11833

1.05

1.30

2.8

3.5

2.19

2.14

mmol/l

0.22

1426

9856

False labour

590

4037

0.91

1.30

2.5

4.1

1.61

1.64

mmol/l

0.06

466

3257

Injury of blood vessels at abdomen, lower back and pelvis level

108

1.76

1.30

7.6

3.4

1.54

2.08

mmol/l

—

Monosomies and deletions from the autosomes, not elsewhere classified

202

1.64

1.29

6.8

13.7

1.34

0.78

mmol/l

0.47

157

Other chromosome abnormalities, not elsewhere classified

285

1.50

1.29

4.4

10.8

0.96

1.10

mmol/l

0.14

212

Transient global amnesia

330

2957

1.13

1.29

2.9

3.6

1.96

2.04

mmol/l

0.14

277

2417

Ankylosing spondylitis

280

2481

1.14

1.29

4.2

4.0

1.97

1.82

mmol/l

0.28

228

1999

All dysplastic lesions of the vagina

556

1.30

1.28

6.1

2.9

1.33

2.15

mmol/l

1.16

447

Hyperfunction of pituitary gland, other and/or unspecified

2.34

1.27

6.4

3.6

1.09

2.54

mmol/l

—

Birth asphyxia

336

1.44

1.27

8.8

11.4

1.12

1.06

mmol/l

0.05

264

Familial erythrocytosis

124

1.69

1.27

4.0

3.4

2.54

2.01

mmol/l

0.28

Family history of malignant neoplasm

254

2238

1.14

1.27

3.0

2.9

1.69

2.07

mmol/l

0.86

205

1794

Circumscribed brain atrophy

594

1.29

1.27

2.9

3.7

2.36

1.95

mmol/l

0.50

468

Maternal care for cervical incompetence

844

0.77

1.27

2.9

3.1

1.59

1.95

mmol/l

0.47

693

Family history of other conditions

254

1.45

1.26

7.9

4.6

0.75

1.79

mmol/l

1.04

197

Endometriosis in cutaneous scar

2.13

1.26

3.5

4.0

0.58

2.83

mmol/l

—

Thalassaemia trait

2.88

1.26

8.0

12.9

0.32

1.08

mmol/l

—

Eclampsia

2.27

1.25

7.5

1.8

1.31

2.08

mmol/l

—

Ankle and foot

197

1.52

1.25

1.6

3.0

2.22

2.12

mmol/l

0.06

147

Use of galantamine

217

2473

0.87

1.25

2.1

3.3

2.21

2.00

mmol/l

0.30

172

1941

Benign neoplasm: Bladder

247

1.47

1.25

5.2

3.4

1.39

1.90

mmol/l

0.40

198

Malignant neoplasm of breast, HER2-negative

1675

11726

1.05

1.24

2.9

3.5

2.20

2.14

mmol/l

0.26

1385

9774

Benign neoplasm: Skin of scalp and neck

666

1.27

1.24

5.7

3.4

1.85

2.07

mmol/l

0.25

533

Acute mastoiditis

197

1.52

1.24

8.2

3.9

1.25

2.15

mmol/l

0.94

153

Mumps

649

0.74

1.24

4.0

3.6

2.52

2.03

mmol/l

0.42

528

Other congenital malformations of face and neck

702

1.26

1.23

5.0

4.0

1.67

1.76

mmol/l

0.06

556

Dementia due to Parkinson's disease

750

1.26

1.23

2.7

3.6

2.84

1.90

mmol/l

1.79

585

Other and unspecified water transport accidents

1.87

1.23

2.1

2.8

2.39

2.05

mmol/l

0.20

Benign lipomatous neoplasm of of intra-abdominal organs

1.84

1.23

3.5

3.6

0.46

2.65

mmol/l

—

Benign neoplasm of thyroid gland

811

1.24

1.23

3.4

3.0

2.56

2.11

mmol/l

0.69

655

Mucinous and mucinous cystic tumor of rectum

126

1.68

1.22

2.6

4.3

1.41

1.93

mmol/l

0.27

Unspecified hairloss

0.00

1.22

0.0

3.5

—

2.55

—

Dyslexia and other symbolic dysfunctions, not elsewhere classified

1.86

1.22

3.4

4.1

2.47

2.30

mmol/l

0.13

Gestational diabetes (for exclusion)

777

5118

1.08

1.22

3.5

3.8

1.32

1.70

mmol/l

2.32

620

4115

Complications associated with artificial fertilization

230

1.46

1.22

2.4

3.4

1.51

1.56

mmol/l

0.04

168

Perichondritis of external ear

500

1.31

1.21

4.0

3.4

2.84

1.90

mmol/l

1.04

396

Alcoholic myopathy

2.66

1.20

3.3

3.7

1.76

2.71

mmol/l

—

Uterine polyps

281

2504

1.13

1.20

3.1

3.5

1.95

2.01

mmol/l

0.10

241

2058

Benign neoplasm: Penis

2.07

1.20

2.1

3.4

2.31

1.50

mmol/l

0.35

Inhalation and ingestion of food causing obstruction of respiratory tract

275

1.43

1.20

3.7

6.4

2.14

1.83

mmol/l

0.26

219

HSIL lesion of the cervix uteri

381

3449

1.11

1.20

4.5

3.6

1.93

1.81

mmol/l

0.27

308

2791

Other and unspecified injuries of forearm

166

1.56

1.20

5.8

4.2

0.89

1.61

mmol/l

0.22

129

Torsion of ovary, ovarian pedicle and fallopian tube

394

1.34

1.19

3.1

3.3

2.54

2.05

mmol/l

0.43

308

Brain glioblastoma and astrocytoma

422

1.34

1.19

2.1

3.8

2.17

1.86

mmol/l

0.33

335

Labour and delivery complicated by fetal stress [distress]

400

2942

0.90

1.18

3.4

3.8

1.14

1.52

mmol/l

1.27

318

2369

Other puerperal infections

142

1205

1.19

1.18

2.2

3.4

1.29

1.69

mmol/l

0.69

115

958

Crushing injury of head

2.18

1.18

2.5

5.1

3.30

1.80

mmol/l

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of head, face and neck

224

1974

1.15

1.17

3.9

3.7

2.00

1.89

mmol/l

0.18

180

1589

Migraine without aura, drug-induced

216

1.47

1.17

2.5

3.0

1.58

2.12

mmol/l

0.28

174

Polyclonal hypergammaglobulinaemia

2.20

1.17

13.9

5.4

-0.20

2.21

mmol/l

—

Benign neoplasm of male genital organs

592

1.28

1.17

3.1

3.3

2.44

1.91

mmol/l

0.67

473

Exposure to excessive natural heat

1.97

1.17

7.2

4.3

1.31

1.98

mmol/l

—

Bacterial meningitis

112

935

1.22

1.16

4.2

3.6

1.59

1.99

mmol/l

0.58

743

Benign neoplasm: Other/unspecified site

397

1.34

1.16

4.4

2.9

2.19

2.03

mmol/l

0.10

315

Ectopic pregnancy

429

3915

1.10

1.16

3.0

3.8

1.70

2.05

mmol/l

1.12

348

3245

Female infertility, tubal origin

107

887

1.22

1.16

3.9

3.4

1.80

1.93

mmol/l

0.16

712

Other benign neoplasm of uterus: Cervix uteri

127

1.63

1.16

3.1

3.0

1.15

2.41

mmol/l

1.30

102

Myelodysplastic syndrome

243

1.45

1.16

3.3

3.6

1.19

1.78

mmol/l

0.28

188

Drug-induced autoimmune haemolytic anaemia

2.47

1.16

6.0

3.2

0.76

2.16

mmol/l

—

Other bursal cyst

415

1.33

1.16

4.2

3.5

2.11

2.02

mmol/l

0.08

328

Viral infections of central nervous system, not elsewhere classified/unspecified

242

1.44

1.16

2.4

3.2

2.26

1.84

mmol/l

0.31

199

Retrobulbar neuritis in diseases classified elsewhere

1.98

1.16

26.9

3.0

1.60

2.42

mmol/l

0.41

Postpartum hemorraghe, parous women as controls

430

4123

0.91

1.15

2.9

3.3

1.66

1.78

mmol/l

0.32

345

3334

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1746

14892

0.95

1.15

3.9

3.8

1.78

1.87

mmol/l

0.42

1423

12121

Vestibular neuronitis

297

2668

1.12

1.14

3.7

3.8

2.06

1.97

mmol/l

0.18

244

2160

Malignant neoplasm of uterus, part unspecified, excluding all cancers (controls excluding all cancers)

137

1.61

1.12

4.6

3.0

0.67

2.85

mmol/l

1.01

113

Pleural plaque

405

3703

1.11

1.12

4.2

3.7

2.58

1.62

mmol/l

6.13

335

2892

Transient synovitis

236

1.44

1.12

14.3

4.8

1.80

1.64

mmol/l

0.17

186

Retained placenta and membranes, without haemorrhage

296

2658

1.12

2.9

3.7

1.89

2.10

mmol/l

0.54

242

2204

Unspecified renal colic

153

1.56

1.11

4.4

3.7

1.79

2.06

mmol/l

0.14

118

Biological medicines for asthma

261

1.41

1.11

2.2

3.4

2.86

2.26

mmol/l

0.35

214

Abnormality of red blood cells

129

1.62

1.11

6.7

3.4

1.75

2.26

mmol/l

0.15

102

Hereditary ataxia

366

1.35

1.11

5.1

4.9

1.59

1.69

mmol/l

0.08

287

Burn and corrosion confined to eye and adnexa

542

1.28

1.10

3.8

2.28

1.93

mmol/l

0.44

439

Ulcer of oesophagus, drug-induced

138

1.59

1.09

3.5

3.6

0.97

1.62

mmol/l

0.21

105

Malignant neoplasm of nasal cavity and middle ear

122

1.64

1.09

2.5

4.0

2.98

1.98

mmol/l

0.89

Cholesteatoma of middle ear

188

1650

1.15

1.08

3.6

2.06

1.89

mmol/l

0.23

146

1309

Supernumerary teeth EXCLUDE clefts and syndromes

106

1.68

1.08

10.0

8.4

0.85

1.56

mmol/l

0.33

Other disorders of male genital organs

131

1119

1.19

1.07

4.8

4.5

1.47

1.87

mmol/l

0.61

103

890

Malignant neoplasm of other and unspecified parts of tongue

377

1.33

1.07

4.1

3.8

4.14

1.99

mmol/l

2.53

305

Malignant neoplasm of other and unspecified male genital organs, excluding all cancers (controls excluding all cancers)

2.04

1.07

5.0

3.7

-2.13

1.57

mmol/l

—

Carcinoma in situ of larynx

2.03

1.06

3.3

4.4

3.00

2.49

mmol/l

—

Carcinoma in situ of larynx

2.03

1.06

3.3

3.2

3.00

2.02

mmol/l

—

Mucinous and mucinous cystic tumor of rectum, excluding all cancers (controls excluding all cancers)

131

1.61

1.06

2.5

3.8

1.41

1.96

mmol/l

0.29

101

Localized scleroderma [morphea]

333

1.35

1.06

4.1

2.8

1.78

2.39

mmol/l

0.56

256

Fourth [trochlear] nerve palsy

627

1.25

1.06

4.7

3.5

1.94

2.04

mmol/l

0.09

498

Malignant melanoma of skin

403

3694

1.10

1.06

4.5

3.7

1.74

2.00

mmol/l

0.76

337

2991

Benign neoplasm: Anus and anal canal

827

1.22

1.06

3.6

3.5

1.55

2.01

mmol/l

0.61

662

Benign neoplasm: Choroid

151

1738

0.86

1.04

3.4

2.09

1.99

mmol/l

0.14

135

1397

Respiratory distress of newborn

148

1203

1.20

1.04

14.6

11.1

0.88

0.97

mmol/l

0.16

115

934

Other demyelinating diseases of the central nervous system

754

1.22

1.03

4.4

3.5

1.56

1.83

mmol/l

0.31

605

conjunctival degenerations and deposits

593

1.25

1.03

5.3

3.3

1.62

2.10

mmol/l

0.69

472

Burkitt lymphoma, excluding all cancers (controls excluding all cancers)

2.20

1.03

18.1

3.9

5.56

1.59

mmol/l

—

Burkitt lymphoma

2.20

1.03

18.1

9.7

5.56

1.40

mmol/l

—

Burkitt lymphoma, helper endpoint

2.20

1.03

18.1

9.7

5.56

1.40

mmol/l

—

Follicular adenocarcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

249

1.40

1.02

1.5

3.3

2.51

1.90

mmol/l

0.48

199

Disorder of thyroid, unspecified

310

1.35

1.01

4.1

3.0

1.47

1.85

mmol/l

0.30

242

Benign neoplasm: Bone and articular cartilage, unspecified

165

1.50

1.01

1.9

2.5

1.75

2.23

mmol/l

0.26

125

Benign neoplasm of ovary

537

4992

1.08

1.00

3.4

3.5

2.08

2.12

mmol/l

0.08

451

4140

Prolapse and hernia of ovary and fallopian tube

162

1404

1.16

1.00

2.9

2.86

2.25

mmol/l

1.68

140

1155

Melanoma of uvea

268

1.38

0.99

2.8

3.5

1.45

2.13

mmol/l

0.62

218

Alpha thalassaemia

2.44

0.98

5.2

3.0

3.17

1.70

mmol/l

—

Anoxic brain damage

374

1.32

0.97

9.5

4.2

1.16

1.85

mmol/l

0.93

295

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, excluding all cancers (controls excluding all cancers)

218

1.43

0.97

6.7

3.2

2.20

2.15

mmol/l

0.02

179

Optic neuritis

112

953

1.19

0.97

4.9

3.4

2.18

1.94

mmol/l

0.38

763

Other disorders of thyroid

321

1.34

0.97

4.0

3.1

1.40

2.19

mmol/l

0.80

246

Carcinoma in situ of uteri, other/unspecified

117

1.58

0.97

3.3

3.2

2.95

2.19

mmol/l

0.42

Other corneal oedema

218

1.43

0.97

3.2

3.3

1.72

2.00

mmol/l

0.18

171

Other and unspecified degenerative diseases of nervous system

708

1.22

0.96

3.1

3.5

1.99

2.19

mmol/l

0.21

552

Normal-pressure hydrocephalus

193

1715

1.14

0.96

2.8

3.5

2.48

2.00

mmol/l

1.15

150

1356

Mandibular prognathia

482

1.27

0.96

3.8

7.2

1.77

1.54

mmol/l

0.26

378

Motorcycle rider injured in other and unspecified transport accidents

169

1486

1.15

0.95

4.3

4.4

1.33

1.86

mmol/l

0.90

134

1186

Ankyloglossia

718

1.22

0.95

8.7

9.5

1.44

1.03

mmol/l

0.52

543

Leiomyoma of uterus

2133

11697

1.04

0.94

3.7

3.4

2.09

2.10

mmol/l

0.03

1790

9684

Cellulitis of external ear

270

1.36

0.94

3.6

4.2

2.34

1.86

mmol/l

0.36

211

Perioral dermatitis

419

1.28

0.94

11.4

3.8

1.97

1.92

mmol/l

0.03

330

Chronic suppurative otitis media

242

2179

1.12

0.94

5.5

4.3

1.72

1.81

mmol/l

0.12

188

1733

Malignant neoplasm of prostate

1876

11408

1.04

0.93

4.0

4.2

1.61

1.72

mmol/l

0.60

1486

9174

Presbycusis

512

5463

0.93

3.1

3.5

1.63

1.97

mmol/l

1.20

408

4398

Other adrenocortical overactivity

238

1.40

0.93

5.7

7.6

1.36

mmol/l

0.00

191

Small cell lung cancer, excluding all cancers (controls excluding all cancers)

652

0.79

0.93

2.4

3.0

1.41

2.01

mmol/l

0.40

509

Increased muscle tone

177

1.46

0.93

3.9

5.5

0.85

1.65

mmol/l

0.40

136

Anti-inflammatory and antirheumatic products, non-steroids

1578

7606

1.05

0.92

3.7

5.3

1.96

1.66

mmol/l

2.20

1252

6185

Malignant neoplasm of nasal cavity and sinuses

169

1.47

0.92

2.5

4.0

3.21

1.93

mmol/l

1.56

122

Pedal cyclist injured in collision with other pedal cycle or other nonmotor vehicle

254

1.37

0.92

3.9

4.5

2.64

2.13

mmol/l

0.50

199

Crushing injury of wrist and hand

404

1.29

0.92

4.7

4.6

0.41

1.72

mmol/l

1.07

321

Balanced rearrangements and structural markers, not elsewhere classified

1.71

0.92

3.8

5.7

1.54

1.83

mmol/l

0.13

Benign neoplasm: Bone and articular cartilage, unspecified

169

1.46

0.91

1.9

3.0

1.75

2.15

mmol/l

0.22

132

Female genital prolapse

1031

5656

1.06

0.90

2.9

3.4

2.15

2.10

mmol/l

0.18

846

4681

Gilbert syndrome

161

1.47

0.90

3.2

3.3

1.66

2.09

mmol/l

0.23

121

Ménière disease

328

3007

1.10

0.90

2.8

3.5

1.75

2.04

mmol/l

0.81

276

2440

Other benign neoplasm of uterus: Other parts/unspecified

117

1352

0.85

0.90

2.6

2.9

1.96

2.27

mmol/l

0.44

1121

Other acute disseminated demyelination

186

1.43

0.90

11.2

3.2

2.22

1.85

mmol/l

0.23

148

Other congenital malformations of skull and face bones

234

1.43

0.89

4.3

11.8

1.41

1.01

mmol/l

0.45

168

Medullary carcinoma of thyroid gland, excluding all cancers (controls excluding all cancers)

1.92

0.89

1.4

2.6

3.07

1.79

mmol/l

—

Benign neoplasm: Skin of lip

344

1.31

0.88

4.3

3.1

1.95

2.00

mmol/l

0.03

284

Chronic suppurative otitis media, including avohilmo

289

2638

1.10

0.88

5.4

4.8

1.58

1.78

mmol/l

0.38

226

2106

Major anomalies of jaw size

697

1.21

0.87

4.9

5.4

2.51

1.90

mmol/l

0.93

562

Bacterial sepsis of newborn

450

1.30

0.87

9.8

10.2

-0.41

1.16

mmol/l

1.25

340

Lichen ruber planus, wide definition including periferal and oral lichen planus

707

6675

1.06

0.87

3.4

3.8

1.89

2.02

mmol/l

0.47

581

5466

Osteomalacia

205

1.40

0.87

4.1

3.2

2.56

2.21

mmol/l

0.24

163

Other complications of labour and delivery, not elsewhere classified

160

1744

0.88

0.86

1.9

3.7

1.59

1.39

mmol/l

0.42

123

1369

Other benign neoplasms of connective and other soft tissue

315

2890

1.10

0.85

3.6

3.8

1.90

1.95

mmol/l

0.08

257

2339

Bullous keratopathy

241

1.37

0.85

2.7

3.3

1.99

2.17

mmol/l

0.07

185

Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs

252

2289

1.11

0.85

5.7

3.8

1.93

1.95

mmol/l

0.03

197

1868

Sequelae of injuries of upper limb

295

2699

1.10

0.85

3.6

4.1

2.06

1.88

mmol/l

0.34

240

2200

Spinal enthesopathy

108

928

1.17

0.85

3.2

3.0

2.03

2.13

mmol/l

0.07

690

Sleepwalking [somnambulism]

1.80

0.85

1.5

1.7

0.01

2.62

mmol/l

—

Injury of blood vessels at neck level

1.67

0.85

6.0

3.3

1.85

mmol/l

0.00

Malignant melanoma

532

4987

1.07

0.84

4.2

3.7

1.78

1.96

mmol/l

0.55

448

4043

Cleft lip, lip and palate or palate

364

1.28

0.84

11.1

7.0

1.99

1.66

mmol/l

0.35

287

Macular pucker, drug-induced

0.00

0.84

0.0

3.6

—

3.08

—

Other hearing loss

1140

10724

1.05

0.83

4.0

3.8

1.77

1.91

mmol/l

0.60

933

8697

Pityriasis rubra pilaris

1.77

0.83

3.5

3.8

1.61

2.61

mmol/l

—

Subacute thyroiditis

102

876

1.18

0.83

3.6

3.7

1.80

1.91

mmol/l

0.14

708

Other abnormal auditory perceptions

259

1.34

0.83

3.9

2.71

2.10

mmol/l

0.77

210

Benign neoplasm: Skin of scalp and neck

702

1.20

0.82

5.7

4.2

1.85

2.03

mmol/l

0.19

550

Benign neoplasm: Other/unspecified site

420

1.26

0.82

4.4

3.3

2.19

2.10

mmol/l

0.05

334

Pemphigus

182

1.42

0.82

3.8

3.7

0.14

1.90

mmol/l

1.15

136

Other sex chromosome abnormalities, female phenotype, not elsewhere classified

0.00

0.81

0.0

5.7

—

1.64

—

Disorders of lacrimal system and orbit in diseases classified elsewhere

584

1.22

0.80

3.0

3.2

2.21

2.11

mmol/l

0.09

472

Endometriosis of pelvic peritoneum

397

3637

1.08

0.80

3.5

3.6

1.95

1.89

mmol/l

0.11

323

2997

Benign neoplasm of male genital organs

622

1.21

0.80

3.1

4.2

2.44

1.75

mmol/l

0.97

496

Fetal alcohol syndrome (dysmorphic)

2.28

0.78

12.4

2.5

3.82

1.38

mmol/l

—

Benign neoplasm of thyroid gland

854

1.17

0.78

3.4

3.1

2.56

1.90

mmol/l

1.19

683

Malignant neoplasm of oral cavity

114

995

1.16

0.78

3.4

3.7

3.34

2.03

mmol/l

2.31

783

Graves ophthalmopathy

577

1.21

0.78

2.8

3.2

2.22

2.19

mmol/l

0.02

468

Venous complications and haemorrhoids in pregnancy

261

1.32

0.78

2.8

3.1

1.48

1.89

mmol/l

0.64

210

Brain meningioma

156

1390

1.13

0.77

3.1

3.3

1.59

2.00

mmol/l

0.89

126

1136

Unattended death

219

1.36

0.77

3.2

4.2

2.03

1.83

mmol/l

0.14

174

Benign neoplasm: Tonsil

298

1.30

0.77

2.9

2.7

2.07

2.14

mmol/l

0.05

240

Chronic laryngitis and laryngotracheitis

462

4326

1.07

0.77

4.1

3.8

1.97

1.90

mmol/l

0.12

391

3493

Synovial hypertrophy, not elsewhere classified

210

1.36

0.76

3.8

3.7

1.80

1.66

mmol/l

0.05

165

Alzheimer’s disease (Atypical or mixed)

357

3307

1.09

0.76

2.8

3.3

1.98

1.95

mmol/l

0.05

283

2595

Carcinoma in situ of oropharynx, excluding all cancers

1.91

0.76

2.3

4.7

1.04

1.70

mmol/l

—

Pollen allergy

584

5451

1.06

0.76

4.4

5.5

1.75

1.63

mmol/l

0.34

484

4392

Feeding problems of newborn

368

1.31

0.76

6.3

10.4

1.55

1.04

mmol/l

0.82

282

Benign neoplasm: Connective and other soft tissue of head, face and neck

406

1.25

0.76

2.9

3.1

1.89

2.45

mmol/l

0.48

322

Benign neoplasm: Trachea

2.15

0.76

6.2

4.8

1.56

1.77

mmol/l

—

Benign neoplasm: Endocrine pancreas

168

1.42

0.75

3.8

3.4

2.16

2.37

mmol/l

0.10

131

Benign neoplasm: Endocrine pancreas

168

1.42

0.75

3.8

4.1

2.16

2.06

mmol/l

0.04

129

Other benign neoplasm of uterus: Cervix uteri

142

1.45

0.75

3.1

2.7

1.15

2.18

mmol/l

1.06

116

Benign neoplasm: Tonsil

299

1.30

0.75

2.9

3.0

2.07

2.22

mmol/l

0.12

231

Immunodeficiency associated with other specified major defects, or unspecified

2.15

0.75

61.2

8.1

1.76

1.66

mmol/l

—

Oral lichen ruber planus, including avohilmo

137

1543

0.88

0.74

2.6

3.7

2.07

2.04

mmol/l

0.05

113

1271

Other protozoal intestinal diseases

335

1.28

0.74

3.2

5.5

1.11

2.05

mmol/l

1.22

265

Graves ophthalmopathy, strict

507

1.22

0.74

2.7

3.2

2.25

2.23

mmol/l

0.01

406

Other specified and unspecified strabismus

327

1.28

0.74

5.3

5.8

2.69

1.59

mmol/l

0.84

253

Benign neoplasm: Bronchus and lung

354

1.27

0.74

5.1

3.4

0.82

2.15

mmol/l

0.73

296

Benign neoplasm: Trachea

2.06

0.73

6.2

3.3

1.56

1.40

mmol/l

—

Infections of breast associated with childbirth

589

1.20

0.73

3.5

3.4

1.76

1.82

mmol/l

0.06

464

Hypersensitivity pneumonitis due to organic dust

454

1.23

0.73

4.7

3.6

1.19

1.97

mmol/l

0.72

364

Knuckle pads

1.80

0.73

7.0

2.7

2.90

2.12

mmol/l

—

Carcinoma in situ of breast, intraductal

193

2129

0.90

0.72

2.9

3.5

2.26

2.11

mmol/l

0.23

162

1784

Persistent hyperplasia of thymus

2.03

0.72

2.4

2.2

1.04

3.46

mmol/l

—

Male infertility

126

1113

1.14

0.72

7.8

4.5

1.65

1.82

mmol/l

0.24

920

Other conditions related to polyarteritis nodosa

1.72

0.72

3.7

2.5

2.69

2.00

mmol/l

—

Other obstructed labour

169

1519

1.12

0.72

3.2

3.8

1.56

2.02

mmol/l

1.15

132

1270

Carcinoma in situ of oral cavity and pharynx

1.77

0.72

2.3

3.7

1.04

2.41

mmol/l

—

Ill-defined and unknown causes of mortality

255

2345

1.10

0.71

4.9

3.6

2.89

1.97

mmol/l

3.51

199

1819

Congenital and developmental myasthenia

1.98

0.71

3.4

8.4

4.08

2.35

mmol/l

—

Other specified transport accidents

127

1.46

0.71

3.3

4.8

1.86

1.90

mmol/l

0.01

Other ill-defined and unspecified causes of mortality

223

2039

1.10

0.71

4.9

3.6

2.97

1.97

mmol/l

3.33

174

1577

Dermatitis due to ingested food

179

1562

1.12

0.70

7.6

9.0

1.18

1.29

mmol/l

0.19

143

1233

Corneal degeneration

375

1.25

0.69

5.8

3.5

1.89

1.98

mmol/l

0.05

298

Respiratory tuberculosis, not confirmed

149

1336

1.13

0.69

4.6

3.5

1.84

2.02

mmol/l

0.24

117

1047

Other specified/unspecified diseases of inner ear

128

1.45

0.69

1.5

3.9

2.09

1.64

mmol/l

0.11

101

Respiratory TBC, ICD-8 codes not specifying whether confirmed bacteriologically or histologically

108

950

1.15

0.68

5.1

3.5

1.71

2.08

mmol/l

0.43

747

Occupant of three-wheeled motor vehicle injured in other and unspecified transport accidents

1.88

0.68

11.6

2.9

4.02

1.71

mmol/l

—

Muscle wasting and atrophy, not elsewhere classified

154

1.40

0.68

3.2

3.9

3.19

1.83

mmol/l

1.06

123

Benign neoplasm: Bronchus and lung

359

1.25

0.67

5.1

3.8

0.82

2.12

mmol/l

0.71

286

Vascular dementia (multiple infarctions)

385

1.24

0.67

3.8

3.6

2.15

2.05

mmol/l

0.09

295

Occupant of streetcar injured in transport accident

1.85

0.66

2.4

3.7

-0.50

2.30

mmol/l

—

Reiter disease

146

1.41

0.66

3.3

4.2

1.01

1.84

mmol/l

0.54

119

Carcinoma in situ of cervix uteri, endocervix

180

1.35

0.66

2.0

3.2

1.59

1.78

mmol/l

0.10

137

Benign neoplasm: Long bones of lower limb

727

1.17

0.66

3.8

3.5

2.10

1.97

mmol/l

0.17

578

Defects in glycoprotein degradation

0.00

0.66

0.0

3.9

—

2.41

—

Cyst of Bartholin Gland

774

1.16

0.65

2.2

3.1

2.45

2.09

mmol/l

0.51

633

Melanocytic naevi of other and unspecified parts of face

167

1512

1.11

0.65

4.8

3.5

1.55

1.91

mmol/l

0.77

133

1217

Lichen sclerosus et atrophicus

292

2712

1.08

0.65

3.0

3.3

2.00

2.07

mmol/l

0.15

240

2234

Dental caries 2

2810

22601

0.98

0.65

6.5

4.0

1.55

1.82

mmol/l

3.53

2380

18406

Other specified disorders of external ear

134

1202

1.13

0.64

4.5

3.9

1.62

2.00

mmol/l

0.58

111

944

Xanthelasma of eyelid

226

1.31

0.64

6.7

2.7

1.56

2.29

mmol/l

0.30

185

Melanoma of uvea

289

1.27

0.64

2.8

3.7

1.45

2.11

mmol/l

0.63

235

Carcinoma in situ of cervix uteri, exocervix

104

1.47

0.64

1.6

3.5

3.61

1.89

mmol/l

—

Coccidioidomycosis

0.00

0.63

0.0

3.5

—

2.42

—

Carcinoma in situ of uteri, other/unspecified

130

1.42

0.63

3.3

2.9

2.95

2.48

mmol/l

0.25

106

Benign neoplasm: Eye, unspecified

122

1.44

0.63

11.5

4.0

1.89

2.43

mmol/l

0.28

Other congenital malformations of ear

307

1.26

0.63

2.4

7.5

1.78

1.21

mmol/l

0.62

235

Benign neoplasm: Skin of lip

362

1.24

0.63

4.3

3.4

1.95

1.86

mmol/l

0.05

289

Inflammation of lacrimal passages (chronic)

463

1.21

0.62

3.2

3.4

1.73

2.00

mmol/l

0.20

362

Hereditary choroidal dystrophy

0.00

0.62

0.0

2.8

—

2.52

—

Other inherited muscular atrophy

1.61

0.62

8.6

5.5

1.99

1.43

mmol/l

—

Infections specific to the perinatal period

747

1.17

0.62

9.8

9.4

0.03

1.22

mmol/l

1.40

581

Habitual aborter

262

1.27

0.62

3.8

3.3

0.61

1.68

mmol/l

1.63

195

Dental caries 2 and operation codes

2738

22253

0.98

0.61

6.4

4.0

1.54

1.82

mmol/l

3.72

2317

18126

Placenta praevia

770

0.85

0.61

2.3

3.6

1.30

1.72

mmol/l

0.46

613

Compression of brain

0.00

0.61

0.0

3.7

—

3.04

—

Complications following myocardial infarction

201

1.32

0.61

5.2

3.2

1.44

1.80

mmol/l

0.18

145

Complicated migraine, drug-induced

0.00

0.61

0.0

3.1

—

2.29

—

Staphylococcal scalded skin syndrome

1.84

0.61

41.7

7.3

0.48

0.72

mmol/l

—

Benign neoplasm: Eye, unspecified

123

1.43

0.61

11.5

3.3

1.89

2.36

mmol/l

0.24

Glucosamine medication

2122

16507

1.03

0.60

3.2

3.7

2.02

1.98

mmol/l

0.21

1757

13505

Use of interferon beta-1a

437

1.20

0.59

2.6

3.6

1.89

1.92

mmol/l

0.02

354

Maternal care for known or suspected disproportion

725

1.15

0.59

2.1

3.5

2.10

1.81

mmol/l

0.34

583

Phlebitis and thrombophlebitis of other deep vessels of lower extremities, drug-induced

0.56

0.59

12.2

3.2

2.58

1.80

mmol/l

—

Unspecified abortion

108

961

1.13

0.58

6.2

4.0

1.74

2.06

mmol/l

0.48

794

Cholesteatoma of external ear

203

1.31

0.58

6.4

3.7

1.44

1.98

mmol/l

0.30

154

Carcinoma in situ of skin of eyelid, including canthus

1.61

0.58

4.9

4.1

-0.47

2.26

mmol/l

—

Carcinoma in situ of skin of eyelid, including canthus

1.61

0.58

4.9

4.1

-0.47

1.55

mmol/l

—

Keratoconus

606

1.17

0.58

4.3

3.7

1.73

1.99

mmol/l

0.19

495

Benign neoplasm of other and unspecified female genital organs

112

1001

1.13

0.57

4.4

3.3

2.28

2.10

mmol/l

0.25

838

Carcinoma in situ of cervix uteri, endocervix

185

1.31

0.57

2.0

2.9

1.59

2.03

mmol/l

0.25

145

Obstructed labour due to maternal pelvic abnormality

386

3639

1.06

0.57

3.2

3.8

2.19

mmol/l

0.00

321

3046

Other and unspecified atrophic disorders of skin

116

1.42

0.57

9.0

3.1

1.35

2.51

mmol/l

0.73

Endometriosis ASRM stages 3,4

636

6080

1.05

0.56

3.8

3.5

2.04

2.00

mmol/l

0.11

534

4998

Erosion and ectropion of cervix uteri

739

1.15

0.56

4.8

3.4

1.28

2.27

mmol/l

1.26

617

Adenomyosis (Endometriosis of uterus)

408

3859

1.06

0.55

3.0

3.4

1.45

2.06

mmol/l

3.26

342

3185

Necrotizing enterocolitis of fetus and newborn

2.31

0.55

9.4

19.8

0.14

0.24

mmol/l

—

Polycystic ovarian syndrome, broad definition

193

1778

1.09

0.54

3.1

3.3

1.37

1.59

mmol/l

0.39

158

1392

Sequelae of tuberculosis

573

1.17

0.54

4.6

3.5

3.15

1.97

mmol/l

1.58

440

Malignant neoplasm of other and ill-defined sites in the lip, oral cavity and pharynx, excluding all cancers (controls excluding all cancers)

1.45

0.53

2.2

3.8

1.77

2.29

mmol/l

—

Acute myringitis

206

1.29

0.53

4.3

6.0

0.67

1.59

mmol/l

0.75

163

Alzheimer disease

1291

9442

1.03

0.53

2.6

3.5

2.04

1.95

mmol/l

0.31

1045

7571

Kaposi sarcoma, excluding all cancers (controls excluding all cancers)

1.55

0.53

4.3

3.9

2.85

2.51

mmol/l

—

Other benign neoplasms of uterus

160

1741

0.91

0.52

2.7

2.9

1.87

2.27

mmol/l

0.85

129

1437

Benign neoplasm: Connective and other soft tissue of head, face and neck

426

1.19

0.52

2.9

3.6

1.89

1.97

mmol/l

0.05

334

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

585

1.16

0.51

4.0

3.2

2.31

2.08

mmol/l

0.18

468

Malignant neoplasm of tongue

549

1.16

0.50

3.7

4.01

2.03

mmol/l

2.76

436

Retinal breaks without detachment

513

4900

1.05

0.50

4.9

3.7

1.92

1.99

mmol/l

0.17

418

3997

Calcium deposit in bursa

1.58

0.50

6.0

3.6

1.91

2.94

mmol/l

—

Rheumatic heart disease, other

1.54

0.49

3.9

2.9

2.03

2.19

mmol/l

—

Pregnancy examination and test

352

2074

1.06

0.49

3.0

3.6

1.37

1.59

mmol/l

0.57

276

1659

Retinoschisis and retinal cysts

682

1.14

0.49

3.8

3.7

2.21

2.09

mmol/l

0.11

545

Benign neoplasm of bone and articular cartilage

218

2031

1.08

0.49

3.6

3.7

1.89

1.99

mmol/l

0.18

182

1658

Endometriosis of rectovaginal septum and vagina

222

2070

1.08

0.49

3.0

3.2

2.21

2.06

mmol/l

0.31

173

1695

Benign neoplasm of breast

341

3225

1.06

0.49

3.1

3.4

2.05

mmol/l

0.01

298

2677

Moderate visual impairment, binocular

105

948

1.12

0.49

7.4

3.9

0.39

2.01

mmol/l

5.21

739

Maternal care for known or suspected abnormality of pelvic organs

506

3657

0.95

0.49

3.2

3.9

1.68

1.73

mmol/l

0.11

406

2973

Benign neoplasm: Testis

120

1.37

0.48

2.6

3.9

1.83

1.48

mmol/l

—

Non-small cell lung cancer, squamous

147

1598

0.91

0.48

3.1

3.7

2.84

1.93

mmol/l

2.14

126

1230

Non-small cell lung cancer, squamous, helper endpoint

147

1598

0.91

0.48

3.1

3.7

2.84

1.93

mmol/l

2.14

126

1230

Rubella [German measles]

105

949

1.12

0.48

4.5

4.4

2.12

1.85

mmol/l

0.34

782

Intrahepatic Cholestasis of Pregnancy (ICP) , excluding more controls

118

1071

1.11

0.48

2.7

3.1

1.33

1.75

mmol/l

0.56

862

Carcinoma in situ of cervix uteri, exocervix

111

1.37

0.48

1.6

3.1

3.61

2.11

mmol/l

—

Pedal cyclist injured in collision with motor vehicle

797

1.13

0.47

2.1

3.8

2.33

2.01

mmol/l

0.38

631

Distal bite

161

1478

1.09

0.47

11.1

6.8

1.60

1.55

mmol/l

0.07

135

1197

Benign neoplasm: Testis

121

1.36

0.46

2.6

2.8

1.83

1.90

mmol/l

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

113

1014

1.12

0.46

10.4

11.5

1.35

0.91

mmol/l

1.15

788

Iliotibial band syndrome

238

1.23

0.45

6.1

3.3

1.36

1.61

mmol/l

0.16

188

Oral leukoplakia, including avohilmo

763

1.13

0.45

4.2

3.4

1.11

2.11

mmol/l

1.17

607

Benign neoplasm: Connective and other soft tissue, unspecified

275

1.22

0.45

2.9

1.61

2.05

mmol/l

0.24

219

Oral leukoplakia

509

1.15

0.44

4.4

3.5

1.61

2.07

mmol/l

0.41

410

Erysipeloid

1.63

0.44

4.0

4.2

4.20

2.03

mmol/l

—

Primary angle-closure glaucoma

152

1407

1.09

0.43

4.9

3.4

1.92

2.06

mmol/l

0.15

130

1136

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

121

1108

1.10

0.43

3.3

3.2

1.79

2.02

mmol/l

0.31

900

Lumbosacral root disorders, not elsewhere classified

323

1.19

0.43

2.6

3.4

2.93

2.22

mmol/l

0.75

260

Plasmodium vivax malaria

0.00

0.43

0.0

4.9

—

0.78

—

Gluteal tendinitis

817

0.89

0.43

3.7

3.2

1.33

1.89

mmol/l

0.58

664

Endometriosis ASRM stages 1,2

410

3915

1.05

0.42

3.7

1.92

1.95

mmol/l

0.06

334

3216

Tarsal tunnel syndrome

259

1.22

0.42

3.3

3.0

2.95

2.15

mmol/l

0.31

220

Other abnormal products of conception

684

4396

1.04

0.41

2.9

3.9

1.67

1.78

mmol/l

0.37

571

3536

Female infertility, uterine origin

1.37

0.41

4.4

3.3

1.61

2.16

mmol/l

—

Acne varioliformis

1.37

0.41

10.5

2.6

1.23

2.24

mmol/l

—

Benign neoplasm of eye and adnexa

291

3067

0.94

0.41

4.2

3.6

1.84

2.03

mmol/l

0.43

251

2474

Presbyopia

163

1517

1.08

0.41

3.5

1.80

2.03

mmol/l

0.34

146

1226

Benign neoplasm of eye and adnexa

291

2761

1.06

0.40

4.2

3.6

1.84

1.99

mmol/l

0.32

251

2258

Benign leiomyoma with endometriosis

448

4295

1.05

0.40

3.2

3.5

1.70

2.20

mmol/l

2.35

376

3560

Chromomycosis and phaeomycotic abscess

1.48

0.40

4.0

8.5

-1.18

1.82

mmol/l

—

Labour and delivery complicated by umbilical cord complications

902

1.10

0.40

3.6

3.5

1.93

mmol/l

0.00

741

Respiratory tuberculosis, clinically confirmed

363

1.17

0.40

3.2

3.9

2.04

1.46

mmol/l

0.70

284

Alzheimer’s disease, wide definition

954

8199

0.97

0.39

2.5

3.5

2.03

1.94

mmol/l

0.31

759

6579

Benign neoplasm: Long bones of lower limb

761

1.11

0.39

3.8

3.7

2.10

1.94

mmol/l

0.22

615

Spermatocele

256

2701

0.94

0.39

4.5

4.2

1.80

1.77

mmol/l

0.05

200

2132

Use of ropinirole

119

1098

1.09

0.39

3.0

3.8

2.62

2.01

mmol/l

0.83

878

Vertical strabismus

102

934

1.10

0.39

3.5

4.3

1.30

1.89

mmol/l

0.99

737

Follicular adenocarcinoma of thyroid gland

170

1.26

0.39

1.4

4.5

2.42

1.82

mmol/l

0.31

136

Malignant neoplasm of respiratory system and intrathoracic organs

859

7679

1.03

0.39

3.5

3.8

2.32

1.82

mmol/l

3.37

720

6129

Hypospadias

171

1.27

0.38

4.3

11.0

0.91

1.19

mmol/l

0.20

135

Merkel cell carcinoma of skin, excluding all cancers (controls excluding all cancers)

1.54

0.38

4.5

2.7

0.92

1.89

mmol/l

—

Benign neoplasm: Prostate

198

1.24

0.38

2.3

3.5

1.92

1.60

mmol/l

0.15

161

Benign neoplasm: Vertebral column

1.32

0.38

7.9

5.2

2.77

1.69

mmol/l

—

Merkel cell carcinoma of skin

1.50

0.38

4.5

3.2

0.92

1.88

mmol/l

—

Other facial nerve disorders

725

1.11

0.37

3.4

3.0

1.89

1.97

mmol/l

0.10

579

Telogen effluvium

1.51

0.37

3.5

2.4

0.78

2.34

mmol/l

—

Malignant neoplasm of gum

125

0.70

0.37

2.2

4.2

6.18

1.84

mmol/l

—

Haemorrhagic and haematological disorders of fetus and newborn

158

1419

1.08

0.35

12.4

10.9

0.91

1.12

mmol/l

0.38

138

1119

Kaposi sarcoma

1.40

0.35

4.3

3.3

2.85

2.34

mmol/l

—

Benign neoplasm: Epididymis

1.36

0.35

2.3

2.8

3.21

1.94

mmol/l

—

Oral lichen ruber planus

626

0.89

0.35

3.2

3.3

1.54

2.16

mmol/l

0.79

507

Oral lichen ruber planus, hypothyreosis or thyroxin

372

0.85

0.35

2.9

2.14

2.39

mmol/l

0.21

303

Transitory endocrine and metabolic disorders specific to fetus and newborn

114

1038

1.10

0.35

10.3

11.4

1.35

0.94

mmol/l

1.04

810

Ovarian hyperstimulation (induction)

227

1.20

0.35

2.7

3.6

1.91

1.53

mmol/l

0.33

173

Alzheimer’s disease (Late onset)

872

7670

0.97

0.35

2.5

3.5

2.03

1.94

mmol/l

0.29

693

6139

Vitiligo

237

1.19

0.34

8.3

3.7

1.00

2.08

mmol/l

0.85

177

Primary open-angle glaucoma, strict

1000

10221

0.97

0.34

3.9

3.6

1.93

1.99

mmol/l

0.21

788

8338

Other disorders of Eustachian tube

730

1.10

0.34

6.6

3.2

2.01

2.07

mmol/l

0.06

578

Contact with nonpowered hand tool

129

1202

1.08

0.34

4.1

4.0

1.95

1.88

mmol/l

0.09

104

960

Benign leiomyoma with endometriosis

448

4647

0.96

0.34

3.2

3.4

1.70

2.13

mmol/l

1.88

376

3863

Other melanin hyperpigmentation

616

1.11

0.34

4.5

3.3

2.28

2.29

mmol/l

0.01

498

Von Willebrand disease

275

1.18

0.33

6.4

3.5

1.98

1.93

mmol/l

0.03

220

Chronic diseases of tonsils and adenoids

3264

20377

1.01

0.33

4.3

4.4

1.89

1.75

mmol/l

1.41

2666

16684

Malignant neoplasm of other and unspecified major salivary glands, excluding all cancers (controls excluding all cancers)

192

1.22

0.33

2.6

3.4

2.22

2.28

mmol/l

0.02

149

Malignant neoplasm of eye and adnexa

248

1.19

0.33

8.8

4.1

2.62

1.85

mmol/l

0.64

198

Dyshidrosis [pompholyx]

327

0.85

0.32

4.4

3.4

2.36

1.85

mmol/l

0.28

257

Occupant of special all-terrain or other motor vehicle designed primarily for off-road use, injured in transport accident

370

1.15

0.32

5.2

3.6

1.86

1.94

mmol/l

0.03

293

Benign neoplasm: Cranial nerves

820

0.91

0.32

3.8

3.4

1.87

2.01

mmol/l

0.10

664

Propionic acid derivatives

1542

7601

1.02

0.32

3.5

5.3

1.89

1.66

mmol/l

1.46

1213

6180

Foreign body on external eye

485

4693

1.04

0.31

4.2

4.4

1.87

1.84

mmol/l

0.06

390

3810

Lesion of sciatic nerve

157

1480

1.07

0.31

2.9

3.4

2.10

1.95

mmol/l

0.23

123

1176

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8, excluding more controls

163

1537

1.06

0.31

3.8

3.0

1.54

1.83

mmol/l

0.44

131

1267

Other mosquito-borne viral fevers

1.30

0.31

1.3

3.4

2.01

2.41

mmol/l

—

Other deformities of toe(s)

105

976

1.08

0.31

5.2

3.6

1.63

1.95

mmol/l

0.28

794

Benign neoplasm: Conjunctiva

803

1.09

0.30

4.4

3.1

1.70

2.07

mmol/l

0.47

641

Primary open-angle glaucoma

1258

12493

0.98

0.29

3.8

3.6

1.91

1.98

mmol/l

0.29

996

10196

Congenital malformations of ovaries, fallopian tubes and broad ligaments

112

1045

1.08

0.29

3.1

3.2

1.19

1.90

mmol/l

1.27

848

Benign neoplasm: Vulva

478

1.12

0.29

6.7

2.9

2.25

2.23

mmol/l

0.01

386

Other and unspecified mononeuropathies of lower limb

757

1.09

0.29

3.3

3.1

1.94

1.86

mmol/l

0.07

618

Maternal care for other known or suspected fetal problems

459

3043

0.97

0.29

3.4

3.9

1.38

1.50

mmol/l

0.34

359

2438

Benign neoplasm: Prostate

205

1.19

0.29

2.3

4.4

1.92

1.35

mmol/l

0.29

155

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1232

9866

0.98

0.28

3.6

1.76

1.92

mmol/l

0.79

1003

8093

Congenital malformations of breast

261

1.16

0.28

2.3

2.8

2.01

1.93

mmol/l

0.02

204

566

1.10

0.28

3.4

3.5

2.19

1.86

mmol/l

0.28

462

Constitutional tall stature

235

0.83

0.27

1.7

10.0

0.69

1.14

mmol/l

0.13

173

Iridocyclitis in diseases classified elsewhere

529

1.11

0.27

5.0

4.6

1.62

1.78

mmol/l

0.14

423

Use of donepezil

764

7518

0.97

0.27

2.7

3.5

2.26

1.97

mmol/l

1.55

626

6047

Endometriosis of ovary

456

4410

1.03

0.27

4.1

3.4

1.98

1.99

mmol/l

0.04

393

3618

Overjet

120

1124

1.07

0.27

15.1

8.0

1.32

1.40

mmol/l

0.11

103

902

Benign neoplasm: Vertebral column

1.26

0.26

7.9

4.4

2.77

1.70

mmol/l

—

Benign neoplasm: Connective and other soft tissue, unspecified

292

1.14

0.26

2.9

3.3

1.61

2.01

mmol/l

0.22

231

Other specified/unspecified disorders of ear

1.22

0.26

3.6

3.1

1.91

2.53

mmol/l

—

Short Achilles tendon (acquired)

633

0.91

0.26

3.9

3.3

3.50

2.07

mmol/l

1.61

509

Exposure to other specified electric current

283

1.14

0.25

6.7

5.0

1.37

1.64

mmol/l

0.23

220

Gastrointestinal stromal tumor and sarcoma, excluding all cancers (controls excluding all cancers)

312

1.13

0.25

3.6

3.2

1.28

2.09

mmol/l

0.92

258

Malignant neoplasm of breast, HER-positive

1038

10426

0.98

0.25

2.6

3.5

2.23

2.17

mmol/l

0.22

864

8699

Secondary malignant neoplasm of other and unspecified sites

398

1.12

0.25

3.1

3.7

3.83

1.97

mmol/l

1.44

319

Tooth agenesis EXCLUDE clefts and syndromes

121

1142

1.06

0.25

9.2

6.3

1.68

1.48

mmol/l

0.39

102

920

Postdysenteric arthropathy

233

0.85

0.24

2.3

3.9

1.34

1.94

mmol/l

0.25

188

Benign neoplasm: Short bones of upper limb

370

0.89

0.24

2.6

3.3

1.97

1.95

mmol/l

0.02

292

Polypectomy (DHB20)

222

2132

1.05

0.24

4.0

3.9

1.61

1.95

mmol/l

0.56

188

1715

Acute poliomyelitis

370

1.12

0.24

3.6

3.0

1.80

2.17

mmol/l

0.22

296

Carcinoma in situ of penis

1.35

0.24

10.0

3.3

0.62

2.25

mmol/l

—

Benign neoplasm: Epididymis

1.27

0.24

2.3

4.4

3.21

1.57

mmol/l

—

Exposure to noise

1.31

0.24

2.6

3.8

2.86

1.33

mmol/l

—

Contact with lifting and transmission devices, not elsewhere classified

486

1.10

0.23

2.7

3.8

1.84

1.85

mmol/l

0.01

388

Ankylosing spondylitis, ICD10

261

2517

1.04

0.23

4.3

4.0

1.94

1.93

mmol/l

0.01

215

2048

Hypotony of eye

1.28

0.23

6.6

3.0

2.54

2.18

mmol/l

—

Fetus and newborn affected by maternal complications of pregnancy

521

0.90

0.23

8.8

13.4

0.68

0.92

mmol/l

0.16

396

Deep endometriosis

246

2371

1.04

0.23

2.9

3.3

2.11

1.98

mmol/l

0.29

191

1960

Other articular cartilage disorders

690

1.08

0.22

3.4

3.7

2.44

1.89

mmol/l

0.68

540

Intentional self-harm by drowning and submersion

1.24

0.22

7.2

2.1

0.08

1.99

mmol/l

—

Trichuriasis

0.00

0.22

0.0

5.4

—

0.89

—

Premature separation of placenta [abruptio placentae]

391

1.10

0.22

3.1

3.9

1.92

1.95

mmol/l

0.02

315

Hypothyroidism, autoimmune, DX-based

1.26

0.21

3.4

5.1

2.47

1.65

mmol/l

0.95

Postpartum haemorrhage due to retained placenta

191

1989

0.96

0.21

2.1

3.1

1.98

1.83

mmol/l

0.23

153

1592

Use of other anti-dementia drugs

1053

9017

1.02

0.21

2.3

3.5

2.17

1.95

mmol/l

1.15

853

7207

Use of memantine

1053

9017

1.02

0.21

2.3

3.5

2.17

1.95

mmol/l

1.15

853

7207

Neonatal jaundice from other and unspecified causes

117

1187

0.94

0.21

14.1

11.3

0.97

1.05

mmol/l

0.12

100

923

Gastrointestinal stromal tumor and sarcoma

316

1.12

0.21

3.6

3.8

1.28

2.09

mmol/l

0.93

246

Lens-induced iridocyclitis

1.31

0.21

4.7

2.9

2.35

3.09

mmol/l

—

Benign neoplasm: Choroid

151

1579

0.95

0.21

3.4

3.3

2.09

2.08

mmol/l

0.01

135

1288

Congenital malformations of nose

1.25

0.21

12.7

7.2

2.23

2.42

mmol/l

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

413

1.10

0.20

5.5

3.1

1.19

2.15

mmol/l

0.94

320

Use of selegiline

142

1485

0.95

0.20

2.6

3.5

2.82

2.04

mmol/l

1.76

110

1173

Contact with machinery

368

3582

1.03

0.20

4.4

4.2

1.60

1.86

mmol/l

0.83

283

2879

Other diseases of appendix

288

1.12

0.20

6.4

3.4

1.80

2.35

mmol/l

0.49

230

Vasomotor rhinitis (mode)

195

2023

0.96

0.19

3.9

3.7

1.65

1.94

mmol/l

0.61

162

1633

Use of rivastigmine

541

5285

1.02

0.19

2.3

3.3

2.29

1.99

mmol/l

1.06

431

4233

Congenital malformations of eyelid, lacrimal apparatus and orbit

376

1.10

0.19

6.1

9.3

0.80

1.06

mmol/l

0.24

280

Occupational exposure to risk-factors

930

0.94

0.19

3.6

4.0

2.46

1.85

mmol/l

0.97

743

Melanoma in situ

119

1246

0.95

0.19

3.7

3.5

1.98

1.97

mmol/l

0.01

105

989

Hereditary corneal dystrophies

911

1.06

0.19

3.4

3.2

2.27

1.98

mmol/l

0.43

732

Postmenopausal atrophic vaginitis

851

5036

1.02

0.19

3.2

3.5

2.10

2.15

mmol/l

0.14

720

4188

Other obstetric trauma

826

0.94

0.18

3.3

3.4

2.03

1.68

mmol/l

0.41

671

Other perinatal haematological disorders

130

1.20

0.18

4.2

13.2

-0.43

1.09

mmol/l

0.51

Sudden idiopathic hearing loss

311

3192

0.97

0.17

4.5

3.8

1.93

1.97

mmol/l

0.08

257

2609

L02BA Anti-estrogens

459

4493

1.02

0.17

2.9

3.5

2.39

2.09

mmol/l

0.96

376

3716

Malignant neoplasm of other and ill-defined sites in the respiratory system and intrathoracic organs, excluding all cancers (controls excluding all cancers)

0.72

0.17

6.6

4.2

2.22

1.79

mmol/l

—

186

1.14

0.17

4.2

5.1

0.61

1.64

mmol/l

0.57

135

Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified

105

1100

0.95

0.17

3.2

3.8

2.70

2.16

mmol/l

1.24

929

Chondromalacia

700

1.06

0.16

3.1

3.8

2.23

1.87

mmol/l

0.64

560

Endometriosis of intestine

214

0.88

0.16

2.5

3.5

1.26

1.98

mmol/l

0.63

158

Female infertility

745

4673

0.98

0.16

3.3

3.5

1.86

1.83

mmol/l

0.06

604

3824

Tularaemia

332

1.09

0.15

4.0

3.4

1.47

1.90

mmol/l

0.34

261

Pregnancy with abortive outcome

2222

11516

1.01

0.15

3.3

3.5

1.91

1.99

mmol/l

0.40

1802

9438

Other and unspecified disease of Bartholin gland

732

1.06

0.15

4.9

2.9

2.49

2.16

mmol/l

0.35

600

Benign neoplasm: Connective and other soft tissue of lower limb, including hip

637

1.06

0.13

4.0

3.3

2.31

2.05

mmol/l

0.21

505

Lesion of plantar nerve

174

1691

1.03

0.13

5.4

3.4

1.94

1.98

mmol/l

0.05

141

1411

Melanoma in situ

119

1150

1.04

0.13

3.7

3.2

1.98

2.02

mmol/l

0.04

105

918

L02BG Aromatase inhibitors

903

8931

1.01

0.12

2.7

3.5

2.20

2.18

mmol/l

0.05

749

7439

Slow fetal growth and fetal malnutrition

471

1.07

0.12

13.9

11.8

0.50

0.94

mmol/l

0.42

373

Benign neoplasm of other and unspecified female genital organs

112

1083

1.04

0.12

4.4

3.0

2.28

2.15

mmol/l

0.17

892

Benign neoplasm: Vagina

312

0.92

0.11

2.9

2.5

2.52

2.50

mmol/l

0.01

257

therapeutic use

828

1.04

0.11

7.2

3.1

1.69

2.06

mmol/l

0.46

658

Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers)

147

1430

1.03

0.11

3.1

3.3

2.84

1.97

mmol/l

1.95

126

1112

Injury of muscle and tendon at ankle and foot level

553

1.05

0.11

4.8

3.7

2.31

1.90

mmol/l

0.42

438

Other and unspecified disorders of skin and subcutaneous tissue

179

1834

0.97

0.11

5.2

3.4

1.57

2.04

mmol/l

1.08

149

1476

Presence of other devices

809

8170

0.99

0.11

4.1

3.2

2.06

1.94

mmol/l

0.41

627

6586

Benign neoplasm: Short bones of upper limb

352

0.93

0.11

2.6

3.3

1.97

1.83

mmol/l

0.08

286

Asymmetry of jaw

311

0.93

0.11

2.3

4.9

0.82

1.88

mmol/l

1.18

248

Other specific arthropathies, wide

535

1.05

0.10

3.0

3.4

2.16

2.01

mmol/l

0.17

429

Glaucoma-related operations

188

1839

1.02

0.10

4.4

3.4

1.33

2.07

mmol/l

1.31

155

1473

Postprocedural disorders of ear and mastoid process, not elsewhere classified

228

0.91

0.10

2.2

4.0

2.82

1.86

mmol/l

0.55

182

251

2556

0.98

0.10

4.4

3.9

1.61

1.93

mmol/l

0.39

167

2006

Malignant neoplasm of accessory sinuses

1.04

0.09

2.2

5.5

4.10

1.78

mmol/l

—

Other infections specific to the perinatal period

321

1.07

0.09

9.9

11.3

0.66

1.44

mmol/l

0.57

258

Endometriosis diagnosis and infertility diagnosis occurring together

195

1990

0.98

0.09

2.8

3.4

1.89

1.81

mmol/l

0.12

158

1620

Oral lichen ruber planus wide, hypothyreosis or thyroxin

148

1446

1.03

0.09

2.9

3.4

1.72

2.01

mmol/l

0.45

116

1203

Malignant neoplasm of other and unspecified parts of mouth

165

1.10

0.09

4.4

3.1

1.97

2.02

mmol/l

0.02

128

Deep bite that required surgery

237

0.92

0.09

3.3

3.2

2.20

1.91

mmol/l

0.17

189

Glaucoma, exfoliation

417

4117

1.01

0.09

3.4

3.3

1.75

2.04

mmol/l

0.93

322

3316

Benign neoplasm of bone and articular cartilage

218

2220

0.98

0.09

3.6

4.0

1.89

1.96

mmol/l

0.12

182

1791

Plasmodium falciparum malaria

0.80

0.08

1.4

3.5

1.78

2.06

mmol/l

—

Varicose veins of other sites

193

1966

0.98

0.08

3.3

4.0

1.80

1.93

mmol/l

0.24

158

1594

Benign neoplasm: Urinary organ, other/unspecified

1.10

0.08

3.3

2.4

-1.19

2.99

mmol/l

—

Benign neoplasm: Connective and other soft tissue of upper limb, including shoulder

121

1181

1.03

0.08

3.3

3.5

1.79

1.98

mmol/l

0.24

950

Benign neoplasm: Urinary organ, other/unspecified

1.03

0.08

3.3

3.2

-1.19

2.96

mmol/l

—

Carcinoma in situ of breast, intraductal

193

1896

1.02

0.08

2.9

3.4

2.26

2.08

mmol/l

0.29

162

1587

Haemolytic disease of fetus and newborn

0.86

0.07

12.7

12.9

0.10

0.62

mmol/l

—

Intrahepatic Cholestasis of Pregnancy (ICP)

118

1153

1.02

0.07

2.7

3.3

1.33

1.70

mmol/l

0.47

934

Other benign neoplasms of uterus

160

1630

0.98

0.07

2.7

3.0

1.87

2.24

mmol/l

0.77

129

1348

Loose body in joint

659

1.03

0.07

2.9

3.8

2.10

1.83

mmol/l

0.23

510

Benign neoplasm: Endocrine gland, other/unspecified

1.04

0.07

2.8

3.7

2.73

2.20

mmol/l

—

Otosclerosis

227

2303

0.98

0.07

4.1

3.8

2.00

1.99

mmol/l

0.00

182

1888

Complications following abortion and ectopic and molar pregnancy

832

0.97

0.07

3.4

3.3

1.96

2.16

mmol/l

0.22

701

Benign neoplasm: Vagina

275

1.06

0.07

2.9

2.52

2.36

mmol/l

0.10

225

Inflammatory disease of cervix uteri

167

1698

0.98

0.06

3.7

3.2

2.27

2.10

mmol/l

0.26

140

1404

Ankylosing spondylitis, strict definition

103

1053

0.98

0.06

3.7

3.8

1.84

2.04

mmol/l

0.27

846

Maxillary retrognathism

523

1.04

0.06

3.7

6.9

1.57

1.46

mmol/l

0.12

421

Hallux rigidus

447

4509

0.99

0.06

2.8

3.7

1.83

2.01

mmol/l

0.48

374

3659

Antepartum haemorrhage, not elsewhere classified

155

1525

1.02

0.06

3.6

4.0

1.80

1.67

mmol/l

0.17

129

1238

Family history of certain disabilities and chronic diseases leading to disablement

900

0.98

0.05

4.5

3.2

1.91

2.01

mmol/l

0.12

711

Female infertility, cervigal, vaginal, other or unspecified origin

680

4521

1.01

0.05

3.1

3.5

1.85

1.82

mmol/l

0.06

553

3713

Migraine, single triptan purchase ok & required. ICD-code if available is included

2758

18610

1.00

0.05

3.6

4.1

1.87

mmol/l

0.02

2286

15328

Triptan medication for migraine, single purchase ok

2758

18610

1.00

0.05

3.6

4.1

1.87

mmol/l

0.02

2286

15328

Abnormal findings on antenatal screening of mother

125

1229

1.02

0.05

2.2

3.4

1.76

1.59

mmol/l

0.36

958

Malignant neoplasm of lip, excluding all cancers (controls excluding all cancers)

307

1.05

0.05

4.5

3.3

3.00

2.11

mmol/l

0.52

246

Cicatricial alopecia [scarring hair loss]

181

0.94

0.05

7.4

2.9

-0.05

2.41

mmol/l

2.05

149

Malignant neoplasm of bronchus and lung

712

6696

0.99

0.04

3.3

3.7

2.37

1.83

mmol/l

3.36

595

5325

Benign neoplasm: Bones of skull and face

199

1.06

0.04

2.9

4.0

1.01

2.33

mmol/l

1.43

157

Spirochaetal infections, other/unspecified

250

2476

1.01

0.04

3.1

3.9

1.39

1.97

mmol/l

1.89

207

2015

Mandibular retrognathia AND surgery (BSSRO)

497

1.03

0.04

2.2

3.3

2.21

1.94

mmol/l

0.32

406

Bilateral sagittal split ramus osteotomy operation

656

1.02

0.04

2.5

3.3

2.17

1.93

mmol/l

0.35

528

Normotensive glaucoma

285

2829

1.01

0.03

3.6

3.4

2.04

2.10

mmol/l

0.10

226

2308

Failed induction of labour

854

0.98

0.03

2.3

4.0

1.04

1.57

mmol/l

0.63

680

Carcinoid syndrome

270

0.96

0.03

4.6

4.0

1.44

2.13

mmol/l

0.29

218

Multiple gestation

167

1687

0.99

0.03

3.7

4.1

1.40

1.80

mmol/l

0.88

136

1378

Perineal laceration during delivery

290

2601

0.99

0.03

2.1

3.8

1.69

1.47

mmol/l

0.55

222

2085

Use of anticholinesterases

1356

10949

1.00

0.02

2.5

3.6

2.22

1.94

mmol/l

2.02

1097

8781

N06DA Anticholinesterases

1356

10949

1.00

0.02

2.5

3.6

2.22

1.94

mmol/l

2.02

1097

8781

Pneumoconiosis due to asbestos and other mineral fibres

690

1.02

0.02

3.9

4.0

3.30

1.76

mmol/l

2.63

527

Medicines for HER+ breast cancer

1121

10942

1.00

0.02

2.7

3.5

2.21

2.14

mmol/l

0.27

934

9115

Intrahepatic Cholestasis of Pregnancy (ICP) , incl. ICD-8

163

1642

0.99

0.02

3.8

3.4

1.54

1.85

mmol/l

0.48

131

1356

LeFortI or BSSRO operation

810

0.99

0.02

2.7

3.6

2.10

1.90

mmol/l

0.32

657

Benign neoplasm: Vulva

521

1.02

0.02

6.7

2.8

2.25

2.11

mmol/l

0.11

421

Malignant neoplasm of breast, HER-negative

637

6380

1.00

0.02

3.3

3.4

2.15

2.14

mmol/l

0.04

521

5295

Alzheimer’s disease (Early onset), excluding more controls

111

1038

1.01

0.01

2.4

3.3

1.71

1.89

mmol/l

0.20

795

Spontaneous abortion

1241

8427

1.00

0.01

3.3

3.6

1.98

1.94

mmol/l

0.14

1009

6934

Pterygium

912

1.01

0.01

3.7

3.6

1.48

1.96

mmol/l

0.55

718

Benign neoplasm: Conjunctiva

877

0.99

0.01

4.4

3.6

1.70

2.03

mmol/l

0.39

700

Melanocytic naevi of ear and external auricular canal

124

1.05

0.00

2.2

3.6

3.44

2.13

mmol/l

—

Melanocytic naevi of ear and external auricular canal

136

0.95

0.00

2.2

4.1

3.44

1.87

mmol/l

—

100

Melanoma in situ of upper limb, including shoulder

176

0.96

0.00

2.2

3.4

2.45

2.18

mmol/l

0.11

136

Gender identity disorders

208

1.01

0.00

2.5

5.0

2.72

1.22

mmol/l

0.75

157

Varus deformity, not elsewhere classified

292

0.99

0.00

3.2

4.0

2.75

1.94

mmol/l

0.88

222

Abnormalities of forces of labour

191

1914

1.00

0.00

4.8

3.9

1.58

2.08

mmol/l

1.30

151

1583

Benign neoplasm: Lower jaw bone

101

0.99

0.00

6.8

3.5

-1.40

2.21

mmol/l

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

109

1080

1.00

0.00

7.7

12.3

0.59

0.97

mmol/l

0.59

836

Malignant neoplasm, without specification of site

942

1.00

0.00

3.3

3.4

2.09

2.12

mmol/l

0.02

744

Palindromic rheumatism

259

1.00

0.00

4.1

3.6

2.34

1.93

mmol/l

0.34

196

Twin gestation

163

1631

1.00

0.00

3.8

4.2

1.39

1.81

mmol/l

0.90

133

1329

Type 1 diabetes, wide definition, subgroup 2

471

1.00

0.00

8.8

5.6

0.80

1.79

mmol/l

0.90

372

Dermatitis herpetiformis

479

1.00

0.00

4.6

3.6

1.65

1.99

mmol/l

0.22

379

Abrasion of teeth

813

5980

1.00

0.00

3.5

3.2

1.83

1.95

mmol/l

0.43

671

4882

Carcinoma in situ of breast

1.03

0.00

1.0

3.0

4.27

2.26

mmol/l

—

Benign neoplasm: Bones of skull and face

213

0.99

0.00

2.9

4.0

1.01

2.41

mmol/l

1.54

166

Other congenital malformations of male genital organs

447

1.01

0.00

8.6

10.7

1.76

1.28

mmol/l

0.73

361

Melanoma in situ of upper limb, including shoulder

167

1.02

0.00

2.2

3.1

2.45

2.17

mmol/l

0.12

133

Benign neoplasm: Lower jaw bone

1.06

0.00

6.8

4.1

-1.40

2.12

mmol/l

—

Carcinoma in situ of breast

1.06

0.00

1.0

3.4

4.27

2.40

mmol/l

—

Anisometropia and aniseikonia

953

1.00

0.00

11.2

4.4

1.64

1.89

mmol/l

0.26

749

Chronic mastoiditis

780

1.00

0.00

3.1

3.6

1.90

2.02

mmol/l

0.12

620

Carcinoma in situ of trachea

0.00

0.0

7.8

—

-0.18

—

Carcinoma in situ, eye

0.00

0.0

6.5

—

1.60

—

Toxic effect of halogen derivatives of aliphatic and aromatic hydrocarbons

0.00

0.0

1.0

—

1.56

—

Miliaria, unspecified

0.00

0.0

2.0

—

3.70

—

Benign neoplasm: Endocrine gland, other/unspecified

1.00

0.00

2.8

3.8

2.73

2.20

mmol/l

—

Infantile papular acrodermatitis [Gianotti-Crosti]

0.00

0.0

5.4

—

-0.54

—

Other specified and unspecified disorders of lens

290

1.00

0.00

3.8

3.0

2.77

2.11

mmol/l

0.67

226

Other sudden death, cause unknown

1.02

0.00

16.2

7.7

3.36

2.14

mmol/l

—

Calcaneal spur

320

1.00

0.00

3.0

3.1

2.37

2.25

mmol/l

0.07

254

Benign neoplasm: Cranial nerves

750

1.00

0.00

3.8

3.2

1.87

2.06

mmol/l

0.13

600

Ovarian dysfunction: androgen excess, drug-induced

0.00

0.0

2.6

—

1.68

—

Carcinoma in situ of penis

1.02

0.00

10.0

3.6

0.62

1.61

mmol/l

—

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Base excess in Venous blood by calculation

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS